1.2.40.0.34.10.73/static-2013-01-10T000000

Diese Terminologie ist eine Momentaufnahme vom . Terminologien können sich im Laufe der Zeit weiterentwickeln. Wenn eine neuere (dynamische) Versionen dieser Terminologie benötigt wird, bitte von der Quelle abrufen.
Id	1.2.40.0.34.10.73	Gültigkeit	2013‑01‑10
Status	Definitiv	Versions-Label
Name	ELGA_whoATC	Bezeichnung	ELGA_whoATC
Beschreibung	ELGA Valueset für ATC
Quell-Codesystem	2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: http://www.whocc.no/atc - HL7 V2: WC
Level/ Typ Code Bezeichnung Codesystem 0‑L A Alimentäres System und Stoffwechsel WHO Anatomical Therapeutic Chemical classification 0‑L A01 Stomatologika WHO Anatomical Therapeutic Chemical classification 0‑L A01a Stomatologika WHO Anatomical Therapeutic Chemical classification 0‑L A01AA Mittel zur Kariesprophylaxe WHO Anatomical Therapeutic Chemical classification 0‑L A01AA01 Natriumfluorid WHO Anatomical Therapeutic Chemical classification 0‑L A01AA02 Natriummonofluorphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A01AA03 Olaflur WHO Anatomical Therapeutic Chemical classification 0‑L A01AA04 Zinn(II)-fluorid WHO Anatomical Therapeutic Chemical classification 0‑L A01AA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A01AA51 Natriumfluorid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A01AB Antiinfektiva und Antiseptika zur oralen Lokalbehandlung WHO Anatomical Therapeutic Chemical classification 0‑L A01AB02 Wasserstoffperoxid WHO Anatomical Therapeutic Chemical classification 0‑L A01AB03 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB04 Amphotericin B WHO Anatomical Therapeutic Chemical classification 0‑L A01AB05 Polynoxylin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB06 Domiphen WHO Anatomical Therapeutic Chemical classification 0‑L A01AB07 Oxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB08 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB09 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L A01AB10 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB11 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L A01AB12 Hexetidin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB13 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB14 Benzoxoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A01AB15 Tibezoniumiodid WHO Anatomical Therapeutic Chemical classification 0‑L A01AB16 Mepartricin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB17 Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A01AB18 Clotrimazol WHO Anatomical Therapeutic Chemical classification 0‑L A01AB19 Natriumperborat WHO Anatomical Therapeutic Chemical classification 0‑L A01AB21 Chlortetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB22 Doxycyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AB23 Minocyclin WHO Anatomical Therapeutic Chemical classification 0‑L A01AC Corticosteroide zur oralen Lokalbehandlung WHO Anatomical Therapeutic Chemical classification 0‑L A01AC01 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L A01AC02 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L A01AC03 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L A01AC54 Prednisolon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A01AD Andere Mittel zur oralen Lokalbehandlung WHO Anatomical Therapeutic Chemical classification 0‑L A01AD01 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L A01AD02 Benzydamin WHO Anatomical Therapeutic Chemical classification 0‑L A01AD05 Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L A01AD06 Adrenalon WHO Anatomical Therapeutic Chemical classification 0‑L A01AD07 Amlexanox WHO Anatomical Therapeutic Chemical classification 0‑L A01AD11 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L A02 Mittel bei säure bedingten Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L A02A Antacida WHO Anatomical Therapeutic Chemical classification 0‑L A02AA Magnesium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AA01 Magnesiumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AA02 Magnesiumoxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AA03 Magnesiumperoxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AA04 Magnesiumhydroxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AA05 Magnesiumsilikat WHO Anatomical Therapeutic Chemical classification 0‑L A02AA10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AB Aluminium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AB01 Aluminiumhydroxid WHO Anatomical Therapeutic Chemical classification 0‑L A02AB02 Algeldrat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB03 Aluminiumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB04 Dihydroxyalumiumnatriumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB05 Aluminiumacetoacetat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB06 Aloglutamol WHO Anatomical Therapeutic Chemical classification 0‑L A02AB07 Aluminiumglycinat WHO Anatomical Therapeutic Chemical classification 0‑L A02AB10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AC Calcium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AC01 Calciumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AC02 Calciumsilikat WHO Anatomical Therapeutic Chemical classification 0‑L A02AC10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AD Kombinationen und Komplexe von Aluminium-, Calcium- und Magnesium-haltigen Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A02AD01 Einfache Salzkombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02AD02 Magaldrat WHO Anatomical Therapeutic Chemical classification 0‑L A02AD03 Almagat WHO Anatomical Therapeutic Chemical classification 0‑L A02AD04 Hydrotalcit WHO Anatomical Therapeutic Chemical classification 0‑L A02AD05 Almasilat WHO Anatomical Therapeutic Chemical classification 0‑L A02AF Antacida mit Karminativa WHO Anatomical Therapeutic Chemical classification 0‑L A02AF01 Magaldrat und Karminativa WHO Anatomical Therapeutic Chemical classification 0‑L A02AF02 Einfache Salzkombinationen und Karminativa WHO Anatomical Therapeutic Chemical classification 0‑L A02AG Antacida mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L A02AH Antacida mit Natriumbicarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A02AX Antacida, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02B Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit WHO Anatomical Therapeutic Chemical classification 0‑L A02BA Histamin-H2-Rezeptorantagonisten WHO Anatomical Therapeutic Chemical classification 0‑L A02BA01 Cimetidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA02 Ranitidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA03 Famotidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA04 Nizatidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA05 Niperotidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA06 Roxatidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA07 Ranitidinbismutcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A02BA08 Lafutidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BA51 Cimetidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02BA53 Famotidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A02BB Prostaglandine WHO Anatomical Therapeutic Chemical classification 0‑L A02BB01 Misoprostol WHO Anatomical Therapeutic Chemical classification 0‑L A02BB02 Enprostil WHO Anatomical Therapeutic Chemical classification 0‑L A02BC Protonenpumpenhemmer WHO Anatomical Therapeutic Chemical classification 0‑L A02BC01 Omeprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC02 Pantoprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC03 Lansoprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC04 Rabeprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC05 Esomeprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BC06 Dexlansoprazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD Kombinationen zur Eradikation von Helicobacter pylori WHO Anatomical Therapeutic Chemical classification 0‑L A02BD01 Omeprazol, Amoxicillin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD02 Lansoprazol, Tetracyclin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD03 Lansoprazol, Amoxicillin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BD04 Pantoprazol, Amoxicillin und Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L A02BD05 Omeprazol, Amoxicillin und Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L A02BD06 Esomeprazol, Amoxicillin und Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L A02BD08 Bismutsubcitrat, Tetracyclin und Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L A02BX Andere Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit WHO Anatomical Therapeutic Chemical classification 0‑L A02BX01 Carbenoxolon WHO Anatomical Therapeutic Chemical classification 0‑L A02BX02 Sucralfat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX03 Pirenzepin WHO Anatomical Therapeutic Chemical classification 0‑L A02BX04 Methiosulfoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX05 Bismutsubcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX06 Proglumid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX07 Gefarnat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX08 Sulglicotid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX09 Acetoxolon WHO Anatomical Therapeutic Chemical classification 0‑L A02BX10 Zolimidin WHO Anatomical Therapeutic Chemical classification 0‑L A02BX11 Troxipid WHO Anatomical Therapeutic Chemical classification 0‑L A02BX12 Bismutsubnitrat WHO Anatomical Therapeutic Chemical classification 0‑L A02BX13 Alginsäure WHO Anatomical Therapeutic Chemical classification 0‑L A02BX51 Carbenoxolon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A02BX71 Carbenoxolon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A02BX77 Gefarnat, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A02X Andere Mittel bei säure bedingten Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L A03 Mittel bei funktionellen gastrointestinalen Störungen WHO Anatomical Therapeutic Chemical classification 0‑L A03A Mittel bei funktionellen Störungen des Darms WHO Anatomical Therapeutic Chemical classification 0‑L A03AA Synthetische Anticholinergika, Ester mit tertiären Aminogruppen WHO Anatomical Therapeutic Chemical classification 0‑L A03AA01 Oxyphencyclimin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA03 Camylofin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA04 Mebeverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA05 Trimebutin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA06 Rociverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA07 Dicycloverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA08 Dihexyverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA09 Difemerin WHO Anatomical Therapeutic Chemical classification 0‑L A03AA30 Piperidolat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB Synthetische Anticholinergika, quartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A03AB01 Benzilon WHO Anatomical Therapeutic Chemical classification 0‑L A03AB02 Glycopyrronium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB03 Oxyphenonium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB04 Penthienat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB05 Propanthelin WHO Anatomical Therapeutic Chemical classification 0‑L A03AB06 Otiloniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB07 Methanthelinium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB08 Tridihexethyl WHO Anatomical Therapeutic Chemical classification 0‑L A03AB09 Isopropamid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB10 Hexocyclium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB11 Poldin WHO Anatomical Therapeutic Chemical classification 0‑L A03AB12 Mepenzolat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB13 Bevonium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB14 Pipenzolat WHO Anatomical Therapeutic Chemical classification 0‑L A03AB15 Diphemanil WHO Anatomical Therapeutic Chemical classification 0‑L A03AB16 (2-Benzhydryloxyethyl)diethylmethyl-ammoniumiodid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB17 Tiemoniumiodid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB18 Prifiniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB19 Timepidiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03AB21 Fenpiverinium WHO Anatomical Therapeutic Chemical classification 0‑L A03AB53 Oxyphenonium, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A03AC Synthetische Spasmolytika, Amide mit tertiären Aminen WHO Anatomical Therapeutic Chemical classification 0‑L A03AC02 Dimethylaminopropionylphenothiazin WHO Anatomical Therapeutic Chemical classification 0‑L A03AC04 Nicofetamid WHO Anatomical Therapeutic Chemical classification 0‑L A03AC05 Tiropramid WHO Anatomical Therapeutic Chemical classification 0‑L A03AD Papaverin und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A03AD01 Papaverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AD02 Drotaverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AD30 Moxaverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AE Auf Serotonin-Rezeptoren wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A03AE01 Alosetron WHO Anatomical Therapeutic Chemical classification 0‑L A03AE02 Tegaserod WHO Anatomical Therapeutic Chemical classification 0‑L A03AE03 Cilansetron WHO Anatomical Therapeutic Chemical classification 0‑L A03AX Andere Mittel bei funktionellen Störungen des Darms WHO Anatomical Therapeutic Chemical classification 0‑L A03AX01 Fenpipran WHO Anatomical Therapeutic Chemical classification 0‑L A03AX02 Diisopromin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX03 Chlorbenzoxamin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX04 Pinaverium WHO Anatomical Therapeutic Chemical classification 0‑L A03AX05 Fenoverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX06 Idanpramin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX07 Proxazol WHO Anatomical Therapeutic Chemical classification 0‑L A03AX08 Alverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX09 Trepibuton WHO Anatomical Therapeutic Chemical classification 0‑L A03AX10 Isomethepten WHO Anatomical Therapeutic Chemical classification 0‑L A03AX11 Caroverin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX12 Phloroglucinol WHO Anatomical Therapeutic Chemical classification 0‑L A03AX13 Silikone WHO Anatomical Therapeutic Chemical classification 0‑L A03AX30 Trimethyldiphenylpropylamin WHO Anatomical Therapeutic Chemical classification 0‑L A03AX58 Alverin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A03B BELLADONNA UND DERIVATE, REIN WHO Anatomical Therapeutic Chemical classification 0‑L A03BA Belladonna-Alkaloide, tertiäre Amine WHO Anatomical Therapeutic Chemical classification 0‑L A03BA01 Atropin WHO Anatomical Therapeutic Chemical classification 0‑L A03BA03 Hyoscyamin WHO Anatomical Therapeutic Chemical classification 0‑L A03BA04 Belladonna-Gesamtalkaloide WHO Anatomical Therapeutic Chemical classification 0‑L A03BB Belladonna-Alkaloide, halbsynthetisch, quartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A03BB01 Butylscopolamin WHO Anatomical Therapeutic Chemical classification 0‑L A03BB02 Methylatropin WHO Anatomical Therapeutic Chemical classification 0‑L A03BB03 Methylscopolamin WHO Anatomical Therapeutic Chemical classification 0‑L A03BB04 Fentonium WHO Anatomical Therapeutic Chemical classification 0‑L A03BB05 Cimetropiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L A03C Spasmolytika in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA Synthetische Anticholinergika in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA01 Isopropamid und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA02 Clidinium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA03 Oxyphencyclimin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA04 Otiloniumbromid und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA05 Glycopyrronium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA06 Bevonium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA07 Ambutonium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA08 Diphemanil und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA30 Emepronium und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CA34 Propanthelin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB Belladonna und Derivate in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB01 Methylscopolamin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB02 Belladonna-Gesamtalkaloide und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB03 Atropin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB04 Methylhomatropin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CB31 Hyoscyamin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03CC Andere Spasmolytika in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L A03D Spasmolytika in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA Synthetische Anticholinergika in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA01 Tropenzilon und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA02 Pitofenon und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA03 Bevonium und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA04 Ciclonium und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA05 Camylofin und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA06 Trospium und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DA07 Tiemoniumiodid und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DB Belladonna und Derivate in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DB04 Butylscopolamin und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03DC Andere Spasmolytika in Kombination mit Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L A03E Spasmolytika und Anticholinergika in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L A03EA Spasmolytika, Psycholeptika und Analgetika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A03ED Spasmolytika in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L A03F Prokinetika WHO Anatomical Therapeutic Chemical classification 0‑L A03FA Prokinetika WHO Anatomical Therapeutic Chemical classification 0‑L A03FA01 Metoclopramid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA02 Cisaprid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA03 Domperidon WHO Anatomical Therapeutic Chemical classification 0‑L A03FA04 Bromoprid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA05 Alizaprid WHO Anatomical Therapeutic Chemical classification 0‑L A03FA06 Cleboprid WHO Anatomical Therapeutic Chemical classification 0‑L A04 Antiemetika und Mittel gegen Übelkeit WHO Anatomical Therapeutic Chemical classification 0‑L A04A Antiemetika und Mittel gegen Übelkeit WHO Anatomical Therapeutic Chemical classification 0‑L A04AA Serotonin-5HT3-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L A04AA01 Ondansetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA02 Granisetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA03 Tropisetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA04 Dolasetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AA05 Palonosetron WHO Anatomical Therapeutic Chemical classification 0‑L A04AD Andere Antiemetika WHO Anatomical Therapeutic Chemical classification 0‑L A04AD01 Scopolamin WHO Anatomical Therapeutic Chemical classification 0‑L A04AD02 Ceriumoxalat WHO Anatomical Therapeutic Chemical classification 0‑L A04AD04 Chlorbutanol WHO Anatomical Therapeutic Chemical classification 0‑L A04AD05 Metopimazin WHO Anatomical Therapeutic Chemical classification 0‑L A04AD10 Dronabinol WHO Anatomical Therapeutic Chemical classification 0‑L A04AD11 Nabilon WHO Anatomical Therapeutic Chemical classification 0‑L A04AD12 Aprepitant WHO Anatomical Therapeutic Chemical classification 0‑L A04AD51 Scopolamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A04AD54 Chlorbutanol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A05 Gallen- und Lebertherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05A Gallentherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05AA Gallensäure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A05AA01 Chenodeoxycholsäure WHO Anatomical Therapeutic Chemical classification 0‑L A05AA02 Ursodeoxycholsäure WHO Anatomical Therapeutic Chemical classification 0‑L A05AB Zubereitungen zur Gallentherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05AB01 N-(Hydroxymethyl)nicotinamid WHO Anatomical Therapeutic Chemical classification 0‑L A05AX Andere Mittel zur Gallentherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05AX01 Piprozolin WHO Anatomical Therapeutic Chemical classification 0‑L A05AX02 Hymecromon WHO Anatomical Therapeutic Chemical classification 0‑L A05AX03 Cyclobutyrol WHO Anatomical Therapeutic Chemical classification 0‑L A05B Lebertherapie, Lipotrope Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L A05BA Lebertherapie WHO Anatomical Therapeutic Chemical classification 0‑L A05BA01 Argininglutamat WHO Anatomical Therapeutic Chemical classification 0‑L A05BA03 Silymarin WHO Anatomical Therapeutic Chemical classification 0‑L A05BA04 Citiolon WHO Anatomical Therapeutic Chemical classification 0‑L A05BA05 Epomediol WHO Anatomical Therapeutic Chemical classification 0‑L A05BA06 Ornithinoxoglurat WHO Anatomical Therapeutic Chemical classification 0‑L A05BA07 Tidiacicarginin WHO Anatomical Therapeutic Chemical classification 0‑L A05C Mittel zur Gallentherapie und Lipotrope Substanzen in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A06 Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06A Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AA Gleitmittel, Emollientia WHO Anatomical Therapeutic Chemical classification 0‑L A06AA01 Dickflüssiges Paraffin WHO Anatomical Therapeutic Chemical classification 0‑L A06AA02 Docusat-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L A06AA51 Dickflüssiges Paraffin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB Kontaktlaxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AB01 Oxyphenisatin WHO Anatomical Therapeutic Chemical classification 0‑L A06AB02 Bisacodyl WHO Anatomical Therapeutic Chemical classification 0‑L A06AB03 Dantron WHO Anatomical Therapeutic Chemical classification 0‑L A06AB04 Phenolphthalein WHO Anatomical Therapeutic Chemical classification 0‑L A06AB05 Rizinusöl WHO Anatomical Therapeutic Chemical classification 0‑L A06AB06 Sennoside WHO Anatomical Therapeutic Chemical classification 0‑L A06AB07 Cascara WHO Anatomical Therapeutic Chemical classification 0‑L A06AB08 Natriumpicosulfat WHO Anatomical Therapeutic Chemical classification 0‑L A06AB09 Bisoxatin WHO Anatomical Therapeutic Chemical classification 0‑L A06AB20 Kontaktlaxanzien in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A06AB30 Kontaktlaxanzien in Kombination mit Belladonna-Alkaloiden WHO Anatomical Therapeutic Chemical classification 0‑L A06AB52 Bisacodyl, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB53 Dantron, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB56 Sennoside, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB57 Cascara, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AB58 Natriumpicosulfat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC Quellmittel WHO Anatomical Therapeutic Chemical classification 0‑L A06AC01 Ispaghula (Flohsamen) WHO Anatomical Therapeutic Chemical classification 0‑L A06AC02 Ethulose WHO Anatomical Therapeutic Chemical classification 0‑L A06AC03 Sterculia WHO Anatomical Therapeutic Chemical classification 0‑L A06AC05 Leinsamen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC06 Methylcellulose WHO Anatomical Therapeutic Chemical classification 0‑L A06AC07 Triticum (Weizenkleie) WHO Anatomical Therapeutic Chemical classification 0‑L A06AC08 Polycarbophil-Calcium WHO Anatomical Therapeutic Chemical classification 0‑L A06AC51 Ispaghula, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC53 Sterculia, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AC55 Leinsamen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AD Osmotisch wirkende Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AD01 Magnesiumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD02 Magnesiumoxid WHO Anatomical Therapeutic Chemical classification 0‑L A06AD03 Magnesiumperoxid WHO Anatomical Therapeutic Chemical classification 0‑L A06AD04 Magnesiumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD10 Mineralsalze in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A06AD11 Lactulose WHO Anatomical Therapeutic Chemical classification 0‑L A06AD12 Lactitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD13 Natriumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD14 Pentaerythrityl WHO Anatomical Therapeutic Chemical classification 0‑L A06AD15 Macrogol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD16 Mannitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD17 Natriumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD18 Sorbitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AD19 Magnesiumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD21 Natriumtartrat WHO Anatomical Therapeutic Chemical classification 0‑L A06AD61 Lactulose, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AD65 Macrogol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG Klysmen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG01 Natriumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A06AG02 Bisacodyl WHO Anatomical Therapeutic Chemical classification 0‑L A06AG03 Dantron, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG04 Glycerol WHO Anatomical Therapeutic Chemical classification 0‑L A06AG06 Öl WHO Anatomical Therapeutic Chemical classification 0‑L A06AG07 Sorbitol WHO Anatomical Therapeutic Chemical classification 0‑L A06AG10 Docusat-Natrium, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG11 Laurylsulfat, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AG20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A06AH01 Methylnaltrexon bromid WHO Anatomical Therapeutic Chemical classification 0‑L A06AX Andere Laxanzien WHO Anatomical Therapeutic Chemical classification 0‑L A06AX01 Glycerol WHO Anatomical Therapeutic Chemical classification 0‑L A06AX02 Kohlendioxid-freisetzende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A07 Antidiarrhoika und intestinale Antiphlogistika/Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L A07A Intestinale Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L A07AA Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L A07AA01 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA02 Nystatin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA03 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA04 Streptomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA05 Polymyxin B WHO Anatomical Therapeutic Chemical classification 0‑L A07AA06 Paromomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA07 Amphotericin B WHO Anatomical Therapeutic Chemical classification 0‑L A07AA08 Kanamycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA09 Vancomycin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA10 Colistin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA11 Rifaximin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA12 Fidaxomicin WHO Anatomical Therapeutic Chemical classification 0‑L A07AA51 Neomycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07AA54 Streptomycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07AB Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L A07AB02 Phthalylsulfathiazol WHO Anatomical Therapeutic Chemical classification 0‑L A07AB03 Sulfaguanidin WHO Anatomical Therapeutic Chemical classification 0‑L A07AB04 Succinylsulfathiazol WHO Anatomical Therapeutic Chemical classification 0‑L A07AC Imidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A07AC01 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L A07AX Andere intestinale Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L A07AX01 Broxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L A07AX02 Acetarsol WHO Anatomical Therapeutic Chemical classification 0‑L A07AX03 Nifuroxazid WHO Anatomical Therapeutic Chemical classification 0‑L A07AX04 Nifurzid WHO Anatomical Therapeutic Chemical classification 0‑L A07B Intestinale Adsorbenzien WHO Anatomical Therapeutic Chemical classification 0‑L A07BA Kohle-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A07BA01 Medizinische Kohle WHO Anatomical Therapeutic Chemical classification 0‑L A07BA51 Medizinische Kohle, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07BB Bismut-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A07BC Andere intestinale Adsorbenzien WHO Anatomical Therapeutic Chemical classification 0‑L A07BC01 Pektin WHO Anatomical Therapeutic Chemical classification 0‑L A07BC02 Kaolin WHO Anatomical Therapeutic Chemical classification 0‑L A07BC03 Crospovidon WHO Anatomical Therapeutic Chemical classification 0‑L A07BC04 Attapulgit WHO Anatomical Therapeutic Chemical classification 0‑L A07BC05 Diosmectit WHO Anatomical Therapeutic Chemical classification 0‑L A07BC30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07BC54 Attapulgit, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07C Elektrolyte mit Kohlenhydraten WHO Anatomical Therapeutic Chemical classification 0‑L A07CA Elektrolyte zur oralen Rehydrierung WHO Anatomical Therapeutic Chemical classification 0‑L A07D Motilitätshemmer WHO Anatomical Therapeutic Chemical classification 0‑L A07DA Motilitätshemmer WHO Anatomical Therapeutic Chemical classification 0‑L A07DA01 Diphenoxylat WHO Anatomical Therapeutic Chemical classification 0‑L A07DA02 Opium WHO Anatomical Therapeutic Chemical classification 0‑L A07DA03 Loperamid WHO Anatomical Therapeutic Chemical classification 0‑L A07DA04 Difenoxin WHO Anatomical Therapeutic Chemical classification 0‑L A07DA05 Loperamidoxid WHO Anatomical Therapeutic Chemical classification 0‑L A07DA52 Morphin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07DA53 Loperamid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07E Intestinale Antiphlogistika WHO Anatomical Therapeutic Chemical classification 0‑L A07EA Corticosteroide mit lokaler Wirkung WHO Anatomical Therapeutic Chemical classification 0‑L A07EA01 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L A07EA02 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L A07EA03 Prednison WHO Anatomical Therapeutic Chemical classification 0‑L A07EA04 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L A07EA05 Tixocortol WHO Anatomical Therapeutic Chemical classification 0‑L A07EA06 Budesonid WHO Anatomical Therapeutic Chemical classification 0‑L A07EA07 Beclometason WHO Anatomical Therapeutic Chemical classification 0‑L A07EB Antiallergika, exkl. Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L A07EB01 Cromoglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L A07EC Aminosalicylsäure und ähnliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A07EC01 Sulfasalazin WHO Anatomical Therapeutic Chemical classification 0‑L A07EC02 Mesalazin WHO Anatomical Therapeutic Chemical classification 0‑L A07EC03 Olsalazin WHO Anatomical Therapeutic Chemical classification 0‑L A07EC04 Balsalazid WHO Anatomical Therapeutic Chemical classification 0‑L A07F Mikrobielle Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07FA Mikrobielle Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07FA01 Milchsäurebildner WHO Anatomical Therapeutic Chemical classification 0‑L A07FA02 Saccharomyces boulardii WHO Anatomical Therapeutic Chemical classification 0‑L A07FA51 Milchsäurebildner, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A07X Andere Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07XA Andere Antidiarrhoika WHO Anatomical Therapeutic Chemical classification 0‑L A07XA01 Albumintannat WHO Anatomical Therapeutic Chemical classification 0‑L A07XA02 Ceratonia WHO Anatomical Therapeutic Chemical classification 0‑L A07XA03 Calcium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L A07XA04 Racecadotril WHO Anatomical Therapeutic Chemical classification 0‑L A07XA51 Albumintannat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A08 Abmagerungsmittel, Exkl. Diätetika WHO Anatomical Therapeutic Chemical classification 0‑L A08A Abmagerungsmittel, Exkl. Diätetika WHO Anatomical Therapeutic Chemical classification 0‑L A08AA Zentral wirkende Abmagerungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L A08AA01 Phentermin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA02 Fenfluramin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA03 Amfepramon WHO Anatomical Therapeutic Chemical classification 0‑L A08AA04 Dexfenfluramin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA05 Mazindol WHO Anatomical Therapeutic Chemical classification 0‑L A08AA06 Etilamfetamin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA07 Cathin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA08 Clobenzorex WHO Anatomical Therapeutic Chemical classification 0‑L A08AA09 Mefenorex WHO Anatomical Therapeutic Chemical classification 0‑L A08AA10 Sibutramin WHO Anatomical Therapeutic Chemical classification 0‑L A08AA56 Ephedrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A08AB Peripher wirkende Abmagerungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L A08AB01 Orlistat WHO Anatomical Therapeutic Chemical classification 0‑L A09 Digestiva, Inkl. Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L A09A Digestiva, Inkl. Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L A09AA Enzym-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A09AA01 Diastase WHO Anatomical Therapeutic Chemical classification 0‑L A09AA02 Multienzyme (Lipase, Protease etc.) WHO Anatomical Therapeutic Chemical classification 0‑L A09AA03 Pepsin WHO Anatomical Therapeutic Chemical classification 0‑L A09AA04 Tilactase WHO Anatomical Therapeutic Chemical classification 0‑L A09AB Säure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A09AB01 Glutaminsäurehydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L A09AB02 Betainhydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L A09AB03 Salzsäure WHO Anatomical Therapeutic Chemical classification 0‑L A09AB04 Zitronensäure WHO Anatomical Therapeutic Chemical classification 0‑L A09AC Enzym- und Säure-haltige Zubereitungen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A09AC01 Pepsin- und Säure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A09AC02 Multienzyme und säure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A10 Antidiabetika WHO Anatomical Therapeutic Chemical classification 0‑L A10A Insuline Und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L A10AA Insulins WHO Anatomical Therapeutic Chemical classification 0‑L A10AB Insuline und Analoga zur Injektion, schnell wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AB01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AB02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AB03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AB04 Insulin lispro WHO Anatomical Therapeutic Chemical classification 0‑L A10AB05 Insulin aspart WHO Anatomical Therapeutic Chemical classification 0‑L A10AB06 Insulin glulisin WHO Anatomical Therapeutic Chemical classification 0‑L A10AB30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AC Insuline und Analoga zur Injektion, intermediär wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AC01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AC02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AC03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AC04 Insulin lispro WHO Anatomical Therapeutic Chemical classification 0‑L A10AC30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AD Insuline und Analoga zur Injektion, intermediär wirkend kombiniert mit schnell wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AD01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AD02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AD03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AD04 Insulin lispro WHO Anatomical Therapeutic Chemical classification 0‑L A10AD05 Insulin aspart WHO Anatomical Therapeutic Chemical classification 0‑L A10AD30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AE Insuline und Analoga zur Injektion, lang wirkend WHO Anatomical Therapeutic Chemical classification 0‑L A10AE01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10AE02 Insulin (Rind) WHO Anatomical Therapeutic Chemical classification 0‑L A10AE03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L A10AE04 Insulin glargin WHO Anatomical Therapeutic Chemical classification 0‑L A10AE05 Insulin detemir WHO Anatomical Therapeutic Chemical classification 0‑L A10AE30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A10AF Insuline und Analoga zur Inhalation WHO Anatomical Therapeutic Chemical classification 0‑L A10AF01 Insulin (human) WHO Anatomical Therapeutic Chemical classification 0‑L A10B Antidiabetika, Exkl. Insuline WHO Anatomical Therapeutic Chemical classification 0‑L A10BA Biguanide WHO Anatomical Therapeutic Chemical classification 0‑L A10BA01 Phenformin WHO Anatomical Therapeutic Chemical classification 0‑L A10BA02 Metformin WHO Anatomical Therapeutic Chemical classification 0‑L A10BA03 Buformin WHO Anatomical Therapeutic Chemical classification 0‑L A10BB Sulfonylharnstoff-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A10BB01 Glibenclamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB02 Chlorpropamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB03 Tolbutamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB04 Glibornurid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB05 Tolazamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB06 Carbutamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB07 Glipizid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB08 Gliquidon WHO Anatomical Therapeutic Chemical classification 0‑L A10BB09 Gliclazid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB10 Metahexamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB11 Glisoxepid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB12 Glimepirid WHO Anatomical Therapeutic Chemical classification 0‑L A10BB31 Acetohexamid WHO Anatomical Therapeutic Chemical classification 0‑L A10BC Sulfonamide (heterozyklisch) WHO Anatomical Therapeutic Chemical classification 0‑L A10BC01 Glymidin WHO Anatomical Therapeutic Chemical classification 0‑L A10BD Kombinationen mit oralen Antidiabetika WHO Anatomical Therapeutic Chemical classification 0‑L A10BD01 Phenformin und Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L A10BD02 Metformin und Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L A10BD03 Metformin und Rosiglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BD04 Glimepirid und Rosiglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BD05 Metformin und Pioglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BD06 Glimepirid und Pioglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BD07 Metformin und Sitagliptin WHO Anatomical Therapeutic Chemical classification 0‑L A10BD08 Metformin und Vildagliptin WHO Anatomical Therapeutic Chemical classification 0‑L A10BD13 Metformin und Alogliptin WHO Anatomical Therapeutic Chemical classification 0‑L A10BF Alpha-Glukosidasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L A10BF01 Acarbose WHO Anatomical Therapeutic Chemical classification 0‑L A10BF02 Miglitol WHO Anatomical Therapeutic Chemical classification 0‑L A10BF03 Voglibose WHO Anatomical Therapeutic Chemical classification 0‑L A10BG Thiazolidindione WHO Anatomical Therapeutic Chemical classification 0‑L A10BG01 Troglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BG02 Rosiglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BG03 Pioglitazon WHO Anatomical Therapeutic Chemical classification 0‑L A10BH01 Sitagliptin WHO Anatomical Therapeutic Chemical classification 0‑L A10BH02 Vildagliptin WHO Anatomical Therapeutic Chemical classification 0‑L A10BH04 Alogliptin WHO Anatomical Therapeutic Chemical classification 0‑L A10BX Andere Antidiabetika, exkl. Insuline WHO Anatomical Therapeutic Chemical classification 0‑L A10BX01 Guar-Mehl WHO Anatomical Therapeutic Chemical classification 0‑L A10BX02 Repaglinid WHO Anatomical Therapeutic Chemical classification 0‑L A10BX03 Nateglinid WHO Anatomical Therapeutic Chemical classification 0‑L A10BX04 Exenatid WHO Anatomical Therapeutic Chemical classification 0‑L A10X Andere Antidiabetika WHO Anatomical Therapeutic Chemical classification 0‑L A10XA Aldosereduktasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L A10XA01 Tolrestat WHO Anatomical Therapeutic Chemical classification 0‑L A11 Vitamine WHO Anatomical Therapeutic Chemical classification 0‑L A11A Multivitamine, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11AA Multivitamine mit Mineralstoffen WHO Anatomical Therapeutic Chemical classification 0‑L A11AA01 Multivitamine und Eisen WHO Anatomical Therapeutic Chemical classification 0‑L A11AA02 Multivitamine und Calcium WHO Anatomical Therapeutic Chemical classification 0‑L A11AA03 Multivitamine und andere Mineralstoffe, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11AA04 Multivitamine und Spurenelemente WHO Anatomical Therapeutic Chemical classification 0‑L A11AB Multivitamine, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11B Multivitamine, Rein WHO Anatomical Therapeutic Chemical classification 0‑L A11BA Multivitamine, rein WHO Anatomical Therapeutic Chemical classification 0‑L A11C Vitamin A und D, inkl. deren Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11CA Vitamin A, rein WHO Anatomical Therapeutic Chemical classification 0‑L A11CA01 Retinol (Vitamin A) WHO Anatomical Therapeutic Chemical classification 0‑L A11CA02 Betacaroten WHO Anatomical Therapeutic Chemical classification 0‑L A11CB Vitamin A und D in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L A11CC Vitamin D und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L A11CC01 Ergocalciferol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC02 Dihydrotachysterol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC03 Alfacalcidol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC04 Calcitriol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC05 Colecalciferol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC06 Calcifediol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC07 Paricalcitol WHO Anatomical Therapeutic Chemical classification 0‑L A11CC20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11D Vitamin-B1, rein und in Kombination mit Vitamin-B6 und Vitamin-B12 WHO Anatomical Therapeutic Chemical classification 0‑L A11DA Vitamin-B1, rein WHO Anatomical Therapeutic Chemical classification 0‑L A11DA01 Thiamin (Vitamin-B1) WHO Anatomical Therapeutic Chemical classification 0‑L A11DA02 Sulbutiamin WHO Anatomical Therapeutic Chemical classification 0‑L A11DA03 Benfotiamin WHO Anatomical Therapeutic Chemical classification 0‑L A11DB Vitamin-B1 in Kombination mit Vitamin-B6 und/oder Vitamin-B12 WHO Anatomical Therapeutic Chemical classification 0‑L A11E Vitamin-B-Komplex, inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11EA Vitamin-B-Komplex, rein WHO Anatomical Therapeutic Chemical classification 0‑L A11EB Vitamin-B-Komplex mit Vitamin C WHO Anatomical Therapeutic Chemical classification 0‑L A11EC Vitamin-B-Komplex mit Mineralstoffen WHO Anatomical Therapeutic Chemical classification 0‑L A11ED Vitamin-B-Komplex mit anabolen Steroiden WHO Anatomical Therapeutic Chemical classification 0‑L A11EX Vitamin-B-Komplex, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11G Ascorbinsäure (Vitamin C), inkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11GA Ascorbinsäure (Vitamin C), rein WHO Anatomical Therapeutic Chemical classification 0‑L A11GA01 Ascorbinsäure (Vitamin C) WHO Anatomical Therapeutic Chemical classification 0‑L A11GB Ascorbinsäure (Vitamin C), Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11GB01 Ascorbinsäure (Vitamin C) und Calcium WHO Anatomical Therapeutic Chemical classification 0‑L A11H Andere Vitaminpräparate, rein WHO Anatomical Therapeutic Chemical classification 0‑L A11HA Andere Vitaminpräparate, rein WHO Anatomical Therapeutic Chemical classification 0‑L A11HA01 Nicotinamid WHO Anatomical Therapeutic Chemical classification 0‑L A11HA02 Pyridoxin (Vitamin-B6) WHO Anatomical Therapeutic Chemical classification 0‑L A11HA03 Tocopherol (Vitamin E) WHO Anatomical Therapeutic Chemical classification 0‑L A11HA04 Riboflavin (Vitamin-B2) WHO Anatomical Therapeutic Chemical classification 0‑L A11HA05 Biotin WHO Anatomical Therapeutic Chemical classification 0‑L A11HA06 Pyridoxalphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A11HA07 Inositol WHO Anatomical Therapeutic Chemical classification 0‑L A11HA30 Dexpanthenol WHO Anatomical Therapeutic Chemical classification 0‑L A11HA31 Calciumpantothenat WHO Anatomical Therapeutic Chemical classification 0‑L A11HA32 Pantethin WHO Anatomical Therapeutic Chemical classification 0‑L A11J Andere Vitaminpräparate, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A11JA Kombinationen von Vitaminen WHO Anatomical Therapeutic Chemical classification 0‑L A11JB Vitamine mit Mineralstoffen WHO Anatomical Therapeutic Chemical classification 0‑L A11JC Vitamine, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A12 Mineralstoffe WHO Anatomical Therapeutic Chemical classification 0‑L A12A Calcium WHO Anatomical Therapeutic Chemical classification 0‑L A12AA Calcium WHO Anatomical Therapeutic Chemical classification 0‑L A12AA01 Calciumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA02 Calciumglubionat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA03 Calciumgluconat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA04 Calciumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA05 Calciumlactat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA06 Calciumlactogluconat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA07 Calciumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A12AA08 Calciumglycerylphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA09 Calciumcitratlysin-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L A12AA10 Calciumglucoheptonat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA11 Calciumpangamat WHO Anatomical Therapeutic Chemical classification 0‑L A12AA12 Calciumacetat, wasserfrei WHO Anatomical Therapeutic Chemical classification 0‑L A12AA20 Calcium (verschiedene Salze in Kombination) WHO Anatomical Therapeutic Chemical classification 0‑L A12AA30 Calciumlaevulat WHO Anatomical Therapeutic Chemical classification 0‑L A12AX Calcium, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L A12AX01 Calciumcarbonat und Colecalciferol WHO Anatomical Therapeutic Chemical classification 0‑L A12B Kalium WHO Anatomical Therapeutic Chemical classification 0‑L A12BA Kalium WHO Anatomical Therapeutic Chemical classification 0‑L A12BA01 Kaliumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A12BA02 Kaliumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A12BA03 Kaliumhydrogentartrat WHO Anatomical Therapeutic Chemical classification 0‑L A12BA04 Kaliumhydrogencarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A12BA05 Kaliumgluconat WHO Anatomical Therapeutic Chemical classification 0‑L A12BA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A12BA51 Kaliumchlorid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A12C Andere Mineralstoffe WHO Anatomical Therapeutic Chemical classification 0‑L A12CA Natrium WHO Anatomical Therapeutic Chemical classification 0‑L A12CA01 Natriumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A12CA02 Natriumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L A12CB Zink WHO Anatomical Therapeutic Chemical classification 0‑L A12CB01 Zinksulfat WHO Anatomical Therapeutic Chemical classification 0‑L A12CB02 Zinkgluconat WHO Anatomical Therapeutic Chemical classification 0‑L A12CB03 Zinkprotein-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L A12CC Magnesium WHO Anatomical Therapeutic Chemical classification 0‑L A12CC01 Magnesiumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L A12CC02 Magnesiumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC03 Magnesiumgluconat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC04 Magnesiumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC05 Magnesiumaspartat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC06 Magnesiumlactat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC07 Magnesiumlevulinat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC08 Magnesiumpidolat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC09 Magnesiumorotat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC10 Magnesiumoxid WHO Anatomical Therapeutic Chemical classification 0‑L A12CC11 Magnesiumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L A12CC30 Magnesium (verschiedene Salze in Kombination) WHO Anatomical Therapeutic Chemical classification 0‑L A12CD Fluorid WHO Anatomical Therapeutic Chemical classification 0‑L A12CD01 Natriumfluorid WHO Anatomical Therapeutic Chemical classification 0‑L A12CD02 Natriummonofluorphosphat WHO Anatomical Therapeutic Chemical classification 0‑L A12CD51 Natriumfluorid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L A12CE Selen WHO Anatomical Therapeutic Chemical classification 0‑L A12CE01 Natriumselenat WHO Anatomical Therapeutic Chemical classification 0‑L A12CE02 Natriumselenit WHO Anatomical Therapeutic Chemical classification 0‑L A12CX Andere Mineralstoff-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L A13 Tonika WHO Anatomical Therapeutic Chemical classification 0‑L A13A Tonika WHO Anatomical Therapeutic Chemical classification 0‑L A14 Anabolika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L A14A Anabole Steroide WHO Anatomical Therapeutic Chemical classification 0‑L A14AA Androstan-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A14AA01 Androstanolon WHO Anatomical Therapeutic Chemical classification 0‑L A14AA02 Stanozolol WHO Anatomical Therapeutic Chemical classification 0‑L A14AA03 Metandienon WHO Anatomical Therapeutic Chemical classification 0‑L A14AA04 Metenolon WHO Anatomical Therapeutic Chemical classification 0‑L A14AA05 Oxymetholon WHO Anatomical Therapeutic Chemical classification 0‑L A14AA06 Quinbolon WHO Anatomical Therapeutic Chemical classification 0‑L A14AA07 Prasteron WHO Anatomical Therapeutic Chemical classification 0‑L A14AA08 Oxandrolon WHO Anatomical Therapeutic Chemical classification 0‑L A14AA09 Norethandrolon WHO Anatomical Therapeutic Chemical classification 0‑L A14AB Estren-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A14AB01 Nandrolon WHO Anatomical Therapeutic Chemical classification 0‑L A14AB02 Ethylestrenol WHO Anatomical Therapeutic Chemical classification 0‑L A14AB03 Oxaboloncipionat WHO Anatomical Therapeutic Chemical classification 0‑L A14B Andere Anabolika WHO Anatomical Therapeutic Chemical classification 0‑L A15 Appetit stimulierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L A16 Andere Mittel für das alimentäre System und den Stoffwechsel WHO Anatomical Therapeutic Chemical classification 0‑L A16A Andere Mittel für das alimentäre System und den Stoffwechsel WHO Anatomical Therapeutic Chemical classification 0‑L A16AA Aminosäuren und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L A16AA01 Levocarnitin WHO Anatomical Therapeutic Chemical classification 0‑L A16AA02 Ademetionin WHO Anatomical Therapeutic Chemical classification 0‑L A16AA03 Glutamin WHO Anatomical Therapeutic Chemical classification 0‑L A16AA04 Mercaptamin WHO Anatomical Therapeutic Chemical classification 0‑L A16AA05 Carglumsäure WHO Anatomical Therapeutic Chemical classification 0‑L A16AA06 Betain WHO Anatomical Therapeutic Chemical classification 0‑L A16AB Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L A16AB01 Alglucerase WHO Anatomical Therapeutic Chemical classification 0‑L A16AB02 Imiglucerase WHO Anatomical Therapeutic Chemical classification 0‑L A16AB03 Agalsidase alfa WHO Anatomical Therapeutic Chemical classification 0‑L A16AB04 Agalsidase beta WHO Anatomical Therapeutic Chemical classification 0‑L A16AB05 Laronidase WHO Anatomical Therapeutic Chemical classification 0‑L A16AB06 Sacrosidase WHO Anatomical Therapeutic Chemical classification 0‑L A16AB07 Alglucosidase alfa WHO Anatomical Therapeutic Chemical classification 0‑L A16AB08 Galsulfase WHO Anatomical Therapeutic Chemical classification 0‑L A16AB09 Idursulfase WHO Anatomical Therapeutic Chemical classification 0‑L A16AB10 Velaglucerase Alfa WHO Anatomical Therapeutic Chemical classification 0‑L A16AX Sonstige Mittel für das alimentäre System und den Stoffwechsel WHO Anatomical Therapeutic Chemical classification 0‑L A16AX01 Alpha-Liponsäure (Thioctsäure) WHO Anatomical Therapeutic Chemical classification 0‑L A16AX02 Anetholtrithion WHO Anatomical Therapeutic Chemical classification 0‑L A16AX03 Natriumphenylbutyrat WHO Anatomical Therapeutic Chemical classification 0‑L A16AX04 Nitisinon WHO Anatomical Therapeutic Chemical classification 0‑L A16AX05 Zinkacetat WHO Anatomical Therapeutic Chemical classification 0‑L A16AX06 Miglustat WHO Anatomical Therapeutic Chemical classification 0‑L A16AX07 Sapropterin WHO Anatomical Therapeutic Chemical classification 0‑L B Blut und Blut bildende Organe WHO Anatomical Therapeutic Chemical classification 0‑L B01 Antithrombotische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L B01A Antithrombotische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L B01AA Vitamin-K-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L B01AA01 Dicoumarol WHO Anatomical Therapeutic Chemical classification 0‑L B01AA02 Phenindion WHO Anatomical Therapeutic Chemical classification 0‑L B01AA03 Warfarin WHO Anatomical Therapeutic Chemical classification 0‑L B01AA04 Phenprocoumon WHO Anatomical Therapeutic Chemical classification 0‑L B01AA07 Acenocoumarol WHO Anatomical Therapeutic Chemical classification 0‑L B01AA08 Ethylbiscoumacetat WHO Anatomical Therapeutic Chemical classification 0‑L B01AA09 Clorindion WHO Anatomical Therapeutic Chemical classification 0‑L B01AA10 Diphenadion WHO Anatomical Therapeutic Chemical classification 0‑L B01AA11 Tioclomarol WHO Anatomical Therapeutic Chemical classification 0‑L B01AB Heparingruppe WHO Anatomical Therapeutic Chemical classification 0‑L B01AB01 Heparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB02 Antithrombin III WHO Anatomical Therapeutic Chemical classification 0‑L B01AB04 Dalteparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB05 Enoxaparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB06 Nadroparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB07 Parnaparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB08 Reviparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB09 Danaparoid WHO Anatomical Therapeutic Chemical classification 0‑L B01AB10 Tinzaparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB11 Sulodexid WHO Anatomical Therapeutic Chemical classification 0‑L B01AB12 Bemiparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AB51 Heparin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B01AC Thrombozytenaggregationshemmer, exkl. Heparin WHO Anatomical Therapeutic Chemical classification 0‑L B01AC01 Ditazol WHO Anatomical Therapeutic Chemical classification 0‑L B01AC02 Cloricromen WHO Anatomical Therapeutic Chemical classification 0‑L B01AC03 Picotamid WHO Anatomical Therapeutic Chemical classification 0‑L B01AC04 Clopidogrel WHO Anatomical Therapeutic Chemical classification 0‑L B01AC05 Ticlopidin WHO Anatomical Therapeutic Chemical classification 0‑L B01AC06 Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L B01AC07 Dipyridamol WHO Anatomical Therapeutic Chemical classification 0‑L B01AC08 Carbasalatcalcium WHO Anatomical Therapeutic Chemical classification 0‑L B01AC09 Epoprostenol WHO Anatomical Therapeutic Chemical classification 0‑L B01AC10 Indobufen WHO Anatomical Therapeutic Chemical classification 0‑L B01AC11 Iloprost WHO Anatomical Therapeutic Chemical classification 0‑L B01AC13 Abciximab WHO Anatomical Therapeutic Chemical classification 0‑L B01AC15 Aloxiprin WHO Anatomical Therapeutic Chemical classification 0‑L B01AC16 Eptifibatid WHO Anatomical Therapeutic Chemical classification 0‑L B01AC17 Tirofiban WHO Anatomical Therapeutic Chemical classification 0‑L B01AC18 Triflusal WHO Anatomical Therapeutic Chemical classification 0‑L B01AC19 Beraprost WHO Anatomical Therapeutic Chemical classification 0‑L B01AC21 Treprostinil WHO Anatomical Therapeutic Chemical classification 0‑L B01AC30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B01AC56 Acetylsalicylsäure und Esomeprazol WHO Anatomical Therapeutic Chemical classification 0‑L B01AD Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L B01AD01 Streptokinase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD02 Alteplase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD03 Anistreplase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD04 Urokinase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD05 Fibrinolysin WHO Anatomical Therapeutic Chemical classification 0‑L B01AD06 Brinase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD07 Reteplase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD08 Saruplase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD09 Ancrod WHO Anatomical Therapeutic Chemical classification 0‑L B01AD10 Drotrecogin alfa (aktiviert) WHO Anatomical Therapeutic Chemical classification 0‑L B01AD11 Tenecteplase WHO Anatomical Therapeutic Chemical classification 0‑L B01AD12 Protein C WHO Anatomical Therapeutic Chemical classification 0‑L B01AE Direkte Thrombininhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L B01AE01 Desirudin WHO Anatomical Therapeutic Chemical classification 0‑L B01AE02 Lepirudin WHO Anatomical Therapeutic Chemical classification 0‑L B01AE03 Argatroban WHO Anatomical Therapeutic Chemical classification 0‑L B01AE04 Melagatran WHO Anatomical Therapeutic Chemical classification 0‑L B01AE05 Ximelagatran WHO Anatomical Therapeutic Chemical classification 0‑L B01AE06 Bivalirudin WHO Anatomical Therapeutic Chemical classification 0‑L B01AE07 Dabigatran etexilat WHO Anatomical Therapeutic Chemical classification 0‑L B01AX Andere antithrombotische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L B01AX01 Defibrotid WHO Anatomical Therapeutic Chemical classification 0‑L B01AX04 Chondroitinsulfat B WHO Anatomical Therapeutic Chemical classification 0‑L B01AX05 Fondaparinux WHO Anatomical Therapeutic Chemical classification 0‑L B01AX06 Rivaroxaban WHO Anatomical Therapeutic Chemical classification 0‑L B02 Antihämorrhagika WHO Anatomical Therapeutic Chemical classification 0‑L B02A Antifibrinolytika WHO Anatomical Therapeutic Chemical classification 0‑L B02AA Aminosäuren WHO Anatomical Therapeutic Chemical classification 0‑L B02AA01 Aminocapronsäure WHO Anatomical Therapeutic Chemical classification 0‑L B02AA02 Tranexamsäure WHO Anatomical Therapeutic Chemical classification 0‑L B02AA03 Aminomethylbenzoesäure WHO Anatomical Therapeutic Chemical classification 0‑L B02AB Proteinasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L B02AB01 Aprotinin WHO Anatomical Therapeutic Chemical classification 0‑L B02AB02 Alfa1-Antitrypsin WHO Anatomical Therapeutic Chemical classification 0‑L B02AB03 C1-Inhibitor WHO Anatomical Therapeutic Chemical classification 0‑L B02AB04 Camostat WHO Anatomical Therapeutic Chemical classification 0‑L B02B Vitamin K und andere Hämostatika WHO Anatomical Therapeutic Chemical classification 0‑L B02BA Vitamin K WHO Anatomical Therapeutic Chemical classification 0‑L B02BA01 Phytomenadion WHO Anatomical Therapeutic Chemical classification 0‑L B02BA02 Menadion WHO Anatomical Therapeutic Chemical classification 0‑L B02BB Fibrinogene WHO Anatomical Therapeutic Chemical classification 0‑L B02BB01 Fibrinogen, human WHO Anatomical Therapeutic Chemical classification 0‑L B02BC Lokale Hämostatika WHO Anatomical Therapeutic Chemical classification 0‑L B02BC01 Absorbierbarer Gelatineschwamm WHO Anatomical Therapeutic Chemical classification 0‑L B02BC02 Oxidierte Zellulose WHO Anatomical Therapeutic Chemical classification 0‑L B02BC03 Tetragalacturonsäurehydroxymethylester WHO Anatomical Therapeutic Chemical classification 0‑L B02BC05 Adrenalon WHO Anatomical Therapeutic Chemical classification 0‑L B02BC06 Thrombin WHO Anatomical Therapeutic Chemical classification 0‑L B02BC07 Kollagen WHO Anatomical Therapeutic Chemical classification 0‑L B02BC08 Calciumalginat WHO Anatomical Therapeutic Chemical classification 0‑L B02BC09 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L B02BC10 Fibrinogen, human WHO Anatomical Therapeutic Chemical classification 0‑L B02BC30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B02BD Blutgerinnungsfaktoren WHO Anatomical Therapeutic Chemical classification 0‑L B02BD01 Gerinnungsfaktoren IX, II, VII und X in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L B02BD02 Gerinnungsfaktor VIII WHO Anatomical Therapeutic Chemical classification 0‑L B02BD03 Faktor-VIII-Inhibitor bypass Aktivität WHO Anatomical Therapeutic Chemical classification 0‑L B02BD04 Gerinnungsfaktor IX WHO Anatomical Therapeutic Chemical classification 0‑L B02BD05 Gerinnungsfaktor VII WHO Anatomical Therapeutic Chemical classification 0‑L B02BD06 Von-Willebrand-Faktor und Gerinnungsfaktor VIII in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L B02BD07 Gerinnungsfaktor XIII WHO Anatomical Therapeutic Chemical classification 0‑L B02BD08 Eptacog alfa (aktiviert) WHO Anatomical Therapeutic Chemical classification 0‑L B02BD09 Nonacog alfa WHO Anatomical Therapeutic Chemical classification 0‑L B02BD10 von-Willebrand-Faktor WHO Anatomical Therapeutic Chemical classification 0‑L B02BD30 Thrombin WHO Anatomical Therapeutic Chemical classification 0‑L B02BX Andere systemische Hämostatika WHO Anatomical Therapeutic Chemical classification 0‑L B02BX01 Etamsylat WHO Anatomical Therapeutic Chemical classification 0‑L B02BX02 Carbazochrom WHO Anatomical Therapeutic Chemical classification 0‑L B02BX03 Batroxobin WHO Anatomical Therapeutic Chemical classification 0‑L B02BX04 Romiplostim WHO Anatomical Therapeutic Chemical classification 0‑L B02BX05 Eltrombopag WHO Anatomical Therapeutic Chemical classification 0‑L B03 Antianämika WHO Anatomical Therapeutic Chemical classification 0‑L B03A Eisen-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L B03AA Eisen zweiwertig, orale Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L B03AA01 Eisen(II)-Glycinsulfat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA02 Eisen(II)fumarat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA03 Eisen(II)gluconat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA04 Eisen(II)carbonat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA05 Eisen(II)chlorid WHO Anatomical Therapeutic Chemical classification 0‑L B03AA06 Eisen(II)succinat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA07 Eisen(II)sulfat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA08 Eisen(II)tartrat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA09 Eisen(II)aspartat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA10 Eisen(II)ascorbat WHO Anatomical Therapeutic Chemical classification 0‑L B03AA11 Eisen(II)iodat WHO Anatomical Therapeutic Chemical classification 0‑L B03AB Eisen dreiwertig, orale Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L B03AB01 Eisen(III)-Natrium-citrat WHO Anatomical Therapeutic Chemical classification 0‑L B03AB02 Eisen(III)oxid-Saccharose-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AB03 Natriumferedetat WHO Anatomical Therapeutic Chemical classification 0‑L B03AB04 Eisen(III)hydroxid WHO Anatomical Therapeutic Chemical classification 0‑L B03AB05 Dextriferron WHO Anatomical Therapeutic Chemical classification 0‑L B03AB06 Eisen(III)citrat WHO Anatomical Therapeutic Chemical classification 0‑L B03AB07 Chondroitinsulfat-Eisen(III)-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AB08 Eisen(III)acetyltransferrin WHO Anatomical Therapeutic Chemical classification 0‑L B03AB09 Eisen(III)proteinsuccinylat WHO Anatomical Therapeutic Chemical classification 0‑L B03AC Eisen dreiwertig, parenterale Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L B03AC01 Dextriferron WHO Anatomical Therapeutic Chemical classification 0‑L B03AC02 Eisen(III)oxid-Saccharose-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AC03 Eisen(III)sorbit-Zitronensäure-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AC05 Eisen(III)sorbit-Gluconsäure-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AC06 Eisen(III)oxid-Dextran-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AC07 Eisen(III)-Natrium-Gluconat-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AD Eisen in Kombination mit Folsäure WHO Anatomical Therapeutic Chemical classification 0‑L B03AD01 Eisen-Aminosäure-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03AD02 Eisen(II)fumarat WHO Anatomical Therapeutic Chemical classification 0‑L B03AD03 Eisen(II)sulfat WHO Anatomical Therapeutic Chemical classification 0‑L B03AD04 Dextriferron WHO Anatomical Therapeutic Chemical classification 0‑L B03AE Eisen in anderen Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B03AE01 Eisen, Vitamin-B12 und Folsäure WHO Anatomical Therapeutic Chemical classification 0‑L B03AE02 Eisen, Multivitamine und Folsäure WHO Anatomical Therapeutic Chemical classification 0‑L B03AE03 Eisen und Multivitamine WHO Anatomical Therapeutic Chemical classification 0‑L B03AE04 Eisen, Multivitamine und Mineralstoffe WHO Anatomical Therapeutic Chemical classification 0‑L B03AE10 Verschiedene Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B03B Vitamin-B12 und Folsäure WHO Anatomical Therapeutic Chemical classification 0‑L B03BA Vitamin-B12 (Cyanocobalamin und Analoga) WHO Anatomical Therapeutic Chemical classification 0‑L B03BA01 Cyanocobalamin WHO Anatomical Therapeutic Chemical classification 0‑L B03BA02 Cyanocobalamin-Tannin-Komplex WHO Anatomical Therapeutic Chemical classification 0‑L B03BA03 Hydroxocobalamin WHO Anatomical Therapeutic Chemical classification 0‑L B03BA04 Cobamamid WHO Anatomical Therapeutic Chemical classification 0‑L B03BA05 Mecobalamin WHO Anatomical Therapeutic Chemical classification 0‑L B03BA51 Cyanocobalamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B03BA53 Hydroxocobalamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B03BB Folsäure und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L B03BB01 Folsäure WHO Anatomical Therapeutic Chemical classification 0‑L B03BB51 Folsäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B03X Andere Antianämika WHO Anatomical Therapeutic Chemical classification 0‑L B03XA Andere Antianämika WHO Anatomical Therapeutic Chemical classification 0‑L B03XA01 Erythropoietin WHO Anatomical Therapeutic Chemical classification 0‑L B03XA02 Darbepoetin alfa WHO Anatomical Therapeutic Chemical classification 0‑L B03XA03 Methoxy-Polyethylenglycol-Epoetin beta WHO Anatomical Therapeutic Chemical classification 0‑L B05 Blutersatzmittel und Perfusionslösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05A Blut und verwandte Produkte WHO Anatomical Therapeutic Chemical classification 0‑L B05AA Blutersatzmittel und Plasmaproteinfraktionen WHO Anatomical Therapeutic Chemical classification 0‑L B05AA01 Albumin WHO Anatomical Therapeutic Chemical classification 0‑L B05AA02 Andere Plasmaproteinfraktionen WHO Anatomical Therapeutic Chemical classification 0‑L B05AA03 Fluorocarbon-Blutersatzmittel WHO Anatomical Therapeutic Chemical classification 0‑L B05AA05 Dextran WHO Anatomical Therapeutic Chemical classification 0‑L B05AA06 Gelatine-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L B05AA07 Hydroxyethylstärke WHO Anatomical Therapeutic Chemical classification 0‑L B05AA08 Hämoglobin crosfumaril WHO Anatomical Therapeutic Chemical classification 0‑L B05AA09 Haemoglobin raffimer WHO Anatomical Therapeutic Chemical classification 0‑L B05B I.V.-Lösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05BA Lösungen zur parenteralen Ernährung WHO Anatomical Therapeutic Chemical classification 0‑L B05BA01 Aminosäuren WHO Anatomical Therapeutic Chemical classification 0‑L B05BA02 Fett-Emulsionen WHO Anatomical Therapeutic Chemical classification 0‑L B05BA03 Kohlenhydrate WHO Anatomical Therapeutic Chemical classification 0‑L B05BA04 Proteinhydrolysate WHO Anatomical Therapeutic Chemical classification 0‑L B05BA10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B05BB Lösungen mit Wirkung auf den Elektrolythaushalt WHO Anatomical Therapeutic Chemical classification 0‑L B05BB01 Elektrolyte WHO Anatomical Therapeutic Chemical classification 0‑L B05BB02 Elektrolyte mit Kohlenhydraten WHO Anatomical Therapeutic Chemical classification 0‑L B05BB03 Trometamol WHO Anatomical Therapeutic Chemical classification 0‑L B05BC Osmodiuretika WHO Anatomical Therapeutic Chemical classification 0‑L B05BC01 Mannitol WHO Anatomical Therapeutic Chemical classification 0‑L B05BC02 Harnstoff WHO Anatomical Therapeutic Chemical classification 0‑L B05C Spüllösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05CA Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L B05CA01 Cetylpyridinium WHO Anatomical Therapeutic Chemical classification 0‑L B05CA02 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L B05CA03 Nitrofural WHO Anatomical Therapeutic Chemical classification 0‑L B05CA04 Sulfamethizol WHO Anatomical Therapeutic Chemical classification 0‑L B05CA05 Taurolidin WHO Anatomical Therapeutic Chemical classification 0‑L B05CA06 Mandelsäure WHO Anatomical Therapeutic Chemical classification 0‑L B05CA07 Noxytiolin WHO Anatomical Therapeutic Chemical classification 0‑L B05CA08 Ethacridinlactat WHO Anatomical Therapeutic Chemical classification 0‑L B05CA09 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L B05CA10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B05CB Salzlösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05CB01 Natriumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05CB02 Natriumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L B05CB03 Magnesiumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L B05CB04 Natriumbicarbonat WHO Anatomical Therapeutic Chemical classification 0‑L B05CB10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B05CX Andere Spüllösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05CX01 Glucose WHO Anatomical Therapeutic Chemical classification 0‑L B05CX02 Sorbitol WHO Anatomical Therapeutic Chemical classification 0‑L B05CX03 Glycin WHO Anatomical Therapeutic Chemical classification 0‑L B05CX04 Mannitol WHO Anatomical Therapeutic Chemical classification 0‑L B05CX10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B05D LÖSUNGEN ZUR PERITONEALDIALYSE WHO Anatomical Therapeutic Chemical classification 0‑L B05DA Isotone Lösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05DB Hypertone Lösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05X ADDITIVA ZU I.V.-LÖSUNGEN WHO Anatomical Therapeutic Chemical classification 0‑L B05XA Elektrolytlösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05XA01 Kaliumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XA02 Natriumbicarbonat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA03 Natriumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XA04 Ammoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XA05 Magnesiumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA06 Kaliumphosphat, inkl. Kombinationen mit anderen Kaliumsalzen WHO Anatomical Therapeutic Chemical classification 0‑L B05XA07 Calciumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XA08 Natriumacetat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA09 Natriumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA10 Magnesiumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA11 Magnesiumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XA12 Zinkchlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XA13 Salzsäure WHO Anatomical Therapeutic Chemical classification 0‑L B05XA14 Dinatrium-1-glycerinphosphat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA15 Kaliumlactat WHO Anatomical Therapeutic Chemical classification 0‑L B05XA16 Kardioplege Lösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05XA30 Kombinationen von Elektrolyten WHO Anatomical Therapeutic Chemical classification 0‑L B05XA31 Elektrolyte in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L B05XB Aminosäuren WHO Anatomical Therapeutic Chemical classification 0‑L B05XB01 Argininhydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L B05XB02 Alanylglutamin WHO Anatomical Therapeutic Chemical classification 0‑L B05XB03 Lysin WHO Anatomical Therapeutic Chemical classification 0‑L B05XC Vitamine WHO Anatomical Therapeutic Chemical classification 0‑L B05XX Andere Additiva zu i.v.-Lösungen WHO Anatomical Therapeutic Chemical classification 0‑L B05XX02 Trometamol WHO Anatomical Therapeutic Chemical classification 0‑L B05Z Hämodialysekonzentrate und Hämofiltrate WHO Anatomical Therapeutic Chemical classification 0‑L B05ZA Hämodialysekonzentrate WHO Anatomical Therapeutic Chemical classification 0‑L B05ZB Hämofiltrate WHO Anatomical Therapeutic Chemical classification 0‑L B06 Andere Hämatologika WHO Anatomical Therapeutic Chemical classification 0‑L B06A Andere Hämatologika WHO Anatomical Therapeutic Chemical classification 0‑L B06AA Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L B06AA02 Fibrinolysin und Desoxyribonuclease WHO Anatomical Therapeutic Chemical classification 0‑L B06AA03 Hyaluronidase WHO Anatomical Therapeutic Chemical classification 0‑L B06AA04 Chymotrypsin WHO Anatomical Therapeutic Chemical classification 0‑L B06AA07 Trypsin WHO Anatomical Therapeutic Chemical classification 0‑L B06AA10 Desoxyribonuclease WHO Anatomical Therapeutic Chemical classification 0‑L B06AA11 Bromelaine WHO Anatomical Therapeutic Chemical classification 0‑L B06AA55 Streptokinase, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L B06AB Andere Hämprodukte WHO Anatomical Therapeutic Chemical classification 0‑L B06AB01 Hematin WHO Anatomical Therapeutic Chemical classification 0‑L B06AC01 C1-Inhibitor, plasma derived WHO Anatomical Therapeutic Chemical classification 0‑L B06AC04 Conestat alfa WHO Anatomical Therapeutic Chemical classification 0‑L C Kardiovaskuläres System WHO Anatomical Therapeutic Chemical classification 0‑L C01 Herztherapie WHO Anatomical Therapeutic Chemical classification 0‑L C01A Herzglykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01AA Digitalisglykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01AA01 Acetyldigitoxin WHO Anatomical Therapeutic Chemical classification 0‑L C01AA02 Acetyldigoxin WHO Anatomical Therapeutic Chemical classification 0‑L C01AA03 Digitalisblätter WHO Anatomical Therapeutic Chemical classification 0‑L C01AA04 Digitoxin WHO Anatomical Therapeutic Chemical classification 0‑L C01AA05 Digoxin WHO Anatomical Therapeutic Chemical classification 0‑L C01AA06 Lanatosid C WHO Anatomical Therapeutic Chemical classification 0‑L C01AA07 Deslanosid WHO Anatomical Therapeutic Chemical classification 0‑L C01AA08 Metildigoxin WHO Anatomical Therapeutic Chemical classification 0‑L C01AA09 Gitoformat WHO Anatomical Therapeutic Chemical classification 0‑L C01AA52 Acetyldigoxin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01AB Scillaglykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01AB01 Proscillaridin WHO Anatomical Therapeutic Chemical classification 0‑L C01AB51 Proscillaridin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01AC Strophanthusglykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01AC01 g-Strophanthin WHO Anatomical Therapeutic Chemical classification 0‑L C01AC03 Cymarin WHO Anatomical Therapeutic Chemical classification 0‑L C01AX Andere Herzglykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01AX02 Peruvosid WHO Anatomical Therapeutic Chemical classification 0‑L C01B Antiarrhythmika, Klasse I und III WHO Anatomical Therapeutic Chemical classification 0‑L C01BA Antiarrhythmika, Klasse Ia WHO Anatomical Therapeutic Chemical classification 0‑L C01BA01 Chinidin WHO Anatomical Therapeutic Chemical classification 0‑L C01BA02 Procainamid WHO Anatomical Therapeutic Chemical classification 0‑L C01BA03 Disopyramid WHO Anatomical Therapeutic Chemical classification 0‑L C01BA04 Spartein WHO Anatomical Therapeutic Chemical classification 0‑L C01BA05 Ajmalin WHO Anatomical Therapeutic Chemical classification 0‑L C01BA08 Prajmalin WHO Anatomical Therapeutic Chemical classification 0‑L C01BA12 Lorajmin WHO Anatomical Therapeutic Chemical classification 0‑L C01BA51 Chinidin, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L C01BA71 Chinidin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L C01BB Antiarrhythmika, Klasse Ib WHO Anatomical Therapeutic Chemical classification 0‑L C01BB01 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L C01BB02 Mexiletin WHO Anatomical Therapeutic Chemical classification 0‑L C01BB03 Tocainid WHO Anatomical Therapeutic Chemical classification 0‑L C01BB04 Aprindin WHO Anatomical Therapeutic Chemical classification 0‑L C01BC Antiarrhythmika, Klasse Ic WHO Anatomical Therapeutic Chemical classification 0‑L C01BC03 Propafenon WHO Anatomical Therapeutic Chemical classification 0‑L C01BC04 Flecainid WHO Anatomical Therapeutic Chemical classification 0‑L C01BC07 Lorcainid WHO Anatomical Therapeutic Chemical classification 0‑L C01BC08 Encainid WHO Anatomical Therapeutic Chemical classification 0‑L C01BD Antiarrhythmika, Klasse III WHO Anatomical Therapeutic Chemical classification 0‑L C01BD01 Amiodaron WHO Anatomical Therapeutic Chemical classification 0‑L C01BD02 Bretyliumtosilat WHO Anatomical Therapeutic Chemical classification 0‑L C01BD03 Bunaftin WHO Anatomical Therapeutic Chemical classification 0‑L C01BD04 Dofetilid WHO Anatomical Therapeutic Chemical classification 0‑L C01BD05 Ibutilid WHO Anatomical Therapeutic Chemical classification 0‑L C01BG Andere Klasse-I-Antiarrhythmika WHO Anatomical Therapeutic Chemical classification 0‑L C01BG01 Moracizin WHO Anatomical Therapeutic Chemical classification 0‑L C01BG07 Cibenzolin WHO Anatomical Therapeutic Chemical classification 0‑L C01BG11 Vernakalant WHO Anatomical Therapeutic Chemical classification 0‑L C01C Kardiostimulanzien, Exkl. Herzglykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01CA Adrenerge und dopaminerge Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C01CA01 Etilefrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA02 Isoprenalin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA03 Norepinephrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA04 Dopamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA05 Norfenefrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA06 Phenylephrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA07 Dobutamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA08 Oxedrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA09 Metaraminol WHO Anatomical Therapeutic Chemical classification 0‑L C01CA10 Methoxamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA11 Mephentermin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA12 Dimetofrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA13 Prenalterol WHO Anatomical Therapeutic Chemical classification 0‑L C01CA14 Dopexamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA15 Gepefrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA16 Ibopamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA17 Midodrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA18 Octopamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA19 Fenoldopam WHO Anatomical Therapeutic Chemical classification 0‑L C01CA21 Cafedrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA22 Arbutamin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA23 Theodrenalin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA24 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA26 Ephedrin WHO Anatomical Therapeutic Chemical classification 0‑L C01CA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01CA51 Etilefrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01CE Phosphodiesterasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L C01CE01 Amrinon WHO Anatomical Therapeutic Chemical classification 0‑L C01CE02 Milrinon WHO Anatomical Therapeutic Chemical classification 0‑L C01CE03 Enoximon WHO Anatomical Therapeutic Chemical classification 0‑L C01CE04 Bucladesin WHO Anatomical Therapeutic Chemical classification 0‑L C01CX Andere Kardiostimulanzien WHO Anatomical Therapeutic Chemical classification 0‑L C01CX06 Angiotensinamid WHO Anatomical Therapeutic Chemical classification 0‑L C01CX07 Xamoterol WHO Anatomical Therapeutic Chemical classification 0‑L C01CX08 Levosimendan WHO Anatomical Therapeutic Chemical classification 0‑L C01D Bei Herzerkrankungen Eingesetzte Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C01DA Organische Nitrate WHO Anatomical Therapeutic Chemical classification 0‑L C01DA02 Glyceroltrinitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA04 Methylpropylpropanedioldinitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA05 Pentaerythrityltetranitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA07 Propatylnitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA08 Isosorbiddinitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA09 Trolnitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA13 Erythrityltetranitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA14 Isosorbidmononitrat WHO Anatomical Therapeutic Chemical classification 0‑L C01DA20 Organische Nitrate in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C01DA38 Tenitramin WHO Anatomical Therapeutic Chemical classification 0‑L C01DA52 Glyceroltrinitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA54 Methylpropylpropanedioldinitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA55 Pentaerythrityltetranitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA57 Propatylnitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA58 Isosorbiddinitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA59 Trolnitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA63 Erythrityltetranitrat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DA70 Organische Nitrate in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L C01DB Chinolon-Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C01DB01 Flosequinan WHO Anatomical Therapeutic Chemical classification 0‑L C01DX Andere bei Herzerkrankungen eingesetzte Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C01DX01 Itramintosilat WHO Anatomical Therapeutic Chemical classification 0‑L C01DX02 Prenylamin WHO Anatomical Therapeutic Chemical classification 0‑L C01DX03 Oxyfedrin WHO Anatomical Therapeutic Chemical classification 0‑L C01DX04 Benziodaron WHO Anatomical Therapeutic Chemical classification 0‑L C01DX05 Carbocromen WHO Anatomical Therapeutic Chemical classification 0‑L C01DX06 Hexobendin WHO Anatomical Therapeutic Chemical classification 0‑L C01DX07 Etafenon WHO Anatomical Therapeutic Chemical classification 0‑L C01DX08 Heptaminol WHO Anatomical Therapeutic Chemical classification 0‑L C01DX09 Imolamin WHO Anatomical Therapeutic Chemical classification 0‑L C01DX10 Dilazep WHO Anatomical Therapeutic Chemical classification 0‑L C01DX11 Trapidil WHO Anatomical Therapeutic Chemical classification 0‑L C01DX12 Molsidomin WHO Anatomical Therapeutic Chemical classification 0‑L C01DX13 Efloxat WHO Anatomical Therapeutic Chemical classification 0‑L C01DX14 Cinepazet WHO Anatomical Therapeutic Chemical classification 0‑L C01DX15 Cloridarol WHO Anatomical Therapeutic Chemical classification 0‑L C01DX16 Nicorandil WHO Anatomical Therapeutic Chemical classification 0‑L C01DX18 Linsidomin WHO Anatomical Therapeutic Chemical classification 0‑L C01DX19 Nesiritid WHO Anatomical Therapeutic Chemical classification 0‑L C01DX51 Itramintosilat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DX52 Prenylamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DX53 Oxyfedrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01DX54 Benziodaron, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C01E Andere Herzmittel WHO Anatomical Therapeutic Chemical classification 0‑L C01EA Prostaglandine WHO Anatomical Therapeutic Chemical classification 0‑L C01EA01 Alprostadil WHO Anatomical Therapeutic Chemical classification 0‑L C01EB Andere Herzmittel WHO Anatomical Therapeutic Chemical classification 0‑L C01EB02 Campher WHO Anatomical Therapeutic Chemical classification 0‑L C01EB03 Indometacin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB04 Crataegus-Glykoside WHO Anatomical Therapeutic Chemical classification 0‑L C01EB05 Creatinolfosfat WHO Anatomical Therapeutic Chemical classification 0‑L C01EB06 Fosfocreatin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB07 Fructose-1,6-diphosphat WHO Anatomical Therapeutic Chemical classification 0‑L C01EB09 Ubidecarenon WHO Anatomical Therapeutic Chemical classification 0‑L C01EB10 Adenosin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB11 Tiracizin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB12 Tedisamil WHO Anatomical Therapeutic Chemical classification 0‑L C01EB13 Acadesin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB15 Trimetazidin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB16 Ibuprofen WHO Anatomical Therapeutic Chemical classification 0‑L C01EB17 Ivabradin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB18 Ranolazin WHO Anatomical Therapeutic Chemical classification 0‑L C01EB21 Regadenoson WHO Anatomical Therapeutic Chemical classification 0‑L C01EX Andere Herzmittel, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C02 Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C02A Antiadrenerge Mittel, zentral wirkend WHO Anatomical Therapeutic Chemical classification 0‑L C02AA Rauwolfia-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L C02AA01 Rescinnamin WHO Anatomical Therapeutic Chemical classification 0‑L C02AA02 Reserpin WHO Anatomical Therapeutic Chemical classification 0‑L C02AA03 Kombinationen von Rauwolfia-Alkaloiden WHO Anatomical Therapeutic Chemical classification 0‑L C02AA04 Rauwolfia-Alkaloide, ganze Wurzel WHO Anatomical Therapeutic Chemical classification 0‑L C02AA05 Deserpidin WHO Anatomical Therapeutic Chemical classification 0‑L C02AA06 Methoserpidin WHO Anatomical Therapeutic Chemical classification 0‑L C02AA07 Bietaserpin WHO Anatomical Therapeutic Chemical classification 0‑L C02AA52 Reserpin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C02AA53 Kombinationen von Rauwolfia-Alkaloiden, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C02AA57 Bietaserpin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C02AB Methyldopa WHO Anatomical Therapeutic Chemical classification 0‑L C02AB01 Methyldopa (linksdrehend) WHO Anatomical Therapeutic Chemical classification 0‑L C02AB02 Methyldopa (racemisch) WHO Anatomical Therapeutic Chemical classification 0‑L C02AC Imidazolin-Rezeptoragonisten WHO Anatomical Therapeutic Chemical classification 0‑L C02AC01 Clonidin WHO Anatomical Therapeutic Chemical classification 0‑L C02AC02 Guanfacin WHO Anatomical Therapeutic Chemical classification 0‑L C02AC04 Tolonidin WHO Anatomical Therapeutic Chemical classification 0‑L C02AC05 Moxonidin WHO Anatomical Therapeutic Chemical classification 0‑L C02AC06 Rilmenidin WHO Anatomical Therapeutic Chemical classification 0‑L C02B Antiadrenerge Mittel, Ganglienblocker WHO Anatomical Therapeutic Chemical classification 0‑L C02BA Sulfonium-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02BA01 Trimetaphan WHO Anatomical Therapeutic Chemical classification 0‑L C02BB Sekundäre und tertiäre Amine WHO Anatomical Therapeutic Chemical classification 0‑L C02BB01 Mecamylamin WHO Anatomical Therapeutic Chemical classification 0‑L C02BC Bisquartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L C02C Antiadrenerge Mittel, peripher wirkend WHO Anatomical Therapeutic Chemical classification 0‑L C02CA Alpha-Adrenorezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L C02CA01 Prazosin WHO Anatomical Therapeutic Chemical classification 0‑L C02CA02 Indoramin WHO Anatomical Therapeutic Chemical classification 0‑L C02CA03 Trimazosin WHO Anatomical Therapeutic Chemical classification 0‑L C02CA04 Doxazosin WHO Anatomical Therapeutic Chemical classification 0‑L C02CA06 Urapidil WHO Anatomical Therapeutic Chemical classification 0‑L C02CC Guanidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02CC01 Betanidin WHO Anatomical Therapeutic Chemical classification 0‑L C02CC02 Guanethidin WHO Anatomical Therapeutic Chemical classification 0‑L C02CC03 Guanoxan WHO Anatomical Therapeutic Chemical classification 0‑L C02CC04 Debrisoquin WHO Anatomical Therapeutic Chemical classification 0‑L C02CC05 Guanoclor WHO Anatomical Therapeutic Chemical classification 0‑L C02CC06 Guanazodin WHO Anatomical Therapeutic Chemical classification 0‑L C02CC07 Guanoxabenz WHO Anatomical Therapeutic Chemical classification 0‑L C02D mittel mit Wirkung auf die arterielle Gefässmuskulatur WHO Anatomical Therapeutic Chemical classification 0‑L C02DA Thiazid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02DA01 Diazoxid WHO Anatomical Therapeutic Chemical classification 0‑L C02DB Hydrazinophthalazin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02DB01 Dihydralazin WHO Anatomical Therapeutic Chemical classification 0‑L C02DB02 Hydralazin WHO Anatomical Therapeutic Chemical classification 0‑L C02DB03 Endralazin WHO Anatomical Therapeutic Chemical classification 0‑L C02DB04 Cadralazin WHO Anatomical Therapeutic Chemical classification 0‑L C02DC Pyrimidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02DC01 Minoxidil WHO Anatomical Therapeutic Chemical classification 0‑L C02DD Nitroferrocyanid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02DD01 Nitroprussid WHO Anatomical Therapeutic Chemical classification 0‑L C02DF Non-thiazide sulfonamides WHO Anatomical Therapeutic Chemical classification 0‑L C02DG Guanidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C02DG01 Pinacidil WHO Anatomical Therapeutic Chemical classification 0‑L C02K Andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C02KA Alkaloide, exkl. Rauwolfia WHO Anatomical Therapeutic Chemical classification 0‑L C02KA01 Veratrum WHO Anatomical Therapeutic Chemical classification 0‑L C02KB Tyrosinhydroxylasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L C02KB01 Metirosin WHO Anatomical Therapeutic Chemical classification 0‑L C02KC MAO-Hemmer WHO Anatomical Therapeutic Chemical classification 0‑L C02KC01 Pargylin WHO Anatomical Therapeutic Chemical classification 0‑L C02KD Serotonin-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L C02KD01 Ketanserin WHO Anatomical Therapeutic Chemical classification 0‑L C02KX Andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C02KX01 Bosentan WHO Anatomical Therapeutic Chemical classification 0‑L C02KX02 Ambrisentan WHO Anatomical Therapeutic Chemical classification 0‑L C02KX03 Sitaxentan WHO Anatomical Therapeutic Chemical classification 0‑L C02L Antihypertonika und Diuretika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C02LA Rauwolfia-Alkaloide und Diuretika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C02LA01 Reserpin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA02 Rescinnamin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA03 Deserpidin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA04 Methoserpidin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA07 Bietaserpin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA08 Rauwolfia-Alkaloide, ganze Wurzel und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA09 Syrosingopin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LA50 Kombinationen von Rauwolfia-Alkaloiden und Diuretika inkl. andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C02LA51 Reserpin und Diuretika, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L C02LA52 Rescinnamin und Diuretika, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L C02LA71 Reserpin und Diuretika, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L C02LB Methyldopa und Diuretika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C02LB01 Methyldopa (linksdrehend) und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LC Imidazolin-Rezeptoragonisten in Kombination mit Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LC01 Clonidin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LC05 Moxonidin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LC51 Clonidin und Diuretika, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L C02LE Alpha-Adrenorezeptor-Antagonisten und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LE01 Prazosin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LF Guanidin-Derivate und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LF01 Guanethidin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LG Hydrazinophthalazin-Derivate und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LG01 Dihydralazin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LG02 Hydralazin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LG03 Picodralazin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LG51 Dihydralazin und Diuretika, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L C02LG73 Picodralazin und Diuretika, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L C02LI Calcium channel blockers and diuretics WHO Anatomical Therapeutic Chemical classification 0‑L C02LK Alkaloide, exkl. Rauwolfia, in Kombination mit Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LK01 Veratrum und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LL MAO-Hemmer und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LL01 Pargylin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LN Serotonin-Antagonisten und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LX Andere Antihypertonika und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02LX01 Pinacidil und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C02N Kombinationen von antihypertensiven Wirkstoffen aus ATC-Gruppe C02 WHO Anatomical Therapeutic Chemical classification 0‑L C03 Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C03A Low-Ceiling-Diuretika, Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C03AA Thiazide, rein WHO Anatomical Therapeutic Chemical classification 0‑L C03AA01 Bendroflumethiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA02 Hydroflumethiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA03 Hydrochlorothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA04 Chlorothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA05 Polythiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA06 Trichlormethiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA07 Cyclopenthiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA08 Methylclothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA09 Cyclothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C03AA13 Mebutizid WHO Anatomical Therapeutic Chemical classification 0‑L C03AB Thiazide und Kalium in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C03AB01 Bendroflumethiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB02 Hydroflumethiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB03 Hydrochlorothiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB04 Chlorothiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB05 Polythiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB06 Trichlormethiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB07 Cyclopenthiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB08 Methylclothiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AB09 Cyclothiazid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03AH Thiazide, Kombinationen mit Psycholeptika und/oder Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L C03AH01 Chlorothiazid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C03AH02 Hydroflumethiazid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C03AX Thiazide, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L C03AX01 Hydrochlorothiazid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C03B Low-Ceiling-Diuretika, exkl. Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C03BA Sulfonamide, rein WHO Anatomical Therapeutic Chemical classification 0‑L C03BA02 Quinethazon WHO Anatomical Therapeutic Chemical classification 0‑L C03BA03 Clopamid WHO Anatomical Therapeutic Chemical classification 0‑L C03BA04 Chlortalidon WHO Anatomical Therapeutic Chemical classification 0‑L C03BA05 Mefrusid WHO Anatomical Therapeutic Chemical classification 0‑L C03BA07 Clofenamid WHO Anatomical Therapeutic Chemical classification 0‑L C03BA08 Metolazon WHO Anatomical Therapeutic Chemical classification 0‑L C03BA09 Meticran WHO Anatomical Therapeutic Chemical classification 0‑L C03BA10 Xipamid WHO Anatomical Therapeutic Chemical classification 0‑L C03BA11 Indapamid WHO Anatomical Therapeutic Chemical classification 0‑L C03BA12 Clorexolon WHO Anatomical Therapeutic Chemical classification 0‑L C03BA13 Fenquizon WHO Anatomical Therapeutic Chemical classification 0‑L C03BA82 Clorexolon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L C03BB Sulfonamide und Kalium in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C03BB02 Quinethazon und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03BB03 Clopamid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03BB04 Chlortalidon und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03BB05 Mefrusid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03BB07 Clofenamid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03BC Quecksilber-haltige Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C03BC01 Mersalyl WHO Anatomical Therapeutic Chemical classification 0‑L C03BD Xanthin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C03BD01 Theobromin WHO Anatomical Therapeutic Chemical classification 0‑L C03BK Sulfonamide, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L C03BX Andere Low-ceiling-Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C03BX03 Cicletanin WHO Anatomical Therapeutic Chemical classification 0‑L C03C High-Ceiling-Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C03CA Sulfonamide, rein WHO Anatomical Therapeutic Chemical classification 0‑L C03CA01 Furosemid WHO Anatomical Therapeutic Chemical classification 0‑L C03CA02 Bumetanid WHO Anatomical Therapeutic Chemical classification 0‑L C03CA03 Piretanid WHO Anatomical Therapeutic Chemical classification 0‑L C03CA04 Torasemid WHO Anatomical Therapeutic Chemical classification 0‑L C03CB Sulfonamide und Kalium in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C03CB01 Furosemid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03CB02 Bumetanid und Kalium WHO Anatomical Therapeutic Chemical classification 0‑L C03CC Aryloxyessigsäure-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C03CC01 Etacrynsäure WHO Anatomical Therapeutic Chemical classification 0‑L C03CC02 Tienilinsäure WHO Anatomical Therapeutic Chemical classification 0‑L C03CD Pyrazolon-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C03CD01 Muzolimin WHO Anatomical Therapeutic Chemical classification 0‑L C03CX Andere High-ceiling-Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C03CX01 Etozolin WHO Anatomical Therapeutic Chemical classification 0‑L C03D Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03DA Aldosteron-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L C03DA01 Spironolacton WHO Anatomical Therapeutic Chemical classification 0‑L C03DA02 Kaliumcanrenoat WHO Anatomical Therapeutic Chemical classification 0‑L C03DA03 Canrenon WHO Anatomical Therapeutic Chemical classification 0‑L C03DA04 Eplerenon WHO Anatomical Therapeutic Chemical classification 0‑L C03DB Andere Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03DB01 Amilorid WHO Anatomical Therapeutic Chemical classification 0‑L C03DB02 Triamteren WHO Anatomical Therapeutic Chemical classification 0‑L C03E Diuretika und Kalium sparende Mittel in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L C03EA Low-ceiling-Diuretika und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA01 Hydrochlorothiazid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA02 Trichlormethiazid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA03 Epitizid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA04 Altizid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA05 Mebutizid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA06 Chlortalidon und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA07 Cyclopenthiazid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA12 Metolazon und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA13 Bendroflumethiazid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EA14 Butizid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EB High-ceiling-Diuretika und Kalium sparende Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C03EB01 Furosemid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C03EB02 Bumetanid und Kalium sparende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C04 Periphere Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C04A Periphere Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C04AA 2-Amino-1-phenylethanol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C04AA01 Isoxsuprin WHO Anatomical Therapeutic Chemical classification 0‑L C04AA02 Buphenin WHO Anatomical Therapeutic Chemical classification 0‑L C04AA31 Bamethan WHO Anatomical Therapeutic Chemical classification 0‑L C04AB Imidazolin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C04AB01 Phentolamin WHO Anatomical Therapeutic Chemical classification 0‑L C04AB02 Tolazolin WHO Anatomical Therapeutic Chemical classification 0‑L C04AC Nicotinsäure und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C04AC01 Nicotinsäure WHO Anatomical Therapeutic Chemical classification 0‑L C04AC02 Nicotinylalkohol (Pyridylcarbinol) WHO Anatomical Therapeutic Chemical classification 0‑L C04AC03 Inositolnicotinat WHO Anatomical Therapeutic Chemical classification 0‑L C04AC07 Ciclonicat WHO Anatomical Therapeutic Chemical classification 0‑L C04AD Purin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C04AD01 Pentifyllin WHO Anatomical Therapeutic Chemical classification 0‑L C04AD02 Xantinolnicotinat WHO Anatomical Therapeutic Chemical classification 0‑L C04AD03 Pentoxifyllin WHO Anatomical Therapeutic Chemical classification 0‑L C04AD04 Etofyllinnicotinat WHO Anatomical Therapeutic Chemical classification 0‑L C04AE Mutterkorn-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L C04AE01 Ergoloidmesylat WHO Anatomical Therapeutic Chemical classification 0‑L C04AE02 Nicergolin WHO Anatomical Therapeutic Chemical classification 0‑L C04AE04 Dihydroergocristin WHO Anatomical Therapeutic Chemical classification 0‑L C04AE51 Ergoloidmesylat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C04AE54 Dihydroergocristin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C04AF Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L C04AF01 Kallidinogenase WHO Anatomical Therapeutic Chemical classification 0‑L C04AX Andere periphere Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C04AX01 Cyclandelat WHO Anatomical Therapeutic Chemical classification 0‑L C04AX02 Phenoxybenzamin WHO Anatomical Therapeutic Chemical classification 0‑L C04AX07 Vincamin WHO Anatomical Therapeutic Chemical classification 0‑L C04AX10 Moxisylyt WHO Anatomical Therapeutic Chemical classification 0‑L C04AX11 Bencyclan WHO Anatomical Therapeutic Chemical classification 0‑L C04AX17 Vinburnin WHO Anatomical Therapeutic Chemical classification 0‑L C04AX19 Suloctidil WHO Anatomical Therapeutic Chemical classification 0‑L C04AX20 Buflomedil WHO Anatomical Therapeutic Chemical classification 0‑L C04AX21 Naftidrofuryl WHO Anatomical Therapeutic Chemical classification 0‑L C04AX23 Butalamin WHO Anatomical Therapeutic Chemical classification 0‑L C04AX24 Visnadin WHO Anatomical Therapeutic Chemical classification 0‑L C04AX26 Cetiedil WHO Anatomical Therapeutic Chemical classification 0‑L C04AX27 Cinepazid WHO Anatomical Therapeutic Chemical classification 0‑L C04AX28 Ifenprodil WHO Anatomical Therapeutic Chemical classification 0‑L C04AX30 Azapetin WHO Anatomical Therapeutic Chemical classification 0‑L C04AX32 Fasudil WHO Anatomical Therapeutic Chemical classification 0‑L C05 Vasoprotektoren WHO Anatomical Therapeutic Chemical classification 0‑L C05A Hämorrhoidenmittel zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L C05AA Corticosteroid-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C05AA01 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L C05AA04 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L C05AA05 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L C05AA06 Fluorometholon WHO Anatomical Therapeutic Chemical classification 0‑L C05AA08 Fluocortolon WHO Anatomical Therapeutic Chemical classification 0‑L C05AA09 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L C05AA10 Fluocinolonacetonid WHO Anatomical Therapeutic Chemical classification 0‑L C05AA11 Fluocinonid WHO Anatomical Therapeutic Chemical classification 0‑L C05AB Antibiotika-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C05AD Lokalanästhetika-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C05AD01 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L C05AD02 Tetracain WHO Anatomical Therapeutic Chemical classification 0‑L C05AD03 Benzocain WHO Anatomical Therapeutic Chemical classification 0‑L C05AD04 Cinchocain WHO Anatomical Therapeutic Chemical classification 0‑L C05AD05 Procain WHO Anatomical Therapeutic Chemical classification 0‑L C05AD06 Oxetacain WHO Anatomical Therapeutic Chemical classification 0‑L C05AD07 Pramocain WHO Anatomical Therapeutic Chemical classification 0‑L C05AE01 Glyceroltrinitrat WHO Anatomical Therapeutic Chemical classification 0‑L C05AX Andere Hämorrhoidenmittel zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L C05AX01 Aluminium-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L C05AX02 Bismutpräparate, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05AX03 Andere Hämorrhoidenmittel, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05AX04 Zinkpräparate WHO Anatomical Therapeutic Chemical classification 0‑L C05AX05 Tribenosid WHO Anatomical Therapeutic Chemical classification 0‑L C05B Antivarikosa WHO Anatomical Therapeutic Chemical classification 0‑L C05BA Heparine oder Heparinoide zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L C05BA01 Heparinoide WHO Anatomical Therapeutic Chemical classification 0‑L C05BA02 Natriumapolat WHO Anatomical Therapeutic Chemical classification 0‑L C05BA03 Heparin WHO Anatomical Therapeutic Chemical classification 0‑L C05BA04 Natriumpentosanpolysulfat WHO Anatomical Therapeutic Chemical classification 0‑L C05BA51 Heparinoid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05BA53 Heparin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05BB Sklerosierende Mittel zur lokalen Injektion WHO Anatomical Therapeutic Chemical classification 0‑L C05BB01 Monoethanolaminoleat WHO Anatomical Therapeutic Chemical classification 0‑L C05BB02 Polidocanol WHO Anatomical Therapeutic Chemical classification 0‑L C05BB03 Invertzucker WHO Anatomical Therapeutic Chemical classification 0‑L C05BB04 Natriumtetradecylsulfat WHO Anatomical Therapeutic Chemical classification 0‑L C05BB05 Phenol WHO Anatomical Therapeutic Chemical classification 0‑L C05BB56 Glucose, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05BX Andere sklerosierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C05BX01 Calciumdobesilat WHO Anatomical Therapeutic Chemical classification 0‑L C05BX51 Calciumdobesilat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05C Kapillarstabilisierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C05CA Bioflavonoide WHO Anatomical Therapeutic Chemical classification 0‑L C05CA01 Rutoside WHO Anatomical Therapeutic Chemical classification 0‑L C05CA02 Monoxerutin WHO Anatomical Therapeutic Chemical classification 0‑L C05CA03 Diosmin WHO Anatomical Therapeutic Chemical classification 0‑L C05CA04 Troxerutin WHO Anatomical Therapeutic Chemical classification 0‑L C05CA05 Hidrosmin WHO Anatomical Therapeutic Chemical classification 0‑L C05CA51 Rutosid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05CA53 Diosmin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05CA54 Troxerutin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C05CP02 Weinlaubblätter WHO Anatomical Therapeutic Chemical classification 0‑L C05CX Andere kapillarstabilisierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C05CX01 Tribenosid WHO Anatomical Therapeutic Chemical classification 0‑L C07 Beta-Adrenorezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L C07A Beta-Adrenorezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L C07AA Beta-Adrenorezeptor-Antagonisten, nichtselektiv WHO Anatomical Therapeutic Chemical classification 0‑L C07AA01 Alprenolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA02 Oxprenolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA03 Pindolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA05 Propranolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA06 Timolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA07 Sotalol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA12 Nadolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA14 Mepindolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA15 Carteolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA16 Tertatolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA17 Bopindolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA19 Bupranolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA23 Penbutolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA27 Cloranolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AA57 Sotalol, Kombinationspackungen WHO Anatomical Therapeutic Chemical classification 0‑L C07AB Beta-Adrenorezeptor-Antagonisten, selektiv WHO Anatomical Therapeutic Chemical classification 0‑L C07AB01 Practolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB02 Metoprolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB03 Atenolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB04 Acebutolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB05 Betaxolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB06 Bevantolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB07 Bisoprolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB08 Celiprolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB09 Esmolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB10 Epanolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB11 S-Atenolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB12 Nebivolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB13 Talinolol WHO Anatomical Therapeutic Chemical classification 0‑L C07AB52 Metoprolol, Kombinationspackungen WHO Anatomical Therapeutic Chemical classification 0‑L C07AB57 Bisoprolol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C07AG Alpha- und Beta-Adrenorezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L C07AG01 Labetalol WHO Anatomical Therapeutic Chemical classification 0‑L C07AG02 Carvedilol WHO Anatomical Therapeutic Chemical classification 0‑L C07B Beta-Adrenorezeptor-Antagonisten und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA02 Oxprenolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA05 Propranolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA06 Timolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA07 Sotalol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA12 Nadolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BA68 Metipranolol und Thiazide, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C07BB Beta-Adrenorezeptor-Antagonisten, selektiv, und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB02 Metoprolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB03 Atenolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB04 Acebutolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB06 Bevantolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB07 Bisoprolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB12 Nebivolol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BB52 Metoprolol und Thiazide, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C07BG Alpha- und Beta-Adrenorezeptor-Antagonisten und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07BG01 Labetalol und Thiazide WHO Anatomical Therapeutic Chemical classification 0‑L C07C Beta-Adrenorezeptor-Antagonisten und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CA Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CA02 Oxprenolol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CA03 Pindolol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CA17 Bopindolol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CA23 Penbutolol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CB Beta-Adrenorezeptor-Antagonisten, selektiv, und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CB02 Metoprolol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CB03 Atenolol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CB53 Atenolol und andere Diuretika, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C07CG Alpha- und Beta-Adrenorezeptor-Antagonisten und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07CG01 Labetalol und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07D Beta-Adrenorezeptor-Antagonisten, Thiazide und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07DA Beta-Adrenorezeptor-Antagonisten, nichtselektiv, Thiazide und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07DA06 Timolol, Thiazide und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07DB Beta-Adrenorezeptor-Antagonisten, selektiv, Thiazide und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07DB01 Atenolol, Thiazide und andere Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C07E Beta-Adrenorezeptor-Antagonisten und Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C07EA Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C07EB Beta-Adrenorezeptor-Antagonisten, selektiv, und Vasodilatatoren WHO Anatomical Therapeutic Chemical classification 0‑L C07F Beta-Adrenorezeptor-Antagonisten und andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C07FA Beta-Adrenorezeptor-Antagonisten, nichtselektiv, und andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C07FA05 Propranolol und andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C07FB Beta-Adrenorezeptor-Antagonisten, selektiv, und andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C07FB02 Metoprolol und andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C07FB03 Atenolol und andere Antihypertonika WHO Anatomical Therapeutic Chemical classification 0‑L C08 Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C08C Selektive Calciumkanalblocker mit vorwiegender Gefässwirkung WHO Anatomical Therapeutic Chemical classification 0‑L C08CA Dihydropyridin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C08CA01 Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA02 Felodipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA03 Isradipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA04 Nicardipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA05 Nifedipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA06 Nimodipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA07 Nisoldipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA08 Nitrendipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA09 Lacidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA10 Nilvadipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA11 Manidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA12 Barnidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA13 Lercanidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA14 Cilnidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA15 Benidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA16 Clevidipin WHO Anatomical Therapeutic Chemical classification 0‑L C08CA55 Nifedipin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C08CX Andere selektive Calciumkanalblocker mit vorwiegender Gefässwirkung WHO Anatomical Therapeutic Chemical classification 0‑L C08CX01 Mibefradil WHO Anatomical Therapeutic Chemical classification 0‑L C08D Selektive Calciumkanalblocker mit direkter Herzwirkung WHO Anatomical Therapeutic Chemical classification 0‑L C08DA Phenylalkylamin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C08DA01 Verapamil WHO Anatomical Therapeutic Chemical classification 0‑L C08DA02 Gallopamil WHO Anatomical Therapeutic Chemical classification 0‑L C08DA51 Verapamil, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C08DB Benzothiazepin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C08DB01 Diltiazem WHO Anatomical Therapeutic Chemical classification 0‑L C08E Nichtselektive Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C08EA Phenylalkylamin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C08EA01 Fendilin WHO Anatomical Therapeutic Chemical classification 0‑L C08EA02 Bepridil WHO Anatomical Therapeutic Chemical classification 0‑L C08EX Andere nichtselektive Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C08EX01 Lidoflazin WHO Anatomical Therapeutic Chemical classification 0‑L C08EX02 Perhexilin WHO Anatomical Therapeutic Chemical classification 0‑L C08G Calciumkanalblocker und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C08GA Calciumkanalblocker und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C08GA01 Nifedipin und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09 Mittel mit Wirkung auf das Renin-Angiotensin-System WHO Anatomical Therapeutic Chemical classification 0‑L C09A ACE-Hemmer, rein WHO Anatomical Therapeutic Chemical classification 0‑L C09AA ACE-Hemmer, rein WHO Anatomical Therapeutic Chemical classification 0‑L C09AA01 Captopril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA02 Enalapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA03 Lisinopril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA04 Perindopril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA05 Ramipril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA06 Quinapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA07 Benazepril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA08 Cilazapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA09 Fosinopril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA10 Trandolapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA11 Spirapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA12 Delapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA13 Moexipril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA14 Temocapril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA15 Zofenopril WHO Anatomical Therapeutic Chemical classification 0‑L C09AA16 Imidapril WHO Anatomical Therapeutic Chemical classification 0‑L C09B ACE-Hemmer, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C09BA ACE-Hemmer und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA01 Captopril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA02 Enalapril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA03 Lisinopril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA04 Perindopril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA05 Ramipril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA06 Quinapril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA07 Benazepril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA08 Cilazapril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA09 Fosinopril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA12 Delapril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA13 Moexipril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BA15 Zofenopril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09BB ACE-Hemmer und Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C09BB02 Enalapril und Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C09BB03 Lisinopril und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09BB04 Perindopril und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09BB05 Ramipril und Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C09BB07 Ramipril und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09BB10 Trandolapril und Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C09BB12 Delapril und Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C09C Angiotensin-Ii-Antagonisten, rein WHO Anatomical Therapeutic Chemical classification 0‑L C09CA Angiotensin-II-Antagonisten, rein WHO Anatomical Therapeutic Chemical classification 0‑L C09CA01 Losartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA02 Eprosartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA03 Valsartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA04 Irbesartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA05 Tasosartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA06 Candesartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA07 Telmisartan WHO Anatomical Therapeutic Chemical classification 0‑L C09CA08 Olmesartan medoxomil WHO Anatomical Therapeutic Chemical classification 0‑L C09D Angiotensin-II-Antagonisten, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C09DA Angiotensin-II-Antagonisten und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA01 Losartan und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA02 Eprosartan und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA03 Valsartan und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA04 Irbesartan und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA06 Candesartan und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA07 Telmisartan und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DA08 Olmesartan medoxomil und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L C09DB Angiotensin-II-Antagonisten und Calciumkanalblocker WHO Anatomical Therapeutic Chemical classification 0‑L C09DB01 Valsartan und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09DB02 Olmesartanmedoxomil und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09DB04 Telmisartan/Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09DX01 Valsartan, Amlodipin und Hydrochlorothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C09DX03 Olmesartan medoxomil, Amlodipin und Hydrochlorothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C09X Andere Mittel mit Wirkung auf das Renin-Angiotensin-System WHO Anatomical Therapeutic Chemical classification 0‑L C09XA Renin-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L C09XA01 Remikiren WHO Anatomical Therapeutic Chemical classification 0‑L C09XA02 Aliskiren WHO Anatomical Therapeutic Chemical classification 0‑L C09XA52 Aliskiren und Hydrochlorothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C09XA53 Aliskiren und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L C09XA54 Aliskiren, Amlodipin und Hydrochlorothiazid WHO Anatomical Therapeutic Chemical classification 0‑L C10 Mittel, die den Lipidstoffwechsel beeinflussen WHO Anatomical Therapeutic Chemical classification 0‑L C10A Mittel, die den Lipidstoffwechsel beeinflussen, rein WHO Anatomical Therapeutic Chemical classification 0‑L C10AA HMG-CoA-Reduktasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L C10AA01 Simvastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA02 Lovastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA03 Pravastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA04 Fluvastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA05 Atorvastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA06 Cerivastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA07 Rosuvastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AA08 Pitavastatin WHO Anatomical Therapeutic Chemical classification 0‑L C10AB Fibrate WHO Anatomical Therapeutic Chemical classification 0‑L C10AB01 Clofibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB02 Bezafibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB03 Aluminiumclofibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB04 Gemfibrozil WHO Anatomical Therapeutic Chemical classification 0‑L C10AB05 Fenofibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB06 Simfibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB07 Ronifibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB08 Ciprofibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB09 Etofibrat WHO Anatomical Therapeutic Chemical classification 0‑L C10AB10 Clofibrid WHO Anatomical Therapeutic Chemical classification 0‑L C10AC Gallensäure bindende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L C10AC01 Colestyramin WHO Anatomical Therapeutic Chemical classification 0‑L C10AC02 Colestipol WHO Anatomical Therapeutic Chemical classification 0‑L C10AC03 Colextran WHO Anatomical Therapeutic Chemical classification 0‑L C10AC04 Colesevelam WHO Anatomical Therapeutic Chemical classification 0‑L C10AD Nicotinsäure und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L C10AD01 Niceritrol WHO Anatomical Therapeutic Chemical classification 0‑L C10AD02 Nicotinsäure WHO Anatomical Therapeutic Chemical classification 0‑L C10AD03 Nicofuranose WHO Anatomical Therapeutic Chemical classification 0‑L C10AD04 Aluminiumnicotinat WHO Anatomical Therapeutic Chemical classification 0‑L C10AD05 Nicotinylalkohol (Pyridylcarbinol) WHO Anatomical Therapeutic Chemical classification 0‑L C10AD06 Acipimox WHO Anatomical Therapeutic Chemical classification 0‑L C10AD52 Nicotinsäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C10AX Andere Mittel, die den Lipidstoffwechsel beeinflussen WHO Anatomical Therapeutic Chemical classification 0‑L C10AX01 Dextrothyroxin WHO Anatomical Therapeutic Chemical classification 0‑L C10AX02 Probucol WHO Anatomical Therapeutic Chemical classification 0‑L C10AX03 Tiadenol WHO Anatomical Therapeutic Chemical classification 0‑L C10AX04 Benfluorex WHO Anatomical Therapeutic Chemical classification 0‑L C10AX05 Meglutol WHO Anatomical Therapeutic Chemical classification 0‑L C10AX06 Omega-3-triglyceride WHO Anatomical Therapeutic Chemical classification 0‑L C10AX07 Magnesiumpyridoxal-5-phosphatglutamat WHO Anatomical Therapeutic Chemical classification 0‑L C10AX08 Policosanol WHO Anatomical Therapeutic Chemical classification 0‑L C10AX09 Ezetimib WHO Anatomical Therapeutic Chemical classification 0‑L C10B Mittel, die den Lipidstoffwechsel beeinflussen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C10BA HMG-CoA-Reduktasehemmer in Kombination mit anderen Mitteln, die den Lipidstoffwechsel beeinflussen WHO Anatomical Therapeutic Chemical classification 0‑L C10BA01 Lovastatin und Nicotinsäure WHO Anatomical Therapeutic Chemical classification 0‑L C10BA02 Simvastatin und Ezetimib WHO Anatomical Therapeutic Chemical classification 0‑L C10BA05 Atorvastatin und Ezetimib WHO Anatomical Therapeutic Chemical classification 0‑L C10BX HMG-CoA-Reduktasehemmer, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L C10BX01 Simvastatin und Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L C10BX02 Pravastatin und Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L C10BX03 Atorvastatin und Amlodipin WHO Anatomical Therapeutic Chemical classification 0‑L D Dermatika WHO Anatomical Therapeutic Chemical classification 0‑L D01 Antimykotika zur dermatologischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D01A Antimykotika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D01AA Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D01AA01 Nystatin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA02 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA03 Hachimycin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA04 Pecilocin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA06 Mepartricin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA07 Pyrrolnitrin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA08 Griseofulvin WHO Anatomical Therapeutic Chemical classification 0‑L D01AA20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D01AC Imidazol- und Triazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D01AC01 Clotrimazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC02 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC03 Econazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC04 Chlormidazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC05 Isoconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC06 Tiabendazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC07 Tioconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC08 Ketoconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC09 Sulconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC10 Bifonazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC11 Oxiconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC12 Fenticonazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC13 Omoconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC14 Sertaconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC15 Fluconazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC16 Flutrimazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AC20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D01AC52 Miconazol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D01AC60 Bifonazol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D01AE Andere Antimykotika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D01AE01 Bromchlorsalicylanilid WHO Anatomical Therapeutic Chemical classification 0‑L D01AE02 Methylrosanilin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE03 Tribrommetacresol WHO Anatomical Therapeutic Chemical classification 0‑L D01AE04 Undecylensäure WHO Anatomical Therapeutic Chemical classification 0‑L D01AE05 Polynoxylin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE06 2-(4-chlorphenoxy)-ethanol WHO Anatomical Therapeutic Chemical classification 0‑L D01AE07 Chlorphenesin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE08 Ticlaton WHO Anatomical Therapeutic Chemical classification 0‑L D01AE09 Sulbentin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE10 Ethylhydroxybenzoat WHO Anatomical Therapeutic Chemical classification 0‑L D01AE11 Haloprogin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE12 Salicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L D01AE13 Selendisulfid WHO Anatomical Therapeutic Chemical classification 0‑L D01AE14 Ciclopirox WHO Anatomical Therapeutic Chemical classification 0‑L D01AE15 Terbinafin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE16 Amorolfin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE17 Dimazol WHO Anatomical Therapeutic Chemical classification 0‑L D01AE18 Tolnaftat WHO Anatomical Therapeutic Chemical classification 0‑L D01AE19 Tolciclat WHO Anatomical Therapeutic Chemical classification 0‑L D01AE20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D01AE21 Flucytosin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE22 Naftifin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE23 Butenafin WHO Anatomical Therapeutic Chemical classification 0‑L D01AE54 Undecylensäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D01B Antimykotika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D01BA Antimykotika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D01BA01 Griseofulvin WHO Anatomical Therapeutic Chemical classification 0‑L D01BA02 Terbinafin WHO Anatomical Therapeutic Chemical classification 0‑L D02 Emollientia und Hautschutzmittel WHO Anatomical Therapeutic Chemical classification 0‑L D02A Emollientia und Hautschutzmittel WHO Anatomical Therapeutic Chemical classification 0‑L D02AA Silikon-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D02AB Zink-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D02AC Vaseline und Fett-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D02AD Flüssige Pflaster WHO Anatomical Therapeutic Chemical classification 0‑L D02AE Harnstoff-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D02AE01 Harnstoff WHO Anatomical Therapeutic Chemical classification 0‑L D02AE51 Harnstoff, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D02AF Salicylsäure-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L D02AX Andere Emollientia und Hautschutzmittel WHO Anatomical Therapeutic Chemical classification 0‑L D02B Protektiva gegen UV-Strahlung WHO Anatomical Therapeutic Chemical classification 0‑L D02BA Protektiva gegen UV-Strahlung zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D02BA01 Aminobenzoesäure WHO Anatomical Therapeutic Chemical classification 0‑L D02BA02 Octinoxat WHO Anatomical Therapeutic Chemical classification 0‑L D02BB Protektiva gegen UV-Strahlung zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D02BB01 Betacaroten WHO Anatomical Therapeutic Chemical classification 0‑L D03 Zubereitungen zur Behandlung von Wunden und Geschwüren WHO Anatomical Therapeutic Chemical classification 0‑L D03A Wundbehandlungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L D03AA Lebertransalben WHO Anatomical Therapeutic Chemical classification 0‑L D03AX Andere Wundbehandlungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L D03AX01 Cadexomer-Iod WHO Anatomical Therapeutic Chemical classification 0‑L D03AX02 Dextranomer WHO Anatomical Therapeutic Chemical classification 0‑L D03AX03 Dexpanthenol WHO Anatomical Therapeutic Chemical classification 0‑L D03AX04 Calciumpantothenat WHO Anatomical Therapeutic Chemical classification 0‑L D03AX05 Hyaluronsäure WHO Anatomical Therapeutic Chemical classification 0‑L D03AX06 Becaplermin WHO Anatomical Therapeutic Chemical classification 0‑L D03AX07 Glyceroltrinitrat WHO Anatomical Therapeutic Chemical classification 0‑L D03AX08 Isosorbiddinitrat WHO Anatomical Therapeutic Chemical classification 0‑L D03AX09 Crilanomer WHO Anatomical Therapeutic Chemical classification 0‑L D03AX10 Enoxolon WHO Anatomical Therapeutic Chemical classification 0‑L D03B Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L D03BA Proteolytische Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L D03BA01 Trypsin WHO Anatomical Therapeutic Chemical classification 0‑L D03BA02 Clostridiopeptidase WHO Anatomical Therapeutic Chemical classification 0‑L D03BA52 Clostridiopeptidase, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D04 Antipruriginosa, inkl. Antihistaminika, Anästhetika etc. WHO Anatomical Therapeutic Chemical classification 0‑L D04A Antipruriginosa, inkl. Antihistaminika, Anästhetika etc. WHO Anatomical Therapeutic Chemical classification 0‑L D04AA Antihistaminika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D04AA01 Thonzylamin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA02 Mepyramin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA03 Thenalidin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA04 Tripelennamin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA09 Chloropyramin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA10 Promethazin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA12 Tolpropamin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA13 Dimetinden WHO Anatomical Therapeutic Chemical classification 0‑L D04AA14 Clemastin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA15 Bamipin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA22 Isothipendyl WHO Anatomical Therapeutic Chemical classification 0‑L D04AA32 Diphenhydramin WHO Anatomical Therapeutic Chemical classification 0‑L D04AA33 Diphenhydraminmethylbromid WHO Anatomical Therapeutic Chemical classification 0‑L D04AA34 Chlorphenoxamin WHO Anatomical Therapeutic Chemical classification 0‑L D04AB Lokalanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L D04AB01 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L D04AB02 Cinchocain WHO Anatomical Therapeutic Chemical classification 0‑L D04AB03 Oxybuprocain WHO Anatomical Therapeutic Chemical classification 0‑L D04AB04 Benzocain WHO Anatomical Therapeutic Chemical classification 0‑L D04AB05 Chinisocain WHO Anatomical Therapeutic Chemical classification 0‑L D04AB06 Tetracain WHO Anatomical Therapeutic Chemical classification 0‑L D04AB07 Pramocain WHO Anatomical Therapeutic Chemical classification 0‑L D04AX Andere Antipruriginosa WHO Anatomical Therapeutic Chemical classification 0‑L D05 Antipsoriatika WHO Anatomical Therapeutic Chemical classification 0‑L D05A Antipsoriatika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D05AA Teere WHO Anatomical Therapeutic Chemical classification 0‑L D05AC Anthracen-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D05AC01 Dithranol WHO Anatomical Therapeutic Chemical classification 0‑L D05AC51 Dithranol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D05AD Psoralene zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D05AD01 Trioxysalen WHO Anatomical Therapeutic Chemical classification 0‑L D05AD02 Methoxsalen WHO Anatomical Therapeutic Chemical classification 0‑L D05AX Andere Antipsoriatika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D05AX01 Fumarsäure WHO Anatomical Therapeutic Chemical classification 0‑L D05AX02 Calcipotriol WHO Anatomical Therapeutic Chemical classification 0‑L D05AX03 Calcitriol WHO Anatomical Therapeutic Chemical classification 0‑L D05AX04 Tacalcitol WHO Anatomical Therapeutic Chemical classification 0‑L D05AX05 Tazaroten WHO Anatomical Therapeutic Chemical classification 0‑L D05AX52 Calcipotriol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D05B Antipsoriatika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D05BA Psoralene zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D05BA01 Trioxysalen WHO Anatomical Therapeutic Chemical classification 0‑L D05BA02 Methoxsalen WHO Anatomical Therapeutic Chemical classification 0‑L D05BA03 Bergapten WHO Anatomical Therapeutic Chemical classification 0‑L D05BB Retinoide zur Behandlung der Psoriasis WHO Anatomical Therapeutic Chemical classification 0‑L D05BB01 Etretinat WHO Anatomical Therapeutic Chemical classification 0‑L D05BB02 Acitretin WHO Anatomical Therapeutic Chemical classification 0‑L D05BX Andere Antipsoriatika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D05BX51 Fumarsäure-Derivate, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D06 Antibiotika und Chemotherapeutika zur Dermatologischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D06A Antibiotika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D06AA Tetracyclin und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D06AA01 Demeclocyclin WHO Anatomical Therapeutic Chemical classification 0‑L D06AA02 Chlortetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L D06AA03 Oxytetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L D06AA04 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX Andere Antibiotika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D06AX01 Fusidinsäure WHO Anatomical Therapeutic Chemical classification 0‑L D06AX02 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L D06AX04 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX05 Bacitracin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX07 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX08 Tyrothricin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX09 Mupirocin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX10 Virginiamycin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX11 Rifaximin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX12 Amikacin WHO Anatomical Therapeutic Chemical classification 0‑L D06AX13 Retapamulin WHO Anatomical Therapeutic Chemical classification 0‑L D06B Chemotherapeutika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D06BA Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L D06BA01 Sulfadiazin-Silber WHO Anatomical Therapeutic Chemical classification 0‑L D06BA02 Sulfathiazol WHO Anatomical Therapeutic Chemical classification 0‑L D06BA03 Mafenid WHO Anatomical Therapeutic Chemical classification 0‑L D06BA04 Sulfamethizol WHO Anatomical Therapeutic Chemical classification 0‑L D06BA05 Sulfanilamid WHO Anatomical Therapeutic Chemical classification 0‑L D06BA06 Sulfamerazin WHO Anatomical Therapeutic Chemical classification 0‑L D06BA51 Sulfadiazin-Silber, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D06BB Antivirale Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D06BB01 Idoxuridin WHO Anatomical Therapeutic Chemical classification 0‑L D06BB02 Tromantadin WHO Anatomical Therapeutic Chemical classification 0‑L D06BB03 Aciclovir WHO Anatomical Therapeutic Chemical classification 0‑L D06BB04 Podophyllotoxin WHO Anatomical Therapeutic Chemical classification 0‑L D06BB05 Inosin WHO Anatomical Therapeutic Chemical classification 0‑L D06BB06 Penciclovir WHO Anatomical Therapeutic Chemical classification 0‑L D06BB07 Lysozym WHO Anatomical Therapeutic Chemical classification 0‑L D06BB08 Ibacitabin WHO Anatomical Therapeutic Chemical classification 0‑L D06BB09 Edoxudin WHO Anatomical Therapeutic Chemical classification 0‑L D06BB10 Imiquimod WHO Anatomical Therapeutic Chemical classification 0‑L D06BB11 Docosanol WHO Anatomical Therapeutic Chemical classification 0‑L D06BB53 Aciclovir, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D06BX Andere Chemotherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L D06BX01 Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L D06C Antibiotika und Chemotherapeutika, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D07 Corticosteroide, Dermatologische Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L D07A Corticosteroide, rein WHO Anatomical Therapeutic Chemical classification 0‑L D07AA Corticosteroide, schwach wirksam (Gruppe I) WHO Anatomical Therapeutic Chemical classification 0‑L D07AA01 Methylprednisolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AA02 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L D07AA03 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AB Corticosteroide, mittelstark wirksam (Gruppe II) WHO Anatomical Therapeutic Chemical classification 0‑L D07AB01 Clobetason WHO Anatomical Therapeutic Chemical classification 0‑L D07AB02 Hydrocortisonbutyrat WHO Anatomical Therapeutic Chemical classification 0‑L D07AB03 Flumetason WHO Anatomical Therapeutic Chemical classification 0‑L D07AB04 Fluocortin WHO Anatomical Therapeutic Chemical classification 0‑L D07AB05 Fluperolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AB06 Fluorometholon WHO Anatomical Therapeutic Chemical classification 0‑L D07AB07 Flupredniden WHO Anatomical Therapeutic Chemical classification 0‑L D07AB08 Desonid WHO Anatomical Therapeutic Chemical classification 0‑L D07AB09 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AB10 Alclometason WHO Anatomical Therapeutic Chemical classification 0‑L D07AB11 Hydrocortisonbuteprat WHO Anatomical Therapeutic Chemical classification 0‑L D07AB19 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L D07AB21 Clocortolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AB30 Kombinationen mittelstark wirksamer Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L D07AC Corticosteroide, stark wirksam (Gruppe III) WHO Anatomical Therapeutic Chemical classification 0‑L D07AC01 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC02 Fluclorolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AC03 Desoximetason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC04 Fluocinolonacetonid WHO Anatomical Therapeutic Chemical classification 0‑L D07AC05 Fluocortolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AC06 Diflucortolon WHO Anatomical Therapeutic Chemical classification 0‑L D07AC07 Fludroxycortid WHO Anatomical Therapeutic Chemical classification 0‑L D07AC08 Fluocinonid WHO Anatomical Therapeutic Chemical classification 0‑L D07AC09 Budesonid WHO Anatomical Therapeutic Chemical classification 0‑L D07AC10 Diflorason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC11 Amcinonid WHO Anatomical Therapeutic Chemical classification 0‑L D07AC12 Halometason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC13 Mometason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC14 Methylprednisolonaceponat WHO Anatomical Therapeutic Chemical classification 0‑L D07AC15 Beclometason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC16 Hydrocortisonaceponat WHO Anatomical Therapeutic Chemical classification 0‑L D07AC17 Fluticason WHO Anatomical Therapeutic Chemical classification 0‑L D07AC18 Prednicarbat WHO Anatomical Therapeutic Chemical classification 0‑L D07AC19 Difluprednat WHO Anatomical Therapeutic Chemical classification 0‑L D07AC21 Ulobetasol WHO Anatomical Therapeutic Chemical classification 0‑L D07AD Corticosteroide, sehr stark wirksam (Gruppe IV) WHO Anatomical Therapeutic Chemical classification 0‑L D07AD01 Clobetasol WHO Anatomical Therapeutic Chemical classification 0‑L D07AD02 Halcinonid WHO Anatomical Therapeutic Chemical classification 0‑L D07B Corticosteroide, Kombinationen mit Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BA Corticosteroide, schwach wirksam, Kombinationen mit Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BA01 Prednisolon und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BA04 Hydrocortison und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BB Corticosteroide, mittelstark wirksam, Kombinationen mit Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BB01 Flumetason und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BB02 Desonid und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BB03 Triamcinolon und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BB04 Hydrocortisonbutyrat und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BC Corticosteroide, stark wirksam, Kombinationen mit Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BC01 Betamethason und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BC02 Fluocinolonacetonid und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BC03 Fluocortolon und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BC04 Diflucortolon und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07BD Corticosteroide, sehr stark wirksam, Kombinationen mit Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L D07C Corticosteroide, Kombinationen mit Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CA Corticosteroide, schwach wirksam, Kombinationen mit Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CA01 Hydrocortison und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CA02 Methylprednisolon und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CA03 Prednisolon und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CB Corticosteroide, mittelstark wirksam, Kombinationen mit Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CB01 Triamcinolon und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CB02 Flupredniden und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CB03 Fluorometholon und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CB04 Dexamethason und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CB05 Flumetason und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC Corticosteroide, stark wirksam, Kombinationen mit Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC01 Betamethason und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC02 Fluocinolonacetonid und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC03 Fludroxycortid und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC04 Beclometason und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC05 Fluocinonid und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CC06 Fluocortolon und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CD Corticosteroide, sehr stark wirksam, Kombinationen mit Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07CD01 Clobetasol und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L D07X Corticosteroide, Andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D07XA Corticosteroide, schwach wirksam, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D07XA01 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L D07XA02 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L D07XB Corticosteroide, mittelstark wirksam, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D07XB01 Flumetason WHO Anatomical Therapeutic Chemical classification 0‑L D07XB02 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L D07XB03 Flupredniden WHO Anatomical Therapeutic Chemical classification 0‑L D07XB04 Fluorometholon WHO Anatomical Therapeutic Chemical classification 0‑L D07XB05 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L D07XB30 Kombinationen mittelstark wirksamer Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L D07XC Corticosteroide, stark wirksam, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D07XC01 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L D07XC02 Desoximetason WHO Anatomical Therapeutic Chemical classification 0‑L D07XC03 Mometason WHO Anatomical Therapeutic Chemical classification 0‑L D07XC04 Diflucortolon WHO Anatomical Therapeutic Chemical classification 0‑L D07XD Corticosteroide, sehr stark wirksam, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D08 Antiseptika und Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L D08A Antiseptika und Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L D08AA Acridin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D08AA01 Ethacridinlactat WHO Anatomical Therapeutic Chemical classification 0‑L D08AA02 Aminoacridin WHO Anatomical Therapeutic Chemical classification 0‑L D08AA03 Euflavin WHO Anatomical Therapeutic Chemical classification 0‑L D08AB Aluminium-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D08AC Biguanide und Amidine WHO Anatomical Therapeutic Chemical classification 0‑L D08AC01 Dibrompropamidin WHO Anatomical Therapeutic Chemical classification 0‑L D08AC02 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L D08AC03 Propamidin WHO Anatomical Therapeutic Chemical classification 0‑L D08AC04 Hexamidin WHO Anatomical Therapeutic Chemical classification 0‑L D08AC05 Polihexanid WHO Anatomical Therapeutic Chemical classification 0‑L D08AC52 Chlorhexidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D08AD Borsäure-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D08AE Phenol und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D08AE01 Hexachlorophen WHO Anatomical Therapeutic Chemical classification 0‑L D08AE02 Policresulen WHO Anatomical Therapeutic Chemical classification 0‑L D08AE03 Phenol WHO Anatomical Therapeutic Chemical classification 0‑L D08AE04 Triclosan WHO Anatomical Therapeutic Chemical classification 0‑L D08AE05 Chloroxylenol WHO Anatomical Therapeutic Chemical classification 0‑L D08AE06 Biphenylol WHO Anatomical Therapeutic Chemical classification 0‑L D08AF Nitrofuran-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D08AF01 Nitrofural WHO Anatomical Therapeutic Chemical classification 0‑L D08AG Iod-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D08AG01 Iodoctylphenoxypolyglycolether WHO Anatomical Therapeutic Chemical classification 0‑L D08AG02 Povidon-Iod WHO Anatomical Therapeutic Chemical classification 0‑L D08AG03 Iod WHO Anatomical Therapeutic Chemical classification 0‑L D08AG04 Diiodhydroxypropan WHO Anatomical Therapeutic Chemical classification 0‑L D08AH Chinolin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L D08AH01 Dequalinium WHO Anatomical Therapeutic Chemical classification 0‑L D08AH02 Chlorquinaldol WHO Anatomical Therapeutic Chemical classification 0‑L D08AH03 Oxichinolin WHO Anatomical Therapeutic Chemical classification 0‑L D08AH30 Clioquinol WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ Quartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ01 Benzalkonium WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ02 Cetrimonium WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ03 Cetylpyridinium WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ04 Cetrimid WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ05 Benzoxoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ06 Didecyldimethylammoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ57 Octenidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ58 Benzethoniumchlorid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D08AJ59 Dodecloniumbromid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D08AK Quecksilber-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D08AK01 Quecksilberamidochlorid WHO Anatomical Therapeutic Chemical classification 0‑L D08AK02 Phenylmercuriborat WHO Anatomical Therapeutic Chemical classification 0‑L D08AK03 Quecksilberchlorid WHO Anatomical Therapeutic Chemical classification 0‑L D08AK04 Merbromin WHO Anatomical Therapeutic Chemical classification 0‑L D08AK05 Metallisches Quecksilber WHO Anatomical Therapeutic Chemical classification 0‑L D08AK06 Thiomersal WHO Anatomical Therapeutic Chemical classification 0‑L D08AK30 Quecksilberiodid WHO Anatomical Therapeutic Chemical classification 0‑L D08AL Silber-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L D08AL01 Silbernitrat WHO Anatomical Therapeutic Chemical classification 0‑L D08AL30 Silber WHO Anatomical Therapeutic Chemical classification 0‑L D08AX Andere Antiseptika und Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L D08AX01 Wasserstoffperoxid WHO Anatomical Therapeutic Chemical classification 0‑L D08AX02 Eosin WHO Anatomical Therapeutic Chemical classification 0‑L D08AX03 Propanol WHO Anatomical Therapeutic Chemical classification 0‑L D08AX04 Tosylchloramid-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L D08AX05 Isopropanol WHO Anatomical Therapeutic Chemical classification 0‑L D08AX06 Kaliumpermanganat WHO Anatomical Therapeutic Chemical classification 0‑L D08AX07 Natriumhypochlorit WHO Anatomical Therapeutic Chemical classification 0‑L D08AX08 Ethanol WHO Anatomical Therapeutic Chemical classification 0‑L D08AX53 Propanol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D09 Medizinische Verbände WHO Anatomical Therapeutic Chemical classification 0‑L D09A Medizinische Verbände WHO Anatomical Therapeutic Chemical classification 0‑L D09AA Medizinische verbände mit Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L D09AA01 Framycetin WHO Anatomical Therapeutic Chemical classification 0‑L D09AA02 Fusidinsäure WHO Anatomical Therapeutic Chemical classification 0‑L D09AA03 Nitrofural WHO Anatomical Therapeutic Chemical classification 0‑L D09AA04 Phenylquecksilbernitrat WHO Anatomical Therapeutic Chemical classification 0‑L D09AA05 Benzododecinium WHO Anatomical Therapeutic Chemical classification 0‑L D09AA06 Triclosan WHO Anatomical Therapeutic Chemical classification 0‑L D09AA07 Cetylpyridinium WHO Anatomical Therapeutic Chemical classification 0‑L D09AA08 Aluminiumhydroxychlorid WHO Anatomical Therapeutic Chemical classification 0‑L D09AA09 Povidon-Iod WHO Anatomical Therapeutic Chemical classification 0‑L D09AA10 Clioquinol WHO Anatomical Therapeutic Chemical classification 0‑L D09AA11 Benzalkonium WHO Anatomical Therapeutic Chemical classification 0‑L D09AA12 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L D09AA13 Iodoform WHO Anatomical Therapeutic Chemical classification 0‑L D09AB Zink-haltige Verbände WHO Anatomical Therapeutic Chemical classification 0‑L D09AB01 Zink-haltige Verbände ohne Zusätze WHO Anatomical Therapeutic Chemical classification 0‑L D09AB02 Zink-haltige Verbände mit Zusätzen WHO Anatomical Therapeutic Chemical classification 0‑L D09AX Vaselin-haltige Verbände WHO Anatomical Therapeutic Chemical classification 0‑L D10 Aknemittel WHO Anatomical Therapeutic Chemical classification 0‑L D10A Aknemittel zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D10AA Corticosteroide, Kombinationen zur Behandlung der Akne WHO Anatomical Therapeutic Chemical classification 0‑L D10AA01 Fluorometholon WHO Anatomical Therapeutic Chemical classification 0‑L D10AA02 Methylprednisolon WHO Anatomical Therapeutic Chemical classification 0‑L D10AA03 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L D10AB Schwefel-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L D10AB01 Bithionol WHO Anatomical Therapeutic Chemical classification 0‑L D10AB02 Schwefel WHO Anatomical Therapeutic Chemical classification 0‑L D10AB03 Tioxolon WHO Anatomical Therapeutic Chemical classification 0‑L D10AB05 Mesulfen WHO Anatomical Therapeutic Chemical classification 0‑L D10AD Retinoide zur topischen Anwendung bei Akne WHO Anatomical Therapeutic Chemical classification 0‑L D10AD01 Tretinoin WHO Anatomical Therapeutic Chemical classification 0‑L D10AD02 Retinol WHO Anatomical Therapeutic Chemical classification 0‑L D10AD03 Adapalen WHO Anatomical Therapeutic Chemical classification 0‑L D10AD04 Isotretinoin WHO Anatomical Therapeutic Chemical classification 0‑L D10AD05 Motretinid WHO Anatomical Therapeutic Chemical classification 0‑L D10AD51 Tretinoin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10AD53 Adapalen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10AD54 Isotretinoin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10AE Peroxide WHO Anatomical Therapeutic Chemical classification 0‑L D10AE01 Benzoylperoxid WHO Anatomical Therapeutic Chemical classification 0‑L D10AE51 Benzoylperoxid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10AF Antiinfektiva zur Behandlung der Akne WHO Anatomical Therapeutic Chemical classification 0‑L D10AF01 Clindamycin WHO Anatomical Therapeutic Chemical classification 0‑L D10AF02 Erythromycin WHO Anatomical Therapeutic Chemical classification 0‑L D10AF03 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L D10AF04 Meclocyclin WHO Anatomical Therapeutic Chemical classification 0‑L D10AF51 Clindamycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10AF52 Erythromycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10AX Andere Aknemittel zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D10AX01 Aluminiumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L D10AX02 Resorcin WHO Anatomical Therapeutic Chemical classification 0‑L D10AX03 Azelainsäure WHO Anatomical Therapeutic Chemical classification 0‑L D10AX04 Aluminiumoxid WHO Anatomical Therapeutic Chemical classification 0‑L D10AX30 Verschiedene Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D10B Aknemittel zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D10BA Retinoide zur Behandlung der Akne WHO Anatomical Therapeutic Chemical classification 0‑L D10BA01 Isotretinoin WHO Anatomical Therapeutic Chemical classification 0‑L D10BX Andere Aknemittel zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D10BX01 Natriumbituminosulfonat WHO Anatomical Therapeutic Chemical classification 0‑L D11 Andere Dermatika WHO Anatomical Therapeutic Chemical classification 0‑L D11A Andere Dermatika WHO Anatomical Therapeutic Chemical classification 0‑L D11AA Antihidrotika WHO Anatomical Therapeutic Chemical classification 0‑L D11AC Medizinische Haarwaschmittel WHO Anatomical Therapeutic Chemical classification 0‑L D11AC01 Cetrimid WHO Anatomical Therapeutic Chemical classification 0‑L D11AC02 Cadmium-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L D11AC03 Selen-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L D11AC06 Povidon-Iod WHO Anatomical Therapeutic Chemical classification 0‑L D11AC08 Schwefel-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L D11AC09 Xenysalat WHO Anatomical Therapeutic Chemical classification 0‑L D11AC30 Andere WHO Anatomical Therapeutic Chemical classification 0‑L D11AE Androgene zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L D11AE01 Metandienon WHO Anatomical Therapeutic Chemical classification 0‑L D11AF Warzenmittel und Keratolytika WHO Anatomical Therapeutic Chemical classification 0‑L D11AH02 Pimecrolimus WHO Anatomical Therapeutic Chemical classification 0‑L D11AH04 Alitretinoin WHO Anatomical Therapeutic Chemical classification 0‑L D11AX Andere Dermatika WHO Anatomical Therapeutic Chemical classification 0‑L D11AX01 Minoxidil WHO Anatomical Therapeutic Chemical classification 0‑L D11AX02 Gamolensäure WHO Anatomical Therapeutic Chemical classification 0‑L D11AX03 Calciumgluconat WHO Anatomical Therapeutic Chemical classification 0‑L D11AX04 Lithiumsuccinat WHO Anatomical Therapeutic Chemical classification 0‑L D11AX05 Magnesiumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L D11AX06 Mequinol WHO Anatomical Therapeutic Chemical classification 0‑L D11AX08 Tiratricol WHO Anatomical Therapeutic Chemical classification 0‑L D11AX09 Oxaceprol WHO Anatomical Therapeutic Chemical classification 0‑L D11AX10 Finasterid WHO Anatomical Therapeutic Chemical classification 0‑L D11AX11 Hydrochinon WHO Anatomical Therapeutic Chemical classification 0‑L D11AX12 Pyrithion zink WHO Anatomical Therapeutic Chemical classification 0‑L D11AX13 Monobenzon WHO Anatomical Therapeutic Chemical classification 0‑L D11AX14 Tacrolimus WHO Anatomical Therapeutic Chemical classification 0‑L D11AX15 Pimecrolimus WHO Anatomical Therapeutic Chemical classification 0‑L D11AX16 Eflornithin WHO Anatomical Therapeutic Chemical classification 0‑L D11AX17 Cromoglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L D11AX18 Diclofenac WHO Anatomical Therapeutic Chemical classification 0‑L D11AX19 Alitretinoin WHO Anatomical Therapeutic Chemical classification 0‑L D11AX52 Gamolensäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L D11AX57 Kollagen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G Urogenitalsystem und Sexualhormone WHO Anatomical Therapeutic Chemical classification 0‑L G01 Gynäkologische Antiinfektiva und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L G01A Antiinfektiva und Antiseptika, exkl. Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G01AA Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L G01AA01 Nystatin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA02 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA03 Amphotericin B WHO Anatomical Therapeutic Chemical classification 0‑L G01AA04 Candicidin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA05 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L G01AA06 Hachimycin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA07 Oxytetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA08 Carfecillin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA09 Mepartricin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA10 Clindamycin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA11 Pentamycin WHO Anatomical Therapeutic Chemical classification 0‑L G01AA51 Nystatin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G01AB Arsen-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L G01AB01 Acetarsol WHO Anatomical Therapeutic Chemical classification 0‑L G01AC Chinolin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G01AC01 Diiodhydroxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L G01AC02 Clioquinol WHO Anatomical Therapeutic Chemical classification 0‑L G01AC03 Chlorquinaldol WHO Anatomical Therapeutic Chemical classification 0‑L G01AC05 Dequalinium WHO Anatomical Therapeutic Chemical classification 0‑L G01AC06 Broxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L G01AC30 Oxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L G01AD Organische Säuren WHO Anatomical Therapeutic Chemical classification 0‑L G01AD01 Milchsäure WHO Anatomical Therapeutic Chemical classification 0‑L G01AD02 Essigsäure WHO Anatomical Therapeutic Chemical classification 0‑L G01AD03 Ascorbinsäure WHO Anatomical Therapeutic Chemical classification 0‑L G01AE Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L G01AE01 Sulfatolamid WHO Anatomical Therapeutic Chemical classification 0‑L G01AE10 Kombinationen von Sulfonamiden WHO Anatomical Therapeutic Chemical classification 0‑L G01AF Imidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G01AF01 Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF02 Clotrimazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF04 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF05 Econazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF06 Ornidazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF07 Isoconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF08 Tioconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF11 Ketoconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF12 Fenticonazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF13 Azanidazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF14 Propenidazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF15 Butoconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF16 Omoconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF17 Oxiconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF18 Flutrimazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AF20 Kombinationen von Imidazol-Derivaten WHO Anatomical Therapeutic Chemical classification 0‑L G01AG Triazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G01AG02 Terconazol WHO Anatomical Therapeutic Chemical classification 0‑L G01AX Andere Antiinfektiva und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L G01AX01 Clodantoin WHO Anatomical Therapeutic Chemical classification 0‑L G01AX02 Inosin WHO Anatomical Therapeutic Chemical classification 0‑L G01AX03 Policresulen WHO Anatomical Therapeutic Chemical classification 0‑L G01AX05 Nifuratel WHO Anatomical Therapeutic Chemical classification 0‑L G01AX06 Furazolidon WHO Anatomical Therapeutic Chemical classification 0‑L G01AX09 Methylrosanilin WHO Anatomical Therapeutic Chemical classification 0‑L G01AX11 Povidon-Iod WHO Anatomical Therapeutic Chemical classification 0‑L G01AX12 Ciclopirox WHO Anatomical Therapeutic Chemical classification 0‑L G01AX13 Protiofat WHO Anatomical Therapeutic Chemical classification 0‑L G01AX14 Lactobacillus-Ferment WHO Anatomical Therapeutic Chemical classification 0‑L G01AX15 Kupferusnat WHO Anatomical Therapeutic Chemical classification 0‑L G01AX66 Octenidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G01B Antiinfektiva/Antiseptika in Kombination mit Corticosteroiden WHO Anatomical Therapeutic Chemical classification 0‑L G01BA Antibiotika und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L G01BC Chinolin-Derivate und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L G01BD Antiseptika und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L G01BE Sulfonamide und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L G01BF Imidazol-Derivate und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L G02 Andere Gynäkologika WHO Anatomical Therapeutic Chemical classification 0‑L G02A Wehen fördernde Mittel WHO Anatomical Therapeutic Chemical classification 0‑L G02AB Mutterkorn-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L G02AB01 Methylergometrin WHO Anatomical Therapeutic Chemical classification 0‑L G02AB02 Mutterkorn-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L G02AB03 Ergometrin WHO Anatomical Therapeutic Chemical classification 0‑L G02AC Mutterkorn-Alkaloide und Oxytocin inkl. Derivate, in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L G02AC01 Methylergometrin und Oxytocin WHO Anatomical Therapeutic Chemical classification 0‑L G02AD Prostaglandine WHO Anatomical Therapeutic Chemical classification 0‑L G02AD01 Dinoprost WHO Anatomical Therapeutic Chemical classification 0‑L G02AD02 Dinoproston WHO Anatomical Therapeutic Chemical classification 0‑L G02AD03 Gemeprost WHO Anatomical Therapeutic Chemical classification 0‑L G02AD04 Carboprost WHO Anatomical Therapeutic Chemical classification 0‑L G02AD05 Sulproston WHO Anatomical Therapeutic Chemical classification 0‑L G02AD06 Misoprostol WHO Anatomical Therapeutic Chemical classification 0‑L G02AX Andere Wehen fördernde Mittel WHO Anatomical Therapeutic Chemical classification 0‑L G02B Kontrazeptiva zur lokalen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L G02BA Intrauterine Kontrazeptiva WHO Anatomical Therapeutic Chemical classification 0‑L G02BA01 Plastik-IUP WHO Anatomical Therapeutic Chemical classification 0‑L G02BA02 Plastik-IUP mit Kupfer WHO Anatomical Therapeutic Chemical classification 0‑L G02BA03 Plastik-IUP mit Progesteron WHO Anatomical Therapeutic Chemical classification 0‑L G02BB Intravaginale Kontrazeptiva WHO Anatomical Therapeutic Chemical classification 0‑L G02BB01 Vaginalring mit Gestagenen und Estrogenen WHO Anatomical Therapeutic Chemical classification 0‑L G02C Andere Gynäkologika WHO Anatomical Therapeutic Chemical classification 0‑L G02CA Sympathomimetika, Wehen hemmend WHO Anatomical Therapeutic Chemical classification 0‑L G02CA01 Ritodrin WHO Anatomical Therapeutic Chemical classification 0‑L G02CA02 Buphenin WHO Anatomical Therapeutic Chemical classification 0‑L G02CA03 Fenoterol WHO Anatomical Therapeutic Chemical classification 0‑L G02CB Prolactinhemmer WHO Anatomical Therapeutic Chemical classification 0‑L G02CB01 Bromocriptin WHO Anatomical Therapeutic Chemical classification 0‑L G02CB02 Lisurid WHO Anatomical Therapeutic Chemical classification 0‑L G02CB03 Cabergolin WHO Anatomical Therapeutic Chemical classification 0‑L G02CB04 Quinagolid WHO Anatomical Therapeutic Chemical classification 0‑L G02CB05 Metergolin WHO Anatomical Therapeutic Chemical classification 0‑L G02CC Antiphlogistika zur vaginalen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L G02CC01 Ibuprofen WHO Anatomical Therapeutic Chemical classification 0‑L G02CC02 Naproxen WHO Anatomical Therapeutic Chemical classification 0‑L G02CC03 Benzydamin WHO Anatomical Therapeutic Chemical classification 0‑L G02CC04 Flunoxaprofen WHO Anatomical Therapeutic Chemical classification 0‑L G02CX Andere Gynäkologika WHO Anatomical Therapeutic Chemical classification 0‑L G02CX01 Atosiban WHO Anatomical Therapeutic Chemical classification 0‑L G03 Sexualhormone und Modulatoren des Genitalsystems WHO Anatomical Therapeutic Chemical classification 0‑L G03A Hormonelle Kontrazeptiva zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L G03AA Gestagene und Estrogene, fixe Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA01 Etynodiol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA02 Quingestanol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA03 Lynestrenol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA04 Megestrol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA05 Norethisteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA06 Norgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA07 Levonorgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA08 Medroxyprogesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA09 Desogestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA10 Gestoden und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA11 Norgestimat und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA12 Drospirenon und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA13 Norelgestromin und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA14 Nomegestrol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AA15 Chlormadinon und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB Gestagene und Estrogene, Sequenzialpräparate WHO Anatomical Therapeutic Chemical classification 0‑L G03AB01 Megestrol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB02 Lynestrenol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB03 Levonorgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB04 Norethisteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB05 Desogestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB06 Gestoden und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB07 Chlormadinon und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03AB08 dienogest and estradiol WHO Anatomical Therapeutic Chemical classification 0‑L G03AC Gestagene WHO Anatomical Therapeutic Chemical classification 0‑L G03AC01 Norethisteron WHO Anatomical Therapeutic Chemical classification 0‑L G03AC02 Lynestrenol WHO Anatomical Therapeutic Chemical classification 0‑L G03AC03 Levonorgestrel WHO Anatomical Therapeutic Chemical classification 0‑L G03AC04 Quingestanol WHO Anatomical Therapeutic Chemical classification 0‑L G03AC05 Megestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03AC06 Medroxyprogesteron WHO Anatomical Therapeutic Chemical classification 0‑L G03AC07 Norgestrienon WHO Anatomical Therapeutic Chemical classification 0‑L G03AC08 Etonogestrel WHO Anatomical Therapeutic Chemical classification 0‑L G03AC09 Desogestrel WHO Anatomical Therapeutic Chemical classification 0‑L G03AD01 Levonorgestrel WHO Anatomical Therapeutic Chemical classification 0‑L G03B Androgene WHO Anatomical Therapeutic Chemical classification 0‑L G03BA 3-Oxoandrosten-4-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G03BA01 Fluoxymesteron WHO Anatomical Therapeutic Chemical classification 0‑L G03BA02 Methyltestosteron WHO Anatomical Therapeutic Chemical classification 0‑L G03BA03 Testosteron WHO Anatomical Therapeutic Chemical classification 0‑L G03BB 5-Androstanon-3-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G03BB01 Mesterolon WHO Anatomical Therapeutic Chemical classification 0‑L G03BB02 Androstanolon WHO Anatomical Therapeutic Chemical classification 0‑L G03C Estrogene WHO Anatomical Therapeutic Chemical classification 0‑L G03CA Natürliche und halbsynthetische Estrogene, rein WHO Anatomical Therapeutic Chemical classification 0‑L G03CA01 Ethinylestradiol WHO Anatomical Therapeutic Chemical classification 0‑L G03CA03 Estradiol WHO Anatomical Therapeutic Chemical classification 0‑L G03CA04 Estriol WHO Anatomical Therapeutic Chemical classification 0‑L G03CA06 Chlorotrianisen WHO Anatomical Therapeutic Chemical classification 0‑L G03CA07 Estron WHO Anatomical Therapeutic Chemical classification 0‑L G03CA09 Promestrien WHO Anatomical Therapeutic Chemical classification 0‑L G03CA53 Estradiol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G03CA57 Konjugierte Estrogene WHO Anatomical Therapeutic Chemical classification 0‑L G03CB Synthetische Estrogene, rein WHO Anatomical Therapeutic Chemical classification 0‑L G03CB01 Dienestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03CB02 Diethylstilbestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03CB03 Methallenestril WHO Anatomical Therapeutic Chemical classification 0‑L G03CB04 Moxestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03CC Estrogene, Kombinationen mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L G03CC02 Dienestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03CC03 Methallenestril WHO Anatomical Therapeutic Chemical classification 0‑L G03CC04 Estron WHO Anatomical Therapeutic Chemical classification 0‑L G03CC05 Diethylstilbestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03CC06 Estriol WHO Anatomical Therapeutic Chemical classification 0‑L G03CX01 Tibolon WHO Anatomical Therapeutic Chemical classification 0‑L G03D Gestagene WHO Anatomical Therapeutic Chemical classification 0‑L G03DA Pregnen-4-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G03DA01 Gestonoron WHO Anatomical Therapeutic Chemical classification 0‑L G03DA02 Medroxyprogesteron WHO Anatomical Therapeutic Chemical classification 0‑L G03DA03 Hydroxyprogesteron WHO Anatomical Therapeutic Chemical classification 0‑L G03DA04 Progesteron WHO Anatomical Therapeutic Chemical classification 0‑L G03DB Pregnadien-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G03DB01 Dydrogesteron WHO Anatomical Therapeutic Chemical classification 0‑L G03DB02 Megestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03DB03 Medrogeston WHO Anatomical Therapeutic Chemical classification 0‑L G03DB04 Nomegestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03DB05 Demegeston WHO Anatomical Therapeutic Chemical classification 0‑L G03DB06 Chlormadinon WHO Anatomical Therapeutic Chemical classification 0‑L G03DB07 Promegeston WHO Anatomical Therapeutic Chemical classification 0‑L G03DB08 Dienogest WHO Anatomical Therapeutic Chemical classification 0‑L G03DC Estren-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L G03DC01 Allylestrenol WHO Anatomical Therapeutic Chemical classification 0‑L G03DC02 Norethisteron WHO Anatomical Therapeutic Chemical classification 0‑L G03DC03 Lynestrenol WHO Anatomical Therapeutic Chemical classification 0‑L G03DC04 Ethisteron WHO Anatomical Therapeutic Chemical classification 0‑L G03DC05 Tibolon WHO Anatomical Therapeutic Chemical classification 0‑L G03DC06 Etynodiol WHO Anatomical Therapeutic Chemical classification 0‑L G03DC31 Methylestrenolon WHO Anatomical Therapeutic Chemical classification 0‑L G03E Androgene und weibliche Sexualhormone in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L G03EA Androgene und Estrogene WHO Anatomical Therapeutic Chemical classification 0‑L G03EA01 Methyltestosteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03EA02 Testosteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03EA03 Prasteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03EB Androgen, Gestagen und Estrogen in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L G03EK Androgene und weibliche Sexualhormone in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L G03EK01 Methyltestosteron WHO Anatomical Therapeutic Chemical classification 0‑L G03F Gestagene und Estrogene in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L G03FA Gestagene und Estrogene, fixe Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA01 Norethisteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA02 Hydroxyprogesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA03 Ethisteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA04 Progesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA05 Methylnortestosteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA06 Etynodiol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA07 Lynestrenol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA08 Megestrol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA09 Noretynodrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA10 Norgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA11 Levonorgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA12 Medroxyprogesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA13 Norgestimat und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA14 Dydrogesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA15 Dienogest und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA16 Trimegeston und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FA17 Drospirenon und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB Gestagene und Estrogene, Sequenzialpräparate WHO Anatomical Therapeutic Chemical classification 0‑L G03FB01 Norgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB02 Lynestrenol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB03 Chlormadinon und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB04 Megestrol und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB05 Norethisteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB06 Medroxyprogesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB07 Medrogeston und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB08 Dydrogesteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB09 Levonorgestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB10 Desogestrel und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03FB11 Trimegeston und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03G Gonadotropine und andere Ovulationsauslöser WHO Anatomical Therapeutic Chemical classification 0‑L G03GA Gonadotropine WHO Anatomical Therapeutic Chemical classification 0‑L G03GA01 Choriongonadotrophin WHO Anatomical Therapeutic Chemical classification 0‑L G03GA02 Humanes menopausales Gonadotrophin WHO Anatomical Therapeutic Chemical classification 0‑L G03GA03 Serumgonadotrophin WHO Anatomical Therapeutic Chemical classification 0‑L G03GA04 Urofollitropin WHO Anatomical Therapeutic Chemical classification 0‑L G03GA05 Follitropin alfa WHO Anatomical Therapeutic Chemical classification 0‑L G03GA06 Follitropin beta WHO Anatomical Therapeutic Chemical classification 0‑L G03GA07 Lutropin alfa WHO Anatomical Therapeutic Chemical classification 0‑L G03GA08 Choriongonadotropin alfa WHO Anatomical Therapeutic Chemical classification 0‑L G03GA09 Corifollitropin alfa WHO Anatomical Therapeutic Chemical classification 0‑L G03GB Ovulationsauslöser, synthetisch WHO Anatomical Therapeutic Chemical classification 0‑L G03GB01 Cyclofenil WHO Anatomical Therapeutic Chemical classification 0‑L G03GB02 Clomifen WHO Anatomical Therapeutic Chemical classification 0‑L G03GB03 Epimestrol WHO Anatomical Therapeutic Chemical classification 0‑L G03H Antiandrogene WHO Anatomical Therapeutic Chemical classification 0‑L G03HA Antiandrogene, rein WHO Anatomical Therapeutic Chemical classification 0‑L G03HA01 Cyproteron WHO Anatomical Therapeutic Chemical classification 0‑L G03HB Antiandrogene und Estrogene WHO Anatomical Therapeutic Chemical classification 0‑L G03HB01 Cyproteron und Estrogen WHO Anatomical Therapeutic Chemical classification 0‑L G03X Andere Sexualhormone und Modulatoren des Genitalsystems WHO Anatomical Therapeutic Chemical classification 0‑L G03XA Antigonadotropine und ähnliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L G03XA01 Danazol WHO Anatomical Therapeutic Chemical classification 0‑L G03XA02 Gestrinon WHO Anatomical Therapeutic Chemical classification 0‑L G03XB Antigestagene WHO Anatomical Therapeutic Chemical classification 0‑L G03XB01 Mifepriston WHO Anatomical Therapeutic Chemical classification 0‑L G03XC Selektive Estrogenrezeptor-Modulatoren WHO Anatomical Therapeutic Chemical classification 0‑L G03XC01 Raloxifen WHO Anatomical Therapeutic Chemical classification 0‑L G03XC02 Bazedoxifen WHO Anatomical Therapeutic Chemical classification 0‑L G04 Urologika WHO Anatomical Therapeutic Chemical classification 0‑L G04A Urinary antiseptics and antiinfectives WHO Anatomical Therapeutic Chemical classification 0‑L G04AA Methenamine preparations WHO Anatomical Therapeutic Chemical classification 0‑L G04AB Quinolone derivatives (excl. J01M) WHO Anatomical Therapeutic Chemical classification 0‑L G04AC Nitrofuran derivatives WHO Anatomical Therapeutic Chemical classification 0‑L G04AD Salicylates WHO Anatomical Therapeutic Chemical classification 0‑L G04AG Other urinary antiseptics and antiinfectives WHO Anatomical Therapeutic Chemical classification 0‑L G04AH Sulfonamides in combination with other drugs WHO Anatomical Therapeutic Chemical classification 0‑L G04AK Urinary antiseptics and antiinfectives comb., excl. sulfonamides WHO Anatomical Therapeutic Chemical classification 0‑L G04B Andere Urologika, inkl. Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L G04BA Harn ansäuernde Mittel WHO Anatomical Therapeutic Chemical classification 0‑L G04BA01 Ammoniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L G04BA03 Calciumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L G04BC Harnkonkrement lösende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L G04BD Urologische Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L G04BD01 Emepronium WHO Anatomical Therapeutic Chemical classification 0‑L G04BD02 Flavoxat WHO Anatomical Therapeutic Chemical classification 0‑L G04BD03 Meladrazin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD04 Oxybutynin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD05 Terodilin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD06 Propiverin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD07 Tolterodin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD08 Solifenacin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD09 Trospium WHO Anatomical Therapeutic Chemical classification 0‑L G04BD10 Darifenacin WHO Anatomical Therapeutic Chemical classification 0‑L G04BD11 Fesoterodin WHO Anatomical Therapeutic Chemical classification 0‑L G04BE Mittel bei erektiler Dysfunktion WHO Anatomical Therapeutic Chemical classification 0‑L G04BE01 Alprostadil WHO Anatomical Therapeutic Chemical classification 0‑L G04BE02 Papaverin WHO Anatomical Therapeutic Chemical classification 0‑L G04BE03 Sildenafil WHO Anatomical Therapeutic Chemical classification 0‑L G04BE04 Yohimbin WHO Anatomical Therapeutic Chemical classification 0‑L G04BE05 Phentolamin WHO Anatomical Therapeutic Chemical classification 0‑L G04BE06 Moxisylyt WHO Anatomical Therapeutic Chemical classification 0‑L G04BE07 Apomorphin WHO Anatomical Therapeutic Chemical classification 0‑L G04BE08 Tadalafil WHO Anatomical Therapeutic Chemical classification 0‑L G04BE09 Vardenafil WHO Anatomical Therapeutic Chemical classification 0‑L G04BE30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G04BE52 Papaverin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L G04BP30 Pflanzliche Urologika WHO Anatomical Therapeutic Chemical classification 0‑L G04BX Andere Urologika WHO Anatomical Therapeutic Chemical classification 0‑L G04BX01 Magnesiumhydroxid WHO Anatomical Therapeutic Chemical classification 0‑L G04BX03 Acetohydroxamsäure WHO Anatomical Therapeutic Chemical classification 0‑L G04BX06 Phenazopyridin WHO Anatomical Therapeutic Chemical classification 0‑L G04BX10 Succinimid WHO Anatomical Therapeutic Chemical classification 0‑L G04BX11 Collagen WHO Anatomical Therapeutic Chemical classification 0‑L G04BX12 Phenylsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L G04BX13 Dimethylsulfoxid WHO Anatomical Therapeutic Chemical classification 0‑L G04BX14 Dapoxetin WHO Anatomical Therapeutic Chemical classification 0‑L G04C Mittel bei Benigner Prostatahyperplasie WHO Anatomical Therapeutic Chemical classification 0‑L G04CA Alpha-Adrenorezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L G04CA01 Alfuzosin WHO Anatomical Therapeutic Chemical classification 0‑L G04CA02 Tamsulosin WHO Anatomical Therapeutic Chemical classification 0‑L G04CA03 Terazosin WHO Anatomical Therapeutic Chemical classification 0‑L G04CA04 Silodosin WHO Anatomical Therapeutic Chemical classification 0‑L G04CA52 Tamsulosin und Dutasterid WHO Anatomical Therapeutic Chemical classification 0‑L G04CA53 Tamsulosin und Solifenacin WHO Anatomical Therapeutic Chemical classification 0‑L G04CB Testosteron-5-alfa-Reduktasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L G04CB01 Finasterid WHO Anatomical Therapeutic Chemical classification 0‑L G04CB02 Dutasterid WHO Anatomical Therapeutic Chemical classification 0‑L G04CX Andere Mittel bei benigner Prostatahyperplasie WHO Anatomical Therapeutic Chemical classification 0‑L G04CX01 Pygeum africanum WHO Anatomical Therapeutic Chemical classification 0‑L G04CX02 Serenoa repens WHO Anatomical Therapeutic Chemical classification 0‑L G04CX03 Mepartricin WHO Anatomical Therapeutic Chemical classification 0‑L H Systemische Hormonpräparate, exkl. Sexualhormone und Insuline WHO Anatomical Therapeutic Chemical classification 0‑L H01 Hypophysen- und Hypothalamushormone und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H01A Hypophysenvorderlappenhormone und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H01AA ACTH WHO Anatomical Therapeutic Chemical classification 0‑L H01AA01 Corticotropin WHO Anatomical Therapeutic Chemical classification 0‑L H01AA02 Tetracosactid WHO Anatomical Therapeutic Chemical classification 0‑L H01AB Thyrotropin WHO Anatomical Therapeutic Chemical classification 0‑L H01AB01 Thyrotropin WHO Anatomical Therapeutic Chemical classification 0‑L H01AC Somatropin und Somatropin-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L H01AC01 Somatropin WHO Anatomical Therapeutic Chemical classification 0‑L H01AC02 Somatrem WHO Anatomical Therapeutic Chemical classification 0‑L H01AC03 Mecasermin WHO Anatomical Therapeutic Chemical classification 0‑L H01AC04 Sermorelin WHO Anatomical Therapeutic Chemical classification 0‑L H01AX Andere Hypophysenvorderlappenhormone und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H01AX01 Pegvisomant WHO Anatomical Therapeutic Chemical classification 0‑L H01B Hypophysenhinterlappenhormone WHO Anatomical Therapeutic Chemical classification 0‑L H01BA Vasopressin und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H01BA01 Vasopressin WHO Anatomical Therapeutic Chemical classification 0‑L H01BA02 Desmopressin WHO Anatomical Therapeutic Chemical classification 0‑L H01BA03 Lypressin WHO Anatomical Therapeutic Chemical classification 0‑L H01BA04 Terlipressin WHO Anatomical Therapeutic Chemical classification 0‑L H01BA05 Ornipressin WHO Anatomical Therapeutic Chemical classification 0‑L H01BA06 Argipressin WHO Anatomical Therapeutic Chemical classification 0‑L H01BB Oxytocin und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H01BB01 Demoxytocin WHO Anatomical Therapeutic Chemical classification 0‑L H01BB02 Oxytocin WHO Anatomical Therapeutic Chemical classification 0‑L H01BB03 Carbetocin WHO Anatomical Therapeutic Chemical classification 0‑L H01C Hypothalamushormone WHO Anatomical Therapeutic Chemical classification 0‑L H01CA Gonadotropin-Releasing-Hormone WHO Anatomical Therapeutic Chemical classification 0‑L H01CA01 Gonadorelin WHO Anatomical Therapeutic Chemical classification 0‑L H01CA02 Nafarelin WHO Anatomical Therapeutic Chemical classification 0‑L H01CA03 Histrelin WHO Anatomical Therapeutic Chemical classification 0‑L H01CA93 Gonadotrophin-releasing hormones WHO Anatomical Therapeutic Chemical classification 0‑L H01CB Anti-Wachstumshormone WHO Anatomical Therapeutic Chemical classification 0‑L H01CB01 Somatostatin WHO Anatomical Therapeutic Chemical classification 0‑L H01CB02 Octreotid WHO Anatomical Therapeutic Chemical classification 0‑L H01CB03 Lanreotid WHO Anatomical Therapeutic Chemical classification 0‑L H01CC Gonadotropin-Releasing-Hormon-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L H01CC01 Ganirelix WHO Anatomical Therapeutic Chemical classification 0‑L H01CC02 Cetrorelix WHO Anatomical Therapeutic Chemical classification 0‑L H02 Corticosteroide zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L H02A Corticosteroide zur systemischen Anwendung, rein WHO Anatomical Therapeutic Chemical classification 0‑L H02AA Mineralocorticoide WHO Anatomical Therapeutic Chemical classification 0‑L H02AA01 Aldosteron WHO Anatomical Therapeutic Chemical classification 0‑L H02AA02 Fludrocortison WHO Anatomical Therapeutic Chemical classification 0‑L H02AA03 Desoxycorton WHO Anatomical Therapeutic Chemical classification 0‑L H02AB Glucocorticoide WHO Anatomical Therapeutic Chemical classification 0‑L H02AB01 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L H02AB02 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L H02AB03 Fluocortolon WHO Anatomical Therapeutic Chemical classification 0‑L H02AB04 Methylprednisolon WHO Anatomical Therapeutic Chemical classification 0‑L H02AB05 Paramethason WHO Anatomical Therapeutic Chemical classification 0‑L H02AB06 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L H02AB07 Prednison WHO Anatomical Therapeutic Chemical classification 0‑L H02AB08 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L H02AB09 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L H02AB10 Cortison WHO Anatomical Therapeutic Chemical classification 0‑L H02AB11 Prednyliden WHO Anatomical Therapeutic Chemical classification 0‑L H02AB12 Rimexolon WHO Anatomical Therapeutic Chemical classification 0‑L H02AB13 Deflazacort WHO Anatomical Therapeutic Chemical classification 0‑L H02AB14 Cloprednol WHO Anatomical Therapeutic Chemical classification 0‑L H02AB15 Meprednison WHO Anatomical Therapeutic Chemical classification 0‑L H02AB17 Cortivazol WHO Anatomical Therapeutic Chemical classification 0‑L H02B Corticosteroide zur systemischen Anwendung, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L H02BX Corticosteroide zur systemischen Anwendung, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L H02BX01 Methylprednisolon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L H02C Nebennierenhemmstoffe WHO Anatomical Therapeutic Chemical classification 0‑L H02CA Anticorticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L H02CA01 Trilostan WHO Anatomical Therapeutic Chemical classification 0‑L H03 Schilddrüsentherapie WHO Anatomical Therapeutic Chemical classification 0‑L H03A Schilddrüsenpräparate WHO Anatomical Therapeutic Chemical classification 0‑L H03AA Schilddrüsenhormone WHO Anatomical Therapeutic Chemical classification 0‑L H03AA01 Levothyroxin-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L H03AA02 Liothyronin-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L H03AA03 Kombinationen von Levothyroxin und Liothyronin WHO Anatomical Therapeutic Chemical classification 0‑L H03AA04 Tiratricol WHO Anatomical Therapeutic Chemical classification 0‑L H03AA05 Zubereitungen aus Schilddrüsengewebe WHO Anatomical Therapeutic Chemical classification 0‑L H03B Thyreostatika WHO Anatomical Therapeutic Chemical classification 0‑L H03BA Thiouracile WHO Anatomical Therapeutic Chemical classification 0‑L H03BA01 Methylthiouracil WHO Anatomical Therapeutic Chemical classification 0‑L H03BA02 Propylthiouracil WHO Anatomical Therapeutic Chemical classification 0‑L H03BA03 Benzylthiouracil WHO Anatomical Therapeutic Chemical classification 0‑L H03BB Schwefel-haltige Imidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L H03BB01 Carbimazol WHO Anatomical Therapeutic Chemical classification 0‑L H03BB02 Thiamazol WHO Anatomical Therapeutic Chemical classification 0‑L H03BB52 Thiamazol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L H03BC Perchlorate WHO Anatomical Therapeutic Chemical classification 0‑L H03BC01 Kaliumperchlorat WHO Anatomical Therapeutic Chemical classification 0‑L H03BX Andere Thyreostatika WHO Anatomical Therapeutic Chemical classification 0‑L H03BX01 Diiodtyrosin WHO Anatomical Therapeutic Chemical classification 0‑L H03BX02 Dibromtyrosin WHO Anatomical Therapeutic Chemical classification 0‑L H03C Iodtherapie WHO Anatomical Therapeutic Chemical classification 0‑L H03CA Iodtherapie WHO Anatomical Therapeutic Chemical classification 0‑L H04 Pankreashormone WHO Anatomical Therapeutic Chemical classification 0‑L H04A Glykogenolytische Hormone WHO Anatomical Therapeutic Chemical classification 0‑L H04AA Glykogenolytische Hormone WHO Anatomical Therapeutic Chemical classification 0‑L H04AA01 Glucagon WHO Anatomical Therapeutic Chemical classification 0‑L H05 Calciumhomöostase WHO Anatomical Therapeutic Chemical classification 0‑L H05A Nebenschilddrüsenhormone und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H05AA Nebenschilddrüsenhormone und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L H05AA01 Nebenschilddrüsenextrakt WHO Anatomical Therapeutic Chemical classification 0‑L H05AA02 Teriparatid WHO Anatomical Therapeutic Chemical classification 0‑L H05AA03 Parathyroid Hormon WHO Anatomical Therapeutic Chemical classification 0‑L H05B Nebenschilddrüsen-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L H05BA Calcitonin-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L H05BA01 Calcitonin (Lachs, synthetisch) WHO Anatomical Therapeutic Chemical classification 0‑L H05BA02 Calcitonin (Schwein, natürlich) WHO Anatomical Therapeutic Chemical classification 0‑L H05BA03 Calcitonin (Mensch, synthetisch) WHO Anatomical Therapeutic Chemical classification 0‑L H05BA04 Elcatonin WHO Anatomical Therapeutic Chemical classification 0‑L H05BX Andere Nebenschilddrüsen-antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L H05BX01 Cinacalcet WHO Anatomical Therapeutic Chemical classification 0‑L H05BX02 Paricalcitol WHO Anatomical Therapeutic Chemical classification 0‑L I07AA inactivated viral vaccines WHO Anatomical Therapeutic Chemical classification 0‑L I07AA06 Canine Herpesvirus vaccine WHO Anatomical Therapeutic Chemical classification 0‑L I09AA07 Inactivated Porcine Circovirus vaccine WHO Anatomical Therapeutic Chemical classification 0‑L J Antiinfektiva zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J01 Antibiotika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J01A Tetracycline WHO Anatomical Therapeutic Chemical classification 0‑L J01AA Tetracycline WHO Anatomical Therapeutic Chemical classification 0‑L J01AA01 Demeclocyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA02 Doxycyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA03 Chlortetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA04 Lymecyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA05 Metacyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA06 Oxytetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA07 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA08 Minocyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA09 Rolitetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA10 Penimepicyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA11 Clomocyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA12 Tigecyclin WHO Anatomical Therapeutic Chemical classification 0‑L J01AA20 Kombinationen von Tetracyclinen WHO Anatomical Therapeutic Chemical classification 0‑L J01AA56 Oxytetracyclin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01B Amphenicole WHO Anatomical Therapeutic Chemical classification 0‑L J01BA Amphenicole WHO Anatomical Therapeutic Chemical classification 0‑L J01BA01 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L J01BA02 Thiamphenicol WHO Anatomical Therapeutic Chemical classification 0‑L J01BA52 Thiamphenicol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01C Betalactam-Antibiotika, Penicilline WHO Anatomical Therapeutic Chemical classification 0‑L J01CA Penicilline mit erweitertem Wirkungsspektrum WHO Anatomical Therapeutic Chemical classification 0‑L J01CA01 Ampicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA02 Pivampicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA03 Carbenicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA04 Amoxicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA05 Carindacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA06 Bacampicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA07 Epicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA08 Pivmecillinam WHO Anatomical Therapeutic Chemical classification 0‑L J01CA09 Azlocillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA10 Mezlocillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA11 Mecillinam WHO Anatomical Therapeutic Chemical classification 0‑L J01CA12 Piperacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA13 Ticarcillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA14 Metampicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA15 Talampicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA16 Sulbenicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA17 Temocillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA18 Hetacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CA20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01CA51 Ampicillin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01CE Beta-Lactamase-sensitive Penicilline WHO Anatomical Therapeutic Chemical classification 0‑L J01CE01 Benzylpenicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE02 Phenoxymethylpenicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE03 Propicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE04 Azidocillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE05 Pheneticillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE06 Penamecillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE07 Clometocillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE08 Benzylpenicillin-Benzathin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE09 Benzylpenicillin-procain WHO Anatomical Therapeutic Chemical classification 0‑L J01CE10 Phenoxymethylpenicillin-Benzathin WHO Anatomical Therapeutic Chemical classification 0‑L J01CE30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01CF Beta-Lactamase-resistente Penicilline WHO Anatomical Therapeutic Chemical classification 0‑L J01CF01 Dicloxacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CF02 Cloxacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CF03 Meticillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CF04 Oxacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CF05 Flucloxacillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CG Beta-Lactamase-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01CG01 Sulbactam WHO Anatomical Therapeutic Chemical classification 0‑L J01CG02 Tazobactam WHO Anatomical Therapeutic Chemical classification 0‑L J01CR Kombinationen von Penicillinen, inkl. Beta-Lactamase-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01CR01 Ampicillin und Enzym-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01CR02 Amoxicillin und Enzym-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01CR03 Ticarcillin und Enzym-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01CR04 Sultamicillin WHO Anatomical Therapeutic Chemical classification 0‑L J01CR05 Piperacillin und Enzym-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01CR50 Kombinationen von Penicillinen WHO Anatomical Therapeutic Chemical classification 0‑L J01D Andere Beta-Lactam-Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01DA Cephalosporins and related substances * WHO Anatomical Therapeutic Chemical classification 0‑L J01DB Cephalosporine der 1. Generation WHO Anatomical Therapeutic Chemical classification 0‑L J01DB01 Cefalexin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB02 Cefaloridin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB03 Cefalotin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB04 Cefazolin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB05 Cefadroxil WHO Anatomical Therapeutic Chemical classification 0‑L J01DB06 Cefazedon WHO Anatomical Therapeutic Chemical classification 0‑L J01DB07 Cefatrizin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB08 Cefapirin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB09 Cefradin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB10 Cefacetril WHO Anatomical Therapeutic Chemical classification 0‑L J01DB11 Cefroxadin WHO Anatomical Therapeutic Chemical classification 0‑L J01DB12 Ceftezol WHO Anatomical Therapeutic Chemical classification 0‑L J01DC Cephalosporine der 2. Generation WHO Anatomical Therapeutic Chemical classification 0‑L J01DC01 Cefoxitin WHO Anatomical Therapeutic Chemical classification 0‑L J01DC02 Cefuroxim WHO Anatomical Therapeutic Chemical classification 0‑L J01DC03 Cefamandol WHO Anatomical Therapeutic Chemical classification 0‑L J01DC04 Cefaclor WHO Anatomical Therapeutic Chemical classification 0‑L J01DC05 Cefotetan WHO Anatomical Therapeutic Chemical classification 0‑L J01DC06 Cefonicid WHO Anatomical Therapeutic Chemical classification 0‑L J01DC07 Cefotiam WHO Anatomical Therapeutic Chemical classification 0‑L J01DC08 Loracarbef WHO Anatomical Therapeutic Chemical classification 0‑L J01DC09 Cefmetazol WHO Anatomical Therapeutic Chemical classification 0‑L J01DC10 Cefprozil WHO Anatomical Therapeutic Chemical classification 0‑L J01DC11 Ceforanid WHO Anatomical Therapeutic Chemical classification 0‑L J01DD Cephalosporine der 3. Generation WHO Anatomical Therapeutic Chemical classification 0‑L J01DD01 Cefotaxim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD02 Ceftazidim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD03 Cefsulodin WHO Anatomical Therapeutic Chemical classification 0‑L J01DD04 Ceftriaxon WHO Anatomical Therapeutic Chemical classification 0‑L J01DD05 Cefmenoxim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD06 Latamoxef WHO Anatomical Therapeutic Chemical classification 0‑L J01DD07 Ceftizoxim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD08 Cefixim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD09 Cefodizim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD10 Cefetamet WHO Anatomical Therapeutic Chemical classification 0‑L J01DD11 Cefpiramid WHO Anatomical Therapeutic Chemical classification 0‑L J01DD12 Cefoperazon WHO Anatomical Therapeutic Chemical classification 0‑L J01DD13 Cefpodoxim WHO Anatomical Therapeutic Chemical classification 0‑L J01DD14 Ceftibuten WHO Anatomical Therapeutic Chemical classification 0‑L J01DD15 Cefdinir WHO Anatomical Therapeutic Chemical classification 0‑L J01DD16 Cefditoren WHO Anatomical Therapeutic Chemical classification 0‑L J01DD54 Ceftriaxon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01DD62 Cefoperazon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01DD91 Cefovecin WHO Anatomical Therapeutic Chemical classification 0‑L J01DE Cephalosporine der 4. Generation WHO Anatomical Therapeutic Chemical classification 0‑L J01DE01 Cefepim WHO Anatomical Therapeutic Chemical classification 0‑L J01DE02 Cefpirom WHO Anatomical Therapeutic Chemical classification 0‑L J01DF Monobactame WHO Anatomical Therapeutic Chemical classification 0‑L J01DF01 Aztreonam WHO Anatomical Therapeutic Chemical classification 0‑L J01DH Carbapeneme WHO Anatomical Therapeutic Chemical classification 0‑L J01DH02 Meropenem WHO Anatomical Therapeutic Chemical classification 0‑L J01DH03 Ertapenem WHO Anatomical Therapeutic Chemical classification 0‑L J01DH04 Doripenem WHO Anatomical Therapeutic Chemical classification 0‑L J01DH51 Imipenem und Enzym-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L J01DI02 Ceftarolin fosamil WHO Anatomical Therapeutic Chemical classification 0‑L J01E Sulfonamide und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EA Trimethoprim und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J01EA01 Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EA02 Brodimoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EB Kurz wirkende Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L J01EB01 Sulfaisodimidin WHO Anatomical Therapeutic Chemical classification 0‑L J01EB02 Sulfamethizol WHO Anatomical Therapeutic Chemical classification 0‑L J01EB03 Sulfadimidin WHO Anatomical Therapeutic Chemical classification 0‑L J01EB04 Sulfapyridin WHO Anatomical Therapeutic Chemical classification 0‑L J01EB05 Sulfafurazol WHO Anatomical Therapeutic Chemical classification 0‑L J01EB06 Sulfanilamid WHO Anatomical Therapeutic Chemical classification 0‑L J01EB07 Sulfathiazol WHO Anatomical Therapeutic Chemical classification 0‑L J01EB08 Sulfathiourea WHO Anatomical Therapeutic Chemical classification 0‑L J01EB20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01EC Mittellang wirkende Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L J01EC01 Sulfamethoxazol WHO Anatomical Therapeutic Chemical classification 0‑L J01EC02 Sulfadiazin WHO Anatomical Therapeutic Chemical classification 0‑L J01EC03 Sulfamoxol WHO Anatomical Therapeutic Chemical classification 0‑L J01EC20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01ED Lang wirkende Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L J01ED01 Sulfadimethoxin WHO Anatomical Therapeutic Chemical classification 0‑L J01ED02 Sulfalen WHO Anatomical Therapeutic Chemical classification 0‑L J01ED03 Sulfametomidin WHO Anatomical Therapeutic Chemical classification 0‑L J01ED04 Sulfametoxydiazin WHO Anatomical Therapeutic Chemical classification 0‑L J01ED05 Sulfamethoxypyridazin WHO Anatomical Therapeutic Chemical classification 0‑L J01ED06 Sulfaperin WHO Anatomical Therapeutic Chemical classification 0‑L J01ED07 Sulfamerazin WHO Anatomical Therapeutic Chemical classification 0‑L J01ED08 Sulfaphenazol WHO Anatomical Therapeutic Chemical classification 0‑L J01ED09 Sulfamazon WHO Anatomical Therapeutic Chemical classification 0‑L J01ED20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J01EE Kombinationen von Sulfonamiden und Trimethoprim, inkl. Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J01EE01 Sulfamethoxazol und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EE02 Sulfadiazin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EE03 Sulfametrol und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EE04 Sulfamoxol und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EE05 Sulfadimidin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EE06 Sulfadiazin und Tetroxoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01EE07 Sulfamerazin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L J01F Makrolide, Lincosamide und Streptogramine WHO Anatomical Therapeutic Chemical classification 0‑L J01FA Makrolide WHO Anatomical Therapeutic Chemical classification 0‑L J01FA01 Erythromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA02 Spiramycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA03 Midecamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA05 Oleandomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA06 Roxithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA07 Josamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA08 Troleandomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA09 Clarithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA10 Azithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA11 Miocamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA12 Rokitamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA13 Dirithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA14 Flurithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA15 Telithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FA95 Gamithromycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FF Lincosamide WHO Anatomical Therapeutic Chemical classification 0‑L J01FF01 Clindamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FF02 Lincomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FG Streptogramine WHO Anatomical Therapeutic Chemical classification 0‑L J01FG01 Pristinamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01FG02 Quinupristin/Dalfopristin WHO Anatomical Therapeutic Chemical classification 0‑L J01G Aminoglykosid-Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01GA Streptomycine WHO Anatomical Therapeutic Chemical classification 0‑L J01GA01 Streptomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01GA02 Streptoduocin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB Andere Aminoglykoside WHO Anatomical Therapeutic Chemical classification 0‑L J01GB01 Tobramycin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB03 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB04 Kanamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB05 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB06 Amikacin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB07 Netilmicin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB08 Sisomicin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB09 Dibekacin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB10 Ribostamycin WHO Anatomical Therapeutic Chemical classification 0‑L J01GB11 Isepamicin WHO Anatomical Therapeutic Chemical classification 0‑L J01M Chinolone WHO Anatomical Therapeutic Chemical classification 0‑L J01MA Fluorchinolone WHO Anatomical Therapeutic Chemical classification 0‑L J01MA01 Ofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA02 Ciprofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA03 Pefloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA04 Enoxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA05 Temafloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA06 Norfloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA07 Lomefloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA08 Fleroxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA09 Sparfloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA10 Rufloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA11 Grepafloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA12 Levofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA13 Trovafloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA14 Moxifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA15 Gemifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA16 Gatifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA17 Prulifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA18 Pazufloxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MA19 Garenoxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MB Andere Chinolone WHO Anatomical Therapeutic Chemical classification 0‑L J01MB01 Rosoxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MB02 Nalidixinsäure WHO Anatomical Therapeutic Chemical classification 0‑L J01MB03 Piromidsäure WHO Anatomical Therapeutic Chemical classification 0‑L J01MB04 Pipemidsäure WHO Anatomical Therapeutic Chemical classification 0‑L J01MB05 Oxolinsäure WHO Anatomical Therapeutic Chemical classification 0‑L J01MB06 Cinoxacin WHO Anatomical Therapeutic Chemical classification 0‑L J01MB07 Flumequin WHO Anatomical Therapeutic Chemical classification 0‑L J01R Kombinationen von Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01RA Kombinationen von Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01RA01 Penicilline, Kombination mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01RA02 Sulfonamide, Kombination mit anderen Antibiotika (exkl. Trimethoprim) WHO Anatomical Therapeutic Chemical classification 0‑L J01RA03 Cefuroxim, Kombination mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01RA04 Spiramycin, Kombination mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01X Andere Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01XA Glycopeptid-Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01XA01 Vancomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01XA02 Teicoplanin WHO Anatomical Therapeutic Chemical classification 0‑L J01XB Polymyxine WHO Anatomical Therapeutic Chemical classification 0‑L J01XB01 Colistin WHO Anatomical Therapeutic Chemical classification 0‑L J01XB02 Polymyxin B WHO Anatomical Therapeutic Chemical classification 0‑L J01XC Steroid-Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01XC01 Fusidinsäure WHO Anatomical Therapeutic Chemical classification 0‑L J01XD Imidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J01XD01 Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L J01XD02 Tinidazol WHO Anatomical Therapeutic Chemical classification 0‑L J01XD03 Ornidazol WHO Anatomical Therapeutic Chemical classification 0‑L J01XE Nitrofuran-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J01XE01 Nitrofurantoin WHO Anatomical Therapeutic Chemical classification 0‑L J01XE02 Nifurtoinol WHO Anatomical Therapeutic Chemical classification 0‑L J01XX Andere Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J01XX01 Fosfomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01XX02 Xibornol WHO Anatomical Therapeutic Chemical classification 0‑L J01XX03 Clofoctol WHO Anatomical Therapeutic Chemical classification 0‑L J01XX04 Spectinomycin WHO Anatomical Therapeutic Chemical classification 0‑L J01XX05 Methenamin WHO Anatomical Therapeutic Chemical classification 0‑L J01XX06 Mandelsäure WHO Anatomical Therapeutic Chemical classification 0‑L J01XX07 Nitroxolin WHO Anatomical Therapeutic Chemical classification 0‑L J01XX08 Linezolid WHO Anatomical Therapeutic Chemical classification 0‑L J01XX09 Daptomycin WHO Anatomical Therapeutic Chemical classification 0‑L J02 Antimykotika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J02A Antimykotika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J02AA Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J02AA01 Amphotericin B WHO Anatomical Therapeutic Chemical classification 0‑L J02AA02 Hachimycin WHO Anatomical Therapeutic Chemical classification 0‑L J02AB Imidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J02AB01 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L J02AB02 Ketoconazol WHO Anatomical Therapeutic Chemical classification 0‑L J02AC Triazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J02AC01 Fluconazol WHO Anatomical Therapeutic Chemical classification 0‑L J02AC02 Itraconazol WHO Anatomical Therapeutic Chemical classification 0‑L J02AC03 Voriconazol WHO Anatomical Therapeutic Chemical classification 0‑L J02AC04 Posaconazol WHO Anatomical Therapeutic Chemical classification 0‑L J02AX Andere Antimykotika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J02AX01 Flucytosin WHO Anatomical Therapeutic Chemical classification 0‑L J02AX04 Caspofungin WHO Anatomical Therapeutic Chemical classification 0‑L J02AX05 Micafungin WHO Anatomical Therapeutic Chemical classification 0‑L J02AX06 Anidulafungin WHO Anatomical Therapeutic Chemical classification 0‑L J04 Mittel gegen Mykobakterien WHO Anatomical Therapeutic Chemical classification 0‑L J04A Mittel zur Behandlung der Tuberkulose WHO Anatomical Therapeutic Chemical classification 0‑L J04AA Aminosalicylsäure und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J04AA01 Aminosalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L J04AA02 Natriumaminosalicylat WHO Anatomical Therapeutic Chemical classification 0‑L J04AA03 Calciumaminosalicylat WHO Anatomical Therapeutic Chemical classification 0‑L J04AB Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L J04AB01 Cycloserin WHO Anatomical Therapeutic Chemical classification 0‑L J04AB02 Rifampicin WHO Anatomical Therapeutic Chemical classification 0‑L J04AB03 Rifamycin WHO Anatomical Therapeutic Chemical classification 0‑L J04AB04 Rifabutin WHO Anatomical Therapeutic Chemical classification 0‑L J04AB05 Rifapentin WHO Anatomical Therapeutic Chemical classification 0‑L J04AB30 Capreomycin WHO Anatomical Therapeutic Chemical classification 0‑L J04AC Hydrazide WHO Anatomical Therapeutic Chemical classification 0‑L J04AC01 Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04AC51 Isoniazid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J04AD Thiocarbamid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J04AD01 Protionamid WHO Anatomical Therapeutic Chemical classification 0‑L J04AD02 Tiocarlid WHO Anatomical Therapeutic Chemical classification 0‑L J04AD03 Ethionamid WHO Anatomical Therapeutic Chemical classification 0‑L J04AK Andere Mittel zur Behandlung der Tuberkulose WHO Anatomical Therapeutic Chemical classification 0‑L J04AK01 Pyrazinamid WHO Anatomical Therapeutic Chemical classification 0‑L J04AK02 Ethambutol WHO Anatomical Therapeutic Chemical classification 0‑L J04AK03 Terizidon WHO Anatomical Therapeutic Chemical classification 0‑L J04AK04 Morinamid WHO Anatomical Therapeutic Chemical classification 0‑L J04AM Kombinationen von Mitteln zur Behandlung der Tuberkulose WHO Anatomical Therapeutic Chemical classification 0‑L J04AM01 Streptomycin und Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04AM02 Rifampicin und Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04AM03 Ethambutol und Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04AM04 Thioacetazon und Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04AM05 Rifampicin, Pyrazinamid und Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04AM06 Rifampicin, Pyrazinamid, Ethambutol und Isoniazid WHO Anatomical Therapeutic Chemical classification 0‑L J04B Mittel zur Behandlung der Lepra WHO Anatomical Therapeutic Chemical classification 0‑L J04BA Mittel zur Behandlung der Lepra WHO Anatomical Therapeutic Chemical classification 0‑L J04BA01 Clofazimin WHO Anatomical Therapeutic Chemical classification 0‑L J04BA02 Dapson WHO Anatomical Therapeutic Chemical classification 0‑L J04BA03 Aldesulfonnatrium WHO Anatomical Therapeutic Chemical classification 0‑L J05 Antivirale Mittel zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J05A Direkt wirkende antivirale Mittel WHO Anatomical Therapeutic Chemical classification 0‑L J05AA Thiosemicarbazone WHO Anatomical Therapeutic Chemical classification 0‑L J05AA01 Metisazon WHO Anatomical Therapeutic Chemical classification 0‑L J05AB Nukleoside und Nukleotide, exkl. Inhibitoren der Reversen Transkriptase WHO Anatomical Therapeutic Chemical classification 0‑L J05AB01 Aciclovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB02 Idoxuridin WHO Anatomical Therapeutic Chemical classification 0‑L J05AB03 Vidarabin WHO Anatomical Therapeutic Chemical classification 0‑L J05AB04 Ribavirin WHO Anatomical Therapeutic Chemical classification 0‑L J05AB06 Ganciclovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB09 Famciclovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB11 Valaciclovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB12 Cidofovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB13 Penciclovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB14 Valganciclovir WHO Anatomical Therapeutic Chemical classification 0‑L J05AB15 Brivudin WHO Anatomical Therapeutic Chemical classification 0‑L J05AC Cyclische Amine WHO Anatomical Therapeutic Chemical classification 0‑L J05AC02 Rimantadin WHO Anatomical Therapeutic Chemical classification 0‑L J05AC03 Tromantadin WHO Anatomical Therapeutic Chemical classification 0‑L J05AD Phosphonsäure-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L J05AD01 Foscarnet WHO Anatomical Therapeutic Chemical classification 0‑L J05AD02 Fosfonet WHO Anatomical Therapeutic Chemical classification 0‑L J05AE Proteasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L J05AE01 Saquinavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE02 Indinavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE03 Ritonavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE04 Nelfinavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE05 Amprenavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE06 Lopinavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE07 Fosamprenavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE08 Atazanavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE09 Tipranavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AE10 Darunavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase WHO Anatomical Therapeutic Chemical classification 0‑L J05AF01 Zidovudin WHO Anatomical Therapeutic Chemical classification 0‑L J05AF02 Didanosin WHO Anatomical Therapeutic Chemical classification 0‑L J05AF03 Zalcitabin WHO Anatomical Therapeutic Chemical classification 0‑L J05AF04 Stavudin WHO Anatomical Therapeutic Chemical classification 0‑L J05AF05 Lamivudin WHO Anatomical Therapeutic Chemical classification 0‑L J05AF06 Abacavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AF07 Tenofovir Disoproxil WHO Anatomical Therapeutic Chemical classification 0‑L J05AF08 Adefovir dipivoxil WHO Anatomical Therapeutic Chemical classification 0‑L J05AF09 Emtricitabin WHO Anatomical Therapeutic Chemical classification 0‑L J05AF10 Entecavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AF11 Telbivudine WHO Anatomical Therapeutic Chemical classification 0‑L J05AG Nicht-Nukleosidale Inhibitoren der Reverse-Transkriptase WHO Anatomical Therapeutic Chemical classification 0‑L J05AG01 Nevirapin WHO Anatomical Therapeutic Chemical classification 0‑L J05AG02 Delavirdin WHO Anatomical Therapeutic Chemical classification 0‑L J05AG03 Efavirenz WHO Anatomical Therapeutic Chemical classification 0‑L J05AG04 Etravirin WHO Anatomical Therapeutic Chemical classification 0‑L J05AH Neuraminidasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L J05AH01 Zanamivir WHO Anatomical Therapeutic Chemical classification 0‑L J05AH02 Oseltamivir WHO Anatomical Therapeutic Chemical classification 0‑L J05AR Antivirale Mittel zur Behandlung von HIV Infektionen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J05AR01 Ziduvudin und Lamivudin WHO Anatomical Therapeutic Chemical classification 0‑L J05AR02 Lamivudin und Abacavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AR03 Tenofovir disoproxil und Emtricitabin WHO Anatomical Therapeutic Chemical classification 0‑L J05AR04 Zidovudin, Lamivudin und Abacavir WHO Anatomical Therapeutic Chemical classification 0‑L J05AR05 Zidovudin, Lamivudin und Nevirapin WHO Anatomical Therapeutic Chemical classification 0‑L J05AR06 Emtricitabin, Tenofovir disoproxil und Efavirenz WHO Anatomical Therapeutic Chemical classification 0‑L J05AX Andere antivirale Mittel WHO Anatomical Therapeutic Chemical classification 0‑L J05AX01 Moroxydin WHO Anatomical Therapeutic Chemical classification 0‑L J05AX02 Lysozym WHO Anatomical Therapeutic Chemical classification 0‑L J05AX05 Inosin-Pranobex WHO Anatomical Therapeutic Chemical classification 0‑L J05AX06 Pleconaril WHO Anatomical Therapeutic Chemical classification 0‑L J05AX07 Enfuvirtid WHO Anatomical Therapeutic Chemical classification 0‑L J05AX08 Raltegravir WHO Anatomical Therapeutic Chemical classification 0‑L J05AX09 Maraviroc WHO Anatomical Therapeutic Chemical classification 0‑L J06 Immunsera und Immunglobuline WHO Anatomical Therapeutic Chemical classification 0‑L J06A Immunsera WHO Anatomical Therapeutic Chemical classification 0‑L J06AA Immunsera WHO Anatomical Therapeutic Chemical classification 0‑L J06AA01 Diphtherie-Antitoxin WHO Anatomical Therapeutic Chemical classification 0‑L J06AA02 Tetanus-Antitoxin WHO Anatomical Therapeutic Chemical classification 0‑L J06AA03 Schlangengift-Antiserum WHO Anatomical Therapeutic Chemical classification 0‑L J06AA04 Botulinum-Antitoxin WHO Anatomical Therapeutic Chemical classification 0‑L J06AA05 Gasbrand-Serum WHO Anatomical Therapeutic Chemical classification 0‑L J06AA06 Tollwut-Serum WHO Anatomical Therapeutic Chemical classification 0‑L J06B Immunglobuline WHO Anatomical Therapeutic Chemical classification 0‑L J06BA Immunglobuline, normal human WHO Anatomical Therapeutic Chemical classification 0‑L J06BA01 Immunglobuline, normal human, zur extravasalen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J06BA02 Immunglobuline, normal human, zur intravasalen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L J06BB Spezifische Immunglobuline WHO Anatomical Therapeutic Chemical classification 0‑L J06BB01 Anti-D(rh)-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB02 Tetanus-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB03 Varicella/Zoster-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB04 Hepatitis B-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB05 Tollwut-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB06 Röteln-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB07 Kuhpocken-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB08 Staphylococcus-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB09 Cytomegalievirus-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB10 Diphtherie-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB11 Hepatitis-A-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB12 FSME-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB13 Pertussis-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB14 Masern-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB15 Mumps-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J06BB16 Palivizumab WHO Anatomical Therapeutic Chemical classification 0‑L J06BB30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J06BC Andere Immunglobuline WHO Anatomical Therapeutic Chemical classification 0‑L J06BC01 Nebacumab WHO Anatomical Therapeutic Chemical classification 0‑L J07 Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07A Bakterielle Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AC Milzbrand-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AC01 Anthrax-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AD Brucellose-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AD01 Brucella-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AE Cholera-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AE01 Cholera, inaktiviert, ganze Zelle WHO Anatomical Therapeutic Chemical classification 0‑L J07AE02 Cholera, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07AE51 Cholera, Kombinationen mit Typhus-Impfstoff, inaktiviert, ganze Zelle WHO Anatomical Therapeutic Chemical classification 0‑L J07AF Diphtherie-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AF01 Diphtherie-Toxoid WHO Anatomical Therapeutic Chemical classification 0‑L J07AG Haemophilus-influenza-B-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AG01 Haemophilus-influenzae B, gereinigtes Antigen konjugiert WHO Anatomical Therapeutic Chemical classification 0‑L J07AG51 Haemophilus-influenzae B, Kombinationen mit Toxoiden WHO Anatomical Therapeutic Chemical classification 0‑L J07AG52 Haemophilus-influenzae B, Kombinationen mit Pertussis und Toxoiden WHO Anatomical Therapeutic Chemical classification 0‑L J07AG53 Haemophilus-influenzae B, Kombinationen mit Meningokokkus C, konjugiert WHO Anatomical Therapeutic Chemical classification 0‑L J07AH Meningokokken-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AH01 Meningokokkus A, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AH02 Andere Meningokokken monovalent, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AH03 Meningokokkus bivalent, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AH04 Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AH05 Andere Meningokokken polyvalent, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AH06 Meningokokkus B, Äußeres-Membranvesikel-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AH07 Meningokokkus C, gereinigtes Polysaccharid-Antigen, konjugiert WHO Anatomical Therapeutic Chemical classification 0‑L J07AH08 Meningokokkus tetravalent, gereinigtes Polysaccharid-Antigen, konjugiert WHO Anatomical Therapeutic Chemical classification 0‑L J07AJ Pertussis-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AJ01 Pertussis, inaktiviert, ganze Zelle WHO Anatomical Therapeutic Chemical classification 0‑L J07AJ02 Pertussis, gereinigtes Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AJ51 Pertussis, inaktiviert, ganze Zelle, Kombinationen mit Toxoiden WHO Anatomical Therapeutic Chemical classification 0‑L J07AJ52 Pertussis, gereinigtes Antigen, Kombinationen mit Toxoiden WHO Anatomical Therapeutic Chemical classification 0‑L J07AK Pest-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AK01 Pest, inaktiviert, ganze Zelle WHO Anatomical Therapeutic Chemical classification 0‑L J07AL Pneumokokken-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AL01 Pneumokokken, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AL02 Pneumokokken, gereinigtes Polysaccharid-Antigen, konjugiert WHO Anatomical Therapeutic Chemical classification 0‑L J07AM Tetanus-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AM01 Tetanus-Toxoid WHO Anatomical Therapeutic Chemical classification 0‑L J07AM51 Tetanus-Toxoid, Kombinationen mit Diphtherie-Toxoid WHO Anatomical Therapeutic Chemical classification 0‑L J07AM52 Tetanus-Toxoid, Kombinationen mit Tetanus-Immunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L J07AN Tuberkulose-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AN01 Tuberkulose, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07AP Typhus-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AP01 Typhus, oral, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07AP02 Typhus, inaktiviert, ganze Zelle WHO Anatomical Therapeutic Chemical classification 0‑L J07AP03 Typhus, gereinigtes Polysaccharid-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07AP10 Typhus, Kombinationen mit Paratyphustypen WHO Anatomical Therapeutic Chemical classification 0‑L J07AR Typhus (exanthematicus)-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07AR01 Typhus exanthematicus, inaktiviert, ganze Zelle WHO Anatomical Therapeutic Chemical classification 0‑L J07AX Andere bakterielle Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07B Virale Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BA Encephalitis-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BA01 FSME, inaktiviert, ganzes Virus WHO Anatomical Therapeutic Chemical classification 0‑L J07BA02 Encephalitis, japanische, inaktiviert, ganzes Virus WHO Anatomical Therapeutic Chemical classification 0‑L J07BB Influenza-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BB01 Influenza, inaktiviert, ganzes Virus WHO Anatomical Therapeutic Chemical classification 0‑L J07BB02 Influenza, gereinigtes Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07BC Hepatitis-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BC01 Hepatitis B, gereinigtes Antigen WHO Anatomical Therapeutic Chemical classification 0‑L J07BC02 Hepatitis A, inaktiviert, ganzes Virus WHO Anatomical Therapeutic Chemical classification 0‑L J07BC20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L J07BD Masern-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BD01 Masern, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BD51 Masern, Kombinationen mit Mumps, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BD52 Masern, Kombinationen mit Mumps und Röteln, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BD53 Masern, Kombinationen mit Röteln, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BD54 Masern, Kombinationen mit Mumps, Röteln und Varicella, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BE Mumps-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BE01 Mumps, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BF Poliomyelitis-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BF01 Poliomyelitis, oral, monovalent, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BF02 Poliomyelitis, oral, trivalent, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BF03 Poliomyelitis, trivalent, inaktiviert, ganzes Virus WHO Anatomical Therapeutic Chemical classification 0‑L J07BG Tollwut-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BG01 Tollwut, inaktiviert, ganzes Virus WHO Anatomical Therapeutic Chemical classification 0‑L J07BH Rotavirus-Diarrhoe-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BH01 Rotavirus, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BH02 Rotavirus, pentavalent, lebend, Reassortanten WHO Anatomical Therapeutic Chemical classification 0‑L J07BJ Röteln-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BJ01 Röteln, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BJ51 Röteln, Kombinationen mit Mumps, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BK Varicella Zoster Impfstoff WHO Anatomical Therapeutic Chemical classification 0‑L J07BK01 Varicella, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BK02 Zoster Virus lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BL Gelbfieber-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BL01 Gelbfieber, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07BM Papillomvirus-Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J07BM01 Humaner Papillomvirus-Impfstoff (Typen 6,11,16,18) WHO Anatomical Therapeutic Chemical classification 0‑L J07BM02 Humaner Papillomvirus-Impfstoff (Typen 16,18) WHO Anatomical Therapeutic Chemical classification 0‑L J07BX Varicella, lebend abgeschwächt WHO Anatomical Therapeutic Chemical classification 0‑L J07C Bakterielle und virale Impfstoffe, kombiniert WHO Anatomical Therapeutic Chemical classification 0‑L J07CA Bakterielle und virale Impfstoffe, kombiniert WHO Anatomical Therapeutic Chemical classification 0‑L J07CA01 Diphtherie-Poliomyelitis-Tetanus WHO Anatomical Therapeutic Chemical classification 0‑L J07CA02 Diphtherie-Pertussis-Poliomyelitis-Tetanus WHO Anatomical Therapeutic Chemical classification 0‑L J07CA03 Diphtherie-Röteln-Tetanus WHO Anatomical Therapeutic Chemical classification 0‑L J07CA04 Haemophilus-influenzae B und Poliomyelitis WHO Anatomical Therapeutic Chemical classification 0‑L J07CA05 Diphtherie-Hepatitis B-Pertussis-Tetanus WHO Anatomical Therapeutic Chemical classification 0‑L J07CA06 Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus WHO Anatomical Therapeutic Chemical classification 0‑L J07CA07 Diphtherie-Hepatitis B-Tetanus WHO Anatomical Therapeutic Chemical classification 0‑L J07CA08 Hämophilus influenzae B und Hepatitis B WHO Anatomical Therapeutic Chemical classification 0‑L J07CA09 Diphtherie-Haemophilus-influenzae B-Pertussis-Poliomyelitis-Tetanus-Hepatitis B WHO Anatomical Therapeutic Chemical classification 0‑L J07CA10 Typhus-Hepatitis A WHO Anatomical Therapeutic Chemical classification 0‑L J07CA11 Diphtherie-Haemophilus-influenzae B-Pertussis-Tetanus-Hepatitis B WHO Anatomical Therapeutic Chemical classification 0‑L J07CA12 Diphtherie-Pertussis-Poliomyelitis-Tetanus-Hepatitis B WHO Anatomical Therapeutic Chemical classification 0‑L J07X Andere Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L J51DB90 Cefalonium WHO Anatomical Therapeutic Chemical classification 0‑L L Antineoplastische und Immunmodulierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01 Antineoplastische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01A Alkylierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01AA Stickstofflost-Analoga WHO Anatomical Therapeutic Chemical classification 0‑L L01AA01 Cyclophosphamid WHO Anatomical Therapeutic Chemical classification 0‑L L01AA02 Chlorambucil WHO Anatomical Therapeutic Chemical classification 0‑L L01AA03 Melphalan WHO Anatomical Therapeutic Chemical classification 0‑L L01AA05 Chlormethin WHO Anatomical Therapeutic Chemical classification 0‑L L01AA06 Ifosfamid WHO Anatomical Therapeutic Chemical classification 0‑L L01AA07 Trofosfamid WHO Anatomical Therapeutic Chemical classification 0‑L L01AA08 Prednimustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AA09 Bendamustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AB Alkylsulfonate WHO Anatomical Therapeutic Chemical classification 0‑L L01AB01 Busulfan WHO Anatomical Therapeutic Chemical classification 0‑L L01AB02 Treosulfan WHO Anatomical Therapeutic Chemical classification 0‑L L01AB03 Mannosulfan WHO Anatomical Therapeutic Chemical classification 0‑L L01AC Ethylenimine WHO Anatomical Therapeutic Chemical classification 0‑L L01AC01 Thiotepa WHO Anatomical Therapeutic Chemical classification 0‑L L01AC02 Triaziquon WHO Anatomical Therapeutic Chemical classification 0‑L L01AC03 Carboquon WHO Anatomical Therapeutic Chemical classification 0‑L L01AD Nitrosoharnstoffe WHO Anatomical Therapeutic Chemical classification 0‑L L01AD01 Carmustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AD02 Lomustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AD03 Semustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AD04 Streptozocin WHO Anatomical Therapeutic Chemical classification 0‑L L01AD05 Fotemustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AD06 Nimustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AD07 Ranimustin WHO Anatomical Therapeutic Chemical classification 0‑L L01AG Epoxide WHO Anatomical Therapeutic Chemical classification 0‑L L01AG01 Etoglucid WHO Anatomical Therapeutic Chemical classification 0‑L L01AX Andere alkylierende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01AX01 Mitobronitol WHO Anatomical Therapeutic Chemical classification 0‑L L01AX02 Pipobroman WHO Anatomical Therapeutic Chemical classification 0‑L L01AX03 Temozolomid WHO Anatomical Therapeutic Chemical classification 0‑L L01AX04 Dacarbazin WHO Anatomical Therapeutic Chemical classification 0‑L L01B Antimetabolite WHO Anatomical Therapeutic Chemical classification 0‑L L01BA Folsäure-Analoga WHO Anatomical Therapeutic Chemical classification 0‑L L01BA01 Methotrexat WHO Anatomical Therapeutic Chemical classification 0‑L L01BA03 Raltitrexed WHO Anatomical Therapeutic Chemical classification 0‑L L01BA04 Pemetrexed WHO Anatomical Therapeutic Chemical classification 0‑L L01BB Purin-Analoga WHO Anatomical Therapeutic Chemical classification 0‑L L01BB02 Mercaptopurin WHO Anatomical Therapeutic Chemical classification 0‑L L01BB03 Tioguanin WHO Anatomical Therapeutic Chemical classification 0‑L L01BB04 Cladribin WHO Anatomical Therapeutic Chemical classification 0‑L L01BB05 Fludarabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BB06 Clofarabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BB07 Nelarabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BC Pyrimidin-Analoga WHO Anatomical Therapeutic Chemical classification 0‑L L01BC01 Cytarabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BC02 Fluorouracil WHO Anatomical Therapeutic Chemical classification 0‑L L01BC03 Tegafur WHO Anatomical Therapeutic Chemical classification 0‑L L01BC04 Carmofur WHO Anatomical Therapeutic Chemical classification 0‑L L01BC05 Gemcitabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BC06 Capecitabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BC08 Decitabin WHO Anatomical Therapeutic Chemical classification 0‑L L01BC52 Fluorouracil, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L L01BC53 Tegafur, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L L01C Pflanzliche Alkaloide und andere Natürliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01CA Vinka-Alkaloide und Analoga WHO Anatomical Therapeutic Chemical classification 0‑L L01CA01 Vinblastin WHO Anatomical Therapeutic Chemical classification 0‑L L01CA02 Vincristin WHO Anatomical Therapeutic Chemical classification 0‑L L01CA03 Vindesin WHO Anatomical Therapeutic Chemical classification 0‑L L01CA04 Vinorelbin WHO Anatomical Therapeutic Chemical classification 0‑L L01CB Podophyllotoxin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L L01CB01 Etoposid WHO Anatomical Therapeutic Chemical classification 0‑L L01CB02 Teniposid WHO Anatomical Therapeutic Chemical classification 0‑L L01CC Colchicin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L L01CC01 Demecolcin WHO Anatomical Therapeutic Chemical classification 0‑L L01CD Taxane WHO Anatomical Therapeutic Chemical classification 0‑L L01CD01 Paclitaxel WHO Anatomical Therapeutic Chemical classification 0‑L L01CD02 Docetaxel WHO Anatomical Therapeutic Chemical classification 0‑L L01CX Andere pflanzliche Alkaloide und natürliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01CX01 Trabectedin WHO Anatomical Therapeutic Chemical classification 0‑L L01D Zytotoxische Antibiotika und verwandte Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L L01DA Actinomycine WHO Anatomical Therapeutic Chemical classification 0‑L L01DA01 Dactinomycin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB Anthracycline und verwandte Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L L01DB01 Doxorubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB02 Daunorubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB03 Epirubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB04 Aclarubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB05 Zorubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB06 Idarubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB07 Mitoxantron WHO Anatomical Therapeutic Chemical classification 0‑L L01DB08 Pirarubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB09 Valrubicin WHO Anatomical Therapeutic Chemical classification 0‑L L01DB11 Pixantron WHO Anatomical Therapeutic Chemical classification 0‑L L01DC Andere zytotoxische Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L L01DC01 Bleomycin WHO Anatomical Therapeutic Chemical classification 0‑L L01DC02 Plicamycin WHO Anatomical Therapeutic Chemical classification 0‑L L01DC03 Mitomycin WHO Anatomical Therapeutic Chemical classification 0‑L L01X Andere antineoplastische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01XA Platin-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L L01XA01 Cisplatin WHO Anatomical Therapeutic Chemical classification 0‑L L01XA02 Carboplatin WHO Anatomical Therapeutic Chemical classification 0‑L L01XA03 Oxaliplatin WHO Anatomical Therapeutic Chemical classification 0‑L L01XB Methylhydrazine WHO Anatomical Therapeutic Chemical classification 0‑L L01XB01 Procarbazin WHO Anatomical Therapeutic Chemical classification 0‑L L01XC Monoklonale Antikörper WHO Anatomical Therapeutic Chemical classification 0‑L L01XC01 Edrecolomab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC02 Rituximab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC03 Trastuzumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC04 Alemtuzumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC05 Gemtuzumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC06 Cetuximab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC07 Bevacizumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC08 Panitumumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC09 Catumaxomab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC10 Ofatumumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XC11 Ipilimumab WHO Anatomical Therapeutic Chemical classification 0‑L L01XD Sensibilisatoren für die photodynamische/Radio- Therapie WHO Anatomical Therapeutic Chemical classification 0‑L L01XD01 Porfimer natrium WHO Anatomical Therapeutic Chemical classification 0‑L L01XD03 Methylaminolevulinat WHO Anatomical Therapeutic Chemical classification 0‑L L01XD04 Aminolevulin-Säure WHO Anatomical Therapeutic Chemical classification 0‑L L01XD05 Temoporfin WHO Anatomical Therapeutic Chemical classification 0‑L L01XD06 Efaproxiral WHO Anatomical Therapeutic Chemical classification 0‑L L01XE Proteinkinase Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L L01XE01 Imatinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE02 Gefitinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE03 Erlotinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE04 Sunitinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE05 Sorafenib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE06 Dasatinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE07 Lapatinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE08 Nilotinib WHO Anatomical Therapeutic Chemical classification 0‑L L01XE09 Temsirolimus WHO Anatomical Therapeutic Chemical classification 0‑L L01XE11 Pazopanib WHO Anatomical Therapeutic Chemical classification 0‑L L01XX Andere antineoplastische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L01XX01 Amsacrin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX02 Asparaginase WHO Anatomical Therapeutic Chemical classification 0‑L L01XX03 Altretamin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX05 Hydroxycarbamid WHO Anatomical Therapeutic Chemical classification 0‑L L01XX07 Lonidamin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX08 Pentostatin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX09 Miltefosin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX10 Masoprocol WHO Anatomical Therapeutic Chemical classification 0‑L L01XX11 Estramustin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX14 Tretinoin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX16 Mitoguazon WHO Anatomical Therapeutic Chemical classification 0‑L L01XX17 Topotecan WHO Anatomical Therapeutic Chemical classification 0‑L L01XX18 Tiazofurin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX19 Irinotecan WHO Anatomical Therapeutic Chemical classification 0‑L L01XX22 Alitretinoin WHO Anatomical Therapeutic Chemical classification 0‑L L01XX23 Mitotan WHO Anatomical Therapeutic Chemical classification 0‑L L01XX24 Pegaspargase WHO Anatomical Therapeutic Chemical classification 0‑L L01XX25 Bexaroten WHO Anatomical Therapeutic Chemical classification 0‑L L01XX27 Arsentrioxid WHO Anatomical Therapeutic Chemical classification 0‑L L01XX29 Denileukin diftitox WHO Anatomical Therapeutic Chemical classification 0‑L L01XX32 Bortezomib WHO Anatomical Therapeutic Chemical classification 0‑L L01XX33 Celecoxib WHO Anatomical Therapeutic Chemical classification 0‑L L01XX35 Anagrelid WHO Anatomical Therapeutic Chemical classification 0‑L L01XY Kombinationen von antineoplastischen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L L02 Endokrine Therapie WHO Anatomical Therapeutic Chemical classification 0‑L L02A Hormone und verwandte Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L02AA Estrogene WHO Anatomical Therapeutic Chemical classification 0‑L L02AA01 Diethylstilbestrol WHO Anatomical Therapeutic Chemical classification 0‑L L02AA02 Polyestradiolphosphat WHO Anatomical Therapeutic Chemical classification 0‑L L02AA03 Ethinylestradiol WHO Anatomical Therapeutic Chemical classification 0‑L L02AA04 Fosfestrol WHO Anatomical Therapeutic Chemical classification 0‑L L02AB Gestagene WHO Anatomical Therapeutic Chemical classification 0‑L L02AB01 Megestrol WHO Anatomical Therapeutic Chemical classification 0‑L L02AB02 Medroxyprogesteron WHO Anatomical Therapeutic Chemical classification 0‑L L02AB03 Gestonoron WHO Anatomical Therapeutic Chemical classification 0‑L L02AE Gonadotropin-Releasing-Hormon-Analoga WHO Anatomical Therapeutic Chemical classification 0‑L L02AE01 Buserelin WHO Anatomical Therapeutic Chemical classification 0‑L L02AE02 Leuprorelin WHO Anatomical Therapeutic Chemical classification 0‑L L02AE03 Goserelin WHO Anatomical Therapeutic Chemical classification 0‑L L02AE04 Triptorelin WHO Anatomical Therapeutic Chemical classification 0‑L L02AX Andere Hormone WHO Anatomical Therapeutic Chemical classification 0‑L L02B Hormonantagonisten und verwandte Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L02BA Antiestrogene WHO Anatomical Therapeutic Chemical classification 0‑L L02BA01 Tamoxifen WHO Anatomical Therapeutic Chemical classification 0‑L L02BA02 Toremifen WHO Anatomical Therapeutic Chemical classification 0‑L L02BA03 Fulvestrant WHO Anatomical Therapeutic Chemical classification 0‑L L02BB Antiandrogene WHO Anatomical Therapeutic Chemical classification 0‑L L02BB01 Flutamid WHO Anatomical Therapeutic Chemical classification 0‑L L02BB02 Nilutamid WHO Anatomical Therapeutic Chemical classification 0‑L L02BB03 Bicalutamid WHO Anatomical Therapeutic Chemical classification 0‑L L02BG Enzym-Inhibitoren WHO Anatomical Therapeutic Chemical classification 0‑L L02BG01 Aminoglutethimid WHO Anatomical Therapeutic Chemical classification 0‑L L02BG02 Formestan WHO Anatomical Therapeutic Chemical classification 0‑L L02BG03 Anastrozol WHO Anatomical Therapeutic Chemical classification 0‑L L02BG04 Letrozol WHO Anatomical Therapeutic Chemical classification 0‑L L02BG05 Vorozol WHO Anatomical Therapeutic Chemical classification 0‑L L02BG06 Exemestan WHO Anatomical Therapeutic Chemical classification 0‑L L02BX Andere Hormonantagonisten und verwandte Mittel WHO Anatomical Therapeutic Chemical classification 0‑L L02BX01 Abarelix WHO Anatomical Therapeutic Chemical classification 0‑L L02BX02 Degarelix WHO Anatomical Therapeutic Chemical classification 0‑L L03 Immunstimulanzien WHO Anatomical Therapeutic Chemical classification 0‑L L03A Zytokine und Immunmodulatoren WHO Anatomical Therapeutic Chemical classification 0‑L L03AA Koloniestimulierende Faktoren WHO Anatomical Therapeutic Chemical classification 0‑L L03AA02 Filgrastim WHO Anatomical Therapeutic Chemical classification 0‑L L03AA03 Molgramostim WHO Anatomical Therapeutic Chemical classification 0‑L L03AA09 Sargramostim WHO Anatomical Therapeutic Chemical classification 0‑L L03AA10 Lenograstim WHO Anatomical Therapeutic Chemical classification 0‑L L03AA12 Ancestim WHO Anatomical Therapeutic Chemical classification 0‑L L03AA13 Pegfilgrastim WHO Anatomical Therapeutic Chemical classification 0‑L L03AB Interferone WHO Anatomical Therapeutic Chemical classification 0‑L L03AB01 Interferon-alfa, natürlich WHO Anatomical Therapeutic Chemical classification 0‑L L03AB02 Interferon-beta, natürlich WHO Anatomical Therapeutic Chemical classification 0‑L L03AB03 Interferon-gamma WHO Anatomical Therapeutic Chemical classification 0‑L L03AB04 Interferon-alfa-2a WHO Anatomical Therapeutic Chemical classification 0‑L L03AB05 Interferon-alfa-2b WHO Anatomical Therapeutic Chemical classification 0‑L L03AB06 Interferon-alfa-n1 WHO Anatomical Therapeutic Chemical classification 0‑L L03AB07 Interferon-beta-1a WHO Anatomical Therapeutic Chemical classification 0‑L L03AB08 Interferon-beta-1b WHO Anatomical Therapeutic Chemical classification 0‑L L03AB09 Interferon alfacon-1 WHO Anatomical Therapeutic Chemical classification 0‑L L03AB10 Peginterferon alfa-2b WHO Anatomical Therapeutic Chemical classification 0‑L L03AB11 Peginterferon alfa-2a WHO Anatomical Therapeutic Chemical classification 0‑L L03AB60 Peginterferon alfa-2b, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L L03AC Interleukine WHO Anatomical Therapeutic Chemical classification 0‑L L03AC01 Aldesleukin WHO Anatomical Therapeutic Chemical classification 0‑L L03AC02 Oprelvekin WHO Anatomical Therapeutic Chemical classification 0‑L L03AX Andere Zytokine und Immunmodulatoren WHO Anatomical Therapeutic Chemical classification 0‑L L03AX01 Lentinan WHO Anatomical Therapeutic Chemical classification 0‑L L03AX02 Roquinimex WHO Anatomical Therapeutic Chemical classification 0‑L L03AX03 BCG-Impfstoff WHO Anatomical Therapeutic Chemical classification 0‑L L03AX04 Pegademase WHO Anatomical Therapeutic Chemical classification 0‑L L03AX05 Pidotimod WHO Anatomical Therapeutic Chemical classification 0‑L L03AX07 Poly I:C WHO Anatomical Therapeutic Chemical classification 0‑L L03AX08 Poly ICLC WHO Anatomical Therapeutic Chemical classification 0‑L L03AX09 Thymopentin WHO Anatomical Therapeutic Chemical classification 0‑L L03AX10 Immunocyanin WHO Anatomical Therapeutic Chemical classification 0‑L L03AX11 Tasonermin WHO Anatomical Therapeutic Chemical classification 0‑L L03AX12 Melanom-Impfstoff WHO Anatomical Therapeutic Chemical classification 0‑L L03AX13 Glatirameracetat WHO Anatomical Therapeutic Chemical classification 0‑L L03AX14 Histamin dihydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L L04 Immunsuppressiva WHO Anatomical Therapeutic Chemical classification 0‑L L04A Immunsuppressiva WHO Anatomical Therapeutic Chemical classification 0‑L L04AA Selektive Immunsuppressiva WHO Anatomical Therapeutic Chemical classification 0‑L L04AA01 Ciclosporin WHO Anatomical Therapeutic Chemical classification 0‑L L04AA02 Muromonab-CD3 WHO Anatomical Therapeutic Chemical classification 0‑L L04AA03 Antilymphocytäres Immunglobulin (Pferd) WHO Anatomical Therapeutic Chemical classification 0‑L L04AA04 Antithymocytäres Immunglobulin (Kaninchen) WHO Anatomical Therapeutic Chemical classification 0‑L L04AA05 Tacrolimus WHO Anatomical Therapeutic Chemical classification 0‑L L04AA06 Mycophenolsäure WHO Anatomical Therapeutic Chemical classification 0‑L L04AA08 Daclizumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA09 Basiliximab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA10 Sirolimus WHO Anatomical Therapeutic Chemical classification 0‑L L04AA11 Etanercept WHO Anatomical Therapeutic Chemical classification 0‑L L04AA12 Infliximab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA13 Leflunomid WHO Anatomical Therapeutic Chemical classification 0‑L L04AA14 Anakinra WHO Anatomical Therapeutic Chemical classification 0‑L L04AA15 Alefacept WHO Anatomical Therapeutic Chemical classification 0‑L L04AA16 Afelimomab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA17 Adalimumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA18 Everolimus WHO Anatomical Therapeutic Chemical classification 0‑L L04AA19 Gusperimus WHO Anatomical Therapeutic Chemical classification 0‑L L04AA21 Efalizumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA22 Abetimus WHO Anatomical Therapeutic Chemical classification 0‑L L04AA23 Natalizumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA24 Abatacept WHO Anatomical Therapeutic Chemical classification 0‑L L04AA25 Eculizumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA26 Belimumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AA28 Belatacept WHO Anatomical Therapeutic Chemical classification 0‑L L04AB02 Infliximab WHO Anatomical Therapeutic Chemical classification 0‑L L04AC03 Anakinra WHO Anatomical Therapeutic Chemical classification 0‑L L04AC05 Ustekinumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AC07 Tocilizumab WHO Anatomical Therapeutic Chemical classification 0‑L L04AD01 Ciclosporin WHO Anatomical Therapeutic Chemical classification 0‑L L04AD02 Tacrolimus WHO Anatomical Therapeutic Chemical classification 0‑L L04AX Andere Immunsuppressiva WHO Anatomical Therapeutic Chemical classification 0‑L L04AX01 Azathioprin WHO Anatomical Therapeutic Chemical classification 0‑L L04AX02 Thalidomid WHO Anatomical Therapeutic Chemical classification 0‑L L04AX03 Methotrexat WHO Anatomical Therapeutic Chemical classification 0‑L L04AX04 Lenalidomid WHO Anatomical Therapeutic Chemical classification 0‑L L04AX05 Pirfenidon WHO Anatomical Therapeutic Chemical classification 0‑L M Muskel- und Skelettsystem WHO Anatomical Therapeutic Chemical classification 0‑L M01 Antiphlogistika und Antirheumatika WHO Anatomical Therapeutic Chemical classification 0‑L M01A Nichtsteroidale antiphlogistika und Antirheumatika WHO Anatomical Therapeutic Chemical classification 0‑L M01AA Butylpyrazolidine WHO Anatomical Therapeutic Chemical classification 0‑L M01AA01 Phenylbutazon WHO Anatomical Therapeutic Chemical classification 0‑L M01AA02 Mofebutazon WHO Anatomical Therapeutic Chemical classification 0‑L M01AA03 Oxyphenbutazon WHO Anatomical Therapeutic Chemical classification 0‑L M01AA05 Clofezon WHO Anatomical Therapeutic Chemical classification 0‑L M01AA06 Kebuzon WHO Anatomical Therapeutic Chemical classification 0‑L M01AB Essigsäure-Derivate und verwandte Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L M01AB01 Indometacin WHO Anatomical Therapeutic Chemical classification 0‑L M01AB02 Sulindac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB03 Tolmetin WHO Anatomical Therapeutic Chemical classification 0‑L M01AB04 Zomepirac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB05 Diclofenac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB06 Alclofenac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB07 Bumadizon WHO Anatomical Therapeutic Chemical classification 0‑L M01AB08 Etodolac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB09 Lonazolac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB10 Fentiazac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB11 Acemetacin WHO Anatomical Therapeutic Chemical classification 0‑L M01AB12 Difenpiramid WHO Anatomical Therapeutic Chemical classification 0‑L M01AB13 Oxametacin WHO Anatomical Therapeutic Chemical classification 0‑L M01AB14 Proglumetacin WHO Anatomical Therapeutic Chemical classification 0‑L M01AB15 Ketorolac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB16 Aceclofenac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB17 Bufexamac WHO Anatomical Therapeutic Chemical classification 0‑L M01AB51 Indometacin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M01AB55 Diclofenac, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M01AC Oxicame WHO Anatomical Therapeutic Chemical classification 0‑L M01AC01 Piroxicam WHO Anatomical Therapeutic Chemical classification 0‑L M01AC02 Tenoxicam WHO Anatomical Therapeutic Chemical classification 0‑L M01AC04 Droxicam WHO Anatomical Therapeutic Chemical classification 0‑L M01AC05 Lornoxicam WHO Anatomical Therapeutic Chemical classification 0‑L M01AC06 Meloxicam WHO Anatomical Therapeutic Chemical classification 0‑L M01AE Propionsäure-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L M01AE01 Ibuprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE02 Naproxen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE03 Ketoprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE04 Fenoprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE05 Fenbufen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE06 Benoxaprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE07 Suprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE08 Pirprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE09 Flurbiprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE10 Indoprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE11 Tiaprofensäure WHO Anatomical Therapeutic Chemical classification 0‑L M01AE12 Oxaprozin WHO Anatomical Therapeutic Chemical classification 0‑L M01AE13 Ibuproxam WHO Anatomical Therapeutic Chemical classification 0‑L M01AE14 Dexibuprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE15 Flunoxaprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE16 Alminoprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE17 Dexketoprofen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE51 Ibuprofen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M01AE52 Naproxen und Esomeprazol WHO Anatomical Therapeutic Chemical classification 0‑L M01AE53 Ketoprofen, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M01AG Fenamate WHO Anatomical Therapeutic Chemical classification 0‑L M01AG01 Mefenaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M01AG02 Tolfenaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M01AG03 Flufenaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M01AG04 Meclofenaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M01AH Coxibe WHO Anatomical Therapeutic Chemical classification 0‑L M01AH01 Celecoxib WHO Anatomical Therapeutic Chemical classification 0‑L M01AH02 Rofecoxib WHO Anatomical Therapeutic Chemical classification 0‑L M01AH03 Valdecoxib WHO Anatomical Therapeutic Chemical classification 0‑L M01AH04 Parecoxib WHO Anatomical Therapeutic Chemical classification 0‑L M01AH05 Etoricoxib WHO Anatomical Therapeutic Chemical classification 0‑L M01AH06 Lumiracoxib WHO Anatomical Therapeutic Chemical classification 0‑L M01AX Andere nichtsteroidale Antiphlogistika und Antirheumatika WHO Anatomical Therapeutic Chemical classification 0‑L M01AX01 Nabumeton WHO Anatomical Therapeutic Chemical classification 0‑L M01AX02 Nifluminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M01AX04 Azapropazon WHO Anatomical Therapeutic Chemical classification 0‑L M01AX05 Glukosamin WHO Anatomical Therapeutic Chemical classification 0‑L M01AX07 Benzydamin WHO Anatomical Therapeutic Chemical classification 0‑L M01AX12 Glukosaminoglycanpolysulfat WHO Anatomical Therapeutic Chemical classification 0‑L M01AX13 Proquazon WHO Anatomical Therapeutic Chemical classification 0‑L M01AX14 Orgotein WHO Anatomical Therapeutic Chemical classification 0‑L M01AX17 Nimesulid WHO Anatomical Therapeutic Chemical classification 0‑L M01AX18 Feprazon WHO Anatomical Therapeutic Chemical classification 0‑L M01AX21 Diacerein WHO Anatomical Therapeutic Chemical classification 0‑L M01AX22 Morniflumat WHO Anatomical Therapeutic Chemical classification 0‑L M01AX23 Tenidap WHO Anatomical Therapeutic Chemical classification 0‑L M01AX24 Oxaceprol WHO Anatomical Therapeutic Chemical classification 0‑L M01AX25 Chondroitinsulfat WHO Anatomical Therapeutic Chemical classification 0‑L M01AX68 Feprazon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M01B Antiphlogistika/Antirheumatika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L M01BA Antiphlogistika/Antirheumatika in Kombination mit Corticosteroiden WHO Anatomical Therapeutic Chemical classification 0‑L M01BA01 Phenylbutazon und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L M01BA02 Dipyrocetyl und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L M01BA03 Acetylsalicylsäure und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L M01BX Andere Antiphlogistika/Antirheumatika in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L M01C Spezifische Antirheumatika WHO Anatomical Therapeutic Chemical classification 0‑L M01CA Chinoline WHO Anatomical Therapeutic Chemical classification 0‑L M01CA03 Oxycinchophen WHO Anatomical Therapeutic Chemical classification 0‑L M01CB Gold-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L M01CB01 Natriumaurothiomalat WHO Anatomical Therapeutic Chemical classification 0‑L M01CB02 Natrium aurothiosulfat WHO Anatomical Therapeutic Chemical classification 0‑L M01CB03 Auranofin WHO Anatomical Therapeutic Chemical classification 0‑L M01CB04 Aurothioglucose WHO Anatomical Therapeutic Chemical classification 0‑L M01CB05 Aurotioprol WHO Anatomical Therapeutic Chemical classification 0‑L M01CC Penicillamin und ähnliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M01CC01 Penicillamin WHO Anatomical Therapeutic Chemical classification 0‑L M01CC02 Bucillamin WHO Anatomical Therapeutic Chemical classification 0‑L M01CX Andere spezifische Antirheumatika WHO Anatomical Therapeutic Chemical classification 0‑L M02 Topische Mittel gegen Gelenk- und Muskelschmerzen WHO Anatomical Therapeutic Chemical classification 0‑L M02A Topische Mittel gegen Gelenk- und Muskelschmerzen WHO Anatomical Therapeutic Chemical classification 0‑L M02AA Nichtsteroidale Antiphlogistika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L M02AA01 Phenylbutazon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA02 Mofebutazon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA03 Clofezon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA04 Oxyphenbutazon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA05 Benzydamin WHO Anatomical Therapeutic Chemical classification 0‑L M02AA06 Etofenamat WHO Anatomical Therapeutic Chemical classification 0‑L M02AA07 Piroxicam WHO Anatomical Therapeutic Chemical classification 0‑L M02AA08 Felbinac WHO Anatomical Therapeutic Chemical classification 0‑L M02AA09 Bufexamac WHO Anatomical Therapeutic Chemical classification 0‑L M02AA10 Ketoprofen WHO Anatomical Therapeutic Chemical classification 0‑L M02AA11 Bendazac WHO Anatomical Therapeutic Chemical classification 0‑L M02AA12 Naproxen WHO Anatomical Therapeutic Chemical classification 0‑L M02AA13 Ibuprofen WHO Anatomical Therapeutic Chemical classification 0‑L M02AA14 Fentiazac WHO Anatomical Therapeutic Chemical classification 0‑L M02AA15 Diclofenac WHO Anatomical Therapeutic Chemical classification 0‑L M02AA16 Feprazon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA17 Nifluminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M02AA18 Meclofenaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L M02AA19 Flurbiprofen WHO Anatomical Therapeutic Chemical classification 0‑L M02AA21 Tolmetin WHO Anatomical Therapeutic Chemical classification 0‑L M02AA22 Suxibuzon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA23 Indometacin WHO Anatomical Therapeutic Chemical classification 0‑L M02AA24 Nifenazon WHO Anatomical Therapeutic Chemical classification 0‑L M02AA25 Aceclofenac WHO Anatomical Therapeutic Chemical classification 0‑L M02AB Capsicum-haltige Zubereitungen und ähnliche Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M02AC Zubereitungen mit Salicylsäure-Derivaten WHO Anatomical Therapeutic Chemical classification 0‑L M02AX Andere topische Mittel gegen Gelenk- und Muskelschmerzen WHO Anatomical Therapeutic Chemical classification 0‑L M02AX02 Tolazolin WHO Anatomical Therapeutic Chemical classification 0‑L M02AX03 Dimethylsulfoxid WHO Anatomical Therapeutic Chemical classification 0‑L M02AX10 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L M03 Muskelrelaxanzien WHO Anatomical Therapeutic Chemical classification 0‑L M03A Muskelrelaxanzien, peripher wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M03AA Curare-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L M03AA01 Alcuronium WHO Anatomical Therapeutic Chemical classification 0‑L M03AA02 Tubocurarin WHO Anatomical Therapeutic Chemical classification 0‑L M03AA04 Dimethyltubocurarin WHO Anatomical Therapeutic Chemical classification 0‑L M03AB Cholin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L M03AB01 Suxamethonium WHO Anatomical Therapeutic Chemical classification 0‑L M03AC Andere quartäre Ammonium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L M03AC01 Pancuronium WHO Anatomical Therapeutic Chemical classification 0‑L M03AC02 Gallamin WHO Anatomical Therapeutic Chemical classification 0‑L M03AC03 Vecuronium WHO Anatomical Therapeutic Chemical classification 0‑L M03AC04 Atracurium WHO Anatomical Therapeutic Chemical classification 0‑L M03AC05 Hexafluronium WHO Anatomical Therapeutic Chemical classification 0‑L M03AC06 Pipecuroniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L M03AC07 Doxacuriumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L M03AC08 Fazadiniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L M03AC09 Rocuroniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L M03AC10 Mivacuriumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L M03AC11 Cisatracurium WHO Anatomical Therapeutic Chemical classification 0‑L M03AX Andere Muskelrelaxanzien, peripher wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M03AX01 Botulinumtoxin WHO Anatomical Therapeutic Chemical classification 0‑L M03B Muskelrelaxanzien, zentral wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M03BA Carbaminsäureester WHO Anatomical Therapeutic Chemical classification 0‑L M03BA01 Phenprobamat WHO Anatomical Therapeutic Chemical classification 0‑L M03BA02 Carisoprodol WHO Anatomical Therapeutic Chemical classification 0‑L M03BA03 Methocarbamol WHO Anatomical Therapeutic Chemical classification 0‑L M03BA04 Styramat WHO Anatomical Therapeutic Chemical classification 0‑L M03BA05 Febarbamat WHO Anatomical Therapeutic Chemical classification 0‑L M03BA51 Phenprobamat, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BA52 Carisoprodol, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BA53 Methocarbamol, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BA71 Phenprobamat, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BA72 Carisoprodol, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BA73 Methocarbamol, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BB Oxazol-, Thiazin- und Triazin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L M03BB02 Chlormezanon WHO Anatomical Therapeutic Chemical classification 0‑L M03BB03 Chlorzoxazon WHO Anatomical Therapeutic Chemical classification 0‑L M03BB52 Chlormezanon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BB53 Chlorzoxazon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BB72 Chlormezanon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BB73 Chlorzoxazon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M03BC Ether, chemisch den Antihistaminika verwandt WHO Anatomical Therapeutic Chemical classification 0‑L M03BC01 Orphenadrin (citrat) WHO Anatomical Therapeutic Chemical classification 0‑L M03BC51 Orphenadrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M03BX Andere zentral wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M03BX01 Baclofen WHO Anatomical Therapeutic Chemical classification 0‑L M03BX02 Tizanidin WHO Anatomical Therapeutic Chemical classification 0‑L M03BX03 Pridinol WHO Anatomical Therapeutic Chemical classification 0‑L M03BX04 Tolperison WHO Anatomical Therapeutic Chemical classification 0‑L M03BX05 Thiocolchicosid WHO Anatomical Therapeutic Chemical classification 0‑L M03BX06 Mephenesin WHO Anatomical Therapeutic Chemical classification 0‑L M03BX07 Tetrazepam WHO Anatomical Therapeutic Chemical classification 0‑L M03BX08 Cyclobenzaprin WHO Anatomical Therapeutic Chemical classification 0‑L M03BX30 Fenyramidol WHO Anatomical Therapeutic Chemical classification 0‑L M03C Muskelrelaxanzien, direkt wirkende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L M03CA Dantrolen und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L M03CA01 Dantrolen WHO Anatomical Therapeutic Chemical classification 0‑L M04 Gichtmittel WHO Anatomical Therapeutic Chemical classification 0‑L M04A Gichtmittel WHO Anatomical Therapeutic Chemical classification 0‑L M04AA Urikostatika WHO Anatomical Therapeutic Chemical classification 0‑L M04AA01 Allopurinol WHO Anatomical Therapeutic Chemical classification 0‑L M04AA02 Tisopurin WHO Anatomical Therapeutic Chemical classification 0‑L M04AA03 Febuxostat WHO Anatomical Therapeutic Chemical classification 0‑L M04AA51 Allopurinol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M04AB Urikosurika WHO Anatomical Therapeutic Chemical classification 0‑L M04AB01 Probenecid WHO Anatomical Therapeutic Chemical classification 0‑L M04AB02 Sulfinpyrazon WHO Anatomical Therapeutic Chemical classification 0‑L M04AB03 Benzbromaron WHO Anatomical Therapeutic Chemical classification 0‑L M04AB04 Isobromindion WHO Anatomical Therapeutic Chemical classification 0‑L M04AC Gichtmittel ohne Effekt auf den Harnsäuremetabolismus WHO Anatomical Therapeutic Chemical classification 0‑L M04AC01 Colchicin WHO Anatomical Therapeutic Chemical classification 0‑L M04AC02 Cinchophen WHO Anatomical Therapeutic Chemical classification 0‑L M04AX Andere Gichtmittel WHO Anatomical Therapeutic Chemical classification 0‑L M04AX01 Uratoxidase WHO Anatomical Therapeutic Chemical classification 0‑L M05 Mittel zur Behandlung von Knochenerkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L M05B Mittel mit Einfluss auf die Knochenstruktur und die Mineralisation WHO Anatomical Therapeutic Chemical classification 0‑L M05BA Bisphosphonate WHO Anatomical Therapeutic Chemical classification 0‑L M05BA01 Etidronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA02 Clodronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA03 Pamidronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA04 Alendronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA05 Tiludronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA06 Ibandronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA07 Risedronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BA08 Zoledronsäure WHO Anatomical Therapeutic Chemical classification 0‑L M05BB Bisphosphonate, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M05BB01 Etidronsäure und Calcium, Sequenzialpräparate WHO Anatomical Therapeutic Chemical classification 0‑L M05BB02 Risedronsäure und Calcium, Sequenzialpräparat WHO Anatomical Therapeutic Chemical classification 0‑L M05BB03 Alendronsäure und Colecalciferol WHO Anatomical Therapeutic Chemical classification 0‑L M05BC Knochenmorphogene Proteine WHO Anatomical Therapeutic Chemical classification 0‑L M05BC01 Dibotermin alfa WHO Anatomical Therapeutic Chemical classification 0‑L M05BC02 Eptotermin alfa WHO Anatomical Therapeutic Chemical classification 0‑L M05BX Andere Mittel mit Einfluß auf die Knochenstruktur und die Mineralisation WHO Anatomical Therapeutic Chemical classification 0‑L M05BX01 Ipriflavon WHO Anatomical Therapeutic Chemical classification 0‑L M05BX02 Aluminiumhydroxychlorid WHO Anatomical Therapeutic Chemical classification 0‑L M05BX03 Strontium ranelat WHO Anatomical Therapeutic Chemical classification 0‑L M05BX04 Denosumab WHO Anatomical Therapeutic Chemical classification 0‑L M09 Andere Mittel gegen Störungen des Muskel- und Skelettsystems WHO Anatomical Therapeutic Chemical classification 0‑L M09A Andere Mittel gegen Störungen des Muskel- und Skelettsystems WHO Anatomical Therapeutic Chemical classification 0‑L M09AA Chinin und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L M09AA01 Hydrochinin WHO Anatomical Therapeutic Chemical classification 0‑L M09AA72 Chinin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L M09AB Enzyme WHO Anatomical Therapeutic Chemical classification 0‑L M09AB01 Chymopapain WHO Anatomical Therapeutic Chemical classification 0‑L M09AB02 Kollagenase aus Clostridium histolyticum WHO Anatomical Therapeutic Chemical classification 0‑L M09AB52 Trypsin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L M09AX Andere Mittel gegen Störungen des Muskel- und Skelettsystems WHO Anatomical Therapeutic Chemical classification 0‑L M09AX01 Hyaluronsäure WHO Anatomical Therapeutic Chemical classification 0‑L N Nervensystem WHO Anatomical Therapeutic Chemical classification 0‑L N01 Anästhetika WHO Anatomical Therapeutic Chemical classification 0‑L N01A Allgemeinanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L N01AA Ether WHO Anatomical Therapeutic Chemical classification 0‑L N01AA01 Diethylether WHO Anatomical Therapeutic Chemical classification 0‑L N01AA02 Vinylether WHO Anatomical Therapeutic Chemical classification 0‑L N01AB Halogenierte Kohlenwasserstoffe WHO Anatomical Therapeutic Chemical classification 0‑L N01AB01 Halothan WHO Anatomical Therapeutic Chemical classification 0‑L N01AB02 Chloroform WHO Anatomical Therapeutic Chemical classification 0‑L N01AB03 Methoxyfluran WHO Anatomical Therapeutic Chemical classification 0‑L N01AB04 Enfluran WHO Anatomical Therapeutic Chemical classification 0‑L N01AB05 Trichlorethylen WHO Anatomical Therapeutic Chemical classification 0‑L N01AB06 Isofluran WHO Anatomical Therapeutic Chemical classification 0‑L N01AB07 Desfluran WHO Anatomical Therapeutic Chemical classification 0‑L N01AB08 Sevofluran WHO Anatomical Therapeutic Chemical classification 0‑L N01AF Barbiturate, rein WHO Anatomical Therapeutic Chemical classification 0‑L N01AF01 Methohexital WHO Anatomical Therapeutic Chemical classification 0‑L N01AF02 Hexobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N01AF03 Thiopental WHO Anatomical Therapeutic Chemical classification 0‑L N01AG Barbiturate in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L N01AG01 Narcobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N01AH Opioidanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L N01AH01 Fentanyl WHO Anatomical Therapeutic Chemical classification 0‑L N01AH02 Alfentanil WHO Anatomical Therapeutic Chemical classification 0‑L N01AH03 Sufentanil WHO Anatomical Therapeutic Chemical classification 0‑L N01AH04 Phenoperidin WHO Anatomical Therapeutic Chemical classification 0‑L N01AH05 Anileridin WHO Anatomical Therapeutic Chemical classification 0‑L N01AH06 Remifentanil WHO Anatomical Therapeutic Chemical classification 0‑L N01AH51 Fentanyl, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01AX Andere Allgemeinanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L N01AX01 Droperidol WHO Anatomical Therapeutic Chemical classification 0‑L N01AX03 Ketamin WHO Anatomical Therapeutic Chemical classification 0‑L N01AX04 Propanidid WHO Anatomical Therapeutic Chemical classification 0‑L N01AX05 Alfaxalon WHO Anatomical Therapeutic Chemical classification 0‑L N01AX07 Etomidate WHO Anatomical Therapeutic Chemical classification 0‑L N01AX10 Propofol WHO Anatomical Therapeutic Chemical classification 0‑L N01AX11 Hydroxybuttersäure WHO Anatomical Therapeutic Chemical classification 0‑L N01AX13 Distickstoffmonoxid WHO Anatomical Therapeutic Chemical classification 0‑L N01AX14 Esketamin WHO Anatomical Therapeutic Chemical classification 0‑L N01AX15 Xenon WHO Anatomical Therapeutic Chemical classification 0‑L N01AX63 Distickstoffmonoxid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01B Lokalanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L N01BA Ester der Aminobenzoesäure WHO Anatomical Therapeutic Chemical classification 0‑L N01BA01 Metabutethamin WHO Anatomical Therapeutic Chemical classification 0‑L N01BA02 Procain WHO Anatomical Therapeutic Chemical classification 0‑L N01BA03 Tetracain WHO Anatomical Therapeutic Chemical classification 0‑L N01BA04 Chloroprocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BA05 Benzocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BA52 Procain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB Amide WHO Anatomical Therapeutic Chemical classification 0‑L N01BB01 Bupivacain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB02 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB03 Mepivacain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB04 Prilocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB05 Butanilicain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB06 Cinchocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB07 Etidocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB08 Articain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB09 Ropivacain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB10 Levobupivacain WHO Anatomical Therapeutic Chemical classification 0‑L N01BB20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB51 Bupivacain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB52 Lidocain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB53 Mepivacain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB54 Prilocain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB57 Etidocain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BB58 Articain, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N01BC Ester der Benzoesäure WHO Anatomical Therapeutic Chemical classification 0‑L N01BC01 Cocain WHO Anatomical Therapeutic Chemical classification 0‑L N01BX Andere Lokalanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L N01BX01 Ethylchlorid WHO Anatomical Therapeutic Chemical classification 0‑L N01BX02 Dyclonin WHO Anatomical Therapeutic Chemical classification 0‑L N01BX03 Phenol WHO Anatomical Therapeutic Chemical classification 0‑L N01BX04 Capsaicin WHO Anatomical Therapeutic Chemical classification 0‑L N02 Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L N02A Opioide WHO Anatomical Therapeutic Chemical classification 0‑L N02AA Natürliche Opium-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L N02AA01 Morphin WHO Anatomical Therapeutic Chemical classification 0‑L N02AA02 Opium WHO Anatomical Therapeutic Chemical classification 0‑L N02AA03 Hydromorphon WHO Anatomical Therapeutic Chemical classification 0‑L N02AA04 Nicomorphin WHO Anatomical Therapeutic Chemical classification 0‑L N02AA05 Oxycodon WHO Anatomical Therapeutic Chemical classification 0‑L N02AA08 Dihydrocodein WHO Anatomical Therapeutic Chemical classification 0‑L N02AA09 Diamorphin WHO Anatomical Therapeutic Chemical classification 0‑L N02AA10 Papaveretum WHO Anatomical Therapeutic Chemical classification 0‑L N02AA51 Morphin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N02AA55 Oxycodon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N02AA58 Dihydrocodein, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N02AA59 Codein, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AA79 Codein, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AB Phenylpiperidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02AB01 Ketobemidon WHO Anatomical Therapeutic Chemical classification 0‑L N02AB02 Pethidin WHO Anatomical Therapeutic Chemical classification 0‑L N02AB03 Fentanyl WHO Anatomical Therapeutic Chemical classification 0‑L N02AB52 Pethidin, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AB72 Pethidin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AC Diphenylpropylamin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02AC01 Dextromoramid WHO Anatomical Therapeutic Chemical classification 0‑L N02AC03 Piritramid WHO Anatomical Therapeutic Chemical classification 0‑L N02AC04 Dextropropoxyphen WHO Anatomical Therapeutic Chemical classification 0‑L N02AC05 Bezitramid WHO Anatomical Therapeutic Chemical classification 0‑L N02AC52 Methadon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AC54 Dextropropoxyphen, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AC74 Dextropropoxyphen, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02AD Benzomorphan-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02AD01 Pentazocin WHO Anatomical Therapeutic Chemical classification 0‑L N02AD02 Phenazocin WHO Anatomical Therapeutic Chemical classification 0‑L N02AE Oripavin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02AE01 Buprenorphin WHO Anatomical Therapeutic Chemical classification 0‑L N02AF Morphinan-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02AF01 Butorphanol WHO Anatomical Therapeutic Chemical classification 0‑L N02AF02 Nalbufin WHO Anatomical Therapeutic Chemical classification 0‑L N02AG Opioide in Kombination mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L N02AG01 Morphin mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L N02AG02 Ketobemidon mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L N02AG03 Pethidin mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L N02AG04 Hydromorphon mit Spasmolytika WHO Anatomical Therapeutic Chemical classification 0‑L N02AX Andere Opioide WHO Anatomical Therapeutic Chemical classification 0‑L N02AX01 Tilidin WHO Anatomical Therapeutic Chemical classification 0‑L N02AX02 Tramadol WHO Anatomical Therapeutic Chemical classification 0‑L N02AX03 Dezocin WHO Anatomical Therapeutic Chemical classification 0‑L N02AX06 Tapentadol WHO Anatomical Therapeutic Chemical classification 0‑L N02AX52 Tramadol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N02B Andere Analgetika und Antipyretika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA Salicylsäure und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02BA01 Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L N02BA02 Aloxiprin WHO Anatomical Therapeutic Chemical classification 0‑L N02BA03 Cholinsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA04 Natriumsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA05 Salicylamid WHO Anatomical Therapeutic Chemical classification 0‑L N02BA06 Salsalat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA07 Ethenzamid WHO Anatomical Therapeutic Chemical classification 0‑L N02BA08 Morpholinsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA09 Dipyrocetyl WHO Anatomical Therapeutic Chemical classification 0‑L N02BA10 Benorilat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA11 Diflunisal WHO Anatomical Therapeutic Chemical classification 0‑L N02BA12 Kaliumsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA14 Guacetisal WHO Anatomical Therapeutic Chemical classification 0‑L N02BA15 Carbasalat calcium WHO Anatomical Therapeutic Chemical classification 0‑L N02BA16 Imidazolsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L N02BA51 Acetylsalicylsäure, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA55 Salicylamid, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA57 Ethenzamid, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA59 Dipyrocetyl, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA65 Carbasalat calcium, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA71 Acetylsalicylsäure, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA75 Salicylamid, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA77 Ethenzamid, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BA79 Dipyrocetyl, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB Pyrazolone WHO Anatomical Therapeutic Chemical classification 0‑L N02BB01 Phenazon WHO Anatomical Therapeutic Chemical classification 0‑L N02BB02 Metamizol-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L N02BB03 Aminophenazon WHO Anatomical Therapeutic Chemical classification 0‑L N02BB04 Propyphenazon WHO Anatomical Therapeutic Chemical classification 0‑L N02BB05 Nifenazon WHO Anatomical Therapeutic Chemical classification 0‑L N02BB51 Phenazon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB52 Metamizol-Natrium, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB53 Aminophenazon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB54 Propyphenazon, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB71 Phenazon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB72 Metamizol-Natrium, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB73 Aminophenazon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BB74 Propyphenazon, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BE Anilide WHO Anatomical Therapeutic Chemical classification 0‑L N02BE01 Paracetamol WHO Anatomical Therapeutic Chemical classification 0‑L N02BE03 Phenacetin WHO Anatomical Therapeutic Chemical classification 0‑L N02BE04 Bucetin WHO Anatomical Therapeutic Chemical classification 0‑L N02BE05 Propacetamol WHO Anatomical Therapeutic Chemical classification 0‑L N02BE51 Paracetamol, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BE53 Phenacetin, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BE54 Bucetin, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BE71 Paracetamol, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BE73 Phenacetin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BE74 Bucetin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02BG Andere Analgetika und Antipyretika WHO Anatomical Therapeutic Chemical classification 0‑L N02BG02 Rimazolium WHO Anatomical Therapeutic Chemical classification 0‑L N02BG03 Glafenin WHO Anatomical Therapeutic Chemical classification 0‑L N02BG04 Floctafenin WHO Anatomical Therapeutic Chemical classification 0‑L N02BG05 Viminol WHO Anatomical Therapeutic Chemical classification 0‑L N02BG06 Nefopam WHO Anatomical Therapeutic Chemical classification 0‑L N02BG07 Flupirtin WHO Anatomical Therapeutic Chemical classification 0‑L N02BG08 Ziconotid WHO Anatomical Therapeutic Chemical classification 0‑L N02BG10 Nabiximols WHO Anatomical Therapeutic Chemical classification 0‑L N02C Migränemittel WHO Anatomical Therapeutic Chemical classification 0‑L N02CA Mutterkorn-Alkaloide WHO Anatomical Therapeutic Chemical classification 0‑L N02CA01 Dihydroergotamin WHO Anatomical Therapeutic Chemical classification 0‑L N02CA02 Ergotamin WHO Anatomical Therapeutic Chemical classification 0‑L N02CA04 Methysergid WHO Anatomical Therapeutic Chemical classification 0‑L N02CA07 Lisurid WHO Anatomical Therapeutic Chemical classification 0‑L N02CA51 Dihydroergotamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N02CA52 Ergotamin, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02CA72 Ergotamin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N02CB Corticosteroid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N02CB01 Flumedroxon WHO Anatomical Therapeutic Chemical classification 0‑L N02CC Selektive Serotonin-5HT1-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L N02CC01 Sumatriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CC02 Naratriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CC03 Zolmitriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CC04 Rizatriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CC05 Almotriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CC06 Eletriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CC07 Frovatriptan WHO Anatomical Therapeutic Chemical classification 0‑L N02CX Andere Migränemittel WHO Anatomical Therapeutic Chemical classification 0‑L N02CX01 Pizotifen WHO Anatomical Therapeutic Chemical classification 0‑L N02CX02 Clonidin WHO Anatomical Therapeutic Chemical classification 0‑L N02CX03 Iprazochrom WHO Anatomical Therapeutic Chemical classification 0‑L N02CX05 Dimetotiazin WHO Anatomical Therapeutic Chemical classification 0‑L N02CX06 Oxetoron WHO Anatomical Therapeutic Chemical classification 0‑L N03 Antiepileptika WHO Anatomical Therapeutic Chemical classification 0‑L N03A Antiepileptika WHO Anatomical Therapeutic Chemical classification 0‑L N03AA Barbiturate und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AA01 Methylphenobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N03AA02 Phenobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N03AA03 Primidon WHO Anatomical Therapeutic Chemical classification 0‑L N03AA04 Barbexaclon WHO Anatomical Therapeutic Chemical classification 0‑L N03AA30 Metharbital WHO Anatomical Therapeutic Chemical classification 0‑L N03AB Hydantoin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AB01 Ethotoin WHO Anatomical Therapeutic Chemical classification 0‑L N03AB02 Phenytoin WHO Anatomical Therapeutic Chemical classification 0‑L N03AB03 Amino(diphenylhydantoin)valeriansäure WHO Anatomical Therapeutic Chemical classification 0‑L N03AB04 Mephenytoin WHO Anatomical Therapeutic Chemical classification 0‑L N03AB05 Fosphenytoin WHO Anatomical Therapeutic Chemical classification 0‑L N03AB52 Phenytoin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N03AB54 Mephenytoin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N03AC Oxazolidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AC01 Paramethadion WHO Anatomical Therapeutic Chemical classification 0‑L N03AC02 Trimethadion WHO Anatomical Therapeutic Chemical classification 0‑L N03AC03 Ethadion WHO Anatomical Therapeutic Chemical classification 0‑L N03AD Succinimid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AD01 Ethosuximid WHO Anatomical Therapeutic Chemical classification 0‑L N03AD02 Phensuximid WHO Anatomical Therapeutic Chemical classification 0‑L N03AD03 Mesuximid WHO Anatomical Therapeutic Chemical classification 0‑L N03AD51 Ethosuximid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N03AE Benzodiazepin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AE01 Clonazepam WHO Anatomical Therapeutic Chemical classification 0‑L N03AF Carboxamid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AF01 Carbamazepin WHO Anatomical Therapeutic Chemical classification 0‑L N03AF02 Oxcarbazepin WHO Anatomical Therapeutic Chemical classification 0‑L N03AF03 Rufinamid WHO Anatomical Therapeutic Chemical classification 0‑L N03AF04 Eslicarbazepin WHO Anatomical Therapeutic Chemical classification 0‑L N03AG Fettsäure-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N03AG01 Valproinsäure WHO Anatomical Therapeutic Chemical classification 0‑L N03AG02 Valpromid WHO Anatomical Therapeutic Chemical classification 0‑L N03AG03 Aminobuttersäure WHO Anatomical Therapeutic Chemical classification 0‑L N03AG04 Vigabatrin WHO Anatomical Therapeutic Chemical classification 0‑L N03AG05 Progabid WHO Anatomical Therapeutic Chemical classification 0‑L N03AG06 Tiagabin WHO Anatomical Therapeutic Chemical classification 0‑L N03AX Andere Antiepileptika WHO Anatomical Therapeutic Chemical classification 0‑L N03AX03 Sultiam WHO Anatomical Therapeutic Chemical classification 0‑L N03AX07 Phenacemid WHO Anatomical Therapeutic Chemical classification 0‑L N03AX09 Lamotrigin WHO Anatomical Therapeutic Chemical classification 0‑L N03AX10 Felbamat WHO Anatomical Therapeutic Chemical classification 0‑L N03AX11 Topiramat WHO Anatomical Therapeutic Chemical classification 0‑L N03AX12 Gabapentin WHO Anatomical Therapeutic Chemical classification 0‑L N03AX13 Pheneturid WHO Anatomical Therapeutic Chemical classification 0‑L N03AX14 Levetiracetam WHO Anatomical Therapeutic Chemical classification 0‑L N03AX15 Zonisamid WHO Anatomical Therapeutic Chemical classification 0‑L N03AX16 Pregabalin WHO Anatomical Therapeutic Chemical classification 0‑L N03AX17 Stiripentol WHO Anatomical Therapeutic Chemical classification 0‑L N03AX18 Lacosamid WHO Anatomical Therapeutic Chemical classification 0‑L N03AX22 Perampanel WHO Anatomical Therapeutic Chemical classification 0‑L N03AX30 Beclamid WHO Anatomical Therapeutic Chemical classification 0‑L N04 Antiparkinsonmittel WHO Anatomical Therapeutic Chemical classification 0‑L N04A Anticholinergika WHO Anatomical Therapeutic Chemical classification 0‑L N04AA Tertiäre Amine WHO Anatomical Therapeutic Chemical classification 0‑L N04AA01 Trihexyphenidyl WHO Anatomical Therapeutic Chemical classification 0‑L N04AA02 Biperiden WHO Anatomical Therapeutic Chemical classification 0‑L N04AA03 Metixen WHO Anatomical Therapeutic Chemical classification 0‑L N04AA04 Procyclidin WHO Anatomical Therapeutic Chemical classification 0‑L N04AA05 Profenamin WHO Anatomical Therapeutic Chemical classification 0‑L N04AA08 Dexetimid WHO Anatomical Therapeutic Chemical classification 0‑L N04AA09 Phenglutarimid WHO Anatomical Therapeutic Chemical classification 0‑L N04AA10 Mazaticol WHO Anatomical Therapeutic Chemical classification 0‑L N04AA11 Bornaprin WHO Anatomical Therapeutic Chemical classification 0‑L N04AA12 Tropatepin WHO Anatomical Therapeutic Chemical classification 0‑L N04AB Ether, chemisch den Antihistaminika verwandt WHO Anatomical Therapeutic Chemical classification 0‑L N04AB01 Etanautin WHO Anatomical Therapeutic Chemical classification 0‑L N04AB02 Orphenadrin (chlorid) WHO Anatomical Therapeutic Chemical classification 0‑L N04AC Tropinether oder Tropin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N04AC01 Benzatropin WHO Anatomical Therapeutic Chemical classification 0‑L N04AC30 Etybenzatropin WHO Anatomical Therapeutic Chemical classification 0‑L N04B Dopaminerge Mittel WHO Anatomical Therapeutic Chemical classification 0‑L N04BA Dopa und Dopa-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N04BA01 Levodopa WHO Anatomical Therapeutic Chemical classification 0‑L N04BA02 Levodopa und Decarboxylasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N04BA03 Levodopa, Decarboxylasehemmer und COMT-Hemmer WHO Anatomical Therapeutic Chemical classification 0‑L N04BA04 Melevodopa WHO Anatomical Therapeutic Chemical classification 0‑L N04BA05 Melevodopa und Decarboxylasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N04BA06 Etilevodopa und Decarboxylasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N04BB Adamantan-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N04BB01 Amantadin WHO Anatomical Therapeutic Chemical classification 0‑L N04BC Dopamin-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L N04BC01 Bromocriptin WHO Anatomical Therapeutic Chemical classification 0‑L N04BC02 Pergolid WHO Anatomical Therapeutic Chemical classification 0‑L N04BC03 Dihydroergocryptinmesilat WHO Anatomical Therapeutic Chemical classification 0‑L N04BC04 Ropinirol WHO Anatomical Therapeutic Chemical classification 0‑L N04BC05 Pramipexol WHO Anatomical Therapeutic Chemical classification 0‑L N04BC06 Cabergolin WHO Anatomical Therapeutic Chemical classification 0‑L N04BC07 Apomorphin WHO Anatomical Therapeutic Chemical classification 0‑L N04BC08 Piribedil WHO Anatomical Therapeutic Chemical classification 0‑L N04BC09 Rotigotin WHO Anatomical Therapeutic Chemical classification 0‑L N04BD Monoaminoxidase-B-Hemmer WHO Anatomical Therapeutic Chemical classification 0‑L N04BD01 Selegilin WHO Anatomical Therapeutic Chemical classification 0‑L N04BD02 Rasagilin WHO Anatomical Therapeutic Chemical classification 0‑L N04BX Andere dopaminerge Mittel WHO Anatomical Therapeutic Chemical classification 0‑L N04BX01 Tolcapon WHO Anatomical Therapeutic Chemical classification 0‑L N04BX02 Entacapon WHO Anatomical Therapeutic Chemical classification 0‑L N04BX03 Budipin WHO Anatomical Therapeutic Chemical classification 0‑L N05 Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N05A Antipsychotika WHO Anatomical Therapeutic Chemical classification 0‑L N05AA Phenothiazine mit aliphatischer Seitenkette WHO Anatomical Therapeutic Chemical classification 0‑L N05AA01 Chlorpromazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AA02 Levomepromazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AA03 Promazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AA04 Acepromazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AA05 Triflupromazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AA06 Cyamemazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AA07 Chlorproethazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB Phenothiazine mit Piperazinstruktur WHO Anatomical Therapeutic Chemical classification 0‑L N05AB01 Dixyrazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB02 Fluphenazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB03 Perphenazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB04 Prochlorperazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB05 Thiopropazat WHO Anatomical Therapeutic Chemical classification 0‑L N05AB06 Trifluoperazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB07 Acetophenazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB08 Thioproperazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB09 Butaperazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AB10 Perazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AC Phenothiazine mit Piperidinstruktur WHO Anatomical Therapeutic Chemical classification 0‑L N05AC01 Periciazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AC02 Thioridazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AC03 Mesoridazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AC04 Pipotiazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AD Butyrophenon-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05AD01 Haloperidol WHO Anatomical Therapeutic Chemical classification 0‑L N05AD02 Trifluperidol WHO Anatomical Therapeutic Chemical classification 0‑L N05AD03 Melperon WHO Anatomical Therapeutic Chemical classification 0‑L N05AD04 Moperon WHO Anatomical Therapeutic Chemical classification 0‑L N05AD05 Pipamperon WHO Anatomical Therapeutic Chemical classification 0‑L N05AD06 Bromperidol WHO Anatomical Therapeutic Chemical classification 0‑L N05AD07 Benperidol WHO Anatomical Therapeutic Chemical classification 0‑L N05AD08 Droperidol WHO Anatomical Therapeutic Chemical classification 0‑L N05AD09 Fluanison WHO Anatomical Therapeutic Chemical classification 0‑L N05AE Indol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05AE01 Oxypertin WHO Anatomical Therapeutic Chemical classification 0‑L N05AE02 Molindon WHO Anatomical Therapeutic Chemical classification 0‑L N05AE03 Sertindol WHO Anatomical Therapeutic Chemical classification 0‑L N05AE04 Ziprasidon WHO Anatomical Therapeutic Chemical classification 0‑L N05AF Thioxanthen-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05AF01 Flupentixol WHO Anatomical Therapeutic Chemical classification 0‑L N05AF02 Clopenthixol WHO Anatomical Therapeutic Chemical classification 0‑L N05AF03 Chlorprothixen WHO Anatomical Therapeutic Chemical classification 0‑L N05AF04 Tiotixen WHO Anatomical Therapeutic Chemical classification 0‑L N05AF05 Zuclopenthixol WHO Anatomical Therapeutic Chemical classification 0‑L N05AG Diphenylbutylpiperidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05AG01 Fluspirilen WHO Anatomical Therapeutic Chemical classification 0‑L N05AG02 Pimozid WHO Anatomical Therapeutic Chemical classification 0‑L N05AG03 Penfluridol WHO Anatomical Therapeutic Chemical classification 0‑L N05AH Diazepine, Oxazepine und Thiazepine WHO Anatomical Therapeutic Chemical classification 0‑L N05AH01 Loxapin WHO Anatomical Therapeutic Chemical classification 0‑L N05AH02 Clozapin WHO Anatomical Therapeutic Chemical classification 0‑L N05AH03 Olanzapin WHO Anatomical Therapeutic Chemical classification 0‑L N05AH04 Quetiapin WHO Anatomical Therapeutic Chemical classification 0‑L N05AH05 Asenapin WHO Anatomical Therapeutic Chemical classification 0‑L N05AK Neuroleptika bei Spätdyskinesien WHO Anatomical Therapeutic Chemical classification 0‑L N05AK01 Tetrabenazin WHO Anatomical Therapeutic Chemical classification 0‑L N05AL Benzamide WHO Anatomical Therapeutic Chemical classification 0‑L N05AL01 Sulpirid WHO Anatomical Therapeutic Chemical classification 0‑L N05AL02 Sultoprid WHO Anatomical Therapeutic Chemical classification 0‑L N05AL03 Tiaprid WHO Anatomical Therapeutic Chemical classification 0‑L N05AL04 Remoxiprid WHO Anatomical Therapeutic Chemical classification 0‑L N05AL05 Amisulprid WHO Anatomical Therapeutic Chemical classification 0‑L N05AL06 Veraliprid WHO Anatomical Therapeutic Chemical classification 0‑L N05AL07 Levosulpirid WHO Anatomical Therapeutic Chemical classification 0‑L N05AN Lithium WHO Anatomical Therapeutic Chemical classification 0‑L N05AN01 Lithium WHO Anatomical Therapeutic Chemical classification 0‑L N05AX Andere Antipsychotika WHO Anatomical Therapeutic Chemical classification 0‑L N05AX07 Prothipendyl WHO Anatomical Therapeutic Chemical classification 0‑L N05AX08 Risperidon WHO Anatomical Therapeutic Chemical classification 0‑L N05AX09 Clotiapin WHO Anatomical Therapeutic Chemical classification 0‑L N05AX10 Mosapramin WHO Anatomical Therapeutic Chemical classification 0‑L N05AX11 Zotepin WHO Anatomical Therapeutic Chemical classification 0‑L N05AX12 Aripiprazol WHO Anatomical Therapeutic Chemical classification 0‑L N05AX13 Paliperidon WHO Anatomical Therapeutic Chemical classification 0‑L N05B Anxiolytika WHO Anatomical Therapeutic Chemical classification 0‑L N05BA Benzodiazepin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05BA01 Diazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA02 Chlordiazepoxid WHO Anatomical Therapeutic Chemical classification 0‑L N05BA03 Medazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA04 Oxazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA05 Dikaliumclorazepat WHO Anatomical Therapeutic Chemical classification 0‑L N05BA06 Lorazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA07 Adinazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA08 Bromazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA09 Clobazam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA10 Ketazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA11 Prazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA12 Alprazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA13 Halazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA14 Pinazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA15 Camazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA16 Nordazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA17 Fludiazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA18 Ethylloflazepat WHO Anatomical Therapeutic Chemical classification 0‑L N05BA19 Etizolam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA21 Clotiazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA22 Cloxazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA23 Tofisopam WHO Anatomical Therapeutic Chemical classification 0‑L N05BA56 Lorazepam, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05BB Diphenylmethan-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05BB01 Hydroxyzin WHO Anatomical Therapeutic Chemical classification 0‑L N05BB02 Captodiam WHO Anatomical Therapeutic Chemical classification 0‑L N05BB51 Hydroxyzin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05BC Carbamate WHO Anatomical Therapeutic Chemical classification 0‑L N05BC01 Meprobamat WHO Anatomical Therapeutic Chemical classification 0‑L N05BC03 Emylcamat WHO Anatomical Therapeutic Chemical classification 0‑L N05BC04 Mebutamat WHO Anatomical Therapeutic Chemical classification 0‑L N05BC51 Meprobamat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05BD Dibenzo-bicyclo-octadien-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05BD01 Benzoctamin WHO Anatomical Therapeutic Chemical classification 0‑L N05BE Azaspirodecandion-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05BE01 Buspiron WHO Anatomical Therapeutic Chemical classification 0‑L N05BX Andere Anxiolytika WHO Anatomical Therapeutic Chemical classification 0‑L N05BX01 Mephenoxalon WHO Anatomical Therapeutic Chemical classification 0‑L N05BX02 Gedocarnil WHO Anatomical Therapeutic Chemical classification 0‑L N05BX03 Etifoxin WHO Anatomical Therapeutic Chemical classification 0‑L N05C Hypnotika und Sedativa WHO Anatomical Therapeutic Chemical classification 0‑L N05CA Barbiturate, rein WHO Anatomical Therapeutic Chemical classification 0‑L N05CA01 Pentobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA02 Amobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA03 Butobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA04 Barbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA05 Aprobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA06 Secobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA07 Talbutal WHO Anatomical Therapeutic Chemical classification 0‑L N05CA08 Vinylbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA09 Vinbarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA10 Cyclobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA11 Heptabarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA12 Reposal WHO Anatomical Therapeutic Chemical classification 0‑L N05CA15 Methohexital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA16 Hexobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA19 Thiopental WHO Anatomical Therapeutic Chemical classification 0‑L N05CA20 Etallobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA21 Allobarbital WHO Anatomical Therapeutic Chemical classification 0‑L N05CA22 Proxibarbal WHO Anatomical Therapeutic Chemical classification 0‑L N05CB Barbiturate, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05CB01 Kombinationen von Barbituraten WHO Anatomical Therapeutic Chemical classification 0‑L N05CB02 Barbiturate in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L N05CC Aldehyde und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05CC01 Chloralhydrat WHO Anatomical Therapeutic Chemical classification 0‑L N05CC02 Chloralodol WHO Anatomical Therapeutic Chemical classification 0‑L N05CC03 Acetylglycinamidchloralhydrat WHO Anatomical Therapeutic Chemical classification 0‑L N05CC04 Dichloralphenazon WHO Anatomical Therapeutic Chemical classification 0‑L N05CC05 Paraldehyd WHO Anatomical Therapeutic Chemical classification 0‑L N05CD Benzodiazepin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05CD01 Flurazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD02 Nitrazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD03 Flunitrazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD04 Estazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD05 Triazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD06 Lormetazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD07 Temazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD08 Midazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD09 Brotizolam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD10 Quazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD11 Loprazolam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD12 Doxefazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CD13 Cinolazepam WHO Anatomical Therapeutic Chemical classification 0‑L N05CE Piperidindion-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N05CE01 Glutethimid WHO Anatomical Therapeutic Chemical classification 0‑L N05CE02 Methyprylon WHO Anatomical Therapeutic Chemical classification 0‑L N05CE03 Pyrithyldion WHO Anatomical Therapeutic Chemical classification 0‑L N05CF Benzodiazepin-verwandte Mittel WHO Anatomical Therapeutic Chemical classification 0‑L N05CF01 Zopiclon WHO Anatomical Therapeutic Chemical classification 0‑L N05CF02 Zolpidem WHO Anatomical Therapeutic Chemical classification 0‑L N05CF03 Zaleplon WHO Anatomical Therapeutic Chemical classification 0‑L N05CM Andere Hypnotika und Sedativa WHO Anatomical Therapeutic Chemical classification 0‑L N05CM01 Methaqualon WHO Anatomical Therapeutic Chemical classification 0‑L N05CM02 Clomethiazol WHO Anatomical Therapeutic Chemical classification 0‑L N05CM03 Bromisoval WHO Anatomical Therapeutic Chemical classification 0‑L N05CM04 Carbromal WHO Anatomical Therapeutic Chemical classification 0‑L N05CM05 Scopolamin WHO Anatomical Therapeutic Chemical classification 0‑L N05CM06 Propiomazin WHO Anatomical Therapeutic Chemical classification 0‑L N05CM07 Triclofos WHO Anatomical Therapeutic Chemical classification 0‑L N05CM08 Ethchlorvynol WHO Anatomical Therapeutic Chemical classification 0‑L N05CM09 Baldrian WHO Anatomical Therapeutic Chemical classification 0‑L N05CM10 Hexapropymate WHO Anatomical Therapeutic Chemical classification 0‑L N05CM11 Bromide WHO Anatomical Therapeutic Chemical classification 0‑L N05CM12 Apronal WHO Anatomical Therapeutic Chemical classification 0‑L N05CM13 Valnoctamid WHO Anatomical Therapeutic Chemical classification 0‑L N05CM15 Methylpentynol WHO Anatomical Therapeutic Chemical classification 0‑L N05CM16 Niaprazin WHO Anatomical Therapeutic Chemical classification 0‑L N05CM17 Melatonin WHO Anatomical Therapeutic Chemical classification 0‑L N05CM18 Dexmedetomidin WHO Anatomical Therapeutic Chemical classification 0‑L N05CX Hypnotika und Sedativa in Kombination, exkl. Barbiturate WHO Anatomical Therapeutic Chemical classification 0‑L N05CX01 Meprobamat, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05CX02 Methaqualon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05CX03 Methylpentynol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05CX04 Clomethiazol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05CX05 Emepronium, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N05CX06 Dipiperonylaminoethanol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N06 Psychoanaleptika WHO Anatomical Therapeutic Chemical classification 0‑L N06A Antidepressiva WHO Anatomical Therapeutic Chemical classification 0‑L N06AA Nichtselektive Monoamin-Wiederaufnahmehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N06AA01 Desipramin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA02 Imipramin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA03 Imipraminoxid WHO Anatomical Therapeutic Chemical classification 0‑L N06AA04 Clomipramin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA05 Opipramol WHO Anatomical Therapeutic Chemical classification 0‑L N06AA06 Trimipramin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA07 Lofepramin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA08 Dibenzepin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA09 Amitriptylin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA10 Nortriptylin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA11 Protriptylin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA12 Doxepin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA13 Iprindol WHO Anatomical Therapeutic Chemical classification 0‑L N06AA14 Melitracen WHO Anatomical Therapeutic Chemical classification 0‑L N06AA15 Butriptylin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA16 Dosulepin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA17 Amoxapin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA18 Dimetacrin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA19 Amineptin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA21 Maprotilin WHO Anatomical Therapeutic Chemical classification 0‑L N06AA23 Quinupramin WHO Anatomical Therapeutic Chemical classification 0‑L N06AB Selektive Serotonin-Wiederaufnahmehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N06AB02 Zimeldin WHO Anatomical Therapeutic Chemical classification 0‑L N06AB03 Fluoxetin WHO Anatomical Therapeutic Chemical classification 0‑L N06AB04 Citalopram WHO Anatomical Therapeutic Chemical classification 0‑L N06AB05 Paroxetin WHO Anatomical Therapeutic Chemical classification 0‑L N06AB06 Sertralin WHO Anatomical Therapeutic Chemical classification 0‑L N06AB07 Alaproclat WHO Anatomical Therapeutic Chemical classification 0‑L N06AB08 Fluvoxamin WHO Anatomical Therapeutic Chemical classification 0‑L N06AB09 Etoperidon WHO Anatomical Therapeutic Chemical classification 0‑L N06AB10 Escitalopram WHO Anatomical Therapeutic Chemical classification 0‑L N06AC N06AC WHO Anatomical Therapeutic Chemical classification 0‑L N06AD N06AD WHO Anatomical Therapeutic Chemical classification 0‑L N06AE N06AE WHO Anatomical Therapeutic Chemical classification 0‑L N06AF Monoaminoxidasehemmer, nichtselektiv WHO Anatomical Therapeutic Chemical classification 0‑L N06AF01 Isocarboxazid WHO Anatomical Therapeutic Chemical classification 0‑L N06AF02 Nialamid WHO Anatomical Therapeutic Chemical classification 0‑L N06AF03 Phenelzin WHO Anatomical Therapeutic Chemical classification 0‑L N06AF04 Tranylcypromin WHO Anatomical Therapeutic Chemical classification 0‑L N06AF05 Iproniazid WHO Anatomical Therapeutic Chemical classification 0‑L N06AF06 Iproclozid WHO Anatomical Therapeutic Chemical classification 0‑L N06AG Monoaminoxidase-A-Hemmer WHO Anatomical Therapeutic Chemical classification 0‑L N06AG02 Moclobemid WHO Anatomical Therapeutic Chemical classification 0‑L N06AG03 Toloxaton WHO Anatomical Therapeutic Chemical classification 0‑L N06AX Andere Antidepressiva WHO Anatomical Therapeutic Chemical classification 0‑L N06AX01 Oxitriptan WHO Anatomical Therapeutic Chemical classification 0‑L N06AX02 Tryptophan WHO Anatomical Therapeutic Chemical classification 0‑L N06AX03 Mianserin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX04 Nomifensin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX05 Trazodon WHO Anatomical Therapeutic Chemical classification 0‑L N06AX06 Nefazodon WHO Anatomical Therapeutic Chemical classification 0‑L N06AX07 Minaprin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX08 Bifemelan WHO Anatomical Therapeutic Chemical classification 0‑L N06AX09 Viloxazin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX10 Oxaflozan WHO Anatomical Therapeutic Chemical classification 0‑L N06AX11 Mirtazapin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX12 Bupropion WHO Anatomical Therapeutic Chemical classification 0‑L N06AX13 Medifoxamin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX14 Tianeptin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX15 Pivagabin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX16 Venlafaxin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX17 Milnacipran WHO Anatomical Therapeutic Chemical classification 0‑L N06AX18 Reboxetin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX19 Gepiron WHO Anatomical Therapeutic Chemical classification 0‑L N06AX21 Duloxetin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX22 Agomelatin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX23 Desvenlafaxin WHO Anatomical Therapeutic Chemical classification 0‑L N06AX25 Hyperici herba WHO Anatomical Therapeutic Chemical classification 0‑L N06B Psychostimulanzien, Mittel für die ADHD und Nootropika WHO Anatomical Therapeutic Chemical classification 0‑L N06BA Zentral wirkende Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L N06BA01 Amfetamin WHO Anatomical Therapeutic Chemical classification 0‑L N06BA02 Dexamfetamin WHO Anatomical Therapeutic Chemical classification 0‑L N06BA03 Metamfetamin WHO Anatomical Therapeutic Chemical classification 0‑L N06BA04 Methylphenidat WHO Anatomical Therapeutic Chemical classification 0‑L N06BA05 Pemolin WHO Anatomical Therapeutic Chemical classification 0‑L N06BA06 Fencamfamin WHO Anatomical Therapeutic Chemical classification 0‑L N06BA07 Modafinil WHO Anatomical Therapeutic Chemical classification 0‑L N06BA08 Fenozolon WHO Anatomical Therapeutic Chemical classification 0‑L N06BA09 Atomoxetin WHO Anatomical Therapeutic Chemical classification 0‑L N06BA10 Fenetyllin WHO Anatomical Therapeutic Chemical classification 0‑L N06BC Xanthin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N06BC01 Coffein WHO Anatomical Therapeutic Chemical classification 0‑L N06BC02 Propentofyllin WHO Anatomical Therapeutic Chemical classification 0‑L N06BX Andere Psychostimulanzien und Nootropika WHO Anatomical Therapeutic Chemical classification 0‑L N06BX01 Meclofenoxat WHO Anatomical Therapeutic Chemical classification 0‑L N06BX02 Pyritinol WHO Anatomical Therapeutic Chemical classification 0‑L N06BX03 Piracetam WHO Anatomical Therapeutic Chemical classification 0‑L N06BX04 Deanol WHO Anatomical Therapeutic Chemical classification 0‑L N06BX05 Fipexid WHO Anatomical Therapeutic Chemical classification 0‑L N06BX06 Citicolin WHO Anatomical Therapeutic Chemical classification 0‑L N06BX07 Oxiracetam WHO Anatomical Therapeutic Chemical classification 0‑L N06BX08 Pirisudanol WHO Anatomical Therapeutic Chemical classification 0‑L N06BX09 Linopirdin WHO Anatomical Therapeutic Chemical classification 0‑L N06BX10 Nizofenon WHO Anatomical Therapeutic Chemical classification 0‑L N06BX11 Aniracetam WHO Anatomical Therapeutic Chemical classification 0‑L N06BX12 Acetylcarnitin WHO Anatomical Therapeutic Chemical classification 0‑L N06BX13 Idebenon WHO Anatomical Therapeutic Chemical classification 0‑L N06BX14 Prolintan WHO Anatomical Therapeutic Chemical classification 0‑L N06BX15 Pipradrol WHO Anatomical Therapeutic Chemical classification 0‑L N06BX16 Pramiracetam WHO Anatomical Therapeutic Chemical classification 0‑L N06BX17 Adrafinil WHO Anatomical Therapeutic Chemical classification 0‑L N06BX18 Vinpocetin WHO Anatomical Therapeutic Chemical classification 0‑L N06C Psycholeptikau und Psychoanaleptika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L N06CA Antidepressiva in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N06CA01 Amitriptylin und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N06CA02 Melitracen und Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N06CB Psychostimulanzien in Kombination mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L N06D Antidementiva WHO Anatomical Therapeutic Chemical classification 0‑L N06DA Cholinesterasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N06DA01 Tacrin WHO Anatomical Therapeutic Chemical classification 0‑L N06DA02 Donepezil WHO Anatomical Therapeutic Chemical classification 0‑L N06DA03 Rivastigmin WHO Anatomical Therapeutic Chemical classification 0‑L N06DA04 Galantamin WHO Anatomical Therapeutic Chemical classification 0‑L N06DX Andere Antidementiva WHO Anatomical Therapeutic Chemical classification 0‑L N06DX01 Memantin WHO Anatomical Therapeutic Chemical classification 0‑L N06DX02 Ginkgo biloba WHO Anatomical Therapeutic Chemical classification 0‑L N07 Andere Mittel für das Nervensystem WHO Anatomical Therapeutic Chemical classification 0‑L N07A Parasympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L N07AA Cholinesterasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L N07AA01 Neostigmin WHO Anatomical Therapeutic Chemical classification 0‑L N07AA02 Pyridostigmin WHO Anatomical Therapeutic Chemical classification 0‑L N07AA03 Distigmin WHO Anatomical Therapeutic Chemical classification 0‑L N07AA30 Ambenonium WHO Anatomical Therapeutic Chemical classification 0‑L N07AA51 Neostigmin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N07AB Cholinester WHO Anatomical Therapeutic Chemical classification 0‑L N07AB01 Carbachol WHO Anatomical Therapeutic Chemical classification 0‑L N07AB02 Bethanechol WHO Anatomical Therapeutic Chemical classification 0‑L N07AX Andere Parasympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L N07AX01 Pilocarpin WHO Anatomical Therapeutic Chemical classification 0‑L N07AX02 Cholinalfoscerat WHO Anatomical Therapeutic Chemical classification 0‑L N07B Mittel zur Behandlung von Suchterkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L N07BA Mittel zur Behandlung der Nikotinabhängigkeit WHO Anatomical Therapeutic Chemical classification 0‑L N07BA01 Nicotin WHO Anatomical Therapeutic Chemical classification 0‑L N07BA02 Bupropion WHO Anatomical Therapeutic Chemical classification 0‑L N07BA03 Vareniclin WHO Anatomical Therapeutic Chemical classification 0‑L N07BB Mittel zur Behandlung der Alkoholabhängigkeit WHO Anatomical Therapeutic Chemical classification 0‑L N07BB01 Disulfiram WHO Anatomical Therapeutic Chemical classification 0‑L N07BB02 Calcium carbimid WHO Anatomical Therapeutic Chemical classification 0‑L N07BB03 Acamprosat WHO Anatomical Therapeutic Chemical classification 0‑L N07BB04 Naltrexon WHO Anatomical Therapeutic Chemical classification 0‑L N07BC Mittel zur Behandlung der Opiatabhängigkeit WHO Anatomical Therapeutic Chemical classification 0‑L N07BC01 Buprenorphin WHO Anatomical Therapeutic Chemical classification 0‑L N07BC02 Methadon WHO Anatomical Therapeutic Chemical classification 0‑L N07BC03 Levacetylmethadol WHO Anatomical Therapeutic Chemical classification 0‑L N07BC04 Lofexidin WHO Anatomical Therapeutic Chemical classification 0‑L N07BC51 Buprenorphin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N07C Antivertiginosa WHO Anatomical Therapeutic Chemical classification 0‑L N07CA Antivertiginosa WHO Anatomical Therapeutic Chemical classification 0‑L N07CA01 Betahistin WHO Anatomical Therapeutic Chemical classification 0‑L N07CA02 Cinnarizin WHO Anatomical Therapeutic Chemical classification 0‑L N07CA03 Flunarizin WHO Anatomical Therapeutic Chemical classification 0‑L N07CA04 Acetylleucin WHO Anatomical Therapeutic Chemical classification 0‑L N07CA52 Cinnarizin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L N07X Andere Mittel für das Nervensystem WHO Anatomical Therapeutic Chemical classification 0‑L N07XA Ganglioside und Gangliosid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L N07XX Andere Mittel für das Nervensystem WHO Anatomical Therapeutic Chemical classification 0‑L N07XX01 Tirilazad WHO Anatomical Therapeutic Chemical classification 0‑L N07XX02 Riluzol WHO Anatomical Therapeutic Chemical classification 0‑L N07XX03 Xaliproden WHO Anatomical Therapeutic Chemical classification 0‑L N07XX04 Hydroxybuttersäure WHO Anatomical Therapeutic Chemical classification 0‑L N07XX05 Amifampridin WHO Anatomical Therapeutic Chemical classification 0‑L N07XX06 Tetrabenazin WHO Anatomical Therapeutic Chemical classification 0‑L N07XX07 Fampridin WHO Anatomical Therapeutic Chemical classification 0‑L P Antiparasitäre Mittel, Insektizide und Repellenzien WHO Anatomical Therapeutic Chemical classification 0‑L P01 Mittel gegen Protozoen-Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L P01A Mittel gegen Amöben und andere Protozoen-Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L P01AA Hydroxychinolin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P01AA01 Broxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L P01AA02 Clioquinol WHO Anatomical Therapeutic Chemical classification 0‑L P01AA04 Chlorquinaldol WHO Anatomical Therapeutic Chemical classification 0‑L P01AA05 Tilbroquinol WHO Anatomical Therapeutic Chemical classification 0‑L P01AA52 Clioquinol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P01AB Nitroimidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P01AB01 Metronidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AB02 Tinidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AB03 Ornidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AB04 Azanidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AB05 Propenidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AB06 Nimorazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AB07 Secnidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01AC Dichloracetamid-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P01AC01 Diloxanid WHO Anatomical Therapeutic Chemical classification 0‑L P01AC02 Clefamid WHO Anatomical Therapeutic Chemical classification 0‑L P01AC03 Etofamid WHO Anatomical Therapeutic Chemical classification 0‑L P01AC04 Teclosan WHO Anatomical Therapeutic Chemical classification 0‑L P01AR Arsen-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L P01AR01 Arsthinol WHO Anatomical Therapeutic Chemical classification 0‑L P01AR02 Difetarson WHO Anatomical Therapeutic Chemical classification 0‑L P01AR03 Glycobiarsol WHO Anatomical Therapeutic Chemical classification 0‑L P01AR53 Glycobiarsol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P01AX Andere Mittel gegen Amöbiasis und andere Protozoen-Erkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L P01AX01 Chiniofon WHO Anatomical Therapeutic Chemical classification 0‑L P01AX02 Emetin WHO Anatomical Therapeutic Chemical classification 0‑L P01AX04 Phanquinon WHO Anatomical Therapeutic Chemical classification 0‑L P01AX05 Mepacrin WHO Anatomical Therapeutic Chemical classification 0‑L P01AX06 Atovaquon WHO Anatomical Therapeutic Chemical classification 0‑L P01AX07 Trimetrexat WHO Anatomical Therapeutic Chemical classification 0‑L P01AX08 Tenonitrozol WHO Anatomical Therapeutic Chemical classification 0‑L P01AX09 Dehydroemetin WHO Anatomical Therapeutic Chemical classification 0‑L P01AX10 Fumagillin WHO Anatomical Therapeutic Chemical classification 0‑L P01AX52 Emetin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P01B Malariamittel WHO Anatomical Therapeutic Chemical classification 0‑L P01BA Aminochinoline WHO Anatomical Therapeutic Chemical classification 0‑L P01BA01 Chloroquin WHO Anatomical Therapeutic Chemical classification 0‑L P01BA02 Hydroxychloroquin WHO Anatomical Therapeutic Chemical classification 0‑L P01BA03 Primaquin WHO Anatomical Therapeutic Chemical classification 0‑L P01BA06 Amodiaquin WHO Anatomical Therapeutic Chemical classification 0‑L P01BB Biguanide WHO Anatomical Therapeutic Chemical classification 0‑L P01BB01 Proguanil WHO Anatomical Therapeutic Chemical classification 0‑L P01BB02 Cycloguanilembonat WHO Anatomical Therapeutic Chemical classification 0‑L P01BB51 Proguanil, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P01BC Methanolchinoline WHO Anatomical Therapeutic Chemical classification 0‑L P01BC01 Chinin WHO Anatomical Therapeutic Chemical classification 0‑L P01BC02 Mefloquin WHO Anatomical Therapeutic Chemical classification 0‑L P01BD Diaminopyrimidine WHO Anatomical Therapeutic Chemical classification 0‑L P01BD01 Pyrimethamin WHO Anatomical Therapeutic Chemical classification 0‑L P01BD51 Pyrimethamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P01BE Artemisinin und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P01BE01 Artemisinin WHO Anatomical Therapeutic Chemical classification 0‑L P01BE02 Artemether WHO Anatomical Therapeutic Chemical classification 0‑L P01BE03 Artesunat WHO Anatomical Therapeutic Chemical classification 0‑L P01BE04 Artemotil WHO Anatomical Therapeutic Chemical classification 0‑L P01BE05 Artenimol WHO Anatomical Therapeutic Chemical classification 0‑L P01BE52 Artemether, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P01BF01 Artemether und Lumefantrin WHO Anatomical Therapeutic Chemical classification 0‑L P01BF05 Artenimol und Piperaquin WHO Anatomical Therapeutic Chemical classification 0‑L P01BX Andere Malariamittel WHO Anatomical Therapeutic Chemical classification 0‑L P01BX01 Halofantrin WHO Anatomical Therapeutic Chemical classification 0‑L P01C Mittel gegen Leishmaniasis und Trypanosomiasis WHO Anatomical Therapeutic Chemical classification 0‑L P01CA Nitroimidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P01CA02 Benznidazol WHO Anatomical Therapeutic Chemical classification 0‑L P01CB Antimon-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L P01CB01 Megluminantimonat WHO Anatomical Therapeutic Chemical classification 0‑L P01CB02 Natriumstibogluconat WHO Anatomical Therapeutic Chemical classification 0‑L P01CC Nitrofuran-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P01CC01 Nifurtimox WHO Anatomical Therapeutic Chemical classification 0‑L P01CC02 Nitrofural WHO Anatomical Therapeutic Chemical classification 0‑L P01CD Arsen-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L P01CD01 Melarsoprol WHO Anatomical Therapeutic Chemical classification 0‑L P01CD02 Acetarsol WHO Anatomical Therapeutic Chemical classification 0‑L P01CX Andere Mittel gegen Leishmaniasis und Trypanosomiasis WHO Anatomical Therapeutic Chemical classification 0‑L P01CX01 Pentamidinisethionat WHO Anatomical Therapeutic Chemical classification 0‑L P01CX02 Suramin natrium WHO Anatomical Therapeutic Chemical classification 0‑L P01CX03 Eflornithin WHO Anatomical Therapeutic Chemical classification 0‑L P02 Anthelmintika WHO Anatomical Therapeutic Chemical classification 0‑L P02B Trematodenmittel WHO Anatomical Therapeutic Chemical classification 0‑L P02BA Chinolin-Derivate und verwandte Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L P02BA01 Praziquantel WHO Anatomical Therapeutic Chemical classification 0‑L P02BA02 Oxamniquin WHO Anatomical Therapeutic Chemical classification 0‑L P02BB Organophosphat-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L P02BB01 Metrifonat WHO Anatomical Therapeutic Chemical classification 0‑L P02BX Andere Trematodenmittel WHO Anatomical Therapeutic Chemical classification 0‑L P02BX01 Bithionol WHO Anatomical Therapeutic Chemical classification 0‑L P02BX02 Niridazol WHO Anatomical Therapeutic Chemical classification 0‑L P02BX03 Stibophen WHO Anatomical Therapeutic Chemical classification 0‑L P02BX04 Triclabendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02C Nematodenmittel WHO Anatomical Therapeutic Chemical classification 0‑L P02CA Benzimidazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P02CA01 Mebendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02CA02 Tiabendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02CA03 Albendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02CA04 Ciclobendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02CA05 Flubendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02CA06 Fenbendazol WHO Anatomical Therapeutic Chemical classification 0‑L P02CA51 Mebendazol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P02CB Piperazin und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P02CB01 Piperazin WHO Anatomical Therapeutic Chemical classification 0‑L P02CB02 Diethylcarbamazin WHO Anatomical Therapeutic Chemical classification 0‑L P02CC Tetrahydropyrimidin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P02CC01 Pyrantel WHO Anatomical Therapeutic Chemical classification 0‑L P02CC02 Oxantel WHO Anatomical Therapeutic Chemical classification 0‑L P02CE Imidazothiazol-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P02CE01 Levamisol WHO Anatomical Therapeutic Chemical classification 0‑L P02CF Avermektine WHO Anatomical Therapeutic Chemical classification 0‑L P02CF01 Ivermectin WHO Anatomical Therapeutic Chemical classification 0‑L P02CX Andere Nematodenmittel WHO Anatomical Therapeutic Chemical classification 0‑L P02CX01 Pyrvinium WHO Anatomical Therapeutic Chemical classification 0‑L P02CX02 Bephenium WHO Anatomical Therapeutic Chemical classification 0‑L P02D Bandwurmmittel WHO Anatomical Therapeutic Chemical classification 0‑L P02DA Salicylsäure-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L P02DA01 Niclosamid WHO Anatomical Therapeutic Chemical classification 0‑L P02DX Andere Bandwurmmittel WHO Anatomical Therapeutic Chemical classification 0‑L P02DX01 Desaspidin WHO Anatomical Therapeutic Chemical classification 0‑L P02DX02 Dichlorophen WHO Anatomical Therapeutic Chemical classification 0‑L P03 Mittel gegen Ektoparasiten, inkl. Antiscabiosa, Insektizide und Repellenzien WHO Anatomical Therapeutic Chemical classification 0‑L P03A Mittel gegen Ektoparasiten, inkl. Antiscabiosa WHO Anatomical Therapeutic Chemical classification 0‑L P03AA Schwefel-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L P03AA01 Dixanthogen WHO Anatomical Therapeutic Chemical classification 0‑L P03AA02 Kaliumpolysulfid WHO Anatomical Therapeutic Chemical classification 0‑L P03AA03 Mesulfen WHO Anatomical Therapeutic Chemical classification 0‑L P03AA04 Disulfiram WHO Anatomical Therapeutic Chemical classification 0‑L P03AA05 Thiram WHO Anatomical Therapeutic Chemical classification 0‑L P03AA54 Disulfiram, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P03AB Chlor-haltige Mittel WHO Anatomical Therapeutic Chemical classification 0‑L P03AB01 Clofenotan WHO Anatomical Therapeutic Chemical classification 0‑L P03AB02 Lindan WHO Anatomical Therapeutic Chemical classification 0‑L P03AB51 Clofenotan, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P03AC Pyrethrine, inkl. synthetische Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L P03AC01 Pyrethrum WHO Anatomical Therapeutic Chemical classification 0‑L P03AC02 Bioallethrin WHO Anatomical Therapeutic Chemical classification 0‑L P03AC03 Phenothrin WHO Anatomical Therapeutic Chemical classification 0‑L P03AC04 Permethrin WHO Anatomical Therapeutic Chemical classification 0‑L P03AC51 Pyrethrum, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P03AC52 Bioallethrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P03AC53 Phenothrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P03AC54 Permethrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L P03AX Andere Mittel gegen Ektoparasiten, inkl. Antiscabiosa WHO Anatomical Therapeutic Chemical classification 0‑L P03AX01 Benzylbenzoat WHO Anatomical Therapeutic Chemical classification 0‑L P03AX02 Kupferoleat WHO Anatomical Therapeutic Chemical classification 0‑L P03AX03 Malathion WHO Anatomical Therapeutic Chemical classification 0‑L P03AX04 Quassia WHO Anatomical Therapeutic Chemical classification 0‑L P03B Insektizide und Repellenzien WHO Anatomical Therapeutic Chemical classification 0‑L P03BA Pyrethrine WHO Anatomical Therapeutic Chemical classification 0‑L P03BA01 Cyfluthrin WHO Anatomical Therapeutic Chemical classification 0‑L P03BA02 Cypermethrin WHO Anatomical Therapeutic Chemical classification 0‑L P03BA03 Decamethrin WHO Anatomical Therapeutic Chemical classification 0‑L P03BA04 Tetramethrin WHO Anatomical Therapeutic Chemical classification 0‑L P03BX Andere Insektizide und Repellenzien WHO Anatomical Therapeutic Chemical classification 0‑L P03BX01 Diethyltoluamid WHO Anatomical Therapeutic Chemical classification 0‑L P03BX02 Dimethylphthalat WHO Anatomical Therapeutic Chemical classification 0‑L P03BX03 Dibutylphthalat WHO Anatomical Therapeutic Chemical classification 0‑L P03BX04 Dibutylsuccinat WHO Anatomical Therapeutic Chemical classification 0‑L P03BX05 Dimethylcarbat WHO Anatomical Therapeutic Chemical classification 0‑L P03BX06 Etohexadiol WHO Anatomical Therapeutic Chemical classification 0‑L P52AF03 Oxantel WHO Anatomical Therapeutic Chemical classification 0‑L P52AG09 Closantel Natrium Dihydrat für Tiere WHO Anatomical Therapeutic Chemical classification 0‑L P53AX25 Metaflumizon WHO Anatomical Therapeutic Chemical classification 0‑L Q veterinär ATC WHO Anatomical Therapeutic Chemical classification 0‑L QA02BC01 Omeprazol WHO Anatomical Therapeutic Chemical classification 0‑L QA03AB91 Synthetische Anticholinergika, quaternäre Ammoniumverbindungen WHO Anatomical Therapeutic Chemical classification 0‑L QA03AX andere Medikamente für funktionelle Darmstörung WHO Anatomical Therapeutic Chemical classification 0‑L QA03AX13 Silikone WHO Anatomical Therapeutic Chemical classification 0‑L QA03BB01 Butylscopolamin WHO Anatomical Therapeutic Chemical classification 0‑L QA03DB04 Butylscopolamin und Analgetika WHO Anatomical Therapeutic Chemical classification 0‑L QA03FA01 Metoclopramid WHO Anatomical Therapeutic Chemical classification 0‑L QA04AD90 Maropitant WHO Anatomical Therapeutic Chemical classification 0‑L QA05AX90 Menbuton WHO Anatomical Therapeutic Chemical classification 0‑L QA07AA06 Paromomycin WHO Anatomical Therapeutic Chemical classification 0‑L QA07AA10 Colistin WHO Anatomical Therapeutic Chemical classification 0‑L QA07AA51 Neomycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QA07AA91 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L QA07AA99 Antibiotika, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QA07BB Bismuth Präparate WHO Anatomical Therapeutic Chemical classification 0‑L QA07BC30 Kombinationen, andere intestinale Adsorbentien WHO Anatomical Therapeutic Chemical classification 0‑L QA07CQ Orale Elektrolyte und Kohlenhydrate WHO Anatomical Therapeutic Chemical classification 0‑L QA07FA01 Milchsäurebildner WHO Anatomical Therapeutic Chemical classification 0‑L QA07XA91 Zinkoxid WHO Anatomical Therapeutic Chemical classification 0‑L QA08AB90 Mitratapid WHO Anatomical Therapeutic Chemical classification 0‑L QA08AB91 Dirlotapide WHO Anatomical Therapeutic Chemical classification 0‑L QA10AC03 Insulin (Schwein) WHO Anatomical Therapeutic Chemical classification 0‑L QA11A Multivitamine, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QA11AB Multivitamins, other combinations WHO Anatomical Therapeutic Chemical classification 0‑L QA11CC05 Colecalciferol WHO Anatomical Therapeutic Chemical classification 0‑L QA11HA andere Vitaminpräparate, rein WHO Anatomical Therapeutic Chemical classification 0‑L QA11JA Kombinationen von Vitaminen WHO Anatomical Therapeutic Chemical classification 0‑L QA11JC Vitamine, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QA12 andere Mineralstoffe WHO Anatomical Therapeutic Chemical classification 0‑L QA12AA03 Calciumgluconat WHO Anatomical Therapeutic Chemical classification 0‑L QA12AA07 Calciumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L QA12AX Calcium, Kombinationen mit Vitamin D und/oder anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L QA12CE99 Selen-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QA12CX91 Butafosfan WHO Anatomical Therapeutic Chemical classification 0‑L QA12CX99 andere Mineralstoffe, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QA16Q Präparate zur Prävention und/oder Behandlung von Acetonämie WHO Anatomical Therapeutic Chemical classification 0‑L QA16QA06 Monensin WHO Anatomical Therapeutic Chemical classification 0‑L QB02BA01 Phytomenadion WHO Anatomical Therapeutic Chemical classification 0‑L QB03AA02 Eisen(II)fumarat WHO Anatomical Therapeutic Chemical classification 0‑L QB03AC Eisen dreiwertig, parenterale Präparate WHO Anatomical Therapeutic Chemical classification 0‑L QB03AC06 ferric oxide dextran complexes WHO Anatomical Therapeutic Chemical classification 0‑L QB03AC90 Eisen Dextran Komplex WHO Anatomical Therapeutic Chemical classification 0‑L QB03AC91 Gleptoferron WHO Anatomical Therapeutic Chemical classification 0‑L QB05AA90 Blutsubstitut und Plasmaprotein-Fraktion WHO Anatomical Therapeutic Chemical classification 0‑L QB05B I.V.-Lösungen WHO Anatomical Therapeutic Chemical classification 0‑L QB05BB Lösungen für Elektrolytenhaushalt WHO Anatomical Therapeutic Chemical classification 0‑L QB05BB01 Elektrolyte WHO Anatomical Therapeutic Chemical classification 0‑L QB05XA30 Kombinationen von Elektrolyten WHO Anatomical Therapeutic Chemical classification 0‑L QC01CE90 Pimobendan WHO Anatomical Therapeutic Chemical classification 0‑L QC03AA56 Trichlormethiazide Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QC03CA01 Furosemid WHO Anatomical Therapeutic Chemical classification 0‑L QC03DA01 Spironolacton WHO Anatomical Therapeutic Chemical classification 0‑L QC04AD90 Propentofyllin WHO Anatomical Therapeutic Chemical classification 0‑L QC09AA02 Enalapril WHO Anatomical Therapeutic Chemical classification 0‑L QC09AA05 Ramipril WHO Anatomical Therapeutic Chemical classification 0‑L QC09AA07 Benazepril WHO Anatomical Therapeutic Chemical classification 0‑L QC09AA16 Imidapril WHO Anatomical Therapeutic Chemical classification 0‑L QC09BA07 Benazepril und Diuretika WHO Anatomical Therapeutic Chemical classification 0‑L QC09CA07 Telmisartan WHO Anatomical Therapeutic Chemical classification 0‑L QD Dermatologika WHO Anatomical Therapeutic Chemical classification 0‑L QD01AA20 Antibiotika, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QD01AC90 Enilconazol WHO Anatomical Therapeutic Chemical classification 0‑L QD01AE20 Kombinationen, Antimykotika für topische Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L QD02AX Andere Emollentia und Hautschutzmittel WHO Anatomical Therapeutic Chemical classification 0‑L QD03AX90 Ketanserin WHO Anatomical Therapeutic Chemical classification 0‑L QD06A Antibiotika für topische Anwendungen WHO Anatomical Therapeutic Chemical classification 0‑L QD06AA02 Chlortetracycline WHO Anatomical Therapeutic Chemical classification 0‑L QD06AA03 Oxytetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L QD07AC Corticosteroide, stark wirksam (Gruppe III) WHO Anatomical Therapeutic Chemical classification 0‑L QD07AC16 Hydrocortisonaceponat WHO Anatomical Therapeutic Chemical classification 0‑L QD07AC90 Resocortolbutyrat WHO Anatomical Therapeutic Chemical classification 0‑L QD07CC01 Betamethason und Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QD07X Kortikosteroide, sehr potent, andere Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QD08 Antiseptika und Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L QD08A Antiseptika und Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L QD08AC02 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L QD08AC52 Chlorhexidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QD08AE02 Policresulen WHO Anatomical Therapeutic Chemical classification 0‑L QD08AG02 Povidon Jod WHO Anatomical Therapeutic Chemical classification 0‑L QD08AG03 Iod WHO Anatomical Therapeutic Chemical classification 0‑L QD08AX Antiseptika und Desinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L QG01AX andere Antiinfektiva und Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L QG02AD01 Dinoprost WHO Anatomical Therapeutic Chemical classification 0‑L QG02AD90 Cloprostenol WHO Anatomical Therapeutic Chemical classification 0‑L QG02AD91 Luprostiol WHO Anatomical Therapeutic Chemical classification 0‑L QG02CB01 Bromocriptin WHO Anatomical Therapeutic Chemical classification 0‑L QG02CB03 Cabergolin WHO Anatomical Therapeutic Chemical classification 0‑L QG03AC06 Medroxyprogesteron WHO Anatomical Therapeutic Chemical classification 0‑L QG03CA04 Estriol WHO Anatomical Therapeutic Chemical classification 0‑L QG03DA04 Progesteron WHO Anatomical Therapeutic Chemical classification 0‑L QG03DA90 Proligeston WHO Anatomical Therapeutic Chemical classification 0‑L QG03DB06 Chlormadinon WHO Anatomical Therapeutic Chemical classification 0‑L QG03DX90 Altrenogest WHO Anatomical Therapeutic Chemical classification 0‑L QG03DX91 Delmadinone WHO Anatomical Therapeutic Chemical classification 0‑L QG03GA01 Chorion-Gonadotropin WHO Anatomical Therapeutic Chemical classification 0‑L QG03GA03 Serum-Gonadotropin WHO Anatomical Therapeutic Chemical classification 0‑L QG03GA90 Follikel stimulierende Hormone WHO Anatomical Therapeutic Chemical classification 0‑L QG03GA99 Gonadotropine, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QG03GB synthetische Eisprungstimulanzien WHO Anatomical Therapeutic Chemical classification 0‑L QG03XA91 Gonadotropin-Releasing-Faktor-Analogon, konjugiert WHO Anatomical Therapeutic Chemical classification 0‑L QG03XB90 Aglepriston WHO Anatomical Therapeutic Chemical classification 0‑L QG04BX91 Phenylpropanolamin WHO Anatomical Therapeutic Chemical classification 0‑L QG04CX Arzneimittel zur Behandlung der benignen Prostatahypertrophie WHO Anatomical Therapeutic Chemical classification 0‑L QG51A Antiinfektiva und Antiseptika für die intrauterine Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L QG51AA Antibakterielle Wirkstoffe WHO Anatomical Therapeutic Chemical classification 0‑L QG51AA02 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L QG51AA09 Formosulfathiazol (intrauterin) WHO Anatomical Therapeutic Chemical classification 0‑L QG51AA30 Antibiotika-Kombinationen zur intrauterinen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L QG52A Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L QG52X diverse Produkte für Zitzen und Euter WHO Anatomical Therapeutic Chemical classification 0‑L QH01BB02 Oxytocin WHO Anatomical Therapeutic Chemical classification 0‑L QH01BB03 Carbetocin WHO Anatomical Therapeutic Chemical classification 0‑L QH01CA Gonadotropin-Releasing-Hormone WHO Anatomical Therapeutic Chemical classification 0‑L QH01CA01 Gonadorelin WHO Anatomical Therapeutic Chemical classification 0‑L QH01CA90 Buserelin WHO Anatomical Therapeutic Chemical classification 0‑L QH01CA92 Lecirelin WHO Anatomical Therapeutic Chemical classification 0‑L QH01CA93 Deslorelin WHO Anatomical Therapeutic Chemical classification 0‑L QH02AB01 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L QH02AB02 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L QH02AB56 Prednisolon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QH02CA01 Trilostan WHO Anatomical Therapeutic Chemical classification 0‑L QH03AA01 Levothyroxin-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L QH03BB01 Carbimazol WHO Anatomical Therapeutic Chemical classification 0‑L QH03BB02 Thiamazole WHO Anatomical Therapeutic Chemical classification 0‑L QI Immunologika WHO Anatomical Therapeutic Chemical classification 0‑L QI 09AB07 Tocopherolacetat WHO Anatomical Therapeutic Chemical classification 0‑L QI01 Immunologika für Aves WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA03 aviäre Infektiöse Bronchitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA06 aviäres infektiöse Bronchitis Virus + aviäres infekt.Bursitis (Gumboro) Virus + Newcastle Disease Virus/Paramyxo-Virus + aviäres Rhinotracheitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA13 Newcastle Disease Virus / Paramyxvirus + aviäre infektiöse Bronchitis Virus + aviäre Adenovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA17 aviäre Rhinotracheitis-Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA18 aviäre infektiöse Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + aviäre Adenovirus + aviäre Rhinotracheitisvirus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA21 aviäre infektiöse Bronchitis Virus + Newcastle Disease Virus / Paramyxovirus + aviäre Rhinotracheitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AA23 aviäres Influenza Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AB Inaktivierter bakterieller Impfstoff WHO Anatomical Therapeutic Chemical classification 0‑L QI01AB01 Salmonella WHO Anatomical Therapeutic Chemical classification 0‑L QI01AB02 Pasteurella WHO Anatomical Therapeutic Chemical classification 0‑L QI01AB05 Escherichia (Aves) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AB07 Ornithobacterium WHO Anatomical Therapeutic Chemical classification 0‑L QI01AB08 Clostridium (Aves) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD aviärer lebend Virus-Impfstoff WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD01 avian rhinotracheitis virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD02 aviäre Enzephalomyelitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD03 Aviäres Herpesvirus (Mareksche Krankheit) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD04 Hühner Anaemie Virus (CIA) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD06 Newcastle Disease Virus / Paramyxovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD07 aviäres Infektiöse Bronchitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD08 Infektiöse Laryngotracheitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD09 avian infectious bursal disease virus (gumboro disease) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AD15 aviärs infektiöses Bursitis Virus (Gumboro) + aviäres Herpesvirus (Marek-Krankheit) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AE Bakterieller Lebendimpfstoff WHO Anatomical Therapeutic Chemical classification 0‑L QI01AE01 Salmonella WHO Anatomical Therapeutic Chemical classification 0‑L QI01AE03 Mycoplasma (Aves) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AE04 Escherichia (Aves) WHO Anatomical Therapeutic Chemical classification 0‑L QI01AN01 Kokzidien WHO Anatomical Therapeutic Chemical classification 0‑L QI01BE bakterieller Lebendimpfstoff für Ente WHO Anatomical Therapeutic Chemical classification 0‑L QI01CA inaktivierter viraler Impfstoff für Puten WHO Anatomical Therapeutic Chemical classification 0‑L QI01CD01 Rhinotracheitisvirus, Puten- WHO Anatomical Therapeutic Chemical classification 0‑L QI01EA01 Paramyxovirus (Tauben) WHO Anatomical Therapeutic Chemical classification 0‑L QI02 Immunologika für Bovidae WHO Anatomical Therapeutic Chemical classification 0‑L QI02AA01 Bovinen Virusdiarrhoe WHO Anatomical Therapeutic Chemical classification 0‑L QI02AA02 Boviner respiratorische Syncytialvirus WHO Anatomical Therapeutic Chemical classification 0‑L QI02AA03 Bovine Rhinotracheitis Virus (IBR) WHO Anatomical Therapeutic Chemical classification 0‑L QI02AA04 Maul- und Klauenseuchen Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI02AA08 Blauzungen Virus (Bovidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI02AB Inaktivierte bakterielle Impfstoffe (inkl. Mycoplasma, Toxoid und Chlamydien) - Bovidae WHO Anatomical Therapeutic Chemical classification 0‑L QI02AB01 Clostridium (Bovidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI02AB04 Pasteurella (Bovidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI02AD01 Bovines Rhinotracheitis Virus (IBR) WHO Anatomical Therapeutic Chemical classification 0‑L QI02AD07 Bovines Respiratorisches Synzytialvirus + Bovines Parainfluenza Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI02AI01 lebend bovines Rotavirus + lebend bovines Coronavirus + inakt. Escherichia WHO Anatomical Therapeutic Chemical classification 0‑L QI02AL01 bovines Rotavirus + bovines Coronavirus + Escherichia WHO Anatomical Therapeutic Chemical classification 0‑L QI02AL04 Bovines Parainfluenza Virus + Bovines Respiratorisches Synzytialvirus + Pasteurella WHO Anatomical Therapeutic Chemical classification 0‑L QI02AM05 bovine Rotavirus Antiserum + bovine Coronavirus Antiserum + Escherichia Antiserum WHO Anatomical Therapeutic Chemical classification 0‑L QI02AP01 Trichophyton WHO Anatomical Therapeutic Chemical classification 0‑L QI02AR01 bovines Tuberculin PPD WHO Anatomical Therapeutic Chemical classification 0‑L QI02AR02 aviäres Tuberculin PPD WHO Anatomical Therapeutic Chemical classification 0‑L QI02AT01 Escherichia WHO Anatomical Therapeutic Chemical classification 0‑L QI03 Immunologika für Capridae WHO Anatomical Therapeutic Chemical classification 0‑L QI03AB Inaktiviere bakterielle Impfung (inkl. Mycoplasma, Toxoid und Chlamydien) - Capridae WHO Anatomical Therapeutic Chemical classification 0‑L QI03AC Inaktivierte bakterielle Impfungen und Antisera WHO Anatomical Therapeutic Chemical classification 0‑L QI04 Immunologika für Ovidae WHO Anatomical Therapeutic Chemical classification 0‑L QI04AA02 Blauzungen Virus (Ovidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI04AB01 Clostridium (Ovidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI04AB03 Bacteroides (Ovidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI05 Immunologika für Equidae WHO Anatomical Therapeutic Chemical classification 0‑L QI05AA Virale Impfstoffe, inaktiviert WHO Anatomical Therapeutic Chemical classification 0‑L QI05AA01 equine Influenza Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI05AA04 equine Rhinopneumonitis-Virus + equine Influenzavirus WHO Anatomical Therapeutic Chemical classification 0‑L QI05AA05 Equines Rhinopneumonitis Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI05AA10 West Nile Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI05AB inakt. bakterielle Impfung (inkl. Mycoplasma, Toxoid u. Chlamydien) WHO Anatomical Therapeutic Chemical classification 0‑L QI05AB01 Streptococcen WHO Anatomical Therapeutic Chemical classification 0‑L QI05AB03 Clostridium WHO Anatomical Therapeutic Chemical classification 0‑L QI05AD02 Equines Influenza Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI05AI01 Equines Influenza Virus + Clostridium WHO Anatomical Therapeutic Chemical classification 0‑L QI05AL01 equine Influenza Virus + Clostridium WHO Anatomical Therapeutic Chemical classification 0‑L QI05AM01 Clostridium WHO Anatomical Therapeutic Chemical classification 0‑L QI05AQ Trichophyton + Microsporum (Equidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI05AX andere Immunologika (Equidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI06 Immunologika für Felidae WHO Anatomical Therapeutic Chemical classification 0‑L QI06AA01 Feline Leukämievirus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AA02 Feline Panleukopenie Virus / Parvovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AA04 felines Rhinotracheitis Virus + felines Calicivirus + felines Panleukopenie Virus / Parvovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AA06 Felines infektiöses Peritonitis (FIP) Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AA09 Panleukopenie + Calicivirus + Rhinotracheitis + Tollwut Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AD01 felines Panleukopenie Virus / Parvovirus (lebend viral) WHO Anatomical Therapeutic Chemical classification 0‑L QI06AD03 felines Rhinotracheitisvirus und felines Calicivirus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AD04 Felines Panleukopenievirus + felines Rhinotracheitisvirus + felines Calicivirus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AE02 Bordetella (Felidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI06AF01 Felines Panleukopenievirus + felines Rhinotracheitisvirus + felines Calicivirus + Chlamydia WHO Anatomical Therapeutic Chemical classification 0‑L QI06AH Lebende und inaktivierte virale Impfungen (Felidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI06AH04 lebend felines Panleukopenie Virus / Parovirus + inakt. Tollwut Virus + inakt. felines Rhinotracheitis Virus + inakt. felines Calicivirus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AH05 lebend felines Panleukopenie Virus / Parvovirus + lebend felines Rhinotracheitis Virus + lebend felines Calicivirus + inakt. Tollwut Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AH07 lebend felines Panleukopenie Virus / Parvovirus + lebend felines Rhinotracheitis Virus + lebend felines Calicivirus + inakt. felines Leukaemie Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI06AH08 lebend felines Rhinotracheitis Virus + inakt. felines Calicivirus-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L QI06AH09 lebend felines Rhinotracheitis Virus + lebend felines Panleukpenie Virus / Parvovirus + inakt. felines Calicivirus-Antigen WHO Anatomical Therapeutic Chemical classification 0‑L QI06AJ lebende und inaktivierte virale und bakterielle Impfstoffe WHO Anatomical Therapeutic Chemical classification 0‑L QI06AJ02 lebend felines Rhinotracheitis Virus + inakt. felines Calicivirus-Antigen + lebend Chlamydien WHO Anatomical Therapeutic Chemical classification 0‑L QI06AJ03 lebend felinesRhinotracheitis Virus + inakt. felines Calicivirus-Antigen + lebend felines Panleukopenie Virus / Parvovirus + lebend Chlamydien WHO Anatomical Therapeutic Chemical classification 0‑L QI06AL01 felines Panleukopenie Virus / Parvovirus + felines Rhinotracheitis Virus + felines Calicivirus + felines infektiöse Leukaemie Virus + Chlamydia WHO Anatomical Therapeutic Chemical classification 0‑L QI06AL02 felines Panleukopenie Virus / Parvovirus + felines Rhinotracheitis Virus + felines Calicivirus + inakt. Chlamydia WHO Anatomical Therapeutic Chemical classification 0‑L QI07 Immunologika für Canidae WHO Anatomical Therapeutic Chemical classification 0‑L QI07AA01 Parvovirose Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AA02 Rabiesvirus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AA06 Canines Herpes-Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AB01 Leptospira WHO Anatomical Therapeutic Chemical classification 0‑L QI07AB04 Borrelia WHO Anatomical Therapeutic Chemical classification 0‑L QI07AD01 canines Parvovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AD02 canines Staupe Virus + canines Adenovirus + canines Parvovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AD03 canines Staupe Virus + canines Parovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AD04 canines Staupe Virus + canines Adenovirus + canines Parvovirus + canines Parainfluenza Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AD08 canine Parainfluenza-Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AE01 Bordetella WHO Anatomical Therapeutic Chemical classification 0‑L QI07AF Lebende bakterielle und virale Impfungen (Canidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI07AI01 lebend canines Staupevirus + lebend canines Adenovirus + inakt. Leptospira WHO Anatomical Therapeutic Chemical classification 0‑L QI07AI02 lebend canines Staupevirus + lebend canines Adenovirus + lebend canines Parainfluenza Virus + lebend canines Parvovirus + inakt. Leptospira WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ Lebende virale und inaktivierte virale und bakterielle Impfungen (Canidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ01 Staupe Virus (lebend) + Adenovirus (inakt.) + Tollwut (inakt.) + Leptospirose (inakt.) Viren WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ02 Staupevirus (lebend) + Adenovirus (inakt.) + Leptospirose (inakt.) Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ03 Staup Virus (lebend) + Adenovirus (inakt.) + Parvovirus (inakt.) + Leptospirose (inakt.) Viren WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ04 Staupe Virus (lebend) + Adenovirus (inakt.) + Parvovirose (inakt.) + Tollwut (inakt.) + Leptospirose (inakt.) Viren WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ05 lebend canines Staupevirus + lebend canines Adenovirus + lebend canines Parvovirus + inakt. Tollwut Virus + inakt. Leptospira WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ06 lebend canines Staupevirus + lebend canines Adenovirus + lebend Parainfluenzavirus + lebend canines Parvovirus + inakt. Tollwutvirus + inakt. Leptospira WHO Anatomical Therapeutic Chemical classification 0‑L QI07AJ10 canine Staupe Virus (lebend) + canine Adenovirus (lebend) + Parainfluenza Virus (lebend) + canine Parvovirus (lebend) + canine Coronavirus (inakt.) + Leptospira (inakt.) WHO Anatomical Therapeutic Chemical classification 0‑L QI07AL01 Tollwut Virus + Leptospira WHO Anatomical Therapeutic Chemical classification 0‑L QI07AL05 Bordetella + Parainfluenza Virus (Canidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI07AO Inaktivierte Impfungen gegen Parasiten WHO Anatomical Therapeutic Chemical classification 0‑L QI07BD lebend viraler Impfstoff (Fuchs) WHO Anatomical Therapeutic Chemical classification 0‑L QI08 Immunologika für Leporidae WHO Anatomical Therapeutic Chemical classification 0‑L QI08AA01 Haemorrhagie-Virus (Kaninchen) WHO Anatomical Therapeutic Chemical classification 0‑L QI08AD viraler Lebendimpfstoff (Leporidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI08AD02 Myxomatose Virus (Leporidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI09 Immunologika für Suidae WHO Anatomical Therapeutic Chemical classification 0‑L QI09AA02 porcines Parvovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AA03 Porcine Influenza Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AA05 Schweine-reproduktive und respiratorische Syndrom (PRRS)-Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AA06 Europäisches Schweinepestvirus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AA07 Porcines Circovirus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB02 Escherichia (Suidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB03 Erysipelothrix WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB04 Bordetella + Pasteurella (Suidae) WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB07 Actinobacillus/Haemophilus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB08 Escherichia + Clostridium WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB13 Mycoplasma WHO Anatomical Therapeutic Chemical classification 0‑L QI09AB17 Mykoplasmen + Haemophilus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AD01 Aujeszkyʹscher Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AD03 PRRS-Virus WHO Anatomical Therapeutic Chemical classification 0‑L QI09AE04 Lawsonia WHO Anatomical Therapeutic Chemical classification 0‑L QI09AL01 porcines Parvovirus + Erysipelothrix WHO Anatomical Therapeutic Chemical classification 0‑L QI10 Immunologika für Pisces WHO Anatomical Therapeutic Chemical classification 0‑L QI10AB01 Aeromonas WHO Anatomical Therapeutic Chemical classification 0‑L QI10BB03 Yersinia WHO Anatomical Therapeutic Chemical classification 0‑L QI11 Immunologika für Rodentia WHO Anatomical Therapeutic Chemical classification 0‑L QI20 Andere Immunologika (Bienen, Frettchen, Nerz,...) WHO Anatomical Therapeutic Chemical classification 0‑L QJ01AA02 Doxycyclin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01AA03 Chlortetrazyklin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01AA06 Oxytetracycline WHO Anatomical Therapeutic Chemical classification 0‑L QJ01AA09 Oxytetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01AA53 Chlortetracyclin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QJ01AA56 oxytetracycline, combinations WHO Anatomical Therapeutic Chemical classification 0‑L QJ01BA01 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L QJ01BA02 Thiamphenicol WHO Anatomical Therapeutic Chemical classification 0‑L QJ01BA90 Florfenicol WHO Anatomical Therapeutic Chemical classification 0‑L QJ01BA99 Amfenicol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CA Penicilline mit erweitertem Spektrum WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CA01 Ampicillin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CA04 Amoxicillin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CE02 Phenoxymethylpenicillin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CE09 Procain-Penicillin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CE90 Penethamat Hydroiodid WHO Anatomical Therapeutic Chemical classification 0‑L QJ01CR02 Amoxicillin und Enzyminhibitor WHO Anatomical Therapeutic Chemical classification 0‑L QJ01DB01 Cefalexin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01DD90 Ceftiofur WHO Anatomical Therapeutic Chemical classification 0‑L QJ01DD91 Cefovecin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01DE90 Cefquinom WHO Anatomical Therapeutic Chemical classification 0‑L QJ01EQ03 Sulfadimidine WHO Anatomical Therapeutic Chemical classification 0‑L QJ01EW03 Sulfadimidin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L QJ01EW10 Sulfadiazin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L QJ01EW11 Sulfamethoxazol und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L QJ01EW12 Sulfachlorpyridazin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L QJ01EW13 Sulfadoxin und Trimethoprim WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA02 Spiramycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA90 Tylosin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA91 Tilmicosin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA92 Tylvalosin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA94 Tulathromycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA95 Gamithromycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FA96 Tildipirosin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FF01 Clindamycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01FF52 Lincomycin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QJ01GA90 Dihydrostreptomycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01GB03 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01GB04 Kanamycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01GB05 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01GB90 Apramycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA90 Enrofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA92 Danofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA93 Marbofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA94 Difloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA95 Orbifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA96 Ibafloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01MA97 Pardofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01RA01 Penicilline, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ01RA02 Sulfonamide, Kombinationen mit anderen Antibiotika (exkl.Trimethoprim) WHO Anatomical Therapeutic Chemical classification 0‑L QJ01RA04 Spiramycin, Kombination mit anderen antibakteriellen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L QJ01RA91 Makrolide, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ01XB01 Colistin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01XQ01 Tiamulin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01XQ02 Valnemulin WHO Anatomical Therapeutic Chemical classification 0‑L QJ01XX92 Tiamulin WHO Anatomical Therapeutic Chemical classification 0‑L QJ02AC02 Itraconazol WHO Anatomical Therapeutic Chemical classification 0‑L QJ51CA51 Ampicillin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QJ51CE09 Procaine-Benzylpenicillin WHO Anatomical Therapeutic Chemical classification 0‑L QJ51CF02 Cloxacillin WHO Anatomical Therapeutic Chemical classification 0‑L QJ51CR50 Kombinationen von Penicillinen WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DA32 Cefoperazon WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DA92 Cefquinom WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DB01 Cefalexin (intramammär) WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DB04 Cefazolin WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DB90 Cefalonium WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DD12 Cefoperazone WHO Anatomical Therapeutic Chemical classification 0‑L QJ51DE90 Cefquinom WHO Anatomical Therapeutic Chemical classification 0‑L QJ51E Sulfonamiden und Trimethoprim für intramammäre Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L QJ51FF90 Pirlimycin WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RC Antibiotika Kombinationen für intramammäre Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RC01 Antibiotika Kombination WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RC22 Benzylpenicillin, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RC23 Procain Benzylpenicillin, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RC26 Cloxacillin, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RD01 Cefalexin, Kombinationen mit anderen antibakteriellen Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RF03 Lincomycin, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RG01 Neomycin, Kombinationen mit anderen Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L QJ51RV01 Antibiotika und Kortikosteroide WHO Anatomical Therapeutic Chemical classification 0‑L QJ51XX01 Rifaximin WHO Anatomical Therapeutic Chemical classification 0‑L QL01XE90 Protein-Kinase-Inhibitor WHO Anatomical Therapeutic Chemical classification 0‑L QL01XE91 Toceranib WHO Anatomical Therapeutic Chemical classification 0‑L QL03AB Interferone WHO Anatomical Therapeutic Chemical classification 0‑L QL03AX Immunstimulanzien WHO Anatomical Therapeutic Chemical classification 0‑L QL04AD01 Ciclosporin WHO Anatomical Therapeutic Chemical classification 0‑L QM01AA01 Phenylbutazon WHO Anatomical Therapeutic Chemical classification 0‑L QM01AA90 Suxibuzon WHO Anatomical Therapeutic Chemical classification 0‑L QM01AC06 Meloxicam WHO Anatomical Therapeutic Chemical classification 0‑L QM01AE03 Ketoprofen WHO Anatomical Therapeutic Chemical classification 0‑L QM01AE90 Vedaprofen WHO Anatomical Therapeutic Chemical classification 0‑L QM01AE91 Carprofen WHO Anatomical Therapeutic Chemical classification 0‑L QM01AE92 Tepoxalin WHO Anatomical Therapeutic Chemical classification 0‑L QM01AG02 Tolfenaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L QM01AG90 Flunixin WHO Anatomical Therapeutic Chemical classification 0‑L QM01AH90 Firocoxib WHO Anatomical Therapeutic Chemical classification 0‑L QM01AH91 Robenacoxib WHO Anatomical Therapeutic Chemical classification 0‑L QM01AH92 Mavacoxib WHO Anatomical Therapeutic Chemical classification 0‑L QM01AH93 Cimicoxib WHO Anatomical Therapeutic Chemical classification 0‑L QM01AX12 Glykosaminoglykan Polysulfat WHO Anatomical Therapeutic Chemical classification 0‑L QM01AX90 Pentosan Polysulfat Natrium WHO Anatomical Therapeutic Chemical classification 0‑L QM01BA01 Phenylbutazon und Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L QM02AC99 Zubereitungen mit Salicylsäure-Derivaten, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QM03BX90 Guaifenesin WHO Anatomical Therapeutic Chemical classification 0‑L QM05BA05 Tiludronsäure WHO Anatomical Therapeutic Chemical classification 0‑L QM05BC01 Dibotermin alfa WHO Anatomical Therapeutic Chemical classification 0‑L QM09AX01 Hyaluronsäure WHO Anatomical Therapeutic Chemical classification 0‑L QN01 Anaesthetika WHO Anatomical Therapeutic Chemical classification 0‑L QN01AB06 Isofluran WHO Anatomical Therapeutic Chemical classification 0‑L QN01AB08 Sevofluran WHO Anatomical Therapeutic Chemical classification 0‑L QN01AC52 Methadon-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QN01AX03 Ketamin WHO Anatomical Therapeutic Chemical classification 0‑L QN01AX10 Propofol WHO Anatomical Therapeutic Chemical classification 0‑L QN01BA02 Procain WHO Anatomical Therapeutic Chemical classification 0‑L QN02AB03 Fentanyl WHO Anatomical Therapeutic Chemical classification 0‑L QN02AC52 Methadon-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QN02AE01 Buprenorphin WHO Anatomical Therapeutic Chemical classification 0‑L QN02AF Morphinderivate WHO Anatomical Therapeutic Chemical classification 0‑L QN02AF01 Butorphanol WHO Anatomical Therapeutic Chemical classification 0‑L QN02BA01 Acetylsalicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L QN02BA04 Natriumsalicylat WHO Anatomical Therapeutic Chemical classification 0‑L QN02BB02 Metamizol Natrium WHO Anatomical Therapeutic Chemical classification 0‑L QN02BB52 Metamizol Natrium, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L QN02BE01 Paracetamol WHO Anatomical Therapeutic Chemical classification 0‑L QN03AA02 Phenobarbital WHO Anatomical Therapeutic Chemical classification 0‑L QN03AX90 Imepitoin WHO Anatomical Therapeutic Chemical classification 0‑L QN04BC02 Pergolid WHO Anatomical Therapeutic Chemical classification 0‑L QN05AA04 Acepromazin WHO Anatomical Therapeutic Chemical classification 0‑L QN05BA01 Diazepam WHO Anatomical Therapeutic Chemical classification 0‑L QN05CB02 Barbiturate in Kombination mit anderen Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L QN05CM11 Bromide WHO Anatomical Therapeutic Chemical classification 0‑L QN05CM18 Dexmedetomidine WHO Anatomical Therapeutic Chemical classification 0‑L QN05CM90 Detomidin WHO Anatomical Therapeutic Chemical classification 0‑L QN05CM91 Medetomidin WHO Anatomical Therapeutic Chemical classification 0‑L QN05CM92 Xylazin WHO Anatomical Therapeutic Chemical classification 0‑L QN06AA04 Clomipramin WHO Anatomical Therapeutic Chemical classification 0‑L QN06AB03 Fluoxetin WHO Anatomical Therapeutic Chemical classification 0‑L QN06BC01 Xanthin-Derivate, Coffein WHO Anatomical Therapeutic Chemical classification 0‑L QN51AA01 Pentobarbital WHO Anatomical Therapeutic Chemical classification 0‑L QNO5AD90 Azaperon WHO Anatomical Therapeutic Chemical classification 0‑L QP51AJ01 Toltrazuril WHO Anatomical Therapeutic Chemical classification 0‑L QP51AJ03 Diclazuril WHO Anatomical Therapeutic Chemical classification 0‑L QP51AX08 Halofuginon WHO Anatomical Therapeutic Chemical classification 0‑L QP52AA01 Praziquantel WHO Anatomical Therapeutic Chemical classification 0‑L QP52AA51 Praziquantel-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP52AA54 Epsiprantel, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC01 Triclabendazol WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC02 Oxfendazole WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC05 Fenbantel WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC06 Netobimin WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC08 Cambendazol WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC09 Mebendazol WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC11 Albendazol WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC12 Flubendazole WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC13 Fenbendazol WHO Anatomical Therapeutic Chemical classification 0‑L QP52AC55 Febantel-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP52ACO1 Triclabendazole WHO Anatomical Therapeutic Chemical classification 0‑L QP52AE01 Levamisol WHO Anatomical Therapeutic Chemical classification 0‑L QP52AE51 Levamisol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP52AF02 Pyrantel WHO Anatomical Therapeutic Chemical classification 0‑L QP52AG05 Rafoxanid WHO Anatomical Therapeutic Chemical classification 0‑L QP52AG09 Closantel WHO Anatomical Therapeutic Chemical classification 0‑L QP52AX09 Monepantel WHO Anatomical Therapeutic Chemical classification 0‑L QP52AX60 Emodepsid und Toltrazuril WHO Anatomical Therapeutic Chemical classification 0‑L QP53AC04 Permethrin WHO Anatomical Therapeutic Chemical classification 0‑L QP53AC05 Flumethrin WHO Anatomical Therapeutic Chemical classification 0‑L QP53AC11 Deltamethrin WHO Anatomical Therapeutic Chemical classification 0‑L QP53AC54 Permethrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP53AC55 Flumethrin-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP53AD01 Amitraz WHO Anatomical Therapeutic Chemical classification 0‑L QP53AD51 Amitraz, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP53AE02 Propoxur WHO Anatomical Therapeutic Chemical classification 0‑L QP53AF01 Phoxime WHO Anatomical Therapeutic Chemical classification 0‑L QP53AF08 Guaifenesin WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX04 Crotamiton WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX15 Fipronil WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX17 Imidacloprid WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX22 Thymol WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX23 Pyriproxifen WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX25 Metaflumizone WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX26 Pyriprole WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX27 Indoxacarb WHO Anatomical Therapeutic Chemical classification 0‑L QP53AX65 Fipronil-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP53BC01 Lufenuron WHO Anatomical Therapeutic Chemical classification 0‑L QP53BC51 Lufenuron, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP53BD01 Methopren WHO Anatomical Therapeutic Chemical classification 0‑L QP53BX02 Nitenpyram WHO Anatomical Therapeutic Chemical classification 0‑L QP53BX03 Spinosad WHO Anatomical Therapeutic Chemical classification 0‑L QP54AA01 Ivermectin WHO Anatomical Therapeutic Chemical classification 0‑L QP54AA03 Doramectin WHO Anatomical Therapeutic Chemical classification 0‑L QP54AA04 Epinomectin WHO Anatomical Therapeutic Chemical classification 0‑L QP54AA05 Selamectin WHO Anatomical Therapeutic Chemical classification 0‑L QP54AA51 Ivermectin-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP54AB02 Moxidectin WHO Anatomical Therapeutic Chemical classification 0‑L QP54AB51 Milbemycin Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QP54AB52 Moxidectin-Kombination WHO Anatomical Therapeutic Chemical classification 0‑L QR03CC13 Clenbuterol WHO Anatomical Therapeutic Chemical classification 0‑L QR03CC90 Clentbuterol Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L QR05CB01 Acetylcystein WHO Anatomical Therapeutic Chemical classification 0‑L QR05CB02 Bromhexin WHO Anatomical Therapeutic Chemical classification 0‑L QR05CB90 Dembrexin hydrochlorid WHO Anatomical Therapeutic Chemical classification 0‑L QS01AA13 Fusidinsäure WHO Anatomical Therapeutic Chemical classification 0‑L QS01AA90 Cloxacillin (ophtalmologische Präparate) WHO Anatomical Therapeutic Chemical classification 0‑L QS01XA18 Ciclosporin WHO Anatomical Therapeutic Chemical classification 0‑L QS02CA Corticosteroide und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L QS02CA01 Prednisolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L QS02CA03 Hydrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L QS02CA91 Mometasone und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L QS02QA03 Ivermectin WHO Anatomical Therapeutic Chemical classification 0‑L QV03AB90 Atipamezole WHO Anatomical Therapeutic Chemical classification 0‑L QV03AN01 Oxygen WHO Anatomical Therapeutic Chemical classification 0‑L QV03AX Nalfurafine WHO Anatomical Therapeutic Chemical classification 0‑L QV06DE Kombinationen aus Aminosäuren, Elektroylten, Glucose und Vitaminen WHO Anatomical Therapeutic Chemical classification 0‑L R Respirationstrakt WHO Anatomical Therapeutic Chemical classification 0‑L R01 Rhinologika WHO Anatomical Therapeutic Chemical classification 0‑L R01A Dekongestiva und andere Rhinologika zur topischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R01AA Sympathomimetika, rein WHO Anatomical Therapeutic Chemical classification 0‑L R01AA02 Cyclopentamin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA03 Ephedrin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA04 Phenylephrin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA05 Oxymetazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA06 Tetryzolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA07 Xylometazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA08 Naphazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA09 Tramazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA10 Metizolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA11 Tuaminoheptan WHO Anatomical Therapeutic Chemical classification 0‑L R01AA12 Fenoxazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA13 Tymazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AA14 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB Sympathomimetika, Kombinationen exkl. Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L R01AB01 Phenylephrin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB02 Naphazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB03 Tetryzolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB05 Ephedrin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB06 Xylometazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB07 Oxymetazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AB08 Tuaminoheptan WHO Anatomical Therapeutic Chemical classification 0‑L R01AC Antiallergika, exkl. Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L R01AC01 Cromoglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L R01AC02 Levocabastin WHO Anatomical Therapeutic Chemical classification 0‑L R01AC03 Azelastin WHO Anatomical Therapeutic Chemical classification 0‑L R01AC04 Antazolin WHO Anatomical Therapeutic Chemical classification 0‑L R01AC05 Spagluminsäure WHO Anatomical Therapeutic Chemical classification 0‑L R01AC06 Thonzylamin WHO Anatomical Therapeutic Chemical classification 0‑L R01AC07 Nedocromil WHO Anatomical Therapeutic Chemical classification 0‑L R01AC08 Olopatadin WHO Anatomical Therapeutic Chemical classification 0‑L R01AC51 Cromoglicinsäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01AD Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L R01AD01 Beclometason WHO Anatomical Therapeutic Chemical classification 0‑L R01AD02 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L R01AD03 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L R01AD04 Flunisolid WHO Anatomical Therapeutic Chemical classification 0‑L R01AD05 Budesonid WHO Anatomical Therapeutic Chemical classification 0‑L R01AD06 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L R01AD07 Tixocortol WHO Anatomical Therapeutic Chemical classification 0‑L R01AD08 Fluticason WHO Anatomical Therapeutic Chemical classification 0‑L R01AD09 Mometason WHO Anatomical Therapeutic Chemical classification 0‑L R01AD11 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L R01AD12 Fluticasonfuroat WHO Anatomical Therapeutic Chemical classification 0‑L R01AD52 Prednisolon, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01AD53 Dexamethason, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01AD57 Tixocortol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01AD58 Fluticason, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01AD60 Hydrocortison, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01AX Andere Rhinologika WHO Anatomical Therapeutic Chemical classification 0‑L R01AX01 Calciumhexaminthiocyanat WHO Anatomical Therapeutic Chemical classification 0‑L R01AX02 Retinol WHO Anatomical Therapeutic Chemical classification 0‑L R01AX03 Ipratropiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L R01AX05 Ritiometan WHO Anatomical Therapeutic Chemical classification 0‑L R01AX06 Mupirocin WHO Anatomical Therapeutic Chemical classification 0‑L R01AX07 Hexamidin WHO Anatomical Therapeutic Chemical classification 0‑L R01AX08 Framycetin WHO Anatomical Therapeutic Chemical classification 0‑L R01AX10 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L R01AX30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01B Nasale Dekongestiva zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R01BA Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R01BA01 Phenylpropanolamin WHO Anatomical Therapeutic Chemical classification 0‑L R01BA02 Pseudoephedrin WHO Anatomical Therapeutic Chemical classification 0‑L R01BA03 Phenylephrin WHO Anatomical Therapeutic Chemical classification 0‑L R01BA51 Phenylpropanolamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01BA52 Pseudoephedrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R01BA53 Phenylephrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R02 Hals- und Rachentherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L R02A Hals- und Rachentherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L R02AA Antiseptika WHO Anatomical Therapeutic Chemical classification 0‑L R02AA01 Ambazon WHO Anatomical Therapeutic Chemical classification 0‑L R02AA02 Dequalinium WHO Anatomical Therapeutic Chemical classification 0‑L R02AA03 Dichlorbenzylalkohol WHO Anatomical Therapeutic Chemical classification 0‑L R02AA05 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L R02AA06 Cetylpyridinium WHO Anatomical Therapeutic Chemical classification 0‑L R02AA09 Benzethonium WHO Anatomical Therapeutic Chemical classification 0‑L R02AA10 Myristylbenzalkonium WHO Anatomical Therapeutic Chemical classification 0‑L R02AA11 Chlorquinaldol WHO Anatomical Therapeutic Chemical classification 0‑L R02AA12 Hexylresorcinol WHO Anatomical Therapeutic Chemical classification 0‑L R02AA13 Acriflaviniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L R02AA14 Oxychinolin WHO Anatomical Therapeutic Chemical classification 0‑L R02AA15 Povidon-Iod WHO Anatomical Therapeutic Chemical classification 0‑L R02AA16 Benzalkonium WHO Anatomical Therapeutic Chemical classification 0‑L R02AA17 Cetrimonium WHO Anatomical Therapeutic Chemical classification 0‑L R02AA18 Hexamidin WHO Anatomical Therapeutic Chemical classification 0‑L R02AA19 Phenol WHO Anatomical Therapeutic Chemical classification 0‑L R02AA20 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L R02AB Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L R02AB01 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L R02AB02 Tyrothricin WHO Anatomical Therapeutic Chemical classification 0‑L R02AB03 Fusafungin WHO Anatomical Therapeutic Chemical classification 0‑L R02AB04 Bacitracin WHO Anatomical Therapeutic Chemical classification 0‑L R02AB30 Gramicidin WHO Anatomical Therapeutic Chemical classification 0‑L R02AD Lokalanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L R02AD01 Benzocain WHO Anatomical Therapeutic Chemical classification 0‑L R02AD02 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L R02AD03 Cocain WHO Anatomical Therapeutic Chemical classification 0‑L R02AD04 Dyclonin WHO Anatomical Therapeutic Chemical classification 0‑L R02AX01 Flurbiprofen WHO Anatomical Therapeutic Chemical classification 0‑L R03 Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03A Inhalative Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03AA Alpha- und Beta-Adrenorezeptor-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03AA01 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L R03AB Nichtselektive Beta-Adrenorezeptor-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03AB02 Isoprenalin WHO Anatomical Therapeutic Chemical classification 0‑L R03AB03 Orciprenalin WHO Anatomical Therapeutic Chemical classification 0‑L R03AC Selektive Beta-2-Adrenorezeptor-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03AC02 Salbutamol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC03 Terbutalin WHO Anatomical Therapeutic Chemical classification 0‑L R03AC04 Fenoterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC05 Rimiterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC06 Hexoprenalin WHO Anatomical Therapeutic Chemical classification 0‑L R03AC07 Isoetarin WHO Anatomical Therapeutic Chemical classification 0‑L R03AC08 Pirbuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC09 Tretoquinol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC10 Carbuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC11 Tulobuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC12 Salmeterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC13 Formoterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC14 Clenbuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC15 Reproterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC16 Procaterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AC17 Bitolterol WHO Anatomical Therapeutic Chemical classification 0‑L R03AH Kombinationen von Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03AK Sympathomimetika und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK01 Epinephrin und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK02 Isoprenalin und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK03 Fenoterol und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK04 Salbutamol und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK05 Reproterol und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK06 Salmeterol und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03AK07 Formoterol und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03B Andere inhalative Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03BA Glucocorticoide WHO Anatomical Therapeutic Chemical classification 0‑L R03BA01 Beclometason WHO Anatomical Therapeutic Chemical classification 0‑L R03BA02 Budesonid WHO Anatomical Therapeutic Chemical classification 0‑L R03BA03 Flunisolid WHO Anatomical Therapeutic Chemical classification 0‑L R03BA04 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L R03BA05 Fluticason WHO Anatomical Therapeutic Chemical classification 0‑L R03BA06 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L R03BA07 Mometason WHO Anatomical Therapeutic Chemical classification 0‑L R03BA08 Ciclesonid WHO Anatomical Therapeutic Chemical classification 0‑L R03BB Anticholinergika WHO Anatomical Therapeutic Chemical classification 0‑L R03BB01 Ipratropiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L R03BB02 Oxitropiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L R03BB03 Stechapfel-haltige Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L R03BB04 Tiotropiumbromid WHO Anatomical Therapeutic Chemical classification 0‑L R03BC Antiallergika, exkl. Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L R03BC01 Cromoglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L R03BC03 Nedocromil WHO Anatomical Therapeutic Chemical classification 0‑L R03BX Andere inhalative Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03BX01 Fenspirid WHO Anatomical Therapeutic Chemical classification 0‑L R03C Sympathomimetika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R03CA Alpha- und Beta-Adrenorezeptor-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03CA02 Ephedrin WHO Anatomical Therapeutic Chemical classification 0‑L R03CB Nichtselektive Beta-Adrenorezeptor-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03CB01 Isoprenalin WHO Anatomical Therapeutic Chemical classification 0‑L R03CB02 Methoxyphenamin WHO Anatomical Therapeutic Chemical classification 0‑L R03CB03 Orciprenalin WHO Anatomical Therapeutic Chemical classification 0‑L R03CB51 Isoprenalin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R03CB53 Orciprenalin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R03CC Selektive Beta2-Adrenorezeptor-Agonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03CC02 Salbutamol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC03 Terbutalin WHO Anatomical Therapeutic Chemical classification 0‑L R03CC04 Fenoterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC05 Hexoprenalin WHO Anatomical Therapeutic Chemical classification 0‑L R03CC06 Isoetarin WHO Anatomical Therapeutic Chemical classification 0‑L R03CC07 Pirbuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC08 Procaterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC09 Tretoquinol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC10 Carbuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC11 Tulobuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC12 Bambuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC13 Clenbuterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC14 Reproterol WHO Anatomical Therapeutic Chemical classification 0‑L R03CC53 Terbutalin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R03CK Sympathomimetika und andere Mittel bei obstruktiven Atemwegserkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L R03D Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R03DA Xanthine WHO Anatomical Therapeutic Chemical classification 0‑L R03DA01 Diprophyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA02 Cholintheophyllinat WHO Anatomical Therapeutic Chemical classification 0‑L R03DA03 Proxyphyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA04 Theophyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA05 Aminophyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA06 Etamiphyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA07 Theobromin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA08 Bamifyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA09 Acefyllinpiperazin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA10 Bufyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA11 Doxofyllin WHO Anatomical Therapeutic Chemical classification 0‑L R03DA20 Kombinationen von Xanthinen WHO Anatomical Therapeutic Chemical classification 0‑L R03DA51 Diprophyllin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R03DA54 Theophyllin, Kombinationen exkl. Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L R03DA55 Aminophyllin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R03DA57 Theobromin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R03DA74 Theophyllin, Kombinationen mit Psycholeptika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB Xanthine und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB01 Diprophyllin und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB02 Cholintheophyllinat und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB03 Proxyphyllin und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB04 Theophyllin und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB05 Aminophyllin und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DB06 Etamiphyllin und Sympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L R03DC Leukotrienrezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L R03DC01 Zafirlukast WHO Anatomical Therapeutic Chemical classification 0‑L R03DC02 Pranlukast WHO Anatomical Therapeutic Chemical classification 0‑L R03DC03 Montelukast WHO Anatomical Therapeutic Chemical classification 0‑L R03DC04 Ibudilast WHO Anatomical Therapeutic Chemical classification 0‑L R03DX Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R03DX01 Amlexanox WHO Anatomical Therapeutic Chemical classification 0‑L R03DX02 Eprozinol WHO Anatomical Therapeutic Chemical classification 0‑L R03DX03 Fenspirid WHO Anatomical Therapeutic Chemical classification 0‑L R03DX05 Omalizumab WHO Anatomical Therapeutic Chemical classification 0‑L R03DX06 Seratrodast WHO Anatomical Therapeutic Chemical classification 0‑L R03DX07 Roflumilast WHO Anatomical Therapeutic Chemical classification 0‑L R05 Husten- und Erkältungspräparate WHO Anatomical Therapeutic Chemical classification 0‑L R05C Expektoranzien, exkl. Kombinationen mit Antitussiva WHO Anatomical Therapeutic Chemical classification 0‑L R05CA Expektoranzien WHO Anatomical Therapeutic Chemical classification 0‑L R05CA01 Tyloxapol WHO Anatomical Therapeutic Chemical classification 0‑L R05CA02 Kaliumiodid WHO Anatomical Therapeutic Chemical classification 0‑L R05CA03 Guaifenesin WHO Anatomical Therapeutic Chemical classification 0‑L R05CA04 Ipecacuanha WHO Anatomical Therapeutic Chemical classification 0‑L R05CA05 Eibischwurzel WHO Anatomical Therapeutic Chemical classification 0‑L R05CA06 Senega WHO Anatomical Therapeutic Chemical classification 0‑L R05CA07 Antimonpentasulfid WHO Anatomical Therapeutic Chemical classification 0‑L R05CA08 Kreosot WHO Anatomical Therapeutic Chemical classification 0‑L R05CA09 Guajacolsulfonat WHO Anatomical Therapeutic Chemical classification 0‑L R05CA10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R05CA11 Levoverbenon WHO Anatomical Therapeutic Chemical classification 0‑L R05CA12 Hederae helicis folium WHO Anatomical Therapeutic Chemical classification 0‑L R05CB Mukolytika WHO Anatomical Therapeutic Chemical classification 0‑L R05CB01 Acetylcystein WHO Anatomical Therapeutic Chemical classification 0‑L R05CB02 Bromhexin WHO Anatomical Therapeutic Chemical classification 0‑L R05CB03 Carbocistein WHO Anatomical Therapeutic Chemical classification 0‑L R05CB04 Eprazinon WHO Anatomical Therapeutic Chemical classification 0‑L R05CB05 Mesna WHO Anatomical Therapeutic Chemical classification 0‑L R05CB06 Ambroxol WHO Anatomical Therapeutic Chemical classification 0‑L R05CB07 Sobrerol WHO Anatomical Therapeutic Chemical classification 0‑L R05CB08 Domiodol WHO Anatomical Therapeutic Chemical classification 0‑L R05CB09 Letostein WHO Anatomical Therapeutic Chemical classification 0‑L R05CB10 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R05CB11 Stepronin WHO Anatomical Therapeutic Chemical classification 0‑L R05CB12 Tiopronin WHO Anatomical Therapeutic Chemical classification 0‑L R05CB13 Dornase alfa (Desoxyribonuclease) WHO Anatomical Therapeutic Chemical classification 0‑L R05CB14 Neltenexin WHO Anatomical Therapeutic Chemical classification 0‑L R05CB15 Erdostein WHO Anatomical Therapeutic Chemical classification 0‑L R05CP01 Thymiankraut WHO Anatomical Therapeutic Chemical classification 0‑L R05CP02 Efeublätter WHO Anatomical Therapeutic Chemical classification 0‑L R05D Antitussiva, exkl. Kombinationen mit Expektoranzien WHO Anatomical Therapeutic Chemical classification 0‑L R05DA Opium-Alkaloide und Derivate WHO Anatomical Therapeutic Chemical classification 0‑L R05DA01 Ethylmorphin WHO Anatomical Therapeutic Chemical classification 0‑L R05DA03 Hydrocodon WHO Anatomical Therapeutic Chemical classification 0‑L R05DA04 Codein WHO Anatomical Therapeutic Chemical classification 0‑L R05DA05 Opium-Alkaloide mit Morphin WHO Anatomical Therapeutic Chemical classification 0‑L R05DA06 Normethadon WHO Anatomical Therapeutic Chemical classification 0‑L R05DA07 Noscapin WHO Anatomical Therapeutic Chemical classification 0‑L R05DA08 Pholcodin WHO Anatomical Therapeutic Chemical classification 0‑L R05DA09 Dextromethorphan WHO Anatomical Therapeutic Chemical classification 0‑L R05DA10 Thebacon WHO Anatomical Therapeutic Chemical classification 0‑L R05DA11 Dimemorfan WHO Anatomical Therapeutic Chemical classification 0‑L R05DA12 Acetyldihydrocodein WHO Anatomical Therapeutic Chemical classification 0‑L R05DA20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R05DB Andere Antitussiva WHO Anatomical Therapeutic Chemical classification 0‑L R05DB01 Benzonatat WHO Anatomical Therapeutic Chemical classification 0‑L R05DB02 Benproperin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB03 Clobutinol WHO Anatomical Therapeutic Chemical classification 0‑L R05DB04 Isoaminil WHO Anatomical Therapeutic Chemical classification 0‑L R05DB05 Pentoxyverin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB07 Oxolamin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB09 Oxeladin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB10 Clofedanol WHO Anatomical Therapeutic Chemical classification 0‑L R05DB11 Pipazetat WHO Anatomical Therapeutic Chemical classification 0‑L R05DB12 Bibenzoniumbromid WHO Anatomical Therapeutic Chemical classification 0‑L R05DB13 Butamirat WHO Anatomical Therapeutic Chemical classification 0‑L R05DB14 Fedrilat WHO Anatomical Therapeutic Chemical classification 0‑L R05DB15 Zipeprol WHO Anatomical Therapeutic Chemical classification 0‑L R05DB16 Dibunat WHO Anatomical Therapeutic Chemical classification 0‑L R05DB17 Droxypropin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB18 Prenoxdiazin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB19 Dropropizin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB20 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R05DB21 Cloperastin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB22 Meprotixol WHO Anatomical Therapeutic Chemical classification 0‑L R05DB23 Piperidion WHO Anatomical Therapeutic Chemical classification 0‑L R05DB24 Tipepidin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB25 Morclofon WHO Anatomical Therapeutic Chemical classification 0‑L R05DB26 Nepinalon WHO Anatomical Therapeutic Chemical classification 0‑L R05DB27 Levodropropizin WHO Anatomical Therapeutic Chemical classification 0‑L R05DB28 Dimethoxanat WHO Anatomical Therapeutic Chemical classification 0‑L R05F Antitussiva und Expektoranzien, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R05FA Opium-Derivate und Expektoranzien WHO Anatomical Therapeutic Chemical classification 0‑L R05FA01 Opium-Derivate und Mukolytika WHO Anatomical Therapeutic Chemical classification 0‑L R05FA02 Opium-Derivate und Expektoranzien WHO Anatomical Therapeutic Chemical classification 0‑L R05FB Andere Antitussiva und Expektoranzien WHO Anatomical Therapeutic Chemical classification 0‑L R05FB01 Antitussiva und Mukolytika WHO Anatomical Therapeutic Chemical classification 0‑L R05FB02 Antitussiva und Expektoranzien WHO Anatomical Therapeutic Chemical classification 0‑L R05X Andere Kombinationspräparate gegen Erkältungskrankheiten WHO Anatomical Therapeutic Chemical classification 0‑L R06 Antihistaminika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R06A Antihistaminika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R06AA Aminoalkylether WHO Anatomical Therapeutic Chemical classification 0‑L R06AA01 Bromazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA02 Diphenhydramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA04 Clemastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA06 Chlorphenoxamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA07 Diphenylpyralin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA08 Carbinoxamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA09 Doxylamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AA52 Diphenhydramin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AA54 Clemastin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AA56 Chlorphenoxamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AA57 Diphenylpyralin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AB Substituierte Alkylamine WHO Anatomical Therapeutic Chemical classification 0‑L R06AB01 Brompheniramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AB02 Dexchlorpheniramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AB03 Dimetinden WHO Anatomical Therapeutic Chemical classification 0‑L R06AB04 Chlorphenamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AB05 Pheniramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AB06 Dexbrompheniramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AB07 Talastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AB51 Brompheniramin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AB52 Dexchlorpheniramin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AB54 Chlorphenamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AB56 Dexbrompheniramin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AC Substituierte Ethylendiamine WHO Anatomical Therapeutic Chemical classification 0‑L R06AC01 Mepyramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AC02 Histapyrrodin WHO Anatomical Therapeutic Chemical classification 0‑L R06AC03 Chloropyramin WHO Anatomical Therapeutic Chemical classification 0‑L R06AC04 Tripelennamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AC05 Methapyrilen WHO Anatomical Therapeutic Chemical classification 0‑L R06AC06 Thonzylamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AC52 Histapyrrodin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AC53 Chloropyramin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AD Phenothiazin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L R06AD01 Alimemazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD02 Promethazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD03 Thiethylperazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD04 Methdilazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD05 Hydroxyethylpromethazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD06 Thiazinam WHO Anatomical Therapeutic Chemical classification 0‑L R06AD07 Mequitazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD08 Oxomemazin WHO Anatomical Therapeutic Chemical classification 0‑L R06AD09 Isothipendyl WHO Anatomical Therapeutic Chemical classification 0‑L R06AD52 Promethazin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AD55 Hydroxyethylpromethazin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AE Piperazin-Derivate WHO Anatomical Therapeutic Chemical classification 0‑L R06AE01 Buclizin WHO Anatomical Therapeutic Chemical classification 0‑L R06AE03 Cyclizin WHO Anatomical Therapeutic Chemical classification 0‑L R06AE04 Chlorcyclizin WHO Anatomical Therapeutic Chemical classification 0‑L R06AE05 Meclozin WHO Anatomical Therapeutic Chemical classification 0‑L R06AE06 Oxatomid WHO Anatomical Therapeutic Chemical classification 0‑L R06AE07 Cetirizin WHO Anatomical Therapeutic Chemical classification 0‑L R06AE09 Levocetirizin WHO Anatomical Therapeutic Chemical classification 0‑L R06AE51 Buclizin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AE53 Cyclizin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AE55 Meclozin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AK Kombinationen von Antihistaminika WHO Anatomical Therapeutic Chemical classification 0‑L R06AX Andere Antihistaminika zur systemischen Anwendung WHO Anatomical Therapeutic Chemical classification 0‑L R06AX01 Bamipin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX02 Cyproheptadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX03 Thenalidin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX04 Phenindamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX05 Antazolin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX07 Triprolidin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX08 Pyrrobutamin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX09 Azatadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX11 Astemizol WHO Anatomical Therapeutic Chemical classification 0‑L R06AX12 Terfenadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX13 Loratadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX15 Mebhydrolin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX16 Deptropin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX17 Ketotifen WHO Anatomical Therapeutic Chemical classification 0‑L R06AX18 Acrivastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX19 Azelastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX21 Tritoqualin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX22 Ebastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX23 Pimethixen WHO Anatomical Therapeutic Chemical classification 0‑L R06AX24 Epinastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX25 Mizolastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX26 Fexofenadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX27 Desloratadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX28 Rupatadin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX29 Bilastin WHO Anatomical Therapeutic Chemical classification 0‑L R06AX53 Thenalidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R06AX58 Pyrrobutamin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R07 Andere Mittel für den Respirationstrakt WHO Anatomical Therapeutic Chemical classification 0‑L R07A Andere Mittel für den Respirationstrakt WHO Anatomical Therapeutic Chemical classification 0‑L R07AA Surfactant-Präparate WHO Anatomical Therapeutic Chemical classification 0‑L R07AA01 Colfoscerilpalmitat WHO Anatomical Therapeutic Chemical classification 0‑L R07AA02 Natürliche Phospholipide WHO Anatomical Therapeutic Chemical classification 0‑L R07AA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R07AB Atemstimulanzien WHO Anatomical Therapeutic Chemical classification 0‑L R07AB01 Doxapram WHO Anatomical Therapeutic Chemical classification 0‑L R07AB02 Nikethamid WHO Anatomical Therapeutic Chemical classification 0‑L R07AB03 Pentetrazol WHO Anatomical Therapeutic Chemical classification 0‑L R07AB04 Etamivan WHO Anatomical Therapeutic Chemical classification 0‑L R07AB05 Bemegrid WHO Anatomical Therapeutic Chemical classification 0‑L R07AB06 Prethcamid WHO Anatomical Therapeutic Chemical classification 0‑L R07AB07 Almitrin WHO Anatomical Therapeutic Chemical classification 0‑L R07AB08 Dimeflin WHO Anatomical Therapeutic Chemical classification 0‑L R07AB09 Mepixanox WHO Anatomical Therapeutic Chemical classification 0‑L R07AB52 Nikethamid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R07AB53 Pentetrazol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L R07AX Andere Mittel für den Respirationstrakt WHO Anatomical Therapeutic Chemical classification 0‑L R07AX01 Stickoxid WHO Anatomical Therapeutic Chemical classification 0‑L S Sinnesorgane WHO Anatomical Therapeutic Chemical classification 0‑L S01 Ophthalmika WHO Anatomical Therapeutic Chemical classification 0‑L S01A Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01AA Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L S01AA01 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L S01AA02 Chlortetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA03 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA04 Oxytetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA05 Tyrothricin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA07 Framycetin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA09 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA10 Natamycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA11 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA12 Tobramycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA13 Fusidinsäure WHO Anatomical Therapeutic Chemical classification 0‑L S01AA14 Benzylpenicillin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA15 Dihydrostreptomycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA16 Rifamycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA17 Erythromycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA18 Polymyxin B WHO Anatomical Therapeutic Chemical classification 0‑L S01AA19 Ampicillin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA20 Antibiotika in Kombination mit anderen Mitteln WHO Anatomical Therapeutic Chemical classification 0‑L S01AA21 Amikacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA22 Micronomicin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA23 Netilmicin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA24 Kanamycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA25 Azidamfenicol WHO Anatomical Therapeutic Chemical classification 0‑L S01AA26 Azithromycin WHO Anatomical Therapeutic Chemical classification 0‑L S01AA27 Cefuroxim WHO Anatomical Therapeutic Chemical classification 0‑L S01AA30 Kombinationen von Antibiotika WHO Anatomical Therapeutic Chemical classification 0‑L S01AB Sulfonamide WHO Anatomical Therapeutic Chemical classification 0‑L S01AB01 Sulfamethizol WHO Anatomical Therapeutic Chemical classification 0‑L S01AB02 Sulfafurazol WHO Anatomical Therapeutic Chemical classification 0‑L S01AB03 Sulfadicramid WHO Anatomical Therapeutic Chemical classification 0‑L S01AB04 Sulfacetamid WHO Anatomical Therapeutic Chemical classification 0‑L S01AB05 Sulfafenazol WHO Anatomical Therapeutic Chemical classification 0‑L S01AD Antivirale Mittel WHO Anatomical Therapeutic Chemical classification 0‑L S01AD01 Idoxuridin WHO Anatomical Therapeutic Chemical classification 0‑L S01AD02 Trifluridin WHO Anatomical Therapeutic Chemical classification 0‑L S01AD03 Aciclovir WHO Anatomical Therapeutic Chemical classification 0‑L S01AD05 Interferon WHO Anatomical Therapeutic Chemical classification 0‑L S01AD06 Vidarabin WHO Anatomical Therapeutic Chemical classification 0‑L S01AD07 Famciclovir WHO Anatomical Therapeutic Chemical classification 0‑L S01AD08 Fomivirsen WHO Anatomical Therapeutic Chemical classification 0‑L S01AD09 Ganciclovir WHO Anatomical Therapeutic Chemical classification 0‑L S01AE01 Ofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX Andere Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01AX01 Quecksilber-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L S01AX02 Silber-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L S01AX03 Zink-haltige Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L S01AX04 Nitrofural WHO Anatomical Therapeutic Chemical classification 0‑L S01AX05 Bibrocathol WHO Anatomical Therapeutic Chemical classification 0‑L S01AX06 Resorcin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX07 Natriumborat WHO Anatomical Therapeutic Chemical classification 0‑L S01AX08 Hexamidin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX09 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX10 Natriumpropionat WHO Anatomical Therapeutic Chemical classification 0‑L S01AX11 Ofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX12 Norfloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX13 Ciprofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX14 Dibrompropamidin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX15 Propamidin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX16 Picloxydin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX17 Lomefloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX18 Povidon-Iod WHO Anatomical Therapeutic Chemical classification 0‑L S01AX19 Levofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX21 Gatifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01AX22 Moxifloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S01B Antiphlogistika WHO Anatomical Therapeutic Chemical classification 0‑L S01BA Corticosteroide, rein WHO Anatomical Therapeutic Chemical classification 0‑L S01BA01 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L S01BA02 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L S01BA03 Cortison WHO Anatomical Therapeutic Chemical classification 0‑L S01BA04 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L S01BA05 Triamcinolon WHO Anatomical Therapeutic Chemical classification 0‑L S01BA06 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L S01BA07 Fluorometholon WHO Anatomical Therapeutic Chemical classification 0‑L S01BA08 Medryson WHO Anatomical Therapeutic Chemical classification 0‑L S01BA09 Clobetason WHO Anatomical Therapeutic Chemical classification 0‑L S01BA10 Alclometason WHO Anatomical Therapeutic Chemical classification 0‑L S01BA11 Desonid WHO Anatomical Therapeutic Chemical classification 0‑L S01BA12 Formocortal WHO Anatomical Therapeutic Chemical classification 0‑L S01BA13 Rimexolon WHO Anatomical Therapeutic Chemical classification 0‑L S01BA14 Loteprednol WHO Anatomical Therapeutic Chemical classification 0‑L S01BA15 Fluocinolon acetonid WHO Anatomical Therapeutic Chemical classification 0‑L S01BB Corticosteroide und Mydriatika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S01BB01 Hydrocortison und Mydriatika WHO Anatomical Therapeutic Chemical classification 0‑L S01BB02 Prednisolon und Mydriatika WHO Anatomical Therapeutic Chemical classification 0‑L S01BB03 Fluorometholon und Mydriatika WHO Anatomical Therapeutic Chemical classification 0‑L S01BB04 Betamethason und Mydriatika WHO Anatomical Therapeutic Chemical classification 0‑L S01BC Nichtsteroidale Antiphlogistika WHO Anatomical Therapeutic Chemical classification 0‑L S01BC01 Indometacin WHO Anatomical Therapeutic Chemical classification 0‑L S01BC02 Oxyphenbutazon WHO Anatomical Therapeutic Chemical classification 0‑L S01BC03 Diclofenac WHO Anatomical Therapeutic Chemical classification 0‑L S01BC04 Flurbiprofen WHO Anatomical Therapeutic Chemical classification 0‑L S01BC05 Ketorolac WHO Anatomical Therapeutic Chemical classification 0‑L S01BC06 Piroxicam WHO Anatomical Therapeutic Chemical classification 0‑L S01BC07 Bendazac WHO Anatomical Therapeutic Chemical classification 0‑L S01BC08 Salicylsäure WHO Anatomical Therapeutic Chemical classification 0‑L S01BC09 Pranoprofen WHO Anatomical Therapeutic Chemical classification 0‑L S01BC10 Nepafenac WHO Anatomical Therapeutic Chemical classification 0‑L S01BC11 Bromfenac WHO Anatomical Therapeutic Chemical classification 0‑L S01C Antiphlogistika und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S01CA Corticosteroide und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S01CA01 Dexamethason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA02 Prednisolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA03 Hydrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA04 Fluocortolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA05 Betamethason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA06 Fludrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA07 Fluorometholon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA08 Methylprednisolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA09 Chlorprednison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA10 Fluocinolonacetonid und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CA11 Clobetason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01CB Corticosteroide/Antiinfektiva/Mydriatika in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S01CB01 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L S01CB02 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L S01CB03 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L S01CB04 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L S01CB05 Fluorometholon WHO Anatomical Therapeutic Chemical classification 0‑L S01CC Nichtsteroidale Antiphlogistika und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S01CC01 Diclofenac und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S01E Glaukommittel und Miotika WHO Anatomical Therapeutic Chemical classification 0‑L S01EA Sympathomimetika in der Glaukomtherapie WHO Anatomical Therapeutic Chemical classification 0‑L S01EA01 Epinephrin WHO Anatomical Therapeutic Chemical classification 0‑L S01EA02 Dipivefrin WHO Anatomical Therapeutic Chemical classification 0‑L S01EA03 Apraclonidin WHO Anatomical Therapeutic Chemical classification 0‑L S01EA04 Clonidin WHO Anatomical Therapeutic Chemical classification 0‑L S01EA05 Brimonidin WHO Anatomical Therapeutic Chemical classification 0‑L S01EA51 Epinephrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01EB Parasympathomimetika WHO Anatomical Therapeutic Chemical classification 0‑L S01EB01 Pilocarpin WHO Anatomical Therapeutic Chemical classification 0‑L S01EB02 Carbachol WHO Anatomical Therapeutic Chemical classification 0‑L S01EB03 Ecothiopat WHO Anatomical Therapeutic Chemical classification 0‑L S01EB04 Demecarium WHO Anatomical Therapeutic Chemical classification 0‑L S01EB05 Physostigmin WHO Anatomical Therapeutic Chemical classification 0‑L S01EB06 Neostigmin WHO Anatomical Therapeutic Chemical classification 0‑L S01EB07 Fluostigmin WHO Anatomical Therapeutic Chemical classification 0‑L S01EB08 Aceclidin WHO Anatomical Therapeutic Chemical classification 0‑L S01EB09 Acetylcholin WHO Anatomical Therapeutic Chemical classification 0‑L S01EB10 Paraoxon WHO Anatomical Therapeutic Chemical classification 0‑L S01EB51 Pilocarpin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01EB58 Aceclidin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01EC Carboanhydrasehemmer WHO Anatomical Therapeutic Chemical classification 0‑L S01EC01 Acetazolamid WHO Anatomical Therapeutic Chemical classification 0‑L S01EC02 Diclofenamid WHO Anatomical Therapeutic Chemical classification 0‑L S01EC03 Dorzolamid WHO Anatomical Therapeutic Chemical classification 0‑L S01EC04 Brinzolamid WHO Anatomical Therapeutic Chemical classification 0‑L S01EC05 Methazolamid WHO Anatomical Therapeutic Chemical classification 0‑L S01ED Beta-Adrenorezeptor-Antagonisten WHO Anatomical Therapeutic Chemical classification 0‑L S01ED01 Timolol WHO Anatomical Therapeutic Chemical classification 0‑L S01ED02 Betaxolol WHO Anatomical Therapeutic Chemical classification 0‑L S01ED03 Levobunolol WHO Anatomical Therapeutic Chemical classification 0‑L S01ED04 Metipranolol WHO Anatomical Therapeutic Chemical classification 0‑L S01ED05 Carteolol WHO Anatomical Therapeutic Chemical classification 0‑L S01ED06 Befunolol WHO Anatomical Therapeutic Chemical classification 0‑L S01ED51 Timolol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01ED52 Betaxolol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01ED54 Metipranolol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01ED55 Carteolol, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01EE Prostaglandin-Analoga WHO Anatomical Therapeutic Chemical classification 0‑L S01EE01 Latanoprost WHO Anatomical Therapeutic Chemical classification 0‑L S01EE02 Unoproston WHO Anatomical Therapeutic Chemical classification 0‑L S01EE03 Bimatoprost WHO Anatomical Therapeutic Chemical classification 0‑L S01EE04 Travoprost WHO Anatomical Therapeutic Chemical classification 0‑L S01EE05 Tafluprost WHO Anatomical Therapeutic Chemical classification 0‑L S01EX Andere Glaukommittel WHO Anatomical Therapeutic Chemical classification 0‑L S01EX01 Guanethidin WHO Anatomical Therapeutic Chemical classification 0‑L S01EX02 Dapiprazol WHO Anatomical Therapeutic Chemical classification 0‑L S01F Mydriatika und Zykloplegika WHO Anatomical Therapeutic Chemical classification 0‑L S01FA Anticholinergika WHO Anatomical Therapeutic Chemical classification 0‑L S01FA01 Atropin WHO Anatomical Therapeutic Chemical classification 0‑L S01FA02 Scopolamin WHO Anatomical Therapeutic Chemical classification 0‑L S01FA03 Methylscopolamin WHO Anatomical Therapeutic Chemical classification 0‑L S01FA04 Cyclopentolat WHO Anatomical Therapeutic Chemical classification 0‑L S01FA05 Homatropin WHO Anatomical Therapeutic Chemical classification 0‑L S01FA06 Tropicamid WHO Anatomical Therapeutic Chemical classification 0‑L S01FA56 Tropicamid, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01FB Sympathomimetika, exkl. Glaukommittel WHO Anatomical Therapeutic Chemical classification 0‑L S01FB01 Phenylephrin WHO Anatomical Therapeutic Chemical classification 0‑L S01FB02 Ephedrin WHO Anatomical Therapeutic Chemical classification 0‑L S01FB03 Ibopamin WHO Anatomical Therapeutic Chemical classification 0‑L S01G Dekongestiva und Antiallergika WHO Anatomical Therapeutic Chemical classification 0‑L S01GA Sympathomimetika als Dekongestiva WHO Anatomical Therapeutic Chemical classification 0‑L S01GA01 Naphazolin WHO Anatomical Therapeutic Chemical classification 0‑L S01GA02 Tetryzolin WHO Anatomical Therapeutic Chemical classification 0‑L S01GA03 Xylometazolin WHO Anatomical Therapeutic Chemical classification 0‑L S01GA04 Oxymetazolin WHO Anatomical Therapeutic Chemical classification 0‑L S01GA05 Phenylephrin WHO Anatomical Therapeutic Chemical classification 0‑L S01GA06 Oxedrin WHO Anatomical Therapeutic Chemical classification 0‑L S01GA51 Naphazolin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01GA52 Tetryzolin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01GA53 Xylometazolin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01GA55 Phenylephrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01GA56 Oxedrin, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01GX Andere Antiallergika WHO Anatomical Therapeutic Chemical classification 0‑L S01GX01 Cromoglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L S01GX02 Levocabastin WHO Anatomical Therapeutic Chemical classification 0‑L S01GX03 Spagluminsäure WHO Anatomical Therapeutic Chemical classification 0‑L S01GX04 Nedocromil WHO Anatomical Therapeutic Chemical classification 0‑L S01GX05 Lodoxamid WHO Anatomical Therapeutic Chemical classification 0‑L S01GX06 Emedastin WHO Anatomical Therapeutic Chemical classification 0‑L S01GX07 Azelastin WHO Anatomical Therapeutic Chemical classification 0‑L S01GX08 Ketotifen WHO Anatomical Therapeutic Chemical classification 0‑L S01GX09 Olopatadin WHO Anatomical Therapeutic Chemical classification 0‑L S01GX10 Epinastin WHO Anatomical Therapeutic Chemical classification 0‑L S01GX51 Cromoglicinsäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01H Lokalanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L S01HA Lokalanästhetika WHO Anatomical Therapeutic Chemical classification 0‑L S01HA01 Cocain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA02 Oxybuprocain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA03 Tetracain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA04 Proxymetacain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA05 Procain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA06 Cinchocain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA07 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L S01HA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01J Diagnostika WHO Anatomical Therapeutic Chemical classification 0‑L S01JA Farbstoffe WHO Anatomical Therapeutic Chemical classification 0‑L S01JA01 Fluorescein WHO Anatomical Therapeutic Chemical classification 0‑L S01JA02 Bengalrosa-Natrium WHO Anatomical Therapeutic Chemical classification 0‑L S01JA51 Fluorescein, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01JX Andere ophthalmologische Diagnostika WHO Anatomical Therapeutic Chemical classification 0‑L S01K Chirurgische Hilfsmittel WHO Anatomical Therapeutic Chemical classification 0‑L S01KA Viskoelastische Substanzen WHO Anatomical Therapeutic Chemical classification 0‑L S01KA01 Hyaluronsäure WHO Anatomical Therapeutic Chemical classification 0‑L S01KA02 Hypromellose WHO Anatomical Therapeutic Chemical classification 0‑L S01KA51 Hyaluronsäure, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S01KX Andere chirurgische Hilfsmittel WHO Anatomical Therapeutic Chemical classification 0‑L S01KX01 Chymotrypsin WHO Anatomical Therapeutic Chemical classification 0‑L S01L Mittel gegen vaskuläre Augenerkrankungen WHO Anatomical Therapeutic Chemical classification 0‑L S01LA Antineovaskuläre Mittel WHO Anatomical Therapeutic Chemical classification 0‑L S01LA01 Verteporfin WHO Anatomical Therapeutic Chemical classification 0‑L S01LA02 Anecortav WHO Anatomical Therapeutic Chemical classification 0‑L S01LA03 Pegaptanib WHO Anatomical Therapeutic Chemical classification 0‑L S01LA04 Ranibizumab WHO Anatomical Therapeutic Chemical classification 0‑L S01X Andere Ophthalmika WHO Anatomical Therapeutic Chemical classification 0‑L S01XA Andere Ophthalmika WHO Anatomical Therapeutic Chemical classification 0‑L S01XA01 Guajazulen WHO Anatomical Therapeutic Chemical classification 0‑L S01XA02 Retinol WHO Anatomical Therapeutic Chemical classification 0‑L S01XA03 Natriumchlorid, hyperton WHO Anatomical Therapeutic Chemical classification 0‑L S01XA04 Kaliumiodid WHO Anatomical Therapeutic Chemical classification 0‑L S01XA05 Natriumedetat WHO Anatomical Therapeutic Chemical classification 0‑L S01XA06 Ethylmorphin WHO Anatomical Therapeutic Chemical classification 0‑L S01XA07 Alaun WHO Anatomical Therapeutic Chemical classification 0‑L S01XA08 Acetylcystein WHO Anatomical Therapeutic Chemical classification 0‑L S01XA09 Iodoheparinat WHO Anatomical Therapeutic Chemical classification 0‑L S01XA10 Inosin WHO Anatomical Therapeutic Chemical classification 0‑L S01XA11 Nandrolon WHO Anatomical Therapeutic Chemical classification 0‑L S01XA12 Dexpanthenol WHO Anatomical Therapeutic Chemical classification 0‑L S01XA13 Alteplase WHO Anatomical Therapeutic Chemical classification 0‑L S01XA14 Heparin WHO Anatomical Therapeutic Chemical classification 0‑L S01XA15 Ascorbinsäure WHO Anatomical Therapeutic Chemical classification 0‑L S01XA20 Künstliche Tränen und andere indifferente Mittel WHO Anatomical Therapeutic Chemical classification 0‑L S02 Otologika WHO Anatomical Therapeutic Chemical classification 0‑L S02A Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02AA Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02AA01 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L S02AA02 Nitrofural WHO Anatomical Therapeutic Chemical classification 0‑L S02AA03 Borsäure WHO Anatomical Therapeutic Chemical classification 0‑L S02AA04 Aluminiumacetattartrat WHO Anatomical Therapeutic Chemical classification 0‑L S02AA05 Clioquinol WHO Anatomical Therapeutic Chemical classification 0‑L S02AA06 Hydrogenperoxid WHO Anatomical Therapeutic Chemical classification 0‑L S02AA07 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA08 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA09 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA10 Essigsäure WHO Anatomical Therapeutic Chemical classification 0‑L S02AA11 Polymyxin B WHO Anatomical Therapeutic Chemical classification 0‑L S02AA12 Rifamycin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA13 Miconazol WHO Anatomical Therapeutic Chemical classification 0‑L S02AA14 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA15 Ciprofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA16 Ofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S02AA30 Antiinfektiva, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S02B Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L S02BA Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L S02BA01 Hydrocortison WHO Anatomical Therapeutic Chemical classification 0‑L S02BA03 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L S02BA06 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L S02BA07 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L S02C Corticosteroide und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S02CA Corticosteroide und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S02CA01 Prednisolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02CA02 Flumetason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02CA03 Hydrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02CA04 Triamcinolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02CA05 Fluocinolonacetonid und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02CA06 Dexamethason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02CA07 Fludrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S02D Andere Otologika WHO Anatomical Therapeutic Chemical classification 0‑L S02DA Analgetika und Anästhetika WHO Anatomical Therapeutic Chemical classification 0‑L S02DA01 Lidocain WHO Anatomical Therapeutic Chemical classification 0‑L S02DA02 Cocain WHO Anatomical Therapeutic Chemical classification 0‑L S02DA30 Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S02DC Indifferente Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L S03 Ophthalmologische und otologische Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L S03A Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03AA Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03AA01 Neomycin WHO Anatomical Therapeutic Chemical classification 0‑L S03AA02 Tetracyclin WHO Anatomical Therapeutic Chemical classification 0‑L S03AA03 Polymyxin B WHO Anatomical Therapeutic Chemical classification 0‑L S03AA04 Chlorhexidin WHO Anatomical Therapeutic Chemical classification 0‑L S03AA05 Hexamidin WHO Anatomical Therapeutic Chemical classification 0‑L S03AA06 Gentamicin WHO Anatomical Therapeutic Chemical classification 0‑L S03AA07 Ciprofloxacin WHO Anatomical Therapeutic Chemical classification 0‑L S03AA08 Chloramphenicol WHO Anatomical Therapeutic Chemical classification 0‑L S03AA30 Antiinfektiva, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L S03B Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L S03BA Corticosteroide WHO Anatomical Therapeutic Chemical classification 0‑L S03BA01 Dexamethason WHO Anatomical Therapeutic Chemical classification 0‑L S03BA02 Prednisolon WHO Anatomical Therapeutic Chemical classification 0‑L S03BA03 Betamethason WHO Anatomical Therapeutic Chemical classification 0‑L S03C Corticosteroide und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S03CA Corticosteroide und Antiinfektiva in Kombination WHO Anatomical Therapeutic Chemical classification 0‑L S03CA01 Dexamethason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03CA02 Prednisolon und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03CA04 Hydrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03CA05 Fludrocortison und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03CA06 Betamethason und Antiinfektiva WHO Anatomical Therapeutic Chemical classification 0‑L S03D Andere ophthalmologische und otologische Zubereitungen WHO Anatomical Therapeutic Chemical classification 0‑L V Varia WHO Anatomical Therapeutic Chemical classification 0‑L V01 Allergene WHO Anatomical Therapeutic Chemical classification 0‑L V01A Allergene WHO Anatomical Therapeutic Chemical classification 0‑L V01AA Allergen-Extrakte WHO Anatomical Therapeutic Chemical classification 0‑L V01AA01 Federn WHO Anatomical Therapeutic Chemical classification 0‑L V01AA02 Gräserpollen WHO Anatomical Therapeutic Chemical classification 0‑L V01AA03 Hausstaub WHO Anatomical Therapeutic Chemical classification 0‑L V01AA04 Schimmel- und Hefepilze WHO Anatomical Therapeutic Chemical classification 0‑L V01AA05 Baumpollen WHO Anatomical Therapeutic Chemical classification 0‑L V01AA07 Insekten WHO Anatomical Therapeutic Chemical classification 0‑L V01AA08 Nahrungsmittel WHO Anatomical Therapeutic Chemical classification 0‑L V01AA09 Textilien WHO Anatomical Therapeutic Chemical classification 0‑L V01AA10 Blüten WHO Anatomical Therapeutic Chemical classification 0‑L V01AA11 Tiere WHO Anatomical Therapeutic Chemical classification 0‑L V01AA20 Verschiedene WHO Anatomical Therapeutic Chemical classification 0‑L V02 Immunosupressive agents WHO Anatomical Therapeutic Chemical classification 0‑L V02C Immunosupressive agents WHO Anatomical Therapeutic Chemical classification 0‑L V02CA Selective immunosuppressive agents WHO Anatomical Therapeutic Chemical classification 0‑L V03 Alle übrigen therapeutischen Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V03A Alle übrigen therapeutischen Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V03AA Drugs for treatment on chronic alcoholism WHO Anatomical Therapeutic Chemical classification 0‑L V03AB Antidote WHO Anatomical Therapeutic Chemical classification 0‑L V03AB01 Ipecacuanha WHO Anatomical Therapeutic Chemical classification 0‑L V03AB02 Nalorphin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB03 Edetate WHO Anatomical Therapeutic Chemical classification 0‑L V03AB04 Pralidoxim WHO Anatomical Therapeutic Chemical classification 0‑L V03AB05 Prednisolon und Promethazin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB06 Thiosulfat WHO Anatomical Therapeutic Chemical classification 0‑L V03AB08 Natriumnitrit WHO Anatomical Therapeutic Chemical classification 0‑L V03AB09 Dimercaprol WHO Anatomical Therapeutic Chemical classification 0‑L V03AB13 Obidoxim WHO Anatomical Therapeutic Chemical classification 0‑L V03AB14 Protamin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB15 Naloxon WHO Anatomical Therapeutic Chemical classification 0‑L V03AB16 Ethanol WHO Anatomical Therapeutic Chemical classification 0‑L V03AB17 Methylthioniniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L V03AB18 Kaliumpermanganat WHO Anatomical Therapeutic Chemical classification 0‑L V03AB19 Physostigmin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB20 Kupfersulfat WHO Anatomical Therapeutic Chemical classification 0‑L V03AB21 Kaliumiodid WHO Anatomical Therapeutic Chemical classification 0‑L V03AB22 Amylnitrit WHO Anatomical Therapeutic Chemical classification 0‑L V03AB23 Acetylcystein WHO Anatomical Therapeutic Chemical classification 0‑L V03AB24 Digitalis-Antitoxin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB25 Flumazenil WHO Anatomical Therapeutic Chemical classification 0‑L V03AB26 Methionin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB27 4-Dimethylaminophenol WHO Anatomical Therapeutic Chemical classification 0‑L V03AB29 Cholinesterase WHO Anatomical Therapeutic Chemical classification 0‑L V03AB31 Eisen(III)hexacyanoferrat(II) WHO Anatomical Therapeutic Chemical classification 0‑L V03AB32 Glutathion WHO Anatomical Therapeutic Chemical classification 0‑L V03AB33 Hydroxocobalamin WHO Anatomical Therapeutic Chemical classification 0‑L V03AB34 Fomepizol WHO Anatomical Therapeutic Chemical classification 0‑L V03AB35 Sugammadex WHO Anatomical Therapeutic Chemical classification 0‑L V03AC Eisen-Chelatbildner WHO Anatomical Therapeutic Chemical classification 0‑L V03AC01 Deferoxamin WHO Anatomical Therapeutic Chemical classification 0‑L V03AC02 Deferipron WHO Anatomical Therapeutic Chemical classification 0‑L V03AC03 Deferasirox WHO Anatomical Therapeutic Chemical classification 0‑L V03AE Mittel zur Behandlung der Hyperkaliämie und Hyperphosphatämie WHO Anatomical Therapeutic Chemical classification 0‑L V03AE01 Polystyrolsulfonat WHO Anatomical Therapeutic Chemical classification 0‑L V03AE02 Sevelamer WHO Anatomical Therapeutic Chemical classification 0‑L V03AE03 Lanthan(III)-carbonat WHO Anatomical Therapeutic Chemical classification 0‑L V03AE04 Calciumacetat und Mangesiumcarbonat WHO Anatomical Therapeutic Chemical classification 0‑L V03AF Entgiftungsmittel für die Behandlung mit Zytostatika WHO Anatomical Therapeutic Chemical classification 0‑L V03AF01 Mesna WHO Anatomical Therapeutic Chemical classification 0‑L V03AF02 Dexrazoxan WHO Anatomical Therapeutic Chemical classification 0‑L V03AF03 Calciumfolinat WHO Anatomical Therapeutic Chemical classification 0‑L V03AF04 Calciumlevofolinat WHO Anatomical Therapeutic Chemical classification 0‑L V03AF05 Amifostin WHO Anatomical Therapeutic Chemical classification 0‑L V03AF06 Natriumfolinat WHO Anatomical Therapeutic Chemical classification 0‑L V03AF07 Rasburicase WHO Anatomical Therapeutic Chemical classification 0‑L V03AF08 Palifermin WHO Anatomical Therapeutic Chemical classification 0‑L V03AF09 Glucarpidase WHO Anatomical Therapeutic Chemical classification 0‑L V03AG Mittel zur Behandlung der Hyperkalzämie WHO Anatomical Therapeutic Chemical classification 0‑L V03AG01 Natriumcellulosephosphat WHO Anatomical Therapeutic Chemical classification 0‑L V03AH Mittel zur Behandlung der Hypoglykämie WHO Anatomical Therapeutic Chemical classification 0‑L V03AH01 Diazoxid WHO Anatomical Therapeutic Chemical classification 0‑L V03AK Gewebekleber WHO Anatomical Therapeutic Chemical classification 0‑L V03AM Mittel zur Embolisation WHO Anatomical Therapeutic Chemical classification 0‑L V03AN Medizinische Gase WHO Anatomical Therapeutic Chemical classification 0‑L V03AN01 Sauerstoff WHO Anatomical Therapeutic Chemical classification 0‑L V03AN02 Kohlendioxid WHO Anatomical Therapeutic Chemical classification 0‑L V03AN03 Helium WHO Anatomical Therapeutic Chemical classification 0‑L V03AN04 Stickstoff WHO Anatomical Therapeutic Chemical classification 0‑L V03AN05 Medizinische Luft WHO Anatomical Therapeutic Chemical classification 0‑L V03AX Andere therapeutische Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V03AZ Nerven dämpfende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V03AZ01 Ethanol WHO Anatomical Therapeutic Chemical classification 0‑L V04 Diagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V04AX Other contrast media WHO Anatomical Therapeutic Chemical classification 0‑L V04B Urin-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04C Andere Diagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V04CA Diabetes-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CA01 Tolbutamid WHO Anatomical Therapeutic Chemical classification 0‑L V04CA02 Glucose WHO Anatomical Therapeutic Chemical classification 0‑L V04CB Fettabsorptions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CB01 Vitamin-A-Konzentrate WHO Anatomical Therapeutic Chemical classification 0‑L V04CC Gallenfluss-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CC01 Sorbitol WHO Anatomical Therapeutic Chemical classification 0‑L V04CC02 Magnesiumsulfat WHO Anatomical Therapeutic Chemical classification 0‑L V04CC03 Sincalid WHO Anatomical Therapeutic Chemical classification 0‑L V04CC04 Ceruletid WHO Anatomical Therapeutic Chemical classification 0‑L V04CD Hypophysenfunktions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CD01 Metyrapon WHO Anatomical Therapeutic Chemical classification 0‑L V04CD03 Sermorelin WHO Anatomical Therapeutic Chemical classification 0‑L V04CD04 Corticoliberin WHO Anatomical Therapeutic Chemical classification 0‑L V04CD05 Somatorelin WHO Anatomical Therapeutic Chemical classification 0‑L V04CE Leberfunktions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CE01 Galactose WHO Anatomical Therapeutic Chemical classification 0‑L V04CE02 Bromsulfalein WHO Anatomical Therapeutic Chemical classification 0‑L V04CF Tuberkulose-Diagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V04CF01 Tuberkulin WHO Anatomical Therapeutic Chemical classification 0‑L V04CG Magensäuresekretions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CG01 Kationenaustauscherharze WHO Anatomical Therapeutic Chemical classification 0‑L V04CG02 Betazol WHO Anatomical Therapeutic Chemical classification 0‑L V04CG03 Histaminphosphat WHO Anatomical Therapeutic Chemical classification 0‑L V04CG04 Pentagastrin WHO Anatomical Therapeutic Chemical classification 0‑L V04CG05 Methylthioniniumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L V04CG30 Coffein und Natriumbenzoat WHO Anatomical Therapeutic Chemical classification 0‑L V04CH Nierenfunktions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CH01 Inulin und andere Polyfructosane WHO Anatomical Therapeutic Chemical classification 0‑L V04CH02 Indigokarmin WHO Anatomical Therapeutic Chemical classification 0‑L V04CH03 Phenolsulfonphthalein WHO Anatomical Therapeutic Chemical classification 0‑L V04CH04 Alsactid WHO Anatomical Therapeutic Chemical classification 0‑L V04CH30 Aminohippursäure WHO Anatomical Therapeutic Chemical classification 0‑L V04CJ Schilddrüsenfunktions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CJ01 Thyrotropin WHO Anatomical Therapeutic Chemical classification 0‑L V04CJ02 Protirelin WHO Anatomical Therapeutic Chemical classification 0‑L V04CK Pankreasfunktions-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CK01 Sekretin WHO Anatomical Therapeutic Chemical classification 0‑L V04CK02 Pankreozymin (Cholecystokinin) WHO Anatomical Therapeutic Chemical classification 0‑L V04CK03 Bentiromid WHO Anatomical Therapeutic Chemical classification 0‑L V04CL Allergie-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CM Fertilitäts-Tests WHO Anatomical Therapeutic Chemical classification 0‑L V04CM01 Gonadorelin WHO Anatomical Therapeutic Chemical classification 0‑L V04CX Andere Diagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V04D Diagnostic radiopharmaceuticals WHO Anatomical Therapeutic Chemical classification 0‑L V06 Allgemeine Diätetika WHO Anatomical Therapeutic Chemical classification 0‑L V06A Diätetika zur Behandlung der Adipositas WHO Anatomical Therapeutic Chemical classification 0‑L V06AA Niedrigkalorische Diäten WHO Anatomical Therapeutic Chemical classification 0‑L V06B Proteinzusatznahrung WHO Anatomical Therapeutic Chemical classification 0‑L V06C Säuglingsnahrung WHO Anatomical Therapeutic Chemical classification 0‑L V06CA Diätetika ohne Phenylalanin WHO Anatomical Therapeutic Chemical classification 0‑L V06D Andere Diätetika WHO Anatomical Therapeutic Chemical classification 0‑L V06DA Kohlenhydrate/Proteine/Mineralstoffe/Vitamine, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L V06DB Fette/Kohlenhydrate/Proteine/Mineralstoffe/Vitamine, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L V06DC Kohlenhydrate WHO Anatomical Therapeutic Chemical classification 0‑L V06DC01 Glucose WHO Anatomical Therapeutic Chemical classification 0‑L V06DC02 Fructose WHO Anatomical Therapeutic Chemical classification 0‑L V06DD Aminosäuren, inkl. Kombination mit Polypeptiden WHO Anatomical Therapeutic Chemical classification 0‑L V06DE Aminosäuren/Kohlenhydrate/Mineralstoffe/Vitamine, Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L V06DF Milchersatzstoffe WHO Anatomical Therapeutic Chemical classification 0‑L V06DX Andere Diätetika-Kombinationen WHO Anatomical Therapeutic Chemical classification 0‑L V07 Alle übrigen nichttherapeutischen Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V07A Alle übrigen nichttherapeutischen Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V07AA Pflaster WHO Anatomical Therapeutic Chemical classification 0‑L V07AB Lösungs- und Verdünnungsmittel, inkl. Spüllösungen WHO Anatomical Therapeutic Chemical classification 0‑L V07AB01 Wasser WHO Anatomical Therapeutic Chemical classification 0‑L V07AB02 Physiologische Kochsalzlösung WHO Anatomical Therapeutic Chemical classification 0‑L V07AC Bluttransfusionen, Hilfsstoffe WHO Anatomical Therapeutic Chemical classification 0‑L V07AD Blut-Tests, Hilfsmittel WHO Anatomical Therapeutic Chemical classification 0‑L V07AN Inkontinenz-Artikel WHO Anatomical Therapeutic Chemical classification 0‑L V07AR Sensitivitäts-Tests, Plättchen und Tabletten WHO Anatomical Therapeutic Chemical classification 0‑L V07AS Stoma-Artikel WHO Anatomical Therapeutic Chemical classification 0‑L V07AT Kosmetika WHO Anatomical Therapeutic Chemical classification 0‑L V07AV Technische Desinfektionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L V07AX Waschsubstanzen etc. WHO Anatomical Therapeutic Chemical classification 0‑L V07AY Andere nichttherapeutische Hilfsmittel WHO Anatomical Therapeutic Chemical classification 0‑L V07AZ Chemikalien und Reagenzien zur Analyse WHO Anatomical Therapeutic Chemical classification 0‑L V08 Kontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08A Röntgenkontrastmittel, Iod-haltig WHO Anatomical Therapeutic Chemical classification 0‑L V08AA Wasserlösliche nephrotrope hochosmolare Röntgenkontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08AA01 Amidotrizoesäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA02 Metrizoesäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA03 Iodamid WHO Anatomical Therapeutic Chemical classification 0‑L V08AA04 Iotalaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA05 Ioxitalaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA06 Ioglicinsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA07 Acetrizoinsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA08 Iocarminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AA09 Methiodal WHO Anatomical Therapeutic Chemical classification 0‑L V08AA10 Diodon WHO Anatomical Therapeutic Chemical classification 0‑L V08AB Wasserlösliche nephrotrope niederosmolare Röntgenkontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08AB01 Metrizamid WHO Anatomical Therapeutic Chemical classification 0‑L V08AB02 Iohexol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB03 Ioxaglinsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AB04 Iopamidol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB05 Iopromid WHO Anatomical Therapeutic Chemical classification 0‑L V08AB06 Iotrolan WHO Anatomical Therapeutic Chemical classification 0‑L V08AB07 Ioversol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB08 Iopentol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB09 Iodixanol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB10 Iomeprol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB11 Iobitridol WHO Anatomical Therapeutic Chemical classification 0‑L V08AB12 Ioxilan WHO Anatomical Therapeutic Chemical classification 0‑L V08AC Wasserlösliche hepatotrope Röntgenkontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08AC01 Iodoxaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC02 Iotroxinsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC03 Ioglycaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC04 Adipiodon WHO Anatomical Therapeutic Chemical classification 0‑L V08AC05 Iobenzaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC06 Iopansäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC07 Iocetaminsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC08 Natriumiopodat WHO Anatomical Therapeutic Chemical classification 0‑L V08AC09 Tyropansäure WHO Anatomical Therapeutic Chemical classification 0‑L V08AC10 Calciumiopodat WHO Anatomical Therapeutic Chemical classification 0‑L V08AD Wasserunlösliche Röntgenkontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08AD01 Ethylester iodierter Fettsäuren WHO Anatomical Therapeutic Chemical classification 0‑L V08AD02 Iopydol WHO Anatomical Therapeutic Chemical classification 0‑L V08AD03 Propyliodon WHO Anatomical Therapeutic Chemical classification 0‑L V08AD04 Iofendylat WHO Anatomical Therapeutic Chemical classification 0‑L V08B Röntgenkontrastmittel, nicht Iod-haltig WHO Anatomical Therapeutic Chemical classification 0‑L V08BA Bariumsulfat-haltige Röntgenkontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08BA01 Bariumsulfat mit Suspensionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08BA02 Bariumsulfat ohne Suspensionsmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08C Kontrastmittel für die Magnetresonanztomographie WHO Anatomical Therapeutic Chemical classification 0‑L V08CA Paramagnetische Kontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08CA01 Gadopentetsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08CA02 Gadotersäure WHO Anatomical Therapeutic Chemical classification 0‑L V08CA03 Gadodiamid WHO Anatomical Therapeutic Chemical classification 0‑L V08CA04 Gadoteridol WHO Anatomical Therapeutic Chemical classification 0‑L V08CA05 Mangafodipir WHO Anatomical Therapeutic Chemical classification 0‑L V08CA06 Gadoversetamid WHO Anatomical Therapeutic Chemical classification 0‑L V08CA07 Ammoniumeisen(III)citrat WHO Anatomical Therapeutic Chemical classification 0‑L V08CA08 Gadobensäure WHO Anatomical Therapeutic Chemical classification 0‑L V08CA09 Gadobutrol WHO Anatomical Therapeutic Chemical classification 0‑L V08CA10 Gadoxetsäure WHO Anatomical Therapeutic Chemical classification 0‑L V08CA11 Gadofosveset WHO Anatomical Therapeutic Chemical classification 0‑L V08CB Superparamagnetische Kontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08CB01 Ferumoxsil WHO Anatomical Therapeutic Chemical classification 0‑L V08CB02 Ferristen WHO Anatomical Therapeutic Chemical classification 0‑L V08CB03 Eisenoxid, Nanopartikel WHO Anatomical Therapeutic Chemical classification 0‑L V08CX Andere Kontrastmittel für die Magnetresonanztomographie WHO Anatomical Therapeutic Chemical classification 0‑L V08CX01 Perflubron WHO Anatomical Therapeutic Chemical classification 0‑L V08D Ultraschall-Kontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08DA Ultraschall-Kontrastmittel WHO Anatomical Therapeutic Chemical classification 0‑L V08DA01 Humanalbumin-Mikrosphären WHO Anatomical Therapeutic Chemical classification 0‑L V08DA02 Galactose-Mikropartikel WHO Anatomical Therapeutic Chemical classification 0‑L V08DA03 Perflenapent WHO Anatomical Therapeutic Chemical classification 0‑L V08DA04 Phospholipid-Mikrosphären WHO Anatomical Therapeutic Chemical classification 0‑L V08DA05 Schwefelhexafluorid WHO Anatomical Therapeutic Chemical classification 0‑L V09 Radiodiagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V09A Zentrales Nervensystem WHO Anatomical Therapeutic Chemical classification 0‑L V09AA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09AA01 [99mTc]Technetium-Exametazim WHO Anatomical Therapeutic Chemical classification 0‑L V09AA02 [99mTc]Technetiumbicisat WHO Anatomical Therapeutic Chemical classification 0‑L V09AB [123I]Iod-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09AB01 [123I]Iod-Iofetamin WHO Anatomical Therapeutic Chemical classification 0‑L V09AB02 [123I]Iod-Ioloprid WHO Anatomical Therapeutic Chemical classification 0‑L V09AB03 [123I]Iod-Ioflupan WHO Anatomical Therapeutic Chemical classification 0‑L V09AX Andere Radiodiagnostika für das zentrale Nervensystem WHO Anatomical Therapeutic Chemical classification 0‑L V09AX01 [111In]Indiumpentetat WHO Anatomical Therapeutic Chemical classification 0‑L V09B Skelett WHO Anatomical Therapeutic Chemical classification 0‑L V09BA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09BA01 [99mTc]Technetiumoxidronat WHO Anatomical Therapeutic Chemical classification 0‑L V09BA02 [99mTc]Technetiummedronat WHO Anatomical Therapeutic Chemical classification 0‑L V09BA03 [99mTc]Technetiumpyrophosphat WHO Anatomical Therapeutic Chemical classification 0‑L V09BA04 [99mTc]Technetiumbutedronat WHO Anatomical Therapeutic Chemical classification 0‑L V09C Nierensystem WHO Anatomical Therapeutic Chemical classification 0‑L V09CA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09CA01 [99mTc]Technetiumpentetat WHO Anatomical Therapeutic Chemical classification 0‑L V09CA02 [99mTc]Technetium-Succimer WHO Anatomical Therapeutic Chemical classification 0‑L V09CA03 [99mTc]Technetiummertiatid WHO Anatomical Therapeutic Chemical classification 0‑L V09CA04 [99mTc]Technetiumglucoheptonat WHO Anatomical Therapeutic Chemical classification 0‑L V09CA05 [99mTc]Technetiumgluconat WHO Anatomical Therapeutic Chemical classification 0‑L V09CX Andere Radiodiagnostika für das Nierensystem WHO Anatomical Therapeutic Chemical classification 0‑L V09CX01 [123I]Natrium-Iodhippurat WHO Anatomical Therapeutic Chemical classification 0‑L V09CX02 [131I]Natrium-Iodhippurat WHO Anatomical Therapeutic Chemical classification 0‑L V09CX03 [125I]Natrium-Iodthalamat WHO Anatomical Therapeutic Chemical classification 0‑L V09CX04 [51Cr]Chromedetat WHO Anatomical Therapeutic Chemical classification 0‑L V09D Leber- und Retikuloendothelialsystem WHO Anatomical Therapeutic Chemical classification 0‑L V09DA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09DA01 [99mTc]Technetium-Disofenin WHO Anatomical Therapeutic Chemical classification 0‑L V09DA02 [99mTc]Technetium-Etifenin WHO Anatomical Therapeutic Chemical classification 0‑L V09DA03 [99mTc]Technetium-Lidofenin WHO Anatomical Therapeutic Chemical classification 0‑L V09DA04 [99mTc]Technetium-Mebrofenin WHO Anatomical Therapeutic Chemical classification 0‑L V09DA05 [99mTc]Technetium-Galtifenin WHO Anatomical Therapeutic Chemical classification 0‑L V09DB [99mTc]Technetium, Partikel und Kolloide WHO Anatomical Therapeutic Chemical classification 0‑L V09DB01 [99mTc]Technetium-Nanokolloid WHO Anatomical Therapeutic Chemical classification 0‑L V09DB02 [99mTc]Technetium-Mikrokolloid WHO Anatomical Therapeutic Chemical classification 0‑L V09DB03 [99mTc]Technetium-Millimikrosphären WHO Anatomical Therapeutic Chemical classification 0‑L V09DB04 [99mTc]Technetium-Zinn-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V09DB05 [99mTc]Technetium-Schwefel-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V09DB06 [99mTc]Technetium-Rheniumsulfid-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V09DB07 [99mTc]Technetiumphytat WHO Anatomical Therapeutic Chemical classification 0‑L V09DX Andere Radiodiagnostika für das Leber- und Retikuloendothelialsystem WHO Anatomical Therapeutic Chemical classification 0‑L V09DX01 [75Se]Selenium-tauroselcholinat WHO Anatomical Therapeutic Chemical classification 0‑L V09E Respirationstrakt WHO Anatomical Therapeutic Chemical classification 0‑L V09EA [99mTc]Technetium, Inhalate WHO Anatomical Therapeutic Chemical classification 0‑L V09EA01 [99mTc]Technetiumpentetat WHO Anatomical Therapeutic Chemical classification 0‑L V09EA02 [99mTc]Technetium, Technegas WHO Anatomical Therapeutic Chemical classification 0‑L V09EA03 [99mTc]Technetium-Nanokolloid WHO Anatomical Therapeutic Chemical classification 0‑L V09EB [99mTc]Technetium, Partikel zur Injektion WHO Anatomical Therapeutic Chemical classification 0‑L V09EB01 [99mTc]Technetium-Macrosalb WHO Anatomical Therapeutic Chemical classification 0‑L V09EB02 [99mTc]Technetium-Mikrosphären WHO Anatomical Therapeutic Chemical classification 0‑L V09EX Andere Radiodiagnostika für den Respirationstrakt WHO Anatomical Therapeutic Chemical classification 0‑L V09EX01 [81mKr]Kryptongas WHO Anatomical Therapeutic Chemical classification 0‑L V09EX02 [127Xe]Xenongas WHO Anatomical Therapeutic Chemical classification 0‑L V09EX03 [133Xe]Xenongas WHO Anatomical Therapeutic Chemical classification 0‑L V09F Schilddrüse WHO Anatomical Therapeutic Chemical classification 0‑L V09FX Verschiedene Radiodiagnostika für die Schilddrüse WHO Anatomical Therapeutic Chemical classification 0‑L V09FX01 [99mTc]Technetiumpertechnetat WHO Anatomical Therapeutic Chemical classification 0‑L V09FX02 [123I]Natriumiodid WHO Anatomical Therapeutic Chemical classification 0‑L V09FX03 [131I]Natriumiodid WHO Anatomical Therapeutic Chemical classification 0‑L V09G Kardiovaskuläres System WHO Anatomical Therapeutic Chemical classification 0‑L V09GA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09GA01 [99mTc]Technetiumsestamibi WHO Anatomical Therapeutic Chemical classification 0‑L V09GA02 [99mTc]Technetiumtetrofosmin WHO Anatomical Therapeutic Chemical classification 0‑L V09GA03 [99mTc]Technetiumteboroxim WHO Anatomical Therapeutic Chemical classification 0‑L V09GA04 [99mTc]Technetium-Humanalbumin WHO Anatomical Therapeutic Chemical classification 0‑L V09GA05 [99mTc]Technetiumfurifosmin WHO Anatomical Therapeutic Chemical classification 0‑L V09GA06 [99mTc]Technetium-Zinn-markierte Zellen WHO Anatomical Therapeutic Chemical classification 0‑L V09GA07 [99mTc]Technetiumapcitid WHO Anatomical Therapeutic Chemical classification 0‑L V09GB [125I]Iod-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09GB01 [125I]Fibrinogen WHO Anatomical Therapeutic Chemical classification 0‑L V09GB02 [125I]Iod-Humanalbumin WHO Anatomical Therapeutic Chemical classification 0‑L V09GX Andere Radiodiagnostika für das kardiovaskuläre System WHO Anatomical Therapeutic Chemical classification 0‑L V09GX01 [201Tl]Thalliumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L V09GX02 [111In]Indiumimciromab WHO Anatomical Therapeutic Chemical classification 0‑L V09GX03 [51Cr]Chromchromat-markierte Zellen WHO Anatomical Therapeutic Chemical classification 0‑L V09H ENtzündungs- und Infektionserkennung WHO Anatomical Therapeutic Chemical classification 0‑L V09HA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09HA01 [99mTc]Technetium-Humanimmunglobulin WHO Anatomical Therapeutic Chemical classification 0‑L V09HA02 [99mTc]Technetium-Exametazim-markierte Zellen WHO Anatomical Therapeutic Chemical classification 0‑L V09HA03 [99mTc]Technetium-Antigranulozyten-Antikörper WHO Anatomical Therapeutic Chemical classification 0‑L V09HA04 [99mTc]Technetium-Sulesomab WHO Anatomical Therapeutic Chemical classification 0‑L V09HB [111In]Indium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09HB01 [111In]Indiumoxinat-markierte Zellen WHO Anatomical Therapeutic Chemical classification 0‑L V09HB02 [111In]Indiumtropolonat-markierte Zellen WHO Anatomical Therapeutic Chemical classification 0‑L V09HX Andere Radiodiagnostika zur Erkennung von Entzündungen und Infektionen WHO Anatomical Therapeutic Chemical classification 0‑L V09HX01 [67Ga]Galliumcitrat WHO Anatomical Therapeutic Chemical classification 0‑L V09I Tumorerkennung WHO Anatomical Therapeutic Chemical classification 0‑L V09IA [99mTc]Technetium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09IA01 [99mTc]Technetium-Anticarcinoembryoantigen-Antikörper WHO Anatomical Therapeutic Chemical classification 0‑L V09IA02 [99mTc]Technetium-Antimelanom-Antikörper WHO Anatomical Therapeutic Chemical classification 0‑L V09IA03 [99mTc]Technetiumsuccimer, pentavalent WHO Anatomical Therapeutic Chemical classification 0‑L V09IA04 [99mTc]Technetiumvotumumab WHO Anatomical Therapeutic Chemical classification 0‑L V09IA05 [99mTc]Technetiumdepreotid WHO Anatomical Therapeutic Chemical classification 0‑L V09IA06 [99mTc]Technetiumarcitumomab WHO Anatomical Therapeutic Chemical classification 0‑L V09IB [111In]Indium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09IB01 [111In]Indiumpentetreotid WHO Anatomical Therapeutic Chemical classification 0‑L V09IB02 [111In]Indium-Satumomab-pendetid WHO Anatomical Therapeutic Chemical classification 0‑L V09IB03 [111In]Indium-Antiovariumkarzinom-Antikörper WHO Anatomical Therapeutic Chemical classification 0‑L V09IB04 [111In]Indium-Capromab-Pendetid WHO Anatomical Therapeutic Chemical classification 0‑L V09IX Andere Radiodiagnostika zur Tumorerkennung WHO Anatomical Therapeutic Chemical classification 0‑L V09IX01 [123I]Iobenguan WHO Anatomical Therapeutic Chemical classification 0‑L V09IX02 [131I]Iobenguan WHO Anatomical Therapeutic Chemical classification 0‑L V09IX03 [125I]Iod-CC49-Monoklonaler Antikörper WHO Anatomical Therapeutic Chemical classification 0‑L V09IX04 [18F]Fludeoxyglucose WHO Anatomical Therapeutic Chemical classification 0‑L V09IX05 [18F]Fluorodopa WHO Anatomical Therapeutic Chemical classification 0‑L V09IX06 [18F]Natriumfluorid WHO Anatomical Therapeutic Chemical classification 0‑L V09IX07 [18F]Fluormethylcholin WHO Anatomical Therapeutic Chemical classification 0‑L V09X Andere Radiodiagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V09XA [131I]Iod-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V09XA01 [131I]Iodnorcholesterol WHO Anatomical Therapeutic Chemical classification 0‑L V09XA02 [131I]Iodcholesterol WHO Anatomical Therapeutic Chemical classification 0‑L V09XA03 [131I]Iod- Humanalbumin WHO Anatomical Therapeutic Chemical classification 0‑L V09XX Verschiedene Radiodiagnostika WHO Anatomical Therapeutic Chemical classification 0‑L V09XX01 [57Co]Cobaltcyanocobalamin WHO Anatomical Therapeutic Chemical classification 0‑L V09XX02 [58Co]Cobaltcyanocobalamin WHO Anatomical Therapeutic Chemical classification 0‑L V09XX03 [75Se]Selennorcholesterol WHO Anatomical Therapeutic Chemical classification 0‑L V09XX04 [59Fe]Eisen(III)-citrat WHO Anatomical Therapeutic Chemical classification 0‑L V10 Radiotherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L V10A Entzündungshemmende Mittel WHO Anatomical Therapeutic Chemical classification 0‑L V10AA [90Y]Yttrium-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V10AA01 [90Y]Yttriumcitrat-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AA02 [90Y]Yttrium-Eisen(III)hydroxid-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AA03 [90Y]Yttriumsilicat-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AX Andere entzündungshemmende Radiotherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L V10AX01 [32P]Chrom(III)phosphat-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AX02 [153Sm]Samariumhydroxyapatit-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AX03 [165Dy]Dysprosium-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AX04 [169Er]Erbiumcitrat-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AX05 [186Re]Rheniumsulfid-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10AX06 [198Au]Gold-Kolloid WHO Anatomical Therapeutic Chemical classification 0‑L V10B Schmerzlinderung (Knochenmetastasen) WHO Anatomical Therapeutic Chemical classification 0‑L V10BX Verschiedene Radiopharmaka zur Schmerzlinderung WHO Anatomical Therapeutic Chemical classification 0‑L V10BX01 [89Sr]Strontiumchlorid WHO Anatomical Therapeutic Chemical classification 0‑L V10BX02 [153Sm]Samariumlexidronam WHO Anatomical Therapeutic Chemical classification 0‑L V10BX03 [186Re]Rheniumetidronat WHO Anatomical Therapeutic Chemical classification 0‑L V10X Andere Radiotherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L V10XA [131I]Iod-Verbindungen WHO Anatomical Therapeutic Chemical classification 0‑L V10XA01 [131I]Natriumiodid WHO Anatomical Therapeutic Chemical classification 0‑L V10XA02 [131I]Iobenguan WHO Anatomical Therapeutic Chemical classification 0‑L V10XA53 Tositumomab/[131I]Iod-Tositumomab WHO Anatomical Therapeutic Chemical classification 0‑L V10XX Verschiedene Radiotherapeutika WHO Anatomical Therapeutic Chemical classification 0‑L V10XX01 [32P]Natriumphosphat WHO Anatomical Therapeutic Chemical classification 0‑L V10XX02 [90Y] Ibritumomab tiuxetan WHO Anatomical Therapeutic Chemical classification 0‑L V20 Wundverbände WHO Anatomical Therapeutic Chemical classification Dieses Value Set beinhaltet 6063 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.